SL_ID,Area_ID,Pat_ID,Capture status,CL_ID,Input LP DNA for capture (ng),Input LP Volume,Post-hyb PCR cycles,Capture Panel,Old Barcode,New Barcode,Date of prep,Notes,Tissue Type,Assigned Projects,Sequencing Run_ID
12_M,2908 Unknown,,,,,NaN,13,Ampliconseq,L2DR11,,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",Tumor,2010-2017,Nimblegen29_BB34
21_5,2762 Normal,,Captured,BB5_CL,44.8,Infinity,,NimV1,L2DR05,,,"Ivanka_21_5_Norm, RIGHT MID UPPER BACK",Normal,2010-2017,Nimblegen2_BB5
21-1,2909 Mel,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR01,,,RIGHT MID UPPER BACK,Mel,2010-2017,Nimblegen2_BB5
21-2,2910 Mel,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR02,,,RIGHT MID UPPER BACK,Mel,2010-2017,Nimblegen2_BB5
21-3,2911 Nevus,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR03,,,RIGHT MID UPPER BACK,Nevus,2010-2017,Nimblegen2_BB5
21-4,2912 Nevus,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR04,,,RIGHT MID UPPER BACK,Nevus,2010-2017,Nimblegen2_BB5
22_IS,2913 Tumor,,Captured,,,NaN,13,NimV2,L2DR09,,,Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13),Tumor,2010-2017,Nimblegen36_BB43
22_Melanoma,2914 Mel,,Captured,,,NaN,13,NimV2,L2DR11,,,Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13),Mel,2010-2017,Nimblegen36_BB43
22_Nevus,2915 Nevus,,Captured,,,NaN,13,NimV2,L2DR10,,,Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13),Nevus,2010-2017,Nimblegen36_BB43
22_Normal,2916 Normal,,Captured,,,NaN,13,NimV2,L2DR12,,,Ivanka Patient Melanoma (Hunter Extraction Rcvd 8-13-13),Normal,2010-2017,Nimblegen36_BB43
24_5_Norm,2763 Normal,,Captured,BB5_CL,33.0,Infinity,,NimV1,L2DR10,,,"Ivanka_24_5_Norm, RIGHT GLUTEUS",Normal,2010-2017,Nimblegen2_BB5
24-3,2921 Nevus,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR08,,,RIGHT GLUTEUS,Nevus,2010-2017,Nimblegen2_BB5
24-4,2922 Nevus,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR09,,,RIGHT GLUTEUS,Nevus,2010-2017,Nimblegen2_BB5
26,2764 Tumor,,,,,NaN,,,,,,,,2010-2017,
28_1,2923 Mel,,Captured,BB5_CL,33.9,Infinity,,NimV1,L2DR11,,,LEFT POPLITEAL FOSSA,Mel,2010-2017,Nimblegen2_BB5
28_2,2924 Mel,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR12,,,LEFT POPLITEAL FOSSA,Mel,2010-2017,Nimblegen2_BB5
28_3,2925 Nevus,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR13,,,LEFT POPLITEAL FOSSA,Nevus,2010-2017,Nimblegen2_BB5
28_4,2926 Nevus,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR14,,,LEFT POPLITEAL FOSSA,Nevus,2010-2017,Nimblegen2_BB5
28_5,2927 Normal,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR15,,,LEFT POPLITEAL FOSSA,Normal,2010-2017,Nimblegen2_BB5
35_M,2928 Tumor,,,,,NaN,13,Ampliconseq,L2DR12,,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",Tumor,2010-2017,Nimblegen29_BB34
49_M,2929 Tumor,,,,,NaN,13,Ampliconseq,L2DR13,,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",Tumor,2010-2017,Nimblegen29_BB34
892_Mel,892 Mel,ME-29,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8I; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
893_Nevus,893 Nevus,ME-29,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MQT6A; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB041
894_Normal,894 Normal,ME-29,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ5L; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
1205lu-1_Unknown,3873 Unknown,,Captured,,,NaN,,,,,,cell line: 1205Lu (RRID:CVCL_5239),,Cell Line,Acral melanoma lines_mRNA_Seq_AL1806051_R1
1205lu-2_Unknown,3874 Unknown,,Captured,,,NaN,,,,,,cell line: 1205Lu (RRID:CVCL_5239),,Cell Line,Acral melanoma lines_mRNA_Seq_AL1806051_R1
1205LU-3_Unknown,3875 Unknown,,Captured,,,NaN,,,,,,cell line: 1205Lu (RRID:CVCL_5239),,Cell Line,Acral melanoma lines_mRNA_Seq_AL1806051_R1
1641_Mel,1641 Mel,CCR-008,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8C; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
1917_Mel,1917 Mel,CCR-011,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7Q; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
1918_MIS,1918 MIS,CCR-011,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7S; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB041
1919_Nevus,1919 Nevus,CCR-011,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7T; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB041
1921_Mel,1921 Mel,CCR-021,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7V; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
1922_Nevus,1922 Nevus,CCR-021,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ87; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB041
1926_Mel,1926 Mel,CCR-142,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7W; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
1927_MIS,1927 MIS,CCR-142,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7X; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB041
1928_Nevus,1928 Nevus,CCR-142,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7Y; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB041
1930_Normal,1930 Normal,CCR-141,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ89; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
1931_Mel,1931 Mel,CCR-141,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8G; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
1932_MIS,1932 MIS,CCR-141,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ85; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB041
1933_Nevus,1933 Nevus,CCR-141,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8A; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB041
1944_Mel,1944 Mel,CCR-302,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8E; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
1945_Nevus,1945 Nevus,CCR-302,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ83; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB041
1946_Normal,1946 Normal,CCR-302,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ84; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
1947_Melanocytoma,1947 Melanocytoma,CCR-008,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ81; GATK4-Mutect2/CNV pipeline,Others,Broad Institute,BCB041
1948_Nevus,1948 Nevus,CCR-008,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ82; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB041
1949_1956_Normal,1949 Normal 1956 Normal,CCR-008,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8B; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
1951_Mel,1951 Mel,ME-37,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8D; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
1952_Nevus,1952 Nevus,ME-37,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ86; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB041
1953_Normal,1953 Normal,ME-37,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8H; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
1954_MIS,1954 MIS,CCR-302,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ8F; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB041
1955_Normal,1955 Normal,CCR-021,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ88; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
1958_Normal,1958 Normal,CCR-142,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7Z; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
2036_Normal,2036 Normal,CCR-011,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ7U; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
2038_Mel,2038 Mel,NM-84,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ5K; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
2039_Mel,2039 Mel,NM-84,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ5J; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
2040_Mel,2040 Mel,NM-84,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ5I; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB041
2041_Normal,2041 Normal,NM-84,Captured,BI-112022,,NaN,,Somatic Human WES v6,,,11/15/2022,SM-MRJ5H; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB041
2043_Mel,2043 Mel,NM-85,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2044_Mel,2044 Mel,NM-85,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2045_Mel,2045 Mel,NM-85,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2046_Normal,2046 Normal,NM-85,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2047_Mel,2047 Mel,NM-86,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2048_Mel,2048 Mel,NM-86,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2049_Mel,2049 Mel,NM-86,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2050_Normal,2050 Normal,NM-86,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2051_Mel,2051 Mel,NM-87,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2052_Mel,2052 Mel,NM-87,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2053_Mel,2053 Mel,NM-87,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2054_Normal,2054 Normal,NM-87,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2180_Mel1,2180 Mel1,ME-47,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSC; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2181_Mel2,2181 Mel2,ME-47,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSD; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2182_Nevus,2182 Nevus,ME-47,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSE; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2183_Normal,2183 Normal,ME-47,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSF; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2184_Mel,2184 Mel,ME-48,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSG; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2185_Nevus,2185 Nevus,ME-48,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSH; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2186_Normal,2186 Normal,ME-48,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MTN3L; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2187_Mel,2187 Mel,ME-49,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MTHZS; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2188_Nevus,2188 Nevus,ME-49,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTUV; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2189_Normal,2189 Normal,ME-49,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSL; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2190_Mel,2190 Mel,ME-50,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSM; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2191_Nevus,2191 Nevus,ME-50,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSN; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2192_Normal,2192 Normal,ME-50,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSO; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2196_Mel,2196 Mel,ME-52,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSS; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2197_MIS,2197 MIS,ME-52,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTST; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB042
2198_Nevus,2198 Nevus,ME-52,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSU; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2199_Normal,2199 Normal,ME-52,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MTLID; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2200_Mel,2200 Mel,ME-53,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTUU; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2201_MIS,2201 MIS,ME-53,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSX; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB042
2202_Nevus,2202 Nevus,ME-53,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSY; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2203_Normal,2203 Normal,ME-53,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSZ; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2204_Mel,2204 Mel,ME-54,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTT1; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2205_Nevus,2205 Nevus,ME-54,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTT2; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2207_MIS,2207 MIS,ME-55,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTT4; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB042
2208_Nevus,2208 Nevus,ME-55,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTT5; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2209_PRAME-positive_Nevus,2209 PRAME-positive_Nevus,ME-55,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTT6; GATK4-Mutect2/CNV pipeline,Others,Broad Institute,BCB042
2210_Normal,2210 Normal,ME-55,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTT7; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2211_Mel,2211 Mel,ME-56,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MTKPX; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2212_MIS,2212 MIS,ME-56,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTUT; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB042
2213_Nevus,2213 Nevus,ME-56,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTA; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2214_Normal,2214 Normal,ME-56,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTB; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2215_Mel,2215 Mel,ME-57,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTC; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2216_Nevus,2216 Nevus,ME-57,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTE; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2217_Regressed-Area,2217 Regressed-Area,ME-57,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTF; GATK4-Mutect2/CNV pipeline,Others,Broad Institute,BCB042
2218_Normal,2218 Normal,ME-57,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTG; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2219_Mel,2219 Mel,ME-58,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTH; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2220_MIS,2220 MIS,ME-58,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTI; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB042
2221_Nevus,2221 Nevus,ME-58,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTJ; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2222_Normal,2222 Normal,ME-58,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MTL7E; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2223_Mel1,2223 Mel1,ME-59,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MTMX4; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2224_Mel2,2224 Mel2,ME-59,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTM; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2225_Nevus,2225 Nevus,ME-59,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTN; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2227_Mel,2227 Mel,ME-60,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTP; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2228_Nevus,2228 Nevus,ME-60,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTQ; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2229_Normal,2229 Normal,ME-60,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTR; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2230_Mel,2230 Mel,ME-61,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTS; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2231_MIS,2231 MIS,ME-61,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTT; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB042
2232_Nevus,2232 Nevus,ME-61,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTU; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2233_Normal,2233 Normal,ME-61,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTV; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2234_Mel,2234 Mel,ME-62,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MVZGV; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2235_Nevus,2235 Nevus,ME-62,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MW1V9; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2236_Normal,2236 Normal,ME-62,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MW3G4; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2237_MIS,2237 MIS,ME-57,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTD; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB042
2238_Mel,2238 Mel,ME-51,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSP; GATK4-Mutect2/CNV pipeline,Mel,Broad Institute,BCB042
2239_Nevus,2239 Nevus,ME-51,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSQ; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2240_Normal,2240 Normal,ME-51,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSR; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2241_Normal,2241 Normal,ME-54,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTT3; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2242_Normal,2242 Normal,ME-59,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTTO; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2243_MIS,2243 MIS,ME-15,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTS9; GATK4-Mutect2/CNV pipeline,MIS,Broad Institute,BCB042
2244_Nevus,2244 Nevus,ME-15,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSA; GATK4-Mutect2/CNV pipeline,Nevus,Broad Institute,BCB042
2245_Normal,2245 Normal,ME-15,Captured,BI-032023,,NaN,,Somatic Human WES v6,,,4/6/2023,SM-MQTSB; GATK4-Mutect2/CNV pipeline,Normal,Broad Institute,BCB042
2268_Met1-2269_Met2,"2268 Met1, 2269 Met2",NM-84,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Met,Broad Institute,BCB060
2270_Normal,2270 Normal,NM-84,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2287_Mel,2287 Mel,ME-63,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2288_Melanocytoma,2288 Melanocytoma,ME-63,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2289_Normal,2289 Normal,ME-63,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2290_Mel,2290 Mel,ME-64,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2291_Nevus,2291 Nevus,ME-64,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Nevus,Broad Institute,BCB060
2292_Mel,2292 Mel,ME-64,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2293_Normal,2293 Normal,ME-64,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2294_Mel,2294 Mel,ME-65,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2295_MIS,2295 MIS,ME-65,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,MIS,Broad Institute,BCB060
2296_Nevus,2296 Nevus,ME-65,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Nevus,Broad Institute,BCB060
2297_Mel,2297 Mel,ME-65,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2298_Normal,2298 Normal,ME-65,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2299_Mel,2299 Mel,ME-66,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2300_Nevus,2300 Nevus,ME-66,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Nevus,Broad Institute,BCB060
2301_Normal,2301 Normal,ME-66,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2443_Mel,2443 Mel,ME-67,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2444_MIS,2444 MIS,ME-67,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,MIS,Broad Institute,BCB060
2445_Nevus,2445 Nevus,ME-67,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Nevus,Broad Institute,BCB060
2446_Normal,2446 Normal,ME-67,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2447_Mel,2447 Mel,ME-68,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Mel,Broad Institute,BCB060
2448_Nevus,2448 Nevus,ME-68,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Nevus,Broad Institute,BCB060
2449_Normal,2449 Normal,ME-68,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2450_Normal,2450 Normal,LMM-06,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2451_MIS,2451 MIS,LMM-06,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,MIS,Broad Institute,BCB060
2452_Invasive,2452 Invasive,LMM-06,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2456_Tumor,2456 Tumor,CS-01,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Tumor,Broad Institute,BCB060
2457_Tumor,2457 Tumor,CS-01,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Tumor,Broad Institute,BCB060
2459_MIS,2459 MIS,ME-69,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,MIS,Broad Institute,BCB060
2460_Nevus,2460 Nevus,ME-69,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Nevus,Broad Institute,BCB060
2461_Normal,2461 Normal,ME-69,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2463_Melanoma-Cell-Line,2463 Melanoma Cell Line,,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2465_Cell-Line,2465 Cell Line,,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2466_Cell-Line,2466 Cell Line,,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2467_Melanoma-Cell-Line,2467 Melanoma Cell Line,,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2468_Melanoma-Cell-Line,2468 Melanoma Cell Line,,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2494_Invasive,2494 Invasive,LMM-02,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2495_MIS,2495 MIS,LMM-02,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,MIS,Broad Institute,BCB060
2496_Normal,2496 Normal,LMM-02,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2497_Invasive,2497 Invasive,LMM-03,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2498_MIS,2498 MIS,LMM-03,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,MIS,Broad Institute,BCB060
2499_Normal_flag,2499 Normal,LMM-04,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2500_Invasive,2500 Invasive,LMM-04,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2501_MIS,2501 MIS,LMM-04,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,MIS,Broad Institute,BCB060
2502_Normal,2502 Normal,LMM-03,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
2503_Invasive,2503 Invasive,LMM-05,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Others,Broad Institute,BCB060
2504_MIS,2504 MIS,LMM-05,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,MIS,Broad Institute,BCB060
2505_Normal,2505 Normal,LMM-05,Captured,BI-082023,,NaN,,Somatic Human WES v6,,,,,Normal,Broad Institute,BCB060
AF13_212,2934 Tumor,,,,,NaN,13,NimV2,L2DR13,,, A. Fouchardiere Project,Tumor,2010-2017,Nimblegen34_BB40
AGLP-01,12 Normal,AM2-001,Captured,AGEX-01,150.0,0.90,,SureSelect XT2 Human All Exon V7,AGXTHS-01,,4/26/2018,SureSelect Library Prep,Normal,Acral Melanoma,Acral_Mel_Exome-01
AGLP-02,14 Mel1,AM2-001,Captured,AGEX-01,150.0,0.65,,SureSelect XT2 Human All Exon V7,AGXTHS-02,,4/26/2018,SureSelect Library Prep,Mel,Acral Melanoma,Acral_Mel_Exome-01
AGLP-03,15 Normal,AM2-002,,,,0.00,,,,,4/26/2018,SureSelect Library Prep,Normal,Acral Melanoma,
AGLP-04,17 Mel1,AM2-002,,,,NaN,,,,,4/26/2018,SureSelect Library Prep,Mel,Acral Melanoma,
Algazi_Tumor,2935 Tumor,,,BB33_CL,,NaN,13,NimV2,L2DR06,,,Alain Algazi,Tumor,2010-2017,Nimblegen28_BB33
ALK_Cntl,2936 Normal,,Captured,BB10_CL,,NaN,,NimV1,L2DR12,,,Tissue Core ALK | Barcode mismatch comment in note,Tumor,2010-2017,Nimblegen7_BB10
AM_7_Tumor,2775 Tumor,,Captured,,,NaN,13,NimV2,L2DR03,,,Iwei Acral Melanoma,Tumor,Acral Melanoma,Nimblegen37_BB44
AM_9_Tumor,2776 Tumor,,Captured,,,NaN,13,NimV2,L2DR04,,,Iwei Acral Melanoma,Tumor,Acral Melanoma,Nimblegen37_BB44
AM_11_Tumor,2772 Tumor,,Captured,,,NaN,13,NimV2,L2DR05,,,Iwei Acral Melanoma,Tumor,Acral Melanoma,Nimblegen37_BB44
AM_13_Tumor,2773 Tumor,,Captured,,,NaN,13,NimV2,L2DR06,,,Iwei Acral Melanoma,Tumor,Acral Melanoma,Nimblegen37_BB44
AM_14_Tumor,2774 Tumor,,Captured,,,NaN,13,NimV2,L2DR07,,,Iwei Acral Melanoma,Tumor,Acral Melanoma,Nimblegen37_BB44
AM-15-Tumor,2697 Tumor,,Captured,BB89_CL,55.6,9.97,,NimV3,A7,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-16-Tumor,2698 Tumor,,Captured,BB89_CL,55.6,1.54,,NimV3,A8,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-17-Tumor,2699 Tumor,,Captured,BB89_CL,55.6,3.07,,NimV3,A9,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-18-Tumor,2700 Tumor,,Captured,BB89_CL,55.6,43.06,,NimV3,A10,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-19-Tumor,2701 Tumor,,Captured,BB89_CL,55.6,3.49,,NimV3,A11,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-20-Tumor,2702 Tumor,,Captured,BB89_CL,55.6,7.69,,NimV3,A12,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-21-Tumor,2703 Tumor,,Captured,BB89_CL,55.6,14.28,,NimV3,B1,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-22-Tumor,2704 Tumor,,Captured,BB89_CL,55.6,5.35,,NimV3,B2,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-23-Tumor,2705 Tumor,,Captured,BB89_CL,55.6,6.17,,NimV3,B3,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-24-Tumor,2706 Tumor,,Captured,BB89_CL,55.6,6.57,,NimV3,B4,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-25-Tumor,2707 Tumor,,Captured,BB89_CL,55.6,4.27,,NimV3,B5,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-26-Tumor,2708 Tumor,,Captured,BB89_CL,55.6,4.29,,NimV3,B6,,,,Tumor,Acral Melanoma,Kapa16_BB89
AM-27-Tumor,2709 Tumor,,Captured,BB90_CL,55.6,1.42,,NimV3,B7,,,,Tumor,Acral Melanoma,Kapa17_BB90
AM-28-Tumor,2710 Tumor,,Captured,BB90_CL,55.6,16.48,,NimV3,B8,,,,Tumor,Acral Melanoma,Kapa17_BB90
AM-29-Tumor,2711 Tumor,,Captured,BB90_CL,55.6,4.95,,NimV3,B9,,,,Tumor,Acral Melanoma,Kapa17_BB90
AM-30-Tumor,2712 Tumor,,Captured,BB90_CL,55.6,3.34,,NimV3,B10,,,,Tumor,Acral Melanoma,Kapa17_BB90
AM-31-Tumor,2713 Tumor,,Captured,BB90_CL,55.6,9.08,,NimV3,B11,,,,Tumor,Acral Melanoma,Kapa17_BB90
AM-32-Tumor,2714 Tumor,,Captured,BB90_CL,55.6,5.29,,NimV3,B12,,,,Tumor,Acral Melanoma,Kapa17_BB90
AMLP-01,12 Normal,AM2-001,Captured,AGEX-01,100.0,47.62,,SureSelect XT2 Human All Exon V7,G1,,5/8/2018,,Normal,Acral Melanoma,AGEX-01
AMLP-02,14 Mel1,AM2-001,Captured,AGEX-01,100.0,33.33,,SureSelect XT2 Human All Exon V7,G2,,5/8/2018,,Mel,Acral Melanoma,AGEX-01
AMLP-03,15 Normal,AM2-002,Captured,AGEX-02,100.8,16.00,,SureSelect XT2 Human All Exon V7,G3,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-04,17 Mel1,AM2-002,Captured,AGEX-02,83.1,63.92,,SureSelect XT2 Human All Exon V7,G4,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-05,22 Normal,AM2-006,Captured,AGEX-02,100.8,59.29,,SureSelect XT2 Human All Exon V7,G5,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-06,23 Mel1,AM2-006,Captured,AGEX-02,201.6,100.80,,SureSelect XT2 Human All Exon V7,G6,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-07,25 Normal,AM2-007,Captured,AGEX-02,100.8,30.55,,SureSelect XT2 Human All Exon V7,G7,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-08,27 Mel1,AM2-007,Captured,AGEX-02,201.6,46.88,,SureSelect XT2 Human All Exon V7,G8,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-09,28 Normal,AM2-008,Captured,AGEX-02,41.0,51.25,,SureSelect XT2 Human All Exon V7,G9,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-10,30 Mel1,AM2-008,Captured,AGEX-02,180.1,94.79,,SureSelect XT2 Human All Exon V7,G10,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-11,35 Normal,AM2-014,Captured,AGEX-02,100.8,77.54,,SureSelect XT2 Human All Exon V7,G11,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-12,37 Mel1,AM2-014,Captured,AGEX-02,84.0,84.00,,SureSelect XT2 Human All Exon V7,G12,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-13,38 Normal,AM2-018,Captured,AGEX-02,100.8,50.40,,SureSelect XT2 Human All Exon V7,H1,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-14,41 Mel1,AM2-018,Captured,AGEX-02,84.0,49.41,,SureSelect XT2 Human All Exon V7,H2,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-15,42 Normal,AM2-019,Captured,AGEX-02,42.0,14.00,,SureSelect XT2 Human All Exon V7,H3,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-16,45 Mel1,AM2-019,Captured,AGEX-02,201.6,87.65,,SureSelect XT2 Human All Exon V7,H4,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-17,46 Normal,AM2-022,Captured,AGEX-02,42.0,38.18,,SureSelect XT2 Human All Exon V7,H5,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-18,48 Mel1,AM2-022,Captured,AGEX-02,79.3,396.50,,SureSelect XT2 Human All Exon V7,H6,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-19_1,78 Normal,AM2-049,Captured,AGEX-08,30.0,27.27,9,SureSelect XT2 Human All Exon V7,H7,,5/8/2018,,Normal,Acral Melanoma,BCB018
AMLP-19_2,78 Normal,AM2-049,Captured,AGEX-08,30.0,33.33,9,SureSelect XT2 Human All Exon V7,B4,,7/23/2018,,Normal,Acral Melanoma,BCB018
AMLP-20_1,81 Mel1,AM2-049,Pending,,,0.00,,,H8,,5/8/2018,,Mel,Acral Melanoma,
AMLP-20_2,81 Mel1,AM2-049,Pending,,,0.00,,,A5,,7/23/2018,,Mel,Acral Melanoma,
AMLP-21,82 Normal,AM2-050,Captured,AGEX-02,94.9,49.95,,SureSelect XT2 Human All Exon V7,H9,,5/8/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-22_1,84 Mel,AM2-050,Captured,AGEX-02,82.5,63.46,,SureSelect XT2 Human All Exon V7,H10,,5/8/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-22_2,84 Mel,AM2-050,Captured,AGEX-02,,0.00,,SureSelect XT2 Human All Exon V7,A6,,7/23/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-23_1,85 Normal,AM2-051,Pending,,,0.00,,,H11,,5/8/2018,,Normal,Acral Melanoma,
AMLP-23_2,85 Normal,AM2-051,Pending,,,0.00,,,A7,,7/23/2018,,Normal,Acral Melanoma,
AMLP-24_1,88 Mel1,AM2-051,Pending,,,0.00,,,H12,,5/8/2018,,Mel,Acral Melanoma,
AMLP-24_2,88 Mel1,AM2-051,Pending,,,0.00,,,A8,,7/23/2018,,Mel,Acral Melanoma,
AMLP-25,89 Normal,AM2-053,Pending,,,0.00,,,A1,,5/8/2018,,Normal,Acral Melanoma,
AMLP-26,91 Mel1,AM2-053,Library failed/low yield,,,0.00,,,A2,,5/8/2018,,Mel,Acral Melanoma,
AMLP-27,92 Normal,AM2-055,Pending,,,0.00,,,A3,,5/8/2018,,Normal,Acral Melanoma,
AMLP-28,95 Mel1,AM2-055,Pending,,,0.00,,,A4,,5/7/2018,,Mel,Acral Melanoma,
AMLP-29,13 MIS1,AM2-001,Captured,AGEX-13,131.0,50.38,9,SureSelect XT2 Human All Exon V7,H7,,,,MIS,Acral Melanoma,BCB028
AMLP-30,16 MIS1,AM2-002,Captured,AGEX-06,100.0,10.75,9,SureSelect XT2 Human All Exon V7,H8,,,,MIS,Acral Melanoma,BCB007
AMLP-31,20 Normal,AM2-004,Pending,,,0.00,,,H9,,6/21/2018,,Normal,Acral Melanoma,
AMLP-32,18 MIS1,AM2-004,Pending,,,0.00,,,H10,,6/21/2018,,MIS,Acral Melanoma,
AMLP-33,19 MIS2,AM2-004,Pending,,,0.00,,,H11,,6/21/2018,,MIS,Acral Melanoma,
AMLP-34,21 Mel1,AM2-004,Pending,,,0.00,,,H12,,6/21/2018,,Mel,Acral Melanoma,
AMLP-35,26 MIS1,AM2-007,Pending,,,0.00,,,A9,,6/21/2018,,MIS,Acral Melanoma,
AMLP-36,29 MIS1,AM2-008,Pending,,,0.00,,,A10,,6/21/2018,,MIS,Acral Melanoma,
AMLP-37,32 MIS,AM2-012,Pending,,,0.00,,,A11,,6/21/2018,,MIS,Acral Melanoma,
AMLP-38,33 MIS,AM2-012,Pending,,,0.00,,,A12,,6/21/2018,,MIS,Acral Melanoma,
AMLP-39,34 Mel1,AM2-012,Pending,,,0.00,,,B1,,6/21/2018,,Mel,Acral Melanoma,
AMLP-40,36 MIS1,AM2-014,Pending,,,0.00,,,B2,,6/21/2018,,MIS,Acral Melanoma,
AMLP-41,24 MIS1,AM2-006,Captured,AGEX-06,100.0,31.25,9,SureSelect XT2 Human All Exon V7,B3,,,,MIS,Acral Melanoma,BCB007
AMLP-42,96 Mel2,AM2-055,Library failed/low yield,,,0.00,,,B5,,7/23/2018,,Mel,Acral Melanoma,
AMLP-43,97 Normal,AM2-061,Pending,,,0.00,,,B6,,7/23/2018,,Normal,Acral Melanoma,
AMLP-44,98 Normal2,AM2-061,Captured,AGEX-03,42.0,42.86,,SureSelect XT2 Human All Exon V7,B7,,7/23/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-45,99 MIS1,AM2-061,Captured,AGEX-06,100.0,46.08,9,SureSelect XT2 Human All Exon V7,B8,,7/23/2018,,MIS,Acral Melanoma,BCB007
AMLP-46,100 Mel1,AM2-061,Captured,AGEX-03,84.0,45.41,,SureSelect XT2 Human All Exon V7,B9,,7/23/2018,,Mel,Acral Melanoma,AGEX-02
AMLP-47,101 Met1,AM2-061,Captured,"AGEX-06,SGPC-20",50.0,29.41,9,,B10,,7/23/2018,"SGPC-20: 12 Cycles post Hyb, 35ng captured",Met,Acral Melanoma,"BCB007,BCB036"
AMLP-48,102 Met2,AM2-061,Captured,AGEX-08,106.6,50.05,9,SureSelect XT2 Human All Exon V7,B11,,7/23/2018,,Met,Acral Melanoma,BCB018
AMLP-49,103 Normal,AM2-062,Captured,AGEX-03,39.7,49.63,,SureSelect XT2 Human All Exon V7,B12,,7/23/2018,,Normal,Acral Melanoma,AGEX-02
AMLP-50,104 MIS1,AM2-062,Captured,"AGEX-06,SGPC-20",100.0,23.26,9,,C1,,7/23/2018,"SGPC-20: 12 Cycles post Hyb, 50ng captured",MIS,Acral Melanoma,"BCB007,BCB036"
AMLP-51,105 MIS2,AM2-062,Captured,AGEX-08,154.4,49.97,9,SureSelect XT2 Human All Exon V7,C2,,7/23/2018,,MIS,Acral Melanoma,BCB018
AMLP-52,106 Mel1,AM2-062,Captured,"AGEX-03,SGPC-20",84.0,36.84,,,C3,,7/23/2018,"SGPC-20: 12 Cycles post Hyb, 30ng captured",Mel,Acral Melanoma,"AGEX-02,BCB036"
AMLP-53,107 Mel2,AM2-062,Captured,AGEX-08,95.6,50.05,9,SureSelect XT2 Human All Exon V7,C4,,7/23/2018,,Mel,Acral Melanoma,BCB018
AMLP-54,108 Met1,AM2-062,Captured,"AGEX-06,SGPC-20",50.0,13.59,9,,C5,,7/23/2018,"SGPC-20: 12 Cycles post Hyb, 50ng captured",Met,Acral Melanoma,"BCB007,BCB036"
AMLP-55,109 Met2,AM2-062,Captured,AGEX-08,141.0,50.00,9,SureSelect XT2 Human All Exon V7,C6,,7/23/2018,,Met,Acral Melanoma,BCB018
AMLP-56,2 Mel1,AM2-057,Library failed/low yield,,,0.00,,,C9,,,,Mel,Acral Melanoma,
AMLP-57,3 Met1,AM2-057,Library failed/low yield,,,0.00,,,C10,,,,Met,Acral Melanoma,
AMLP-58,4 Mel1,AM2-058,Captured,AGEX-10,150.0,34.88,9,SureSelect XT2 Human All Exon V7,C11,,,,Mel,Acral Melanoma,BCB019
AMLP-59,5 Met1,AM2-058,Pending,,,0.00,,,C12,,,,Met,Acral Melanoma,
AMLP-60,6 Normal,AM2-059,Library failed/low yield,,,0.00,,,D1,,,,Normal,Acral Melanoma,
AMLP-61,8 Met1,AM2-059,Captured,AGEX-10,150.0,37.50,9,SureSelect XT2 Human All Exon V7,D2,,,,Met,Acral Melanoma,BCB019
AMLP-62,9 Normal,AM2-060,Library failed/low yield,,,0.00,,,D3,,,,Normal,Acral Melanoma,
AMLP-63,10 Mel1,AM2-060,Library failed/low yield,,,0.00,,,D4,,,,Mel,Acral Melanoma,
AMLP-64,11 Met1,AM2-060,Captured,AGEX-10,85.5,50.29,9,SureSelect XT2 Human All Exon V7,F4,,,,Met,Acral Melanoma,BCB019
AMLP-65,359 Normal 1,AM2-063,Pending,,,0.00,,,,39,11/27/2018,,Normal,Acral Melanoma,
AMLP-66,360 Normal 2,AM2-063,Captured,AGEX-04,101.6,44.97,9,SureSelect XT2 Human All Exon V7,,40,11/27/2018,,Normal,Acral Melanoma,BCB007
AMLP-67,361 MIS1,AM2-063,Pending,,,0.00,,,,41,11/27/2018,,MIS,Acral Melanoma,
AMLP-68,362 MIS2,AM2-063,Captured,AGEX-11,54.5,50.00,9,SureSelect XT2 Human All Exon V7,,42,11/27/2018,,MIS,Acral Melanoma,BCB021
AMLP-69,363 Mel1,AM2-063,Captured,AGEX-04,203.3,89.93,9,SureSelect XT2 Human All Exon V7,,43,2/27/2019,repeated sequencing,Mel,Acral Melanoma,BCB007
AMLP-70,364 Normal 1,AM2-065,Pending,,,0.00,,,,44,11/27/2018,,Normal,Acral Melanoma,
AMLP-71,365 MIS1,AM2-065,Pending,,,0.00,,,,45,11/27/2018,,MIS,Acral Melanoma,
AMLP-72,366 MIS2,AM2-065,Pending,,,0.00,,,,46,11/27/2018,,MIS,Acral Melanoma,
AMLP-73,367 Mel1,AM2-065,Pending,,,0.00,,,,47,11/27/2018,,Mel,Acral Melanoma,
AMLP-74,368 Mel2,AM2-065,Pending,,,0.00,,,,48,11/27/2018,,Mel,Acral Melanoma,
AMLP-75,369 Normal1,AM2-066,Captured,AGEX-04,83.5,39.04,9,SureSelect XT2 Human All Exon V7,,49,11/27/2018,,Normal,Acral Melanoma,BCB007
AMLP-76-164,370 MIS1,AM2-066,Captured,AGEX-12,61.0,50.00,9,SureSelect XT2 Human All Exon V7,,50,11/27/2018,"Sequenced as: AMLP-76. 120s shear time; DNA repaired (AMLP-164 captured 10ng, AGEX-12). (AMLP-76 captured 61.0 ng in AGEX-12). Same adapter #50. AMLP-164: 1/31/2020",MIS,Acral Melanoma,BCB021
AMLP-77,371 Mel1,AM2-066,Captured,AGEX-04,167.1,81.11,9,SureSelect XT2 Human All Exon V7,,51,2/27/2019,repeated sequencing,Mel,Acral Melanoma,BCB007
AMLP-78,372 Normal1,AM2-067,Captured,AGEX-09,33.0,25.00,9,SureSelect XT2 Human All Exon V7,,52,11/27/2018,,Normal,Acral Melanoma,BCB019
AMLP-79,373 MIS1,AM2-067,Pending,,,0.00,,,,53,11/27/2018,,MIS,Acral Melanoma,
AMLP-80,374 MIS2,AM2-067,Captured,AGEX-12,22.5,50.00,9,SureSelect XT2 Human All Exon V7,,54,11/27/2018,,MIS,Acral Melanoma,BCB021
AMLP-82,376 Normal1,AM2-068,Captured,AGEX-09,46.0,50.00,9,SureSelect XT2 Human All Exon V7,,56,11/27/2018,,Normal,Acral Melanoma,BCB019
AMLP-83,377 MIS1,AM2-068,Captured,AGEX-11,76.0,50.00,9,SureSelect XT2 Human All Exon V7,,57,11/27/2018,,MIS,Acral Melanoma,BCB021
AMLP-84,378 Mel1,AM2-068,Captured,AGEX-08,130.0,56.52,9,SureSelect XT2 Human All Exon V7,,58,2/27/2019,,Mel,Acral Melanoma,BCB018
AMLP-85,379 LN Met 1,AM2-068,Captured,"AGEX-08,AGEX-10",181.0,49.86,9,SureSelect XT2 Human All Exon V7,,59,11/27/2018,,Met,Acral Melanoma,"BCB018,BCB019"
AMLP-86,380 Normal 1,AM2-069,Pending,,,0.00,,,,60,11/27/2018,,Normal,Acral Melanoma,
AMLP-87,381 Normal 2,AM2-069,Captured,AGEX-04,87.3,50.14,9,SureSelect XT2 Human All Exon V7,,61,11/27/2018,,Normal,Acral Melanoma,BCB007
AMLP-88,382 MIS1,AM2-069,Captured,AGEX-11,100.0,50.00,9,SureSelect XT2 Human All Exon V7,,62,11/27/2018,,MIS,Acral Melanoma,BCB021
AMLP-89,384 Mel1,AM2-069,Captured,"AGEX-04,SGPC-20",174.5,66.85,9,SureSelect XT2 Human All Exon V7,,63,2/27/2019,"repeated sequencing. SGPC-20: 12 Cycles post Hyb, 50ng captured",Mel,Acral Melanoma,"BCB007,BCB036"
AMLP-90,385 LN Met 1,AM2-069,Captured,AGEX-08,98.0,49.75,9,SureSelect XT2 Human All Exon V7,,64,11/27/2018,,Met,Acral Melanoma,BCB018
AMLP-91,383 MIS2,AM2-069,Captured,AGEX-12,40.0,50.00,9,SureSelect XT2 Human All Exon V7,,17,11/30/2018,,MIS,Acral Melanoma,BCB021
AMLP-92,386 MIS1,AM2-070,Captured,AGEX-12,67.0,50.00,9,SureSelect XT2 Human All Exon V7,,18,11/30/2018,,MIS,Acral Melanoma,BCB021
AMLP-93,387 MIS2,AM2-070,Captured,AGEX-11,127.0,49.80,9,SureSelect XT2 Human All Exon V7,,19,11/30/2018,,MIS,Acral Melanoma,BCB021
AMLP-94,388 MIS3,AM2-070,Pending,,,0.00,,,,20,11/30/2018,,MIS,Acral Melanoma,
AMLP-95,389 Mel1,AM2-070,Captured,AGEX-04,200.0,45.87,9,SureSelect XT2 Human All Exon V7,,21,11/30/2018,,Mel,Acral Melanoma,BCB007
AMLP-96,390 Normal 1,AM2-070,Captured,AGEX-04,100.0,15.08,9,SureSelect XT2 Human All Exon V7,,22,11/30/2018,,Normal,Acral Melanoma,BCB007
AMLP-97,391 Normal 1,AM2-071,Captured,AGEX-05,93.3,86.41,9,SureSelect XT2 Human All Exon V7,,23,11/30/2018,re-LP on 2/27/19; repeated sequencing,Normal,Acral Melanoma,BCB007
AMLP-98,392 MIS1,AM2-071,Pending,,,0.00,,,,24,11/30/2018,,MIS,Acral Melanoma,
AMLP-99,393 Mel1,AM2-071,Captured,AGEX-04,200.0,35.78,9,SureSelect XT2 Human All Exon V7,,25,11/30/2018,,Mel,Acral Melanoma,BCB007
AMLP-100,394 Normal 1,AM2-072,Pending,,,0.00,,,,26,11/30/2018,,Normal,Acral Melanoma,
AMLP-101,395 Normal 1,AM2-073,Pending,,,0.00,,,,27,11/30/2018,,Normal,Acral Melanoma,
AMLP-102,398 Normal 1,AM2-074,Captured,AGEX-05,100.0,21.51,9,SureSelect XT2 Human All Exon V7,,28,11/30/2018,,Normal,Acral Melanoma,BCB007
AMLP-103,399 MIS1,AM2-074,Captured,AGEX-12,25.5,50.00,9,SureSelect XT2 Human All Exon V7,,29,11/30/2018,,MIS,Acral Melanoma,BCB021
AMLP-104,401 Mel1,AM2-074,Captured,"AGEX-05,AGEX-10",208.4,74.96,9,SureSelect XT2 Human All Exon V7,,30,11/30/2018,re-LP on 2/27/19; repeated sequencing,Mel,Acral Melanoma,"BCB007,BCB019"
AMLP-105,402 Mel2,AM2-074,Captured,AGEX-10,41.0,50.00,9,SureSelect XT2 Human All Exon V7,,31,11/30/2018,,Mel,Acral Melanoma,BCB019
AMLP-106,403 Normal 1,AM2-075,Pending,,,0.00,,,,32,11/30/2018,,Normal,Acral Melanoma,
AMLP-107,404 Normal 1,AM2-076,Captured,AGEX-05,100.0,26.46,9,SureSelect XT2 Human All Exon V7,,33,11/30/2018,,Normal,Acral Melanoma,BCB007
AMLP-108,405 MIS1,AM2-076,Captured,AGEX-12,86.0,50.00,9,SureSelect XT2 Human All Exon V7,,34,11/30/2018,,MIS,Acral Melanoma,BCB021
AMLP-109,406 Mel1,AM2-076,Captured,AGEX-05,196.1,50.03,9,SureSelect XT2 Human All Exon V7,,35,11/30/2018,,Mel,Acral Melanoma,BCB007
AMLP-110,407 Normal 1,AM2-079,Captured,AGEX-05,100.0,17.54,9,SureSelect XT2 Human All Exon V7,,36,11/30/2018,re-LP on 2/27/19; repeated sequencing,Normal,Acral Melanoma,BCB007
AMLP-111,408 MIS1,AM2-079,Captured,AGEX-28,100.0,29.24,10,SureSelect XT Low Input Human All Exon V7,,37,11/30/2018,,MIS,Acral Melanoma,BCB031
AMLP-112,409 MIS2,AM2-079,Captured,AGEX-11,120.0,23.67,9,SureSelect XT2 Human All Exon V7,,38,11/30/2018,,MIS,Acral Melanoma,BCB021
AMLP-113,410 Mel1,AM2-079,Captured,AGEX-05,200.0,36.63,9,SureSelect XT2 Human All Exon V7,,91,11/30/2018,,Mel,Acral Melanoma,BCB007
AMLP-114,411 Normal 1,AM2-080,Captured,AGEX-05,91.9,16.12,9,SureSelect XT2 Human All Exon V7,,92,11/30/2018,,Normal,Acral Melanoma,BCB007
AMLP-115,412 MIS1,AM2-080,Pending,,,0.00,,,,93,12/7/2018,,MIS,Acral Melanoma,
AMLP-116,413 MIS2,AM2-080,Pending,,,0.00,,,,94,12/7/2018,,MIS,Acral Melanoma,
AMLP-117,414 Mel1,AM2-080,Captured,AGEX-05,183.8,171.75,9,SureSelect XT2 Human All Exon V7,,95,12/7/2018,repeated sequencing,Mel,Acral Melanoma,BCB007
AMLP-118,417 MIS2,AM2-081,Library failed/low yield,,,0.00,,,,96,12/7/2018,,MIS,Acral Melanoma,
AMLP-119,418 Mel1,AM2-081,Library failed/low yield,,,0.00,,,,1,12/7/2018,,Mel,Acral Melanoma,
AMLP-120,419 Normal 1,AM2-082,Pending,,,0.00,,,,2,12/7/2018,,Normal,Acral Melanoma,
AMLP-121,420 MIS1,AM2-082,Captured,AGEX-11,27.0,50.00,9,SureSelect XT2 Human All Exon V7,,3,12/7/2018,,MIS,Acral Melanoma,BCB021
AMLP-122,421 MIS2,AM2-082,Pending,,,0.00,,,,4,12/7/2018,,MIS,Acral Melanoma,
AMLP-123,422 Mel1,AM2-082,Captured,AGEX-10,33.0,49.25,9,SureSelect XT2 Human All Exon V7,,5,12/7/2018,,Mel,Acral Melanoma,BCB019
AMLP-124,423 Mel1,AM2-083,Pending,,,0.00,,,,6,12/7/2018,,Mel,Acral Melanoma,
AMLP-125,83 MIS1,AM2-050,Captured,AGEX-06,95.5,50.00,9,SureSelect XT2 Human All Exon V7,,71,6/4/2019,,MIS,Acral Melanoma,BCB007
AMLP-126,81 Mel1,AM2-049,Captured,AGEX-07,122.6,50.04,9,SureSelect XT2 Human All Exon V7,,40,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-127,1154 LN Met 1,AM2-049,Captured,AGEX-07,81.3,49.88,9,SureSelect XT2 Human All Exon V7,,41,12/3/2019,120s shear time; DNA repaired,Met,Acral Melanoma,BCB018
AMLP-128,1153 LN Met 2,AM2-049,Captured,AGEX-07,104.5,50.00,9,SureSelect XT2 Human All Exon V7,,48,12/3/2019,120s shear time; DNA repaired,Met,Acral Melanoma,BCB018
AMLP-129,83 MIS1,AM2-050,Captured,AGEX-08,88.7,50.11,9,SureSelect XT2 Human All Exon V7,,50,12/3/2019,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB018
AMLP-130,84 Mel,AM2-050,Captured,AGEX-07,86.4,49.94,9,SureSelect XT2 Human All Exon V7,,51,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-131,1152 Met1,AM2-050,Captured,AGEX-07,65.2,50.15,9,SureSelect XT2 Human All Exon V7,,52,12/3/2019,120s shear time; DNA repaired,Met,Acral Melanoma,BCB018
AMLP-132,100 Mel1,AM2-061,Captured,AGEX-07,70.0,16.36,9,SureSelect XT2 Human All Exon V7,,53,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-133,108 Met1,AM2-062,Captured,AGEX-07,70.0,23.57,9,SureSelect XT2 Human All Exon V7,,54,12/3/2019,120s shear time; DNA repaired,Met,Acral Melanoma,BCB018
AMLP-135,384 Mel1,AM2-069,Captured,AGEX-07,121.0,50.00,9,SureSelect XT2 Human All Exon V7,,56,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-136,389 Mel1,AM2-070,Captured,AGEX-08,80.0,25.48,9,SureSelect XT2 Human All Exon V7,,66,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-137,393 Mel1,AM2-071,Captured,AGEX-07,120.0,25.00,9,SureSelect XT2 Human All Exon V7,,67,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-138,404 Normal 1,AM2-076,Captured,AGEX-08,40.0,7.30,9,SureSelect XT2 Human All Exon V7,,70,12/3/2019,120s shear time; DNA repaired,Normal,Acral Melanoma,BCB018
AMLP-139,406 Mel1,AM2-076,Captured,AGEX-08,100.0,17.18,9,SureSelect XT2 Human All Exon V7,,73,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-140,410 Mel1,AM2-079,Captured,AGEX-07,120.0,29.85,9,SureSelect XT2 Human All Exon V7,,74,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-141,407 Normal 1,AM2-079,Captured,SGPC-08,50.0,23.81,9,SureSelect XT2 Human All Exon V7,,75,12/3/2019,120s shear time; DNA repaired,Normal,Acral Melanoma,BCB018
AMLP-142,414 Mel1,AM2-080,Captured,AGEX-07,70.0,19.89,9,SureSelect XT2 Human All Exon V7,,76,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-143,411 Normal 1,AM2-080,Captured,AGEX-08,60.0,31.58,9,SureSelect XT2 Human All Exon V7,,77,12/3/2019,120s shear time; DNA repaired,Normal,Acral Melanoma,BCB018
AMLP-144,51 Mel1,AM2-027,Pending,,,0.00,,,,78,12/3/2019,"120s shear time; DNA repaired, combined with AM2 D-176 (area 1145 Mel1)",Mel,Acral Melanoma,
AMLP-145,76 Mel1,AM2-048,Captured,"AGEX-08,SGPC-20",90.5,50.00,9,SureSelect XT2 Human All Exon V7,,79,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-146,77 Mel2,AM2-048,Captured,AGEX-08,130.0,35.52,9,SureSelect XT2 Human All Exon V7,,80,12/3/2019,"120s shear time; DNA repaired. SGPC-20: 12 Cycles post Hyb, 43ng captured",Mel,Acral Melanoma,"BCB018,BCB036"
AMLP-147,1148 LN Met 1,AM2-048,Captured,AGEX-07,124.3,49.92,9,SureSelect XT2 Human All Exon V7,,81,12/3/2019,120s shear time; DNA repaired,Met,Acral Melanoma,BCB018
AMLP-148,31 Normal,AM2-012,Captured,AGEX-08,60.0,15.83,9,SureSelect XT2 Human All Exon V7,,82,12/3/2019,120s shear time; DNA repaired,Normal,Acral Melanoma,BCB018
AMLP-149,34 Mel1,AM2-012,Captured,AGEX-07,117.0,50.00,9,SureSelect XT2 Human All Exon V7,,83,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-150,37 Mel1,AM2-014,Captured,AGEX-07,81.3,49.88,9,SureSelect XT2 Human All Exon V7,,84,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-151,45 Mel1,AM2-019,Captured,AGEX-07,200.0,40.90,9,SureSelect XT2 Human All Exon V7,,85,12/3/2019,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB018
AMLP-152,79 MIS1,AM2-049,Captured,"AGEX-12,SGPC-24",90.0,25.94,9,SureSelect XT2 Human All Exon V7,,7,1/31/2020,"120s shear time; DNA repaired. SGPC-24: 12 Cycles post Hyb, 60ng captured",MIS,Acral Melanoma,"BCB021,BCB040"
AMLP-153,80 MIS2,AM2-049,Captured,AGEX-11,115.0,50.00,9,SureSelect XT2 Human All Exon V7,,11,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB021
AMLP-154,81 Mel1,AM2-049,Pending,,,0.00,,,,14,1/31/2020,120s shear time; DNA repaired,Mel,Acral Melanoma,
AMLP-155,1154 LN Met 1,AM2-049,Pending,,,0.00,,,,15,1/31/2020,120s shear time; DNA repaired,Met,Acral Melanoma,
AMLP-156,1153 LN Met 2,AM2-049,Captured,AGEX-09,87.5,50.00,9,SureSelect XT2 Human All Exon V7,,16,1/31/2020,120s shear time; DNA repaired,Met,Acral Melanoma,BCB019
AMLP-157,1152 Met1,AM2-050,Pending,,,0.00,,,,21,1/31/2020,120s shear time; DNA repaired,Met,Acral Melanoma,
AMLP-158,106 Mel1,AM2-062,Pending,,,0.00,,,,22,1/31/2020,120s shear time; DNA repaired,Mel,Acral Melanoma,
AMLP-159,1237 LN Met 3,AM2-062,Pending,,,0.00,,,,23,1/31/2020,120s shear time; DNA repaired,Met,Acral Melanoma,
AMLP-160,1236 LN Met 4,AM2-062,Captured,AGEX-09,110.5,50.00,9,SureSelect XT2 Human All Exon V7,,24,1/31/2020,120s shear time; DNA repaired,Met,Acral Melanoma,BCB019
AMLP-161,361 MIS1,AM2-063,Captured,AGEX-28,100.0,44.25,10,SureSelect XT Low Input Human All Exon V7,,25,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB031
AMLP-162,362 MIS2,AM2-063,Captured,AGEX-11,57.0,50.00,9,SureSelect XT2 Human All Exon V7,,26,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB021
AMLP-163,363 Mel1,AM2-063,Captured,AGEX-09,93.5,50.00,9,SureSelect XT2 Human All Exon V7,,27,1/31/2020,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB019
AMLP-165,1240 MIS2,AM2-066,Captured,AGEX-12,88.5,50.00,9,SureSelect XT2 Human All Exon V7,,73,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB021
AMLP-166,1239 MIS3,AM2-066,Captured,SGPC-20,26.0,50.00,12,Small Gene Panel,,75,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB036
AMLP-167,1238 MIS4,AM2-066,Captured,SGPC-20,14.5,50.00,12,Small Gene Panel,,78,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB036
AMLP-168,371 Mel1,AM2-066,Captured,AGEX-09,58.0,50.00,9,SureSelect XT2 Human All Exon V7,,79,1/31/2020,120s shear time; DNA repaired,Mel,Acral Melanoma,BCB019
AMLP-169,372 Normal1,AM2-067,Captured,AGEX-09,88.0,50.00,9,SureSelect XT2 Human All Exon V7,,80,1/31/2020,120s shear time; DNA repaired,Normal,Acral Melanoma,BCB019
AMLP-170,373 MIS1,AM2-067,Captured,AGEX-11,173.0,72.69,9,SureSelect XT2 Human All Exon V7,,81,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB021
AMLP-171,374 MIS2,AM2-067,Captured,AGEX-12,40.5,50.00,9,SureSelect XT2 Human All Exon V7,,86,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB021
AMLP-172-81,375 Mel1,AM2-067,Captured,AGEX-09,78.5,50.00,9,SureSelect XT2 Human All Exon V7,,55,1/31/2020,120s shear time; DNA repaired. Sequenced as: AMLP-172 (AMLP-172 captured 79 ng in AGEX-9; AMLP-81 captured 69 ng in AGEX-9). Same adapter #55,Mel,Acral Melanoma,BCB019
AMLP-173,412 MIS1,AM2-080,Captured,AGEX-11,170.0,50.00,9,SureSelect XT2 Human All Exon V7,,93,1/31/2020,120s shear time; DNA repaired. Accidentally added an excess of 71 ng in the capture.,MIS,Acral Melanoma,BCB021
AMLP-174,413 MIS2,AM2-080,Captured,AGEX-10,229.0,50.00,9,SureSelect XT2 Human All Exon V7,,94,1/31/2020,120s shear time; DNA repaired,MIS,Acral Melanoma,BCB019
AMLP-175,1153 LN Met 2,AM2-049,Captured,AGEX-09,70.5,50.00,9,SureSelect XT2 Human All Exon V7,,97,2/7/2020,,Met,Acral Melanoma,BCB019
AMLP-176,1236 LN Met 4,AM2-062,Captured,AGEX-09,72.5,50.00,9,SureSelect XT2 Human All Exon V7,,98,2/7/2020,,Met,Acral Melanoma,BCB019
AMLP-177,377 MIS1,AM2-068,Captured,AGEX-11,42.5,50.00,9,SureSelect XT2 Human All Exon V7,,99,2/7/2020,,MIS,Acral Melanoma,BCB021
AMLP-178,378 Mel1,AM2-068,Captured,AGEX-10,130.0,50.00,9,SureSelect XT2 Human All Exon V7,,100,2/7/2020,,Mel,Acral Melanoma,BCB019
AMLP-179,379 LN Met 1,AM2-068,Captured,AGEX-10,148.5,50.00,9,SureSelect XT2 Human All Exon V7,,101,2/7/2020,,Met,Acral Melanoma,BCB019
AMLP-180,385 LN Met 1,AM2-069,Captured,AGEX-10,38.5,50.00,9,SureSelect XT2 Human All Exon V7,,102,2/7/2020,,Met,Acral Melanoma,BCB019
AMLP-181,398 Normal 1,AM2-074,Captured,AGEX-10,60.0,25.21,9,SureSelect XT2 Human All Exon V7,,103,2/7/2020,,Normal,Acral Melanoma,BCB019
AMLP-182,399 MIS1,AM2-074,Captured,AGEX-12,60.0,50.00,9,SureSelect XT2 Human All Exon V7,,104,2/7/2020,,MIS,Acral Melanoma,BCB021
AMLP-183,400 MIS2,AM2-074,Pending,SGPC-24,26.5,50.00,12,Small Gene Panel,,105,2/7/2020,,MIS,Acral Melanoma,BCB040
AMLP-184,401 Mel1,AM2-074,Captured,AGEX-10,65.5,50.00,9,SureSelect XT2 Human All Exon V7,,106,2/7/2020,,Mel,Acral Melanoma,BCB019
AMLP-185,402 Mel2,AM2-074,Captured,AGEX-10,69.0,50.00,9,SureSelect XT2 Human All Exon V7,,107,2/7/2020,,Mel,Acral Melanoma,BCB019
AMLP-186,1242 Normal2,AM2-081,Captured,AGEX-09,73.0,50.00,9,SureSelect XT2 Human All Exon V7,,108,2/7/2020,,Normal,Acral Melanoma,BCB019
AMLP-187,416 MIS1,AM2-081,Library failed/low yield,,,0.00,,,,109,2/7/2020,,MIS,Acral Melanoma,
AMLP-188,417 MIS2,AM2-081,Library failed/low yield,,,0.00,,,,110,2/7/2020,,MIS,Acral Melanoma,
AMLP-189,1241 MIS3,AM2-081,Pending,,,0.00,,,,111,2/7/2020,,MIS,Acral Melanoma,
AMLP-190,418 Mel1,AM2-081,Library failed/low yield,,,0.00,,,,112,2/7/2020,,Mel,Acral Melanoma,
AMLP-191,1243 Normal,AM2-082,Captured,AGEX-10,85.5,50.00,9,SureSelect XT2 Human All Exon V7,,113,2/7/2020,,Normal,Acral Melanoma,BCB019
AMLP-192,1244 MIS1,AM2-082,Captured,AGEX-11,99.0,50.00,9,SureSelect XT2 Human All Exon V7,,114,2/7/2020,,MIS,Acral Melanoma,BCB021
AMLP-193,1245 MIS2,AM2-082,Captured,AGEX-28,70.0,50.00,10,SureSelect XT Low Input Human All Exon V7,,115,2/7/2020,,MIS,Acral Melanoma,BCB031
AMLP-194,422 Mel1,AM2-082,Captured,AGEX-10,56.0,50.00,9,SureSelect XT2 Human All Exon V7,,116,2/7/2020,,Mel,Acral Melanoma,BCB019
AMLP-195,81 Mel1,AM2-049,Captured,AGEX-09,100.0,50.00,9,SureSelect XT2 Human All Exon V7,,117,2/7/2020,,Mel,Acral Melanoma,BCB019
AMLP-196,1154 LN Met 1,AM2-049,Captured,AGEX-09,94.0,50.00,9,SureSelect XT2 Human All Exon V7,,118,2/7/2020,,Met,Acral Melanoma,BCB019
AMLP-197,1152 Met1,AM2-050,Captured,AGEX-09,132.5,50.00,9,SureSelect XT2 Human All Exon V7,,119,2/7/2020,,Met,Acral Melanoma,BCB019
AMLP-198,106 Mel1,AM2-062,Captured,AGEX-09,100.0,23.81,9,SureSelect XT2 Human All Exon V7,,120,2/7/2020,,Mel,Acral Melanoma,BCB019
AMLP-199,1422 Normal; 72 Normal,AM2-048,Captured,AGEX-11,234.0,50.00,9,SureSelect XT2 Human All Exon V7,,134,8/2/2020,Accidentally added an excess of 154 ng in the capture.,Normal,Acral Melanoma,BCB021
AMLP-200,74 MIS2,AM2-048,Captured,AGEX-19,93.0,50.00,10,SureSelect XT HS Human All Exon V7,,135,8/2/2020,,MIS,Acral Melanoma,BCB029
AMLP-201,75 MIS3,AM2-048,Captured,"AGEX-13,AGEX-30",130.0,23.17,9,SureSelect XT2 Human All Exon V7,,136,8/2/2020,"AGEX-30: 150ng, SSXTHS Hu All Exon V7",MIS,Acral Melanoma,"BCB028,BCB033"
AMLP-202,76 Mel1,AM2-048,Captured,AGEX-30,168.0,50.00,10,SureSelect XT HS Human All Exon V7,,137,8/2/2020,,Mel,Acral Melanoma,BCB033
AMLP-203,77 Mel2,AM2-048,Captured,AGEX-30,166.5,24.96,10,SureSelect XT HS Human All Exon V7,,138,8/2/2020,,Mel,Acral Melanoma,BCB033
AMLP-204,1148 LN Met 1,AM2-048,Captured,AGEX-12,80.0,19.18,9,SureSelect XT2 Human All Exon V7,,139,8/2/2020,,Met,Acral Melanoma,BCB021
AMLP-205,4 Mel1,AM2-058,Captured,"AGEX-28,SGPC-24",100.0,23.87,10,SureSelect XT Low Input Human All Exon V7,,140,8/2/2020,"SGPC-24: 12 Cycles post Hyb, 50ng captured",Mel,Acral Melanoma,"BCB031,BCB040"
AMLP-206,1286 Mel2,AM2-058,Captured,"AGEX-13,AGEX-20",120.0,36.36,9,SureSelect XT2 Human All Exon V7,,141,8/2/2020,"RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 45 ng library",Mel,Acral Melanoma,"BCB028,BCB029"
AMLP-207,5 Met1,AM2-058,Captured,"AGEX-13,AGEX-20,SGPC-24",120.0,17.75,9,SureSelect XT2 Human All Exon V7,,142,8/2/2020,"RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 100 ng library. SGPC-24: 12 Cycles post Hyb, 50ng captured",Met,Acral Melanoma,"BCB028,BCB029,BCB040"
AMLP-208,9 Normal,AM2-060,Captured,"AGEX-13,AGEX-20",80.0,29.09,9,SureSelect XT2 Human All Exon V7,,143,8/2/2020,"RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 50 ng library",Normal,Acral Melanoma,"BCB028,BCB029"
AMLP-209,10 Mel1,AM2-060,Captured,"AGEX-13,AGEX-20,SGPC-24",120.0,20.34,9,SureSelect XT2 Human All Exon V7,,144,8/2/2020,"RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 100 ng library. SGPC-24: 12 Cycles post Hyb, 50ng captured",Mel,Acral Melanoma,"BCB028,BCB029,BCB040"
AMLP-210,1289 Mel2,AM2-006,Captured,AGEX-12,76.8,49.87,9,SureSelect XT2 Human All Exon V7,,145,8/6/2020,,Mel,Acral Melanoma,BCB021
AMLP-211,1290 LN Met,AM2-006,Captured,AGEX-13,130.0,32.66,9,SureSelect XT2 Human All Exon V7,,146,8/6/2020,,Met,Acral Melanoma,BCB028
AMLP-212,35 Normal; 1291 Normal,AM2-014,Pending,,,0.00,,,,147,8/6/2020,,Normal,Acral Melanoma,
AMLP-213,36 MIS1,AM2-014,Pending,,,0.00,,,,148,8/6/2020,,MIS,Acral Melanoma,
AMLP-214,11 Met1,AM2-060,Captured,AGEX-13,72.0,50.00,9,SureSelect XT2 Human All Exon V7,,149,8/6/2020,,Met,Acral Melanoma,BCB028
AMLP-215,67 Mel1,AM2-042,Captured,"AGEX-20,SGPC-20",100.0,34.13,10,SureSelect XT HS Human All Exon V7,,150,8/6/2020,"SGPC-20: 12 Cycles post Hyb, 43ng captured",Mel,Acral Melanoma,"BCB029,BCB036"
AMLP-216,1427 Lung Metastasis,AM2-042,Captured,"AGEX-20,SGPC-20",100.0,7.39,10,SureSelect XT HS Human All Exon V7,,151,8/6/2020,"SGPC-20: 12 Cycles post Hyb, 50ng captured",Met,Acral Melanoma,"BCB029,BCB036"
AMLP-217,69 MIS1,AM2-045,Captured,AGEX-20,120.0,42.86,10,SureSelect XT HS Human All Exon V7,,152,8/6/2020,,MIS,Acral Melanoma,BCB029
AMLP-218,70 MIS2,AM2-045,Captured,AGEX-13,115.4,50.17,9,SureSelect XT2 Human All Exon V7,,153,8/6/2020,,MIS,Acral Melanoma,BCB028
AMLP-219,71 Mel1,AM2-045,Captured,AGEX-13,129.7,49.88,9,SureSelect XT2 Human All Exon V7,,154,8/6/2020,,Mel,Acral Melanoma,BCB028
AMLP-220,1423 LN Met 1,AM2-045,Captured,"AGEX-13,AGEX-20",130.0,33.33,9,SureSelect XT2 Human All Exon V7,,155,8/6/2020,"RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 65 ng library",Met,Acral Melanoma,"BCB028,BCB029"
AMLP-221,1302 Normal,AM2-043,Captured,AGEX-19,40.0,50.00,10,SureSelect XT HS Human All Exon V7,,156,8/6/2020,,Normal,Acral Melanoma,BCB029
AMLP-222,1303 Mel1,AM2-043,Captured,AGEX-19,90.0,50.00,10,SureSelect XT HS Human All Exon V7,,157,8/6/2020,,Mel,Acral Melanoma,BCB029
AMLP-223,1304 Subcutaneous Metastasis,AM2-043,Captured,"AGEX-19,SGPC-20",100.0,28.57,10,SureSelect XT HS Human All Exon V7,,158,8/6/2020,"SGPC-20: 12 Cycles post Hyb, 50ng captured",Met,Acral Melanoma,"BCB029,BCB036"
AMLP-224,1305 Normal; 1425 Normal,AM2-046,Captured,AGEX-19,45.0,28.13,10,SureSelect XT HS Human All Exon V7,,159,8/6/2020,,Normal,Acral Melanoma,BCB029
AMLP-225,1306 Mel1,AM2-046,Captured,AGEX-19,40.0,50.00,10,SureSelect XT HS Human All Exon V7,,160,8/6/2020,,Mel,Acral Melanoma,BCB029
AMLP-226,1307 LN Met 1,AM2-046,Captured,AGEX-19,60.0,50.00,10,SureSelect XT HS Human All Exon V7,,161,8/6/2020,,Met,Acral Melanoma,BCB029
AMLP-227,1308 Bladder Metastasis,AM2-046,Captured,AGEX-19,100.0,19.61,10,SureSelect XT HS Human All Exon V7,,162,8/6/2020,,Met,Acral Melanoma,BCB029
AMLP-228,1292 Normal,AM2-040,Pending,,,0.00,,,,163,8/6/2020,,Normal,Acral Melanoma,
AMLP-229,1293 Mel1,AM2-040,Pending,,,0.00,,,,164,8/6/2020,,Mel,Acral Melanoma,
AMLP-230,1294 LN Met,AM2-040,Pending,,,0.00,,,,165,8/6/2020,,Met,Acral Melanoma,
AMLP-231,422 Mel1,AM2-082,Captured,AGEX-12,70.0,33.33,9,SureSelect XT2 Human All Exon V7,,166,8/6/2020,,Mel,Acral Melanoma,BCB021
AMLP-232,1241 MIS3,AM2-081,Pending,,,0.00,,,,167,8/6/2020,,MIS,Acral Melanoma,
AMLP-233,1474 Met1,AM2-086,Pending,,,0.00,,,,168,12/5/2020,,Met,Acral Melanoma,
AMLP-234,1475 Mel1,AM2-088,Pending,,,0.00,,,,97,3/17/2021,,Mel,Acral Melanoma,
AMLP-235,1478 Normal,AM2-088,Pending,,,0.00,,,,98,3/17/2021,,Normal,Acral Melanoma,
AMLP-236,1479 LN Met 1,AM2-088,Pending,,,0.00,,,,99,3/17/2021,,Met,Acral Melanoma,
AMLP-237,1515 Mel1,AM2-096,Captured,AGEX-17,19.6,50.23,10,SureSelect XT HS Human All Exon V7,,100,3/17/2021,,Mel,Acral Melanoma,BCB027
AMLP-238,1612 Normal,AM2-096,Captured,AGEX-16,40.0,31.25,10,SureSelect XT HS Human All Exon V7,,101,3/17/2021,,Normal,Acral Melanoma,"BCB027,BCB029"
AMLP-239,1519 LN Met 1,AM2-096,Captured,"AGEX-15,SGPC-24",90.0,31.80,10,SureSelect XT HS Human All Exon V7,,102,3/17/2021,"SGPC-24: 12 Cycles post Hyb, 45ng captured",LN Met,Acral Melanoma,"BCB027,BCB029,BCB040"
AMLP-240,1520 Met2,AM2-096,Captured,AGEX-15,90.0,39.82,10,SureSelect XT HS Human All Exon V7,,103,3/17/2021,,Met,Acral Melanoma,"BCB027,BCB029"
AMLP-241,1529 Mel1,AM2-099,Captured,AGEX-16,43.0,50.00,10,SureSelect XT HS Human All Exon V7,,104,3/17/2021,,Mel,Acral Melanoma,"BCB027,BCB029"
AMLP-242,1530 Mel2,AM2-099,Pending,,,0.00,,,,106,3/17/2021,,Mel,Acral Melanoma,
AMLP-243,1531 Mel3,AM2-099,Library failed/low yield,,,0.00,,,,107,3/17/2021,,Mel,Acral Melanoma,
AMLP-244,1532 Mel4,AM2-099,Pending,SGPC-24,,0.00,12,Small Gene Panel,,108,3/17/2021,"SGPC-24: 12 Cycles post Hyb, 20.5ng captured",Mel,Acral Melanoma,BCB040
AMLP-245,"1535 Normal, 1613 Normal",AM2-099,Captured,AGEX-16,16.0,48.48,10,SureSelect XT HS Human All Exon V7,,109,3/17/2021,,Normal,Acral Melanoma,"BCB027,BCB029"
AMLP-246,1536 Skin Met2,AM2-099,Pending,,,0.00,,,,110,3/17/2021,,Met,Acral Melanoma,
AMLP-247,1538 Skin Met3,AM2-099,Captured,AGEX-15,80.0,50.31,10,SureSelect XT HS Human All Exon V7,,112,3/17/2021,,Met,Acral Melanoma,"BCB027,BCB029"
AMLP-248,1540 MIS2,AM2-100,Captured,AGEX-27,18.3,49.57,10,SureSelect XT Low Input Human All Exon V7,,113,3/17/2021,,MIS,Acral Melanoma,BCB031
AMLP-249,1541 Normal,AM2-100,Captured,AGEX-27,13.6,50.22,10,SureSelect XT Low Input Human All Exon V7,,114,3/17/2021,,Normal,Acral Melanoma,BCB031
AMLP-250,1542 Skin Met1,AM2-100,Captured,AGEX-24,11.0,49.77,10,SureSelect XT HS Human All Exon V7,,116,3/17/2021,,Met,Acral Melanoma,BCB031
AMLP-251,1543 Brain Met2,AM2-100,Pending,,,0.00,,,,117,3/17/2021,,Met,Acral Melanoma,
AMLP-252,1548 Mel1,AM2-101,Captured,AGEX-16,8.0,50.00,10,SureSelect XT HS Human All Exon V7,,118,3/17/2021,,Mel,Acral Melanoma,"BCB027,BCB029"
AMLP-253,1549 Mel2,AM2-101,Pending,,,0.00,,,,119,3/17/2021,,Mel,Acral Melanoma,
AMLP-254,1614 Normal,AM2-101,Captured,AGEX-21,41.1,50.16,10,SureSelect XT HS Human All Exon V7,,120,3/17/2021,,Normal,Acral Melanoma,BCB030
AMLP-255,1551 Salivary Met1,AM2-101,Captured,AGEX-21,59.6,50.09,10,SureSelect XT HS Human All Exon V7,,121,3/17/2021,,Met,Acral Melanoma,BCB030
AMLP-256,"1552 Normal, 1564 Normal, 1566 Normal",AM2-102,Captured,AGEX-16,40.0,38.10,10,SureSelect XT HS Human All Exon V7,,122,3/17/2021,,Normal,Acral Melanoma,"BCB027,BCB029"
AMLP-257,1553 Mel1,AM2-102,Captured,AGEX-16,53.0,49.53,10,SureSelect XT HS Human All Exon V7,,123,3/17/2021,,Mel,Acral Melanoma,"BCB027,BCB029"
AMLP-258,1554 Mel2,AM2-102,Pending,,,0.00,,,,124,3/17/2021,,Mel,Acral Melanoma,
AMLP-259,1560 LN Met 3,AM2-102,Captured,AGEX-16,63.0,50.00,10,SureSelect XT HS Human All Exon V7,,125,3/17/2021,,Met,Acral Melanoma,"BCB027,BCB029"
AMLP-260,1561 LN Met 4,AM2-102,Pending,,,0.00,,,,126,3/17/2021,,Met,Acral Melanoma,
AMLP-261,"1562 Brain Met 5, 1563 Brain Met 6",AM2-102,Captured,AGEX-16,46.0,50.55,10,SureSelect XT HS Human All Exon V7,,127,3/17/2021,,Met,Acral Melanoma,"BCB027,BCB029"
AMLP-262,1567 LN Met 7,AM2-102,Captured,AGEX-21,47.8,49.83,10,SureSelect XT HS Human All Exon V7,,128,3/17/2021,,LN Met,Acral Melanoma,BCB030
AMLP-263,1579 Met1,AM2-104,Captured,AGEX-15,95.0,8.44,10,SureSelect XT HS Human All Exon V7,,129,3/17/2021,,Met,Acral Melanoma,"BCB027,BCB029"
AMLP-264,1581 Normal,AM2-104,Captured,AGEX-15,45.0,28.66,10,SureSelect XT HS Human All Exon V7,,130,3/17/2021,,Normal,Acral Melanoma,"BCB027,BCB029"
AMLP-265,1582 Invasive Mel 1,AM2-104,Captured,AGEX-15,90.0,39.82,10,SureSelect XT HS Human All Exon V7,,131,3/17/2021,,Mel,Acral Melanoma,"BCB027,BCB029"
AMLP-266,1583 Invasive Mel 2,AM2-104,Captured,AGEX-15,90.0,25.57,10,SureSelect XT HS Human All Exon V7,,132,3/17/2021,,Mel,Acral Melanoma,"BCB027,BCB029"
AMLP-267,1576 Subcutaneous Met 2,AM2-105,Captured,AGEX-14,100.0,36.76,10,SureSelect XT HS Human All Exon V7,,133,3/17/2021,,Mel,Acral Melanoma,BCB026
AMLP-268,1584 Normal,AM2-105,Captured,AGEX-15,45.0,26.79,10,SureSelect XT HS Human All Exon V7,,134,3/17/2021,,Normal,Acral Melanoma,"BCB027,BCB029"
AMLP-269,1585 Invasive Mel 1,AM2-105,Captured,AGEX-14,83.0,50.00,10,SureSelect XT HS Human All Exon V7,,135,3/17/2021,,Mel,Acral Melanoma,BCB026
AMLP-270,1586 LN Met,AM2-105,Captured,"AGEX-18,SGPC-20",90.0,31.36,10,SureSelect XT HS Human All Exon V7,,139,3/17/2021,"SGPC-20: 12 Cycles post Hyb, 40ng captured",LN Met,Acral Melanoma,"BCB027,BCB030,BCB036"
AMLP-271,1587 MIS1,AM2-108,Captured,"AGEX-18,SGPC-22",100.0,31.15,10,SureSelect XT HS Human All Exon V7,,140,3/17/2021,"SGPC-22: 12 Cycles post Hyb, 49ng captured",MIS,Acral Melanoma,"BCB027,BCB030,BCB037"
AMLP-272,1588 MIS2,AM2-108,Captured,AGEX-17,59.2,50.16,10,SureSelect XT HS Human All Exon V7,,145,3/17/2021,,MIS,Acral Melanoma,BCB027
AMLP-273,1589 Primary Mel 1,AM2-108,Captured,AGEX-18,89.0,50.00,10,SureSelect XT HS Human All Exon V7,,147,3/17/2021,,Mel,Acral Melanoma,"BCB027,BCB030"
AMLP-274,1590 Primary Mel 2,AM2-108,Captured,AGEX-18,83.0,50.00,10,SureSelect XT HS Human All Exon V7,,148,3/17/2021,,Mel,Acral Melanoma,"BCB027,BCB030"
AMLP-275,1591 Normal,AM2-108,Captured,AGEX-18,45.0,25.42,10,SureSelect XT HS Human All Exon V7,,152,3/17/2021,,Normal,Acral Melanoma,"BCB027,BCB030"
AMLP-276,1592 In Transit Met,AM2-108,Captured,"AGEX-18,SGPC-20",90.0,19.07,10,SureSelect XT HS Human All Exon V7,,159,3/17/2021,"SGPC-20: 12 Cycles post Hyb, 40ng captured",Met,Acral Melanoma,"BCB027,BCB030,BCB036"
AMLP-277,1593 Normal,AM2-110,Captured,AGEX-18,45.0,14.24,10,SureSelect XT HS Human All Exon V7,,160,3/17/2021,,Normal,Acral Melanoma,"BCB027,BCB030"
AMLP-278,1594 MIS1,AM2-110,Captured,AGEX-23,81.9,49.92,10,SureSelect XT HS Human All Exon V7,,161,3/17/2021,,MIS,Acral Melanoma,BCB030
AMLP-279,1595 Invasive Primary Mel 1,AM2-110,Captured,AGEX-18,90.0,37.04,10,SureSelect XT HS Human All Exon V7,,162,3/17/2021,,Mel,Acral Melanoma,"BCB027,BCB030"
AMLP-280,1596 Invasive Primary Mel 2,AM2-110,Captured,AGEX-21,90.0,27.86,10,SureSelect XT HS Human All Exon V7,,163,3/17/2021,,Mel,Acral Melanoma,BCB030
AMLP-281,1601 Invasive Primary Mel,AM2-111,Captured,AGEX-23,9.6,50.58,10,SureSelect XT HS Human All Exon V7,,164,3/17/2021,,Mel,Acral Melanoma,BCB030
AMLP-282,1602 Metastatic Mel 2,AM2-111,Captured,AGEX-21,71.6,50.06,10,SureSelect XT HS Human All Exon V7,,165,3/17/2021,,Met,Acral Melanoma,BCB030
AMLP-283,"1603 Normal 2, 1604 Normal",AM2-111,Captured,AGEX-23,33.8,49.71,10,SureSelect XT HS Human All Exon V7,,166,3/17/2021,,Normal,Acral Melanoma,BCB030
AMLP-284,1605 Metastatic Mel 1,AM2-111,Captured,AGEX-28,44.7,50.18,10,SureSelect XT Low Input Human All Exon V7,,168,3/17/2021,,Met,Acral Melanoma,BCB031
AMLP-285,1606 Invasive Primary Mel 1,AM2-113,Captured,AGEX-23,67.0,50.03,10,SureSelect XT HS Human All Exon V7,,169,3/17/2021,,Mel,Acral Melanoma,BCB030
AMLP-286,1607 Invasive Primary Mel 2,AM2-113,Captured,AGEX-23,52.8,49.79,10,SureSelect XT HS Human All Exon V7,,170,3/17/2021,,Mel,Acral Melanoma,BCB030
AMLP-287,1608 Normal,AM2-113,Captured,AGEX-23,37.4,49.89,10,SureSelect XT HS Human All Exon V7,,171,3/17/2021,,Normal,Acral Melanoma,BCB030
AMLP-288,1609 LN Met 1,AM2-113,Captured,AGEX-23,69.3,49.83,10,SureSelect XT HS Human All Exon V7,,172,3/17/2021,,LN Met,Acral Melanoma,BCB030
AMLP-289,1610 Invasive Primary Mel,AM2-114,Captured,AGEX-14,100.0,40.16,10,SureSelect XT HS Human All Exon V7,,173,3/17/2021,,Mel,Acral Melanoma,BCB026
AMLP-290,1578 Local Recurrent-Met2,AM2-114,Captured,AGEX-14,68.5,50.00,10,SureSelect XT HS Human All Exon V7,,174,3/17/2021,,Met,Acral Melanoma,BCB026
AMLP-291,1611 Normal,AM2-114,Captured,AGEX-14,60.0,36.81,10,SureSelect XT HS Human All Exon V7,,175,3/17/2021,,Normal,Acral Melanoma,BCB026
AMLP-292,1616 Normal,AM2-045,Captured,AGEX-21,55.0,19.57,10,SureSelect XT HS Human All Exon V7,,176,3/17/2021,,Normal,Acral Melanoma,BCB030
AMLP-293,1617 Normal,AM2-058,Captured,AGEX-21,59.6,50.07,10,SureSelect XT HS Human All Exon V7,,177,3/17/2021,,Normal,Acral Melanoma,BCB030
AMLP-294,DO NOT USE,AM2-067,Library failed/low yield,,,0.00,,,,178,3/17/2021,DISCARD. DO NOT USE THIS LIBRARY. THE SAMPLE WAS POOLED WITH MEL1.,Mel,Acral Melanoma,
AMLP-295,1536 Skin Met2,AM2-099,Captured,AGEX-17,62.3,49.84,10,SureSelect XT HS Human All Exon V7,,179,4/7/2021,,Met,Acral Melanoma,BCB027
AMLP-296,1537 Skin Met4,AM2-099,Captured,AGEX-17,110.0,46.22,10,SureSelect XT HS Human All Exon V7,,180,4/7/2021,,Met,Acral Melanoma,BCB027
AMLP-297,1543 Brain Met2,AM2-100,Captured,"AGEX-25,SGPC-20",150.0,35.55,10,SureSelect XT HS Human All Exon V7,,181,4/7/2021,"SGPC-20: 12 Cycles post Hyb, 50ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Met,Acral Melanoma,"BCB031,BCB036"
AMLP-298,1548 Mel1,AM2-101,Captured,AGEX-17,48.3,49.79,10,SureSelect XT HS Human All Exon V7,,182,4/7/2021,,Mel,Acral Melanoma,BCB027
AMLP-299,1614 Normal,AM2-101,Captured,AGEX-17,55.0,10.54,10,SureSelect XT HS Human All Exon V7,,183,4/7/2021,,Normal,Acral Melanoma,BCB027
AMLP-300,1551 Salivary Met1,AM2-101,Captured,"AGEX-17,AGEX-22",110.0,21.57,10,SureSelect XT HS Human All Exon V7,,184,4/7/2021,70 ng in AGEX-22,Met,Acral Melanoma,"BCB027,BCB030"
AMLP-301,1567 LN Met 7,AM2-102,Captured,"AGEX-17,AGEX-25",110.0,36.30,10,SureSelect XT HS Human All Exon V7,,185,4/7/2021,42 ng in AGEX-25,Met,Acral Melanoma,"BCB027,BCB031"
AMLP-302,1621 MIS4,AM2-049,Captured,AGEX-27,95.1,50.05,10,SureSelect XT Low Input Human All Exon V7,,186,4/7/2021,,MIS,Acral Melanoma,BCB031
AMLP-303,413 MIS2,AM2-080,Captured,AGEX-27,83.7,50.12,10,SureSelect XT Low Input Human All Exon V7,,136,5/13/2021,,MIS,Acral Melanoma,BCB031
AMLP-304,1619 MIS4,AM2-082,Captured,AGEX-27,29.1,50.17,10,SureSelect XT Low Input Human All Exon V7,,137,5/13/2021,,MIS,Acral Melanoma,BCB031
AMLP-305-306,1622 Mel2,AM2-067,Captured,"AGEX-27,AGEX-28",91.7,52.40,10,SureSelect XT Low Input Human All Exon V7,,138,5/13/2021,"Merged AMLP-305 (91.7ng captured in AGEX-27), and AMLP-306 (83.4ng captured in AGEX-28; 302bp size) and submitted as AMLP-305 in BCB031. Same adapter #138.",Mel,Acral Melanoma,BCB031
AMLP-307,1623 Invasive Mel 1,AM2-046,Captured,AGEX-27,36.4,49.86,10,SureSelect XT Low Input Human All Exon V7,,144,5/13/2021,,Mel,Acral Melanoma,BCB031
AMLP-308,13 MIS1,AM2-001,Captured,SGPC-20,50.0,14.20,12,Small Gene Panel,,146,5/13/2021,"Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",MIS,Acral Melanoma,BCB036
AMLP-309,1536 Skin Met2,AM2-099,Pending,,,0.00,,,,147,5/13/2021,,Met,Acral Melanoma,
AMLP-310,1515 Mel1,AM2-096,Captured,AGEX-24,83.8,49.88,10,SureSelect XT HS Human All Exon V7,,110,5/20/2021,,Mel,Acral Melanoma,BCB031
AMLP-311,1518 Mel4,AM2-096,Captured,"AGEX-24,SGPC-24",150.0,41.55,10,SureSelect XT HS Human All Exon V7,,111,5/20/2021,"SGPC-24: 12 Cycles post Hyb, 25ng captured",Mel,Acral Melanoma,"BCB031,BCB040"
AMLP-312,1529 Mel1,AM2-099,Captured,AGEX-22,150.0,47.32,10,SureSelect XT HS Human All Exon V7,,115,5/20/2021,,Mel,Acral Melanoma,BCB030
AMLP-313,1532 Mel4,AM2-099,Captured,"AGEX-24,SGPC-24",150.0,41.21,10,SureSelect XT HS Human All Exon V7,,133,5/20/2021,"SGPC-24: 12 Cycles post Hyb, 32ng captured",Mel,Acral Melanoma,"BCB031,BCB040"
AMLP-314,1534 Skin Met1,AM2-099,Captured,AGEX-24,150.0,42.61,10,SureSelect XT HS Human All Exon V7,,135,5/20/2021,,Met,Acral Melanoma,BCB031
AMLP-315,1548 Mel1,AM2-101,Captured,AGEX-24,144.6,50.03,10,SureSelect XT HS Human All Exon V7,,141,5/20/2021,,Mel,Acral Melanoma,BCB031
AMLP-316,1549 Mel2,AM2-101,Captured,AGEX-24,132.9,49.96,10,SureSelect XT HS Human All Exon V7,,142,5/20/2021,,Mel,Acral Melanoma,BCB031
AMLP-317,1563 Brain Met 6,AM2-102,Captured,"AGEX-22,SGPC-20",150.0,37.69,10,SureSelect XT HS Human All Exon V7,,143,5/20/2021,"SGPC-20: 12 Cycles post Hyb, 44ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Met,Acral Melanoma,"BCB030,BCB036"
AMLP-318,1553 Mel1,AM2-102,Captured,AGEX-22,122.2,50.08,10,SureSelect XT HS Human All Exon V7,,145,5/20/2021,,Mel,Acral Melanoma,BCB030
AMLP-319,1554 Mel2,AM2-102,Captured,"AGEX-22,SGPC-20",120.0,38.83,10,SureSelect XT HS Human All Exon V7,,149,5/20/2021,"SGPC-20: 12 Cycles post Hyb, 31ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,"BCB030,BCB036"
AMLP-320,1557 MIS3,AM2-102,Captured,AGEX-22,113.9,49.96,10,SureSelect XT HS Human All Exon V7,,150,5/20/2021,,MIS,Acral Melanoma,BCB030
AMLP-321,1470 Normal; 1624 Normal,AM2-086,Captured,AGEX-25,46.3,49.78,10,SureSelect XT HS Human All Exon V7,,105,5/27/2021,,Normal,Acral Melanoma,BCB031
AMLP-322,1473 Recurrence 1,AM2-086,Captured,AGEX-25,123.0,50.00,10,SureSelect XT HS Human All Exon V7,,151,5/27/2021,,,Acral Melanoma,BCB031
AMLP-323,1471 Mel1,AM2-086,Captured,AGEX-25,93.3,49.89,10,SureSelect XT HS Human All Exon V7,,153,5/27/2021,,Mel,Acral Melanoma,BCB031
AMLP-324,1474 Met1,AM2-086,Captured,AGEX-26,47.0,50.00,10,SureSelect XT HS Human All Exon V7,,154,5/27/2021,,Met,Acral Melanoma,BCB031
AMLP-325,1541 Normal,AM2-100,Captured,AGEX-26,43.8,49.77,10,SureSelect XT HS Human All Exon V7,,155,5/27/2021,,Normal,Acral Melanoma,BCB031
AMLP-326,1542 Skin Met1,AM2-100,Captured,AGEX-26,68.0,50.00,10,SureSelect XT HS Human All Exon V7,,156,5/27/2021,,Met,Acral Melanoma,BCB031
AMLP-327,1540 MIS2; 1625 MIS2 In situ,AM2-100,Captured,AGEX-26,71.0,50.00,10,SureSelect XT HS Human All Exon V7,,157,5/27/2021,,MIS,Acral Melanoma,BCB031
AMLP-328,1568 LN Met 8,AM2-102,Pending,,,0.00,,,,158,5/27/2021,,Met,Acral Melanoma,
AMLP-329,1588 MIS2,AM2-108,Pending,,,0.00,,,,167,5/27/2021,,MIS,Acral Melanoma,
AMLP-330,1603 Normal 2; 1604 Normal,AM2-111,Captured,AGEX-26,75.0,27.88,10,SureSelect XT HS Human All Exon V7,,179,5/27/2021,,Normal,Acral Melanoma,BCB031
AMLP-331,1602 Metastatic Mel 2,AM2-111,Captured,AGEX-25,110.0,19.30,10,SureSelect XT HS Human All Exon V7,,180,5/27/2021,,Met,Acral Melanoma,BCB031
AMLP-332,1601 Invasive Primary Mel,AM2-111,Captured,AGEX-26,19.0,50.00,10,SureSelect XT HS Human All Exon V7,,183,5/27/2021,,Mel,Acral Melanoma,BCB031
AMLP-333,1472 MIS1,AM2-086,Library failed/low yield,,,0.00,,,,179,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,MIS,Acral Melanoma,
AMLP-334,1476 Mel2,AM2-088,Library failed/low yield,,,0.00,,,,180,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,Mel,Acral Melanoma,
AMLP-335,1516 Mel2,AM2-096,Library failed/low yield,,,0.00,,,,181,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,Mel,Acral Melanoma,
AMLP-336,1472 MIS1,AM2-086,Library failed/low yield,,,0.00,,,,182,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,MIS,Acral Melanoma,
AMLP-337,1476 Mel2,AM2-088,Library failed/low yield,,,0.00,,,,183,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,Mel,Acral Melanoma,
AMLP-338,1516 Mel2,AM2-096,Library failed/low yield,,,0.00,,,,184,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,Mel,Acral Melanoma,
AMLP-339,1472 MIS1,AM2-086,Captured,SGPC-19,6.5,50.00,12,Small Gene Panel,,136,8/6/2021,"HyperPREP, Ligation: 17 hrs,16oC.",MIS,Acral Melanoma,BCB032
AMLP-340,1476 Mel2,AM2-088,Captured,SGPC-19,11.0,50.00,12,Small Gene Panel,,137,8/6/2021,"HyperPREP, Ligation: 17 hrs,16oC.",Mel,Acral Melanoma,BCB032
AMLP-341,1516 Mel2,AM2-096,Captured,SGPC-19,35.5,50.00,12,Small Gene Panel,,138,8/6/2021,"HyperPREP, Ligation: 17 hrs,16oC.",Mel,Acral Melanoma,BCB032
AMLP-342,1472 MIS1,AM2-086,Captured,SGPC-19,2.0,25.00,12,Small Gene Panel,,189,8/6/2021,"HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 16 ng DNA.",MIS,Acral Melanoma,BCB032
AMLP-343,1476 Mel2,AM2-088,Captured,SGPC-19,14.0,50.00,12,Small Gene Panel,,190,8/6/2021,"HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 90 ng of DNA.",Mel,Acral Melanoma,BCB032
AMLP-344,1516 Mel2,AM2-096,Captured,SGPC-19,44.0,50.00,12,Small Gene Panel,,191,8/6/2021,"HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 40 ng of DNA.",Mel,Acral Melanoma,BCB032
AMLP-345,1236 LN Met 4,AM2-062,Captured,SGPC-20,50.0,37.31,12,Small Gene Panel,,155,9/8/2021,"KAPA HyperPLUS, 10 min Frag at 37oC, 60 min ligation at 20oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Met,Acral Melanoma,BCB036
AMLP-346,1148 LN Met 1,AM2-048,Captured,SGPC-20,38.0,41.76,12,Small Gene Panel,,156,9/8/2021,"KAPA HyperPLUS, 10 min Frag at 37oC, 120 min ligation at 20oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Met,Acral Melanoma,BCB036
AMLP-347,1822 Invasive Mel 1,AM2-107,Captured,AGEX-29,289.5,50.00,10,SureSelect XT HS Human All Exon V7,,97,9/15/2021,HyperPREP; Ligation: 15 min at 20 oC,Mel,Acral Melanoma,BCB033
AMLP-348,1824 Normal,AM2-107,Captured,AGEX-29,117.5,25.00,10,SureSelect XT HS Human All Exon V7,,98,9/15/2021,HyperPREP; Ligation: 15 min at 20 oC,Normal,Acral Melanoma,BCB033
AMLP-349-352,1475 Mel1,AM2-088,Captured,"AGEX-29,AGEX-30",87.5,50.00,10,SureSelect XT HS Human All Exon V7,,99,9/15/2021,"Sequenced as: AMLP-349; HyperPREP; Ligation: 60 min at 20 oC., HyperPREP; Ligation: 15 min at 20 oC. AMLP-349: capture 87.5 ng in AGEX-29. AMLP-352: capture 81.0 ng in AGEX-30.",Mel,Acral Melanoma,BCB033
AMLP-350,1822 Invasive Mel 1,AM2-107,Captured,SGPC-20,50.0,8.99,12,Small Gene Panel,,97,9/15/2021,"HyperPREP; Ligation: 60 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-351,1824 Normal,AM2-107,Pending,,,0.00,,,,98,9/15/2021,HyperPREP; Ligation: 60 min at 20 oC,Normal,Acral Melanoma,
AMLP-353,1822 Invasive Mel 1,AM2-107,Captured,SGPC-19,30.0,4.46,12,Small Gene Panel,,97,9/16/2021,HyperPREP; Ligation: O/N (23hrs) at 4 oC,Mel,Acral Melanoma,BCB032
AMLP-354,1824 Normal,AM2-107,Captured,SGPC-19,30.0,4.80,12,Small Gene Panel,,98,9/16/2021,HyperPREP; Ligation: O/N (23hrs) at 4 oC,Normal,Acral Melanoma,BCB032
AMLP-355,1475 Mel1,AM2-088,Captured,SGPC-19,20.0,35.71,12,Small Gene Panel,,99,9/16/2021,HyperPREP; Ligation: O/N (23hrs) at 4 oC,Mel,Acral Melanoma,BCB032
AMLP-356,1822 Invasive Mel 1,AM2-107,Pending,,,0.00,,,,116,9/15/2021,"HyperPLUS, Ligation: 15 min at 20 oC",Mel,Acral Melanoma,
AMLP-357,1824 Normal,AM2-107,Pending,,,0.00,,,,117,9/15/2021,"HyperPLUS, Ligation: 15 min at 20 oC",Normal,Acral Melanoma,
AMLP-358,1475 Mel1,AM2-088,Pending,,,0.00,,,,118,9/15/2021,"HyperPLUS, Ligation: 15 min at 20 oC",Mel,Acral Melanoma,
AMLP-359,1822 Invasive Mel 1,AM2-107,Pending,,,0.00,,,,116,9/15/2021,"HyperPLUS, Ligation: 60 min at 20 oC",Mel,Acral Melanoma,
AMLP-360,1824 Normal,AM2-107,Pending,,,0.00,,,,117,9/15/2021,"HyperPLUS, Ligation: 60 min at 20 oC",Normal,Acral Melanoma,
AMLP-361,1475 Mel1,AM2-088,Pending,,,0.00,,,,118,9/15/2021,"HyperPLUS, Ligation: 60 min at 20 oC",Mel,Acral Melanoma,
AMLP-362,1822 Invasive Mel 1,AM2-107,Captured,SGPC-19,30.0,3.10,12,Small Gene Panel,,116,9/16/2021,"HyperPLUS, Ligation: O/N at 4 oC",Mel,Acral Melanoma,BCB032
AMLP-363,1824 Normal,AM2-107,Captured,SGPC-19,30.0,2.84,12,Small Gene Panel,,117,9/16/2021,"HyperPLUS, Ligation: O/N at 4 oC",Normal,Acral Melanoma,BCB032
AMLP-364,1475 Mel1,AM2-088,Captured,SGPC-19,20.0,29.41,12,Small Gene Panel,,118,9/16/2021,"HyperPLUS, Ligation: O/N at 4 oC",Mel,Acral Melanoma,BCB032
AMLP-365,375 Mel1,AM2-067,Library failed/low yield,,,0.00,,,,102,9/18/2021,"HyperPREP, Ligation: 30 min at 20 oC",Mel,Acral Melanoma,
AMLP-366,375 Mel1,AM2-067,Captured,"SGPC-19,SGPC-20",50.0,33.11,12,Small Gene Panel,,103,9/18/2021,"HyperPREP, Ligation: 30 min at 20 oC. SGPC-20: 12 Cycles post Hyb, 25ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,"BCB032,BCB036"
AMLP-367,1823 Invasive Mel 2,AM2-107,Captured,AGEX-29,266.0,50.00,10,SureSelect XT HS Human All Exon V7,,104,9/18/2021,"HyperPREP, Ligation: 30 min at 20 oC",Mel,Acral Melanoma,BCB033
AMLP-368,1479 LN Met 1,AM2-088,Pending,,,0.00,,,,105,9/18/2021,"HyperPREP, Ligation: 30 min at 20 oC",Met,Acral Melanoma,
AMLP-369,1303 Mel1,AM2-043,Captured,"SGPC-19,SGPC-20",50.0,17.36,12,Small Gene Panel,,106,9/18/2021,"HyperPREP, Ligation: 30 min at 20 oC. SGPC-20: 12 Cycles post Hyb, 50ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,"BCB032,BCB036"
AMLP-370,1304 Subcutaneous Metastasis,AM2-043,Captured,SGPC-19,50.0,12.53,12,Small Gene Panel,,107,9/27/2021,"HyperPREP, Ligation: 30 min at 20 oC",Met,Acral Melanoma,BCB032
AMLP-371,1478 Normal,AM2-088,Pending,,,0.00,,,,108,9/18/2021,"HyperPREP, Ligation: 30 min at 20 oC",Normal,Acral Melanoma,
AMLP-372,1618 MIS3,AM2-082,Captured,SGPC-19,20.0,37.04,12,Small Gene Panel,,109,9/18/2021,"HyperPREP, Ligation: 30 min at 20 oC",MIS,Acral Melanoma,BCB032
AMLP-373,1478 Normal,AM2-088,Captured,AGEX-30,123.0,50.00,10,SureSelect XT HS Human All Exon V7,,108,9/27/2021,"HyperPREP, Ligation: 30 min at 20 oC",Normal,Acral Melanoma,BCB033
AMLP-374,1478 Normal,AM2-088,Pending,,,0.00,,,,108,9/27/2021,"HyperPREP, Ligation: 30 min at 20 oC",Normal,Acral Melanoma,
AMLP-375,1479 LN Met 1,AM2-088,Captured,AGEX-29,226.0,50.00,10,SureSelect XT HS Human All Exon V7,,105,9/27/2021,"HyperPREP, Ligation: 30 min at 20 oC",Met,Acral Melanoma,BCB033
AMLP-376,14 Mel1,AM2-001,Captured,SGPC-20,50.0,8.21,12,Small Gene Panel,,100,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-377,100 Mel1,AM2-061,Captured,SGPC-20,50.0,6.13,12,Small Gene Panel,,101,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-378,107 Mel2,AM2-062,Captured,SGPC-20,50.0,5.75,12,Small Gene Panel,,127,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-379,109 Met2,AM2-062,Captured,SGPC-20,50.0,6.72,12,Small Gene Panel,,128,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Met,Acral Melanoma,BCB036
AMLP-380,371 Mel1,AM2-066,Library failed/low yield,,,NaN,,,,129,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC",,Acral Melanoma,
AMLP-381,401 Mel1,AM2-074,Captured,SGPC-20,50.0,13.77,12,Small Gene Panel,,130,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-382,1543 Brain Met2,AM2-100,Pending,,,0.00,,,,131,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC",,Acral Melanoma,
AMLP-383,1556 MIS2,AM2-102,Captured,SGPC-20,50.0,20.00,12,Small Gene Panel,,132,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",MIS,Acral Melanoma,BCB036
AMLP-384,1553 Mel1,AM2-102,Captured,SGPC-20,50.0,9.42,12,Small Gene Panel,,133,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-385,1568 LN Met 8,AM2-102,Library failed/low yield,,,NaN,,,,134,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC",,Acral Melanoma,
AMLP-386,"1558 LN Met 1, 1559 LN Met 2",AM2-102,Captured,SGPC-20,50.0,19.38,12,Small Gene Panel,,135,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Met,Acral Melanoma,BCB036
AMLP-387,1585 Invasive Mel 1,AM2-105,Captured,SGPC-20,50.0,6.48,12,Small Gene Panel,,136,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-388,1576 Subcutaneous Met 2,AM2-105,Captured,SGPC-20,50.0,5.67,12,Small Gene Panel,,137,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Met,Acral Melanoma,BCB036
AMLP-389,1823 Invasive Mel 2,AM2-107,Captured,SGPC-20,50.0,8.08,12,Small Gene Panel,,138,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-390,413 MIS2,AM2-080,Captured,SGPC-20,60.0,15.83,12,Small Gene Panel,,140,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",MIS,Acral Melanoma,BCB036
AMLP-391,414 Mel1,AM2-080,Captured,SGPC-20,50.0,5.37,12,Small Gene Panel,,141,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Mel,Acral Melanoma,BCB036
AMLP-392,"420 MIS1, 1244 MIS1",AM2-082,Captured,SGPC-20,56.0,50.00,12,Small Gene Panel,,142,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",MIS,Acral Melanoma,BCB036
AMLP-393,"421 MIS2, 1245 MIS2",AM2-082,Pending,,,0.00,,,,144,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC",,Acral Melanoma,
AMLP-394,1618 MIS3,AM2-082,Pending,,,0.00,,,,145,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC",,Acral Melanoma,
AMLP-395,1619 MIS4,AM2-082,Captured,SGPC-20,58.0,48.33,12,Small Gene Panel,,147,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",MIS,Acral Melanoma,BCB036
AMLP-396,1542 Skin Met1,AM2-100,Captured,SGPC-20,60.0,12.85,12,Small Gene Panel,,148,1/26/2022,"HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.",Met,Acral Melanoma,BCB036
AMLP-397,1621 MIS4,AM2-049,Captured,SGPC-24,60.0,20.69,12,Small Gene Panel,,106,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",MIS,Acral Melanoma,BCB040
AMLP-398,84 Mel,AM2-050,Captured,SGPC-24,50.0,12.32,12,Small Gene Panel,,112,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-399,378 Mel1,AM2-068,Captured,SGPC-24,60.0,10.12,12,Small Gene Panel,,113,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-400,379 LN Met 1,AM2-068,Captured,SGPC-24,60.0,8.06,12,Small Gene Panel,,114,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-401,422 Mel1,AM2-082,Captured,SGPC-24,50.0,17.24,12,Small Gene Panel,,120,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-402,1529 Mel1,AM2-099,Captured,SGPC-24,50.0,7.58,12,Small Gene Panel,,121,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-403,1534 Skin Met1,AM2-099,Captured,SGPC-24,50.0,8.40,12,Small Gene Panel,,122,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-404,1538 Skin Met3,AM2-099,Captured,SGPC-24,50.0,7.89,12,Small Gene Panel,,123,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-405,1565 LN Met 9,AM2-102,Captured,SGPC-24,50.0,12.72,12,Small Gene Panel,,124,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-406,1609 LN Met 1,AM2-113,Captured,SGPC-24,60.0,8.20,12,Small Gene Panel,,125,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-407,1610 Invasive Primary Mel,AM2-114,Captured,SGPC-24,60.0,6.72,12,Small Gene Panel,,126,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-408,1580 Local Recurrent-Met3,AM2-114,Captured,SGPC-24,60.0,5.69,12,Small Gene Panel,,127,4/27/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-409,1520 Met2,AM2-096,Captured,SGPC-24,50.0,4.58,12,Small Gene Panel,,129,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-410,2035 MIS3,AM2-050,Captured,SGPC-24,10.6,50.48,12,Small Gene Panel,,134,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",MIS,Acral Melanoma,BCB040
AMLP-411,11 Met1,AM2-060,Captured,SGPC-24,50.0,18.94,12,Small Gene Panel,,136,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-412,99 MIS1,AM2-061,Captured,SGPC-24,60.0,25.64,12,Small Gene Panel,,137,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",MIS,Acral Melanoma,BCB040
AMLP-413,2033 Met2,AM2-069,Captured,SGPC-24,50.0,10.96,12,Small Gene Panel,,138,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-414,399 MIS1,AM2-074,Captured,SGPC-24,60.0,35.29,12,Small Gene Panel,,139,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",MIS,Acral Melanoma,BCB040
AMLP-415,402 Mel2,AM2-074,Captured,SGPC-24,60.0,18.75,12,Small Gene Panel,,146,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-416,1517 Mel3,AM2-096,Captured,SGPC-24,50.0,17.18,12,Small Gene Panel,,151,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-417,1540 MIS2; 1625 MIS2 In situ,AM2-100,Captured,SGPC-24,60.0,18.75,12,Small Gene Panel,,154,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",MIS,Acral Melanoma,BCB040
AMLP-418,1557 MIS3,AM2-102,Captured,SGPC-24,60.0,12.20,12,Small Gene Panel,,155,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",MIS,Acral Melanoma,BCB040
AMLP-419,1589 Primary Mel 1,AM2-108,Captured,SGPC-24,50.0,9.11,12,Small Gene Panel,,156,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-420,1606 Invasive Primary Mel 1,AM2-113,Captured,SGPC-24,50.0,13.62,12,Small Gene Panel,,157,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-421,1607 Invasive Primary Mel 2,AM2-113,Captured,SGPC-24,50.0,39.37,12,Small Gene Panel,,158,5/20/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-422,81 Mel1,AM2-049,Captured,SGPC-24,50.0,10.48,12,Small Gene Panel,,167,5/31/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,BCB040
AMLP-423,1154 LN Met 1,AM2-049,Captured,SGPC-24,50.0,10.55,12,Small Gene Panel,,181,5/31/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-424,1152 Met1,AM2-050,Captured,SGPC-24,50.0,16.56,12,Small Gene Panel,,189,5/31/2022,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,BCB040
AMLP-425,75 MIS3,AM2-048,Pending,,,0.00,,,,100,1/10/2023,65oC X 1 min; 1.5 uM adapter; 8 cycles,MIS,Acral Melanoma,
AMLP-426,76 Mel1,AM2-048,Pending,,,0.00,,,,101,1/10/2023,65oC X 1 min; 1.5 uM adapter; 8 cycles,Mel,Acral Melanoma,
AMLP-427,1495 Mel2,AM2-091,Pending,,,0.00,,,,102,1/10/2023,65oC X 1 min; 1.5 uM adapter; 8 cycles,Mel,Acral Melanoma,
AMLP-428,75 MIS3,AM2-048,Pending,,,0.00,,,,103,1/10/2023,85oC X 3 min; 1.5 uM adapter; 8 cycles,MIS,Acral Melanoma,
AMLP-429,76 Mel1,AM2-048,Pending,,,0.00,,,,106,1/10/2023,85oC X 3 min; 1.5 uM adapter; 8 cycles,Mel,Acral Melanoma,
AMLP-430,1495 Mel2,AM2-091,Pending,,,0.00,,,,112,1/10/2023,85oC X 3 min; 1.5 uM adapter; 8 cycles,Mel,Acral Melanoma,
AMLP-431,75 MIS3,AM2-048,Pending,,,0.00,,,,113,1/10/2023,85oC x 6 min; 1.5 uM adapter; 8 cycles,MIS,Acral Melanoma,
AMLP-432,76 Mel1,AM2-091,Pending,,,0.00,,,,114,1/10/2023,85oC x 6 min; 1.5 uM adapter; 8 cycles,Mel,Acral Melanoma,
AMLP-433,1495 Mel2,AM2-091,Pending,,,0.00,,,,115,1/10/2023,85oC x 6 min; 1.5 uM adapter; 8 cycles,Mel,Acral Melanoma,
AMLP-434,75 MIS3,AM2-048,Captured,KAPAEX-19,200.0,46.95,13,KAPA HyperExome V1 Probes,,119,1/13/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,BCB057
AMLP-435,76 Mel1,AM2-091,Captured,KAPAEX-19,200.0,40.90,13,KAPA HyperExome V1 Probes,,120,1/13/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB057
AMLP-436,1495 Mel2,AM2-091,Pending,,,0.00,,,,121,1/13/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-437,74 MIS2,AM2-048,Captured,KAPAEX-19,200.0,29.41,13,KAPA HyperExome V1 Probes,,122,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,BCB057
AMLP-438,77 Mel2,AM2-048,Captured,KAPAEX-19,200.0,47.06,13,KAPA HyperExome V1 Probes,,123,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB057
AMLP-439,4 Mel1,AM2-058,Captured,KAPAEX-20,39.0,50.00,13,KAPA HyperExome V1 Probes,,124,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB054
AMLP-440,1286 Mel2,AM2-058,Captured,KAPAEX-20,102.0,50.00,13,KAPA HyperExome V1 Probes,,125,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB054
AMLP-441,10 Mel1,AM2-060,Pending,,,0.00,,,,126,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-442,11 Met1,AM2-060,Pending,,,0.00,,,,127,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-443,67 Mel1,AM2-042,Captured,KAPAEX-21,154.0,50.00,13,KAPA HyperExome V1 Probes,,128,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING",Mel,Acral Melanoma,
AMLP-444,1427 Lung Metastasis,AM2-042,Captured,KAPAEX-21,180.0,34.35,13,KAPA HyperExome V1 Probes,,129,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING",Met,Acral Melanoma,
AMLP-445,1474 Met1,AM2-086,Captured,KAPAEX-23,61.0,50.41,13,KAPA HyperExome V1 Probes,,130,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB055
AMLP-446,1493 Lung Met 1,AM2-090,Pending,,,0.00,,,,131,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-447,1494 Mel1,AM2-091,Pending,,,0.00,,,,132,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-448,1496 Mel3,AM2-091,Pending,,,0.00,,,,133,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-449,"1513 Brain Met 4, 1514 Met5",AM2-095,Pending,,,0.00,,,,134,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-450,1529 Mel1,AM2-099,Captured,KAPAEX-26,200.0,42.46,13,KAPA HyperExome V1 Probes,,135,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB054
AMLP-451,1530 Mel2,AM2-099,Captured,KAPAEX-26,90.0,49.72,13,KAPA HyperExome V1 Probes,,136,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB054
AMLP-452,1531 Mel3,AM2-099,Pending,,,0.00,,,,137,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-453,1532 Mel4,AM2-099,Captured,KAPAEX-26,125.0,50.00,13,KAPA HyperExome V1 Probes,,138,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB054
AMLP-454,1533 MIS1,AM2-099,Captured,KAPAEX-26,135.5,50.00,13,KAPA HyperExome V1 Probes,,139,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,BCB054
AMLP-455,1534 Skin Met1,AM2-099,Captured,KAPAEX-26,200.0,34.13,13,KAPA HyperExome V1 Probes,,140,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB054
AMLP-456,1538 Skin Met3,AM2-099,Captured,KAPAEX-26,203.0,50.00,13,KAPA HyperExome V1 Probes,,141,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB054
AMLP-457,1540 MIS2,AM2-100,Captured,KAPAEX-24,150.0,50.00,13,KAPA HyperExome V1 Probes,,143,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,BCB056
AMLP-458,1548 Mel1,AM2-101,Captured,KAPAEX-24,46.5,50.00,13,KAPA HyperExome V1 Probes,,144,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB056
AMLP-459,1549 Mel2,AM2-101,Pending,,,0.00,,,,146,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-460,1551 Salivary Met1,AM2-101,Captured,KAPAEX-24,200.0,23.12,13,KAPA HyperExome V1 Probes,,151,1/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB056
AMLP-461,1553 Mel1,AM2-102,Captured,KAPAEX-17,187.5,15.94,13,KAPA HyperExome V1 Probes,,149,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-462,1554 Mel2,AM2-102,Captured,KAPAEX-17,187.5,21.19,13,KAPA HyperExome V1 Probes,,150,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-463,1556 MIS2,AM2-102,Captured,KAPAEX-17,187.5,20.49,13,KAPA HyperExome V1 Probes,,152,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,BCB043
AMLP-464,1560 LN Met 3,AM2-102,Captured,KAPAEX-17,187.5,16.98,13,KAPA HyperExome V1 Probes,,153,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB043
AMLP-465,1567 LN Met 7,AM2-102,Captured,KAPAEX-17,187.5,16.82,13,KAPA HyperExome V1 Probes,,154,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB043
AMLP-466,1517 Mel3,AM2-096,Captured,KAPAEX-23,167.0,25.00,13,KAPA HyperExome V1 Probes,,155,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB055
AMLP-467,1475 Mel1,AM2-088,Pending,,,0.00,,,,156,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-468,1582 Invasive Mel 1,AM2-104,Captured,KAPAEX-16,187.5,10.45,13,KAPA HyperExome V1 Probes,,157,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-469,1583 Invasive Mel 2,AM2-104,Captured,KAPAEX-16,187.5,20.29,13,KAPA HyperExome V1 Probes,,158,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-470,1576 Subcutaneous Met 2,AM2-105,Captured,KAPAEX-16,187.5,11.81,13,KAPA HyperExome V1 Probes,,169,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB043
AMLP-471,1585 Invasive Mel 1,AM2-105,Captured,KAPAEX-16,187.5,10.01,13,KAPA HyperExome V1 Probes,,170,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-472,1586 LN Met,AM2-105,Captured,KAPAEX-16,187.5,11.62,13,KAPA HyperExome V1 Probes,,171,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB043
AMLP-473,1822 Invasive Mel 1,AM2-107,Captured,KAPAEX-16,187.5,14.07,13,KAPA HyperExome V1 Probes,,172,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-474,1823 Invasive Mel 2,AM2-107,Captured,KAPAEX-16,187.5,6.43,13,KAPA HyperExome V1 Probes,,173,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-475,1594 MIS1,AM2-110,Captured,KAPAEX-17,187.5,19.31,13,KAPA HyperExome V1 Probes,,174,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,BCB043
AMLP-476,1595 Invasive Primary Mel 1,AM2-110,Captured,KAPAEX-17,187.5,16.70,13,KAPA HyperExome V1 Probes,,175,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-477,1596 Invasive Primary Mel 2,AM2-110,Captured,KAPAEX-17,187.5,25.00,13,KAPA HyperExome V1 Probes,,176,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB043
AMLP-478,1579 Met1,AM2-104,Captured,KAPAEX-16,187.5,10.70,13,KAPA HyperExome V1 Probes,,177,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB043
AMLP-479,1606 Invasive Primary Mel 1,AM2-113,Captured,KAPAEX-25,97.0,50.00,13,KAPA HyperExome V1 Probes,,178,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB056
AMLP-480,1607 Invasive Primary Mel 2,AM2-113,Captured,KAPAEX-25,87.0,50.00,13,KAPA HyperExome V1 Probes,,179,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB056
AMLP-481,1609 LN Met 1,AM2-113,Captured,KAPAEX-25,128.0,49.81,13,KAPA HyperExome V1 Probes,,180,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB056
AMLP-482,1622 Mel2,AM2-067,Captured,KAPAEX-21,180.0,27.48,13,KAPA HyperExome V1 Probes,,181,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING",Mel,Acral Melanoma,
AMLP-483,1515 Mel1,AM2-096,Captured,KAPAEX-23,95.0,50.26,13,KAPA HyperExome V1 Probes,,182,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB055
AMLP-484,1518 Mel4,AM2-096,Captured,KAPAEX-23,159.0,50.16,13,KAPA HyperExome V1 Probes,,183,1/24/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB055
AMLP-485,1562 Brain Met 5,AM2-102,Pending,,,0.00,,,,184,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-486,1578 Local Recurrent-Met2,AM2-114,Captured,KAPAEX-19,200.0,30.40,13,KAPA HyperExome V1 Probes,,185,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB057
AMLP-487,1473 Recurrence 1,AM2-086,Captured,KAPAEX-23,130.0,50.19,13,KAPA HyperExome V1 Probes,,186,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Acral Melanoma,BCB055
AMLP-488,1471 Mel1,AM2-086,Captured,KAPAEX-23,52.0,50.00,13,KAPA HyperExome V1 Probes,,187,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB055
AMLP-489,1542 Skin Met1,AM2-100,Pending,,,0.00,,,,188,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-490,1479 LN Met 1,AM2-088,Pending,,,0.00,,,,189,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-491,375 Mel1,AM2-067,Captured,KAPAEX-21,169.0,49.85,13,KAPA HyperExome V1 Probes,,190,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING",Mel,Acral Melanoma,
AMLP-492,413 MIS2,AM2-080,Captured,KAPAEX-21,180.0,29.95,13,KAPA HyperExome V1 Probes,,191,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING",MIS,Acral Melanoma,
AMLP-493,414 Mel1,AM2-080,Captured,KAPAEX-21,180.0,29.85,13,KAPA HyperExome V1 Probes,,192,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING",Mel,Acral Melanoma,
AMLP-494,99 MIS1,AM2-061,Pending,,,0.00,,,,87,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,
AMLP-495,399 MIS1,AM2-074,Pending,,,0.00,,,,88,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,
AMLP-496,402 Mel2,AM2-074,Pending,,,0.00,,,,89,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-497,4 Mel1,AM2-058,Pending,,,0.00,,,,167,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-498,4 Mel1,AM2-058,Pending,,,0.00,,,,168,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-499,11 Met1,AM2-060,Pending,,,0.00,,,,169,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-500,11 Met1,AM2-060,Pending,,,0.00,,,,170,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-501,1474 Met1,AM2-086,Pending,,,0.00,,,,171,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-502,1493 Lung Met 1,AM2-090,Pending,,,0.00,,,,172,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-503,1493 Lung Met 1,AM2-090,Pending,,,0.00,,,,173,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-504,1494 Mel1,AM2-091,Pending,,,0.00,,,,174,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-505,1494 Mel1,AM2-091,Pending,,,0.00,,,,175,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-506,1496 Mel3,AM2-091,Pending,,,0.00,,,,176,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-507,1496 Mel3,AM2-091,Pending,,,0.00,,,,177,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-508,"1513 Brain Met 4, 1514 Met5",AM2-095,Pending,,,0.00,,,,178,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-509,"1513 Brain Met 4, 1514 Met5",AM2-095,Pending,,,0.00,,,,179,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-510,1548 Mel1,AM2-101,Pending,,,0.00,,,,180,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-511,1549 Mel2,AM2-101,Pending,,,0.00,,,,181,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-512,1475 Mel1,AM2-088,Pending,,,0.00,,,,182,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-513,1475 Mel1,AM2-088,Pending,,,0.00,,,,183,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-514,1471 Mel1,AM2-086,Pending,,,0.00,,,,184,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-515,1542 Skin Met1,AM2-100,Pending,,,0.00,,,,185,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-516,1479 LN Met 1,AM2-088,Pending,,,0.00,,,,186,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-517,1491 Mel1,AM2-090,Pending,,,0.00,,,,190,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-518,1492 Mel2,AM2-090,Pending,,,0.00,,,,191,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-519,101 Met1,AM2-061,Pending,,,0.00,,,,192,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-520,2246 Mel2 (New area) (MM2),AM2-061,Pending,,,0.00,,,,92,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-521,5 Met1,AM2-058,Captured,KAPAEX-20,167.0,50.00,13,KAPA HyperExome V1 Probes,,160,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB054
AMLP-522,1509 Met1,AM2-095,Pending,,,0.00,,,,96,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-523,"1511 Intestine Met 2, 1512 Met3",AM2-095,Pending,,,0.00,,,,159,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-524,1524 Mel1,AM2-097,Pending,,,0.00,,,,100,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-525,1525 MIS1,AM2-097,Pending,,,0.00,,,,101,3/2/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,
AMLP-526,2246 Mel2,AM2-061,Pending,,,0.00,,,,109,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,
AMLP-527,1490 Normal,AM2-090,Captured,KAPAEX-40,150.0,19.31,13,KAPA HyperExome V1 Probes,,102,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Normal,Acral Melanoma,
AMLP-528,1491 Mel1,AM2-090,Captured,KAPAEX-40,200.0,30.82,13,KAPA HyperExome V1 Probes,,111,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,
AMLP-529,1492 Mel2,AM2-090,Captured,KAPAEX-40,164.0,50.15,13,KAPA HyperExome V1 Probes,,115,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,
AMLP-530,1510 Normal,AM2-095,Captured,KAPAEX-40,43.0,50.00,13,KAPA HyperExome V1 Probes,,126,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Normal,Acral Melanoma,
AMLP-531,1509 Met1,AM2-095,Captured,KAPAEX-40,194.0,50.00,13,KAPA HyperExome V1 Probes,,128,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,
AMLP-532,"1511 Intestine Met 2, 1512 Met3",AM2-095,Captured,KAPAEX-40,79.0,50.32,13,KAPA HyperExome V1 Probes,,129,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Met,Acral Melanoma,
AMLP-533,1526 Normal,AM2-097,Captured,KAPAEX-40,58.0,50.43,13,KAPA HyperExome V1 Probes,,130,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Normal,Acral Melanoma,
AMLP-534,1524 Mel1,AM2-097,Captured,KAPAEX-40,125.0,50.00,13,KAPA HyperExome V1 Probes,,131,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,
AMLP-535,1525 MIS1,AM2-097,Captured,KAPAEX-40,117.0,50.00,13,KAPA HyperExome V1 Probes,,132,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",MIS,Acral Melanoma,
AMLP-536,1531 Mel3,AM2-099,Pending,,,0.00,,,,133,3/31/2023,"HyperPREP, Ligation: 30 min at 20 oC.",Mel,Acral Melanoma,
AMLP-537,1610 Invasive Primary Mel,AM2-114,Captured,KAPAEX-19,200.0,34.36,13,KAPA HyperExome V1 Probes,,110,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB057
AMLP-538,1562 Brain Met 5,AM2-102,Pending,,,0.00,,,,117,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-539,1563 Brain Met 6,AM2-102,Pending,,,0.00,,,,134,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-540,99 MIS1,AM2-061,Captured,KAPAEX-22,68.0,50.37,13,KAPA HyperExome V1 Probes,,135,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-577 in BCB055",MIS,Acral Melanoma,
AMLP-541,399 MIS1,AM2-074,Captured,KAPAEX-18,97.0,50.00,13,KAPA HyperExome V1 Probes,,139,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,BCB057
AMLP-542,402 Mel2,AM2-074,Captured,KAPAEX-18,79.0,50.32,13,KAPA HyperExome V1 Probes,,140,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-580 in BCB057",Mel,Acral Melanoma,
AMLP-543,1491 Mel1,AM2-090,Pending,,,0.00,,,,141,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-544,1492 Mel2,AM2-090,Captured,KAPAEX-25,127.5,50.00,13,KAPA HyperExome V1 Probes,,142,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB056
AMLP-545,101 Met1,AM2-061,Pending,,,0.00,,,,143,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-546,2246 Mel2 (New area) (MM2),AM2-061,Pending,,,0.00,,,,144,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-547,1524 Mel1,AM2-097,Pending,,,0.00,,,,145,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-548,1525 MIS1,AM2-097,Pending,,,0.00,,,,146,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,
AMLP-549,1531 Mel3,AM2-099,Captured,KAPAEX-26,102.0,50.25,13,KAPA HyperExome V1 Probes,,147,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB054
AMLP-550,1543 Brain Met2,AM2-100,Pending,,,0.00,,,,148,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-551,100 Mel1,AM2-061,Pending,,,0.00,,,,149,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-552,401 Mel1,AM2-074,Captured,KAPAEX-18,46.0,50.00,13,KAPA HyperExome V1 Probes,,150,4/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB057
AMLP-553,4 Mel1,AM2-058,Captured,KAPAEX-20,54.0,50.47,13,KAPA HyperExome V1 Probes,,124,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles. Sequenced as AMLP-439",Mel,Acral Melanoma,BCB054
AMLP-554,4 Mel1,AM2-058,Pending,KAPAEX-20,62.0,50.41,13,KAPA HyperExome V1 Probes,,124,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles. Sequenced as AMLP-439",Mel,Acral Melanoma,BCB054
AMLP-555,4 Mel1,AM2-058,Pending,,,0.00,,,,124,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-556,1474 Met1,AM2-086,Captured,KAPAEX-23,57.0,50.00,13,KAPA HyperExome V1 Probes,,130,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-445 in BCB055",Met,Acral Melanoma,
AMLP-557,1474 Met1,AM2-086,Pending,,,0.00,,,,130,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-558,1548 Mel1,AM2-101,Captured,KAPAEX-24,37.0,50.00,13,KAPA HyperExome V1 Probes,,144,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-458 in BCB056",Mel,Acral Melanoma,
AMLP-559,1548 Mel1,AM2-101,Captured,KAPAEX-24,42.5,50.00,13,KAPA HyperExome V1 Probes,,144,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-458 in BCB056",Mel,Acral Melanoma,
AMLP-560,1471 Mel1,AM2-086,Captured,KAPAEX-23,62.0,50.41,13,KAPA HyperExome V1 Probes,,187,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-488 in BCB055",Mel,Acral Melanoma,
AMLP-561,1471 Mel1,AM2-086,Pending,,,0.00,,,,187,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-562,1542 Skin Met1,AM2-100,Captured,KAPAEX-24,57.5,50.00,13,KAPA HyperExome V1 Probes,,188,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB056
AMLP-563,1542 Skin Met1,AM2-100,Captured,KAPAEX-24,57.5,50.00,13,KAPA HyperExome V1 Probes,,188,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-562 in BCB056",Met,Acral Melanoma,
AMLP-564,11 Met1,AM2-060,Pending,,,0.00,,,,127,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-565,11 Met1,AM2-060,Pending,,,0.00,,,,127,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,
AMLP-566,101 Met1,AM2-061,Captured,KAPAEX-22,67.0,50.38,13,KAPA HyperExome V1 Probes,,192,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Acral Melanoma,BCB055
AMLP-567,101 Met1,AM2-061,Captured,KAPAEX-22,71.0,50.00,13,KAPA HyperExome V1 Probes,,192,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-566 in BCB055",Met,Acral Melanoma,
AMLP-568,1524 Mel1,AM2-097,Pending,,,0.00,,,,145,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-569,1524 Mel1,AM2-097,Pending,,,0.00,,,,145,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-570,1524 Mel1,AM2-097,Pending,,,0.00,,,,145,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-571,1525 MIS1,AM2-097,Pending,,,0.00,,,,146,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,
AMLP-572,1525 MIS1,AM2-097,Pending,,,0.00,,,,146,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,
AMLP-573,100 Mel1,AM2-061,Captured,KAPAEX-22,63.0,50.40,13,KAPA HyperExome V1 Probes,,149,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB055
AMLP-574,100 Mel1,AM2-061,Captured,KAPAEX-22,63.0,48.09,13,KAPA HyperExome V1 Probes,,149,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-573 in BCB055",Mel,Acral Melanoma,
AMLP-575,401 Mel1,AM2-074,Captured,KAPAEX-18,27.5,50.00,13,KAPA HyperExome V1 Probes,,150,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-552 in BCB057",Mel,Acral Melanoma,
AMLP-576,401 Mel1,AM2-074,Captured,KAPAEX-18,23.5,50.00,13,KAPA HyperExome V1 Probes,,150,4/21/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-552 in BCB057",Mel,Acral Melanoma,
AMLP-577,99 MIS1,AM2-061,Captured,KAPAEX-22,68.0,50.37,13,KAPA HyperExome V1 Probes,,135,4/28/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Acral Melanoma,BCB055
AMLP-578,2246 Mel2,AM2-061,Captured,KAPAEX-22,78.0,50.00,13,KAPA HyperExome V1 Probes,,144,4/28/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB055
AMLP-579,2246 Mel2,AM2-061,Captured,KAPAEX-22,79.0,50.00,13,KAPA HyperExome V1 Probes,,144,4/28/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-578 in BCB055",Mel,Acral Melanoma,
AMLP-580,402 Mel2,AM2-074,Captured,KAPAEX-18,79.0,50.00,13,KAPA HyperExome V1 Probes,,140,4/28/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB057
AMLP-581,1549 Mel2,AM2-101,Pending,,,0.00,,,,146,4/28/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-582,1549 Mel2,AM2-101,Pending,,,0.00,,,,146,4/28/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,
AMLP-583,1491 Mel1,AM2-090,Captured,KAPAEX-25,116.5,50.00,13,KAPA HyperExome V1 Probes,,141,4/28/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB056
AMLP-584,1549 Mel2,AM2-101,Captured,KAPAEX-24,145.0,50.00,13,KAPA HyperExome V1 Probes,,146,4/28/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Acral Melanoma,BCB056
BB008_CGH10-013,2938 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR08,,,,Tumor,"2010-2017,Iwei Translocations",Nimblegen5_BB8
BB008_CGH11-036,2939 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR10,,,,Tumor,"2010-2017,Iwei Translocations",Nimblegen5_BB8
BB008_CGH11-153,2940 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR09,,,,Tumor,"2010-2017,Iwei Translocations",Nimblegen5_BB8
BB008_CGH11-386,2941 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR11,,,,Tumor,"2010-2017,Iwei Translocations",Nimblegen5_BB8
BB008_CGH12-047,2942 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR07,,,,Tumor,"2010-2017,Iwei Translocations",Nimblegen5_BB8
BB008_HW2NC,2943 Normal,,Captured,BB8_CL,,NaN,16,NimV1,L2DR01,,,"Mucosal Melanoma, vulva, Hong Wu",Normal,"2010-2017,Mucosal Melanoma",Nimblegen5_BB8
BB008_HW2TC,2944 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR02,,,"Mucosal Melanoma, vulva, Hong Wu",Tumor,"2010-2017,Mucosal Melanoma",Nimblegen5_BB8
BB008_HW8NC,2945 Normal,,Captured,BB8_CL,,NaN,16,NimV1,L2DR03,,,"Mucosal Melanoma, Urethra, Hong Wu",Normal,"2010-2017,Mucosal Melanoma",Nimblegen5_BB8
BB008_HW8TC,2946 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR04,,,"Mucosal Melanoma, Urethra, Hong Wu",Tumor,"2010-2017,Mucosal Melanoma",Nimblegen5_BB8
BB008_HW9-NB,2947 Normal,,Captured,BB8_CL,,NaN,16,NimV1,L2DR05,,,"Mucosal Melanoma, Blood, Hong Wu",Normal,2010-2017,Nimblegen5_BB8
BB008_HW9TC,2948 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR06,,,"Mucosla Melanoma, vulva, Hong Wu",Tumor,2010-2017,Nimblegen5_BB8
BB008_Kit 227 Acral WT,2949 Tumor,,Captured,BB8_CL,,NaN,16,NimV1,L2DR12,,,,Tumor,2010-2017,Nimblegen5_BB8
BB008_LAL-L1,2950 Cell Line,,Captured,BB8_CL,,NaN,16,NimV1,L2DR15,,,,Tumor,2010-2017,Nimblegen5_BB8
BB008_LAL-L2,2951 Cell Line,,Captured,BB8_CL,,NaN,16,NimV1,L2DR16,,,,Tumor,2010-2017,Nimblegen5_BB8
BB008_NB2107,2952 Cell Line,,Captured,BB8_CL,,NaN,16,NimV1,L2DR14,,,,Tumor,2010-2017,Nimblegen5_BB8
BB008_WM3211,2953 Cell Line,,Captured,BB8_CL,,NaN,16,NimV1,L2DR13,,,,Tumor,2010-2017,Nimblegen5_BB8
BB09_Bivona_L7,3819 Lung Cell Line,,Captured,BB9_CL,,NaN,13,NimV1,L2DR01,,,Unknown,Tumor,2010-2017,Nimblegen6_BB9
BB09_Bivona_L8,3820 Lung Cell Line,,Captured,BB9_CL,,NaN,13,NimV1,L2DR02,,,Unknown,Tumor,2010-2017,Nimblegen6_BB9
BB09_Bivona_L9,3821 Lung Cell Line,,Captured,BB9_CL,,NaN,13,NimV1,L2DR03,,,Unknown,Tumor,2010-2017,Nimblegen6_BB9
BB09_Bivona_L10,3811 Lung Cell Line,,Captured,BB9_CL,,NaN,13,NimV1,L2DR04,,,Unknown,Tumor,2010-2017,Nimblegen6_BB9
BB09_Bivona_L11,3812 Lung Cell Line,,Captured,BB9_CL,,NaN,13,NimV1,L2DR16,,,Unknown,Tumor,2010-2017,Nimblegen6_BB9
BB09_CGH11_029,2959 Tumor,,Captured,BB9_CL,,NaN,13,NimV1,L2DR11,,,NTRK3 Translocation case,Tumor,2010-2017,Nimblegen6_BB9
BB09_CGH11_045,2960 Tumor,,Captured,BB9_CL,,NaN,13,NimV1,L2DR12,,,ROS1 Translocation case,Tumor,2010-2017,Nimblegen6_BB9
BB09_CGH11_092,2961 Tumor,,Captured,BB9_CL,,NaN,13,NimV1,L2DR13,,,ROS1 Translocation case,Tumor,2010-2017,Nimblegen6_BB9
BB09_CGH11_125,2962 Tumor,,Captured,BB9_CL,,NaN,13,NimV1,L2DR14,,,NTRK3 Translocation case,Tumor,2010-2017,Nimblegen6_BB9
BB09_CGH11_194,2963 Tumor,,Captured,BB9_CL,,NaN,13,NimV1,L2DR15,,,BRAF Translocation case,Tumor,2010-2017,Nimblegen6_BB9
BB09_HW3_N,2964 Normal,,Captured,BB9_CL,,NaN,13,NimV1,L2DR06,,,"Normal Melanoma, Mucosal nasal sinus",Normal,2010-2017,Nimblegen6_BB9
BB09_HW3_T,2965 Tumor,,Captured,BB9_CL,,NaN,13,NimV1,L2DR05,,,"TUMOR Mucosal Melanoma, nasal sinus",Tumor,2010-2017,Nimblegen6_BB9
BB09_HW4_N,2966 Normal,,Captured,BB9_CL,,NaN,13,NimV1,L2DR08,,,"Normal Melanoma, Mucosal nasal sinus",Normal,2010-2017,Nimblegen6_BB9
BB09_HW4_T,2967 Tumor,,Captured,BB9_CL,,NaN,13,NimV1,L2DR07,,,"TUMOR Melanoma, Mucosal nasal sinus",Tumor,2010-2017,Nimblegen6_BB9
BB09_HW6_ND,2968 Normal,,Captured,BB9_CL,,NaN,13,NimV1,L2DR10,,,"Normal Melanoma, Mucosal vulva",Normal,2010-2017,Nimblegen6_BB9
BB09_HW6_TD,2969 Tumor,,Captured,BB9_CL,,NaN,13,NimV1,L2DR09,,,"Tumor Melanoma, Mucosal vulva",Tumor,2010-2017,Nimblegen6_BB9
Bivona__L_17,3823 Lung Cell Line,,Captured,BB7_CL,,NaN,13,NimV1,L2DR11,,,,Tumor,2010-2017,Nimblegen4 (BB007)
Bivona_L_1,3813 Lung Cells,,Captured,BB4_CL,,NaN,,NimV1,L2DR11,,,,Tumor,2010-2017,Nimblegen1_BB004
Bivona_L_18,3824 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR12,,,,Tumor,2010-2017,Nimblegen4 (BB007)
Bivona_L_19,3825 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR13,,,,Tumor,2010-2017,Nimblegen4 (BB007)
Bivona_L2,3814 Lung Cells,,Captured,BB4_CL,,NaN,,NimV1,L2DR12,,,,Tumor,2010-2017,Nimblegen1_BB004
Bivona_L3,3815 Lung Cells,,Captured,BB4_CL,,NaN,,NimV1,L2DR13,,,,Tumor,2010-2017,Nimblegen1_BB004
Bivona_L4,3816 Lung Cells,,Captured,BB4_CL,,NaN,,NimV1,L2DR14,,,,Tumor,2010-2017,Nimblegen1_BB004
Bivona_L5,3817 Lung Cells,,Captured,BB4_CL,,NaN,,NimV1,L2DR15,,,,Tumor,2010-2017,Nimblegen1_BB004
Bivona_L6,3817 Lung Cells,,Captured,BB4_CL,,NaN,,NimV1,L2DR16,,,,Tumor,2010-2017,Nimblegen1_BB004
bMV_10_0206,2979 Tumor,,Captured,,,NaN,13,Ampliconseq,L2DR15,,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",Tumor,2010-2017,Nimblegen29_BB34
BN_M1,2980 Tumor,,Captured,,,NaN,13,NimV2,L2DR15,,,Hunter Blue Nevus (Melanoma in Nevus Project),Tumor,2010-2017,Nimblegen36_BB43
BN_M2,2981 Tumor,,Captured,,,NaN,13,NimV2,L2DR16,,,Hunter Blue Nevus (Melanoma in Nevus Project),Tumor,2010-2017,Nimblegen36_BB43
BN_N1,2982 Normal,,Captured,,,NaN,13,NimV2,L2DR13,,,Hunter Blue Nevus (Melanoma in Nevus Project),Tumor,2010-2017,Nimblegen36_BB43
BN_N2,2983 Normal,,Captured,,,NaN,13,NimV2,L2DR14,,,Hunter Blue Nevus (Melanoma in Nevus Project),Tumor,2010-2017,Nimblegen36_BB43
Buffy_Coat,2420 Buffy Coat DNA,,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-28,,5/14/2012,Buffy Coat Derived DNA,Tumor,2010-2017,HiSeq1_BB2
CCRLP-0001,1634 Mel,CCR-003,Captured,SGPC-23,20.5,50.00,12,Small Gene Panel,,107,10/16/2021,"HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0002,1764 Mel,CCR-004,Captured,SGPC-23,66.0,50.00,12,Small Gene Panel,,108,10/16/2021,"HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0003,1648 Mel,CCR-005,Captured,SGPC-23,9.5,50.00,12,Small Gene Panel,,116,10/16/2021,"HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0004,1645 Mel,CCR-007,Captured,SGPC-23,15.5,50.00,12,Small Gene Panel,,117,10/16/2021,"HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0005,1641 Mel,CCR-008,Captured,SGPC-23,52.0,50.00,12,Small Gene Panel,,118,10/16/2021,"HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0006,1651 Mel,CCR-009,Captured,SGPC-23,136.0,36.07,12,Small Gene Panel,,119,10/16/2021,"HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0007,1644 Mel,CCR-014,Captured,SGPC-23,136.0,35.32,12,Small Gene Panel,,120,10/16/2021,"HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0008,1653 Mel,CCR-015,Captured,SGPC-23,78.0,50.00,12,Small Gene Panel,,121,10/16/2021,"HyperPlus; Frag: 10min,37oC; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0009,1695 Mel,CCR-090,Captured,SGPC-23,61.5,50.00,12,Small Gene Panel,,122,10/22/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0010,1686 Mel,CCR-083,Captured,SGPC-23,99.5,50.00,12,Small Gene Panel,,123,10/22/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0011,1682 Mel,CCR-074,Captured,SGPC-23,4.0,50.00,12,Small Gene Panel,,124,10/22/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0012,1680 Mel,CCR-066,Captured,SGPC-23,89.0,50.00,12,Small Gene Panel,,125,10/22/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0013,1635 Mel,CCR-058,Captured,SGPC-23,37.0,50.00,12,Small Gene Panel,,126,10/22/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0015,1672 Mel,CCR-048,Captured,SGPC-23,74.0,50.00,12,Small Gene Panel,,127,10/22/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0019,1660 Mel,MP-01,Captured,SGPC-23,17.0,50.00,12,Small Gene Panel,,129,10/22/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0020,1754 Mel,CCR-031,Captured,SGPC-23,75.5,50.00,12,Small Gene Panel,,130,10/22/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0021,1657 Mel,CCR-029,Captured,SGPC-23,136.0,26.15,12,Small Gene Panel,,131,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0022,1633 Mel,CCR-024,Captured,SGPC-23,135.0,50.00,12,Small Gene Panel,,132,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0023,1637 Mel,CCR-203,Captured,SGPC-23,109.5,50.00,12,Small Gene Panel,,134,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0024,1630 Mel,CCR-204,Captured,SGPC-23,54.0,50.00,12,Small Gene Panel,,136,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0025,1650 Mel,CCR-205,Captured,SGPC-23,83.0,50.00,12,Small Gene Panel,,137,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0026,1646 Mel,CCR-206,Captured,SGPC-23,79.0,50.00,12,Small Gene Panel,,138,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0027,1640 Mel,CCR-207,Captured,SGPC-23,68.0,50.00,12,Small Gene Panel,,139,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0028,1652 Mel,CCR-208,Captured,SGPC-23,61.0,50.00,12,Small Gene Panel,,140,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0029,1632 Mel,CCR-212,Captured,SGPC-23,98.0,50.00,12,Small Gene Panel,,141,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0030,1655 Mel,CCR-213,Captured,SGPC-23,136.0,33.09,12,Small Gene Panel,,142,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0031,1699 Mel,CCR-258,Captured,SGPC-23,89.5,50.00,12,Small Gene Panel,,143,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0032,1774 Mel,CCR-256,Library failed/low yield,,,0.00,,,,186,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,Mel,California Cancer Registry,
CCRLP-0034,1765 Mel,CCR-066,Captured,SGPC-23,57.5,50.00,12,Small Gene Panel,,186,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0035,1724 Mel,CCR-241,Captured,SGPC-23,53.0,50.00,12,Small Gene Panel,,147,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0037,1677 Mel,CCR-233,Captured,SGPC-23,120.5,50.00,12,Small Gene Panel,,148,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0038,1712 Mel,CCR-231,Captured,SGPC-23,61.0,50.00,12,Small Gene Panel,,149,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0039,1629 Mel,CCR-224,Captured,SGPC-23,136.0,32.00,12,Small Gene Panel,,150,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0040,1627 Mel,CCR-225,Library failed/low yield,,,0.00,,,,187,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,Mel,California Cancer Registry,
CCRLP-0041,1661 Mel,CCR-220,Captured,SGPC-23,146.0,50.00,12,Small Gene Panel,,187,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0042,1757 Mel,CCR-221,Library failed/low yield,,,0.00,,,,185,8/4/2021,DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC,Mel,California Cancer Registry,
CCRLP-0043,1658 Mel,CCR-219,Captured,SGPC-23,46.0,50.00,12,Small Gene Panel,,152,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0044,1631 Mel,CCR-217,Captured,SGPC-23,98.5,50.00,12,Small Gene Panel,,153,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0045,1757 Mel,CCR-221,Captured,"SGPC-19,SGPC-23",15.0,8.43,12,Small Gene Panel,,192,8/6/2021,"HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 66ng captured",Mel,California Cancer Registry,"BCB032,BCB038"
CCRLP-0046,1774 Mel,CCR-256,Captured,"SGPC-19,SGPC-23",15.0,8.11,12,Small Gene Panel,,157,8/6/2021,"HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 67ng captured",Mel,California Cancer Registry,"BCB032,BCB038"
CCRLP-0047,1627 Mel,CCR-225,Captured,"SGPC-19,SGPC-23",10.0,9.80,12,Small Gene Panel,,158,8/6/2021,"HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 36ng captured",Mel,California Cancer Registry,"BCB032,BCB038"
CCRLP-0048,1757 Mel,CCR-221,Captured,"SGPC-19,SGPC-23",15.0,18.99,12,Small Gene Panel,,144,8/6/2021,"HyperPrep, Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 20ng captured",Mel,California Cancer Registry,"BCB032,BCB038"
CCRLP-0049,1774 Mel,CCR-256,Captured,"SGPC-19,SGPC-23",15.0,18.29,12,Small Gene Panel,,146,8/6/2021,"HyperPrep, Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 21ng captured",Mel,California Cancer Registry,"BCB032,BCB038"
CCRLP-0050,1627 Mel,CCR-225,Captured,"SGPC-19,SGPC-23",10.0,25.64,12,Small Gene Panel,,151,8/6/2021,"HyperPrep, Ligation: 17 hrs,16oC. SGPC-23: xx Cycles post Hyb, 7ng captured",Mel,California Cancer Registry,"BCB032,BCB038"
CCRLP-0051,1681 Mel,CCR-051,Captured,SGPC-23,,0.00,12,Small Gene Panel,,97,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0052,1755 Mel,CCR-046,Captured,SGPC-23,,0.00,12,Small Gene Panel,,98,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0053,1628 Mel,CCR-034,Captured,SGPC-23,,0.00,12,Small Gene Panel,,99,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0054,1626 Mel,CCR-035,Captured,SGPC-23,,0.00,12,Small Gene Panel,,102,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0055 (DO NOT USE),1769 Mel,CCR-250,Library failed/low yield,,,NaN,,,,103,7/6/2021,Jessica practice LP,Mel,California Cancer Registry,
CCRLP-0056 (DO NOT USE),1700 Mel,CCR-235,Library failed/low yield,,,NaN,,,,104,7/6/2021,Jessica practice LP,Mel,California Cancer Registry,
CCRLP-0057 (DO NOT USE),1627 Mel,CCR-225,Library failed/low yield,,,NaN,,,,105,7/6/2021,Jessica practice LP,Mel,California Cancer Registry,
CCRLP-0058 (DO NOT USE),1757 Mel,CCR-221,Library failed/low yield,,,NaN,,,,106,7/6/2021,Jessica practice LP,Mel,California Cancer Registry,
CCRLP-0059,1769 Mel,CCR-250,Captured,SGPC-23,,0.00,12,Small Gene Panel,,103,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CCRLP-0060,1700 Mel,CCR-235,Captured,SGPC-23,,0.00,12,Small Gene Panel,,104,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Mel,California Cancer Registry,BCB038
CGH_11_361,2988 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR01,,,Iwei Translocation Project,Tumor,2010-2017,Nimblegen13_BB16
CGH_11_366,2989 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR02,,,Iwei Translocation Project,Tumor,2010-2017,Nimblegen13_BB16
CGH_11_376,2990 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR03,,,Iwei Translocation Project,Tumor,2010-2017,Nimblegen13_BB16
CGH_11_388,2991 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR04,,,Iwei Translocation Project,Tumor,2010-2017,Nimblegen13_BB16
CGH_11_422,2992 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR05,,,Iwei Translocation Project,Tumor,2010-2017,Nimblegen13_BB16
CGH_12_016,2993 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR06,,,Iwei Translocation Project,Tumor,2010-2017,Nimblegen13_BB16
CGH10_16,2994 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR13,,,Iwei Translocation Case | Barcode mismatch comment in note,Tumor,2010-2017,Nimblegen7_BB10
CGH10_17,2995 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR16,,,Iwei Translocation Case,Tumor,2010-2017,Nimblegen7_BB10
CGH10_020,2996 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR06,,,Iwei Translocation Cases,Tumor,2010-2017,Nimblegen11_BB14
CGH10_049,2997 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR07,,,Iwei Translocation Cases,Tumor,2010-2017,Nimblegen11_BB14
CGH10_058,2998 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR04,,,Iwei Translocation Cases,Tumor,2010-2017,Nimblegen11_BB14
CGH10-028,2999 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR06,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH10-045,3000 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR07,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH10-058,3001 Tumor,,Captured,BB22_CL,,NaN,,WGS,L2DR04,,,,Tumor,2010-2017,WGS1_BB22
CGH10-062,3002 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR08,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11_020,3003 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR08,,,Iwei Translocation Cases,Tumor,2010-2017,Nimblegen11_BB14
CGH11_035,3004 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR09,,,Iwei Translocation Case,Tumor,2010-2017,Nimblegen7_BB10
CGH11_60,3005 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR14,,,Iwei Translocation Case,Tumor,2010-2017,Nimblegen7_BB10
CGH11_078,3006 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR01,,,Iwei Translocation Cases,Tumor,2010-2017,Nimblegen11_BB14
CGH11_080,3007 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR02,,,Iwei Translocation Cases,Tumor,2010-2017,Nimblegen11_BB14
CGH11_091,3008 Tumor,,,,,NaN,13,NimV2,L2DR12,,,"Iwei CGH, Translocation",Tumor,2010-2017,Nimblegen34_BB40
CGH11_109,2768 Tumor,,,,,NaN,13,NimV2,L2DR13,,,"Iwei CGH, Translocation ",Tumor,2010-2017,Nimblegen33_BB39
CGH11_252,3009 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR15,,,Iwei Translocation Case,Tumor,2010-2017,Nimblegen7_BB10
CGH11_281,3010 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR03,,,Iwei Translocation Cases,Tumor,2010-2017,Nimblegen11_BB14
CGH11_283,3011 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR05,,,Iwei Translocation Cases,Tumor,2010-2017,Nimblegen11_BB14
CGH11_292,3012 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR01,,,"ALK Iwei, Translocation",Tumor,2010-2017,Nimblegen18_BB21
CGH11_305,3013 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR02,,,"NTRK1 Iwei, Translocation",Tumor,2010-2017,Nimblegen18_BB21
CGH11_310,3014 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR03,,,"ALK Iwei, Translocation",Tumor,2010-2017,Nimblegen18_BB21
CGH11_319,3015 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR04,,,"NTRK1 Iwei, Translocation",Tumor,2010-2017,Nimblegen18_BB21
CGH11_343,3016 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR10,,,Iwei Translocation Case,Tumor,2010-2017,Nimblegen7_BB10
CGH11_348,3017 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR05,,,"NTRK1 Iwei, Translocation",Tumor,2010-2017,Nimblegen18_BB21
CGH11_410,3018 Tumor,,,,,NaN,13,NimV2,L2DR16,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen33_BB39
CGH11_424,3019 Tumor,,,,,NaN,13,NimV2,L2DR01,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen33_BB39
CGH11-011,3020 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR09,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11-035,3021 Tumor,,Captured,BB22_CL,,NaN,,WGS,L2DR09,,,,Tumor,2010-2017,WGS1_BB22
CGH11-051,3440 Unknown,,Captured,BB53_CL,,NaN,,NimV2,NextFlex 1,,7/31/2013,Iwei Translocation,,Kinome CGH Project,BioSci3_BB53
CGH11-072,3022 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR10,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11-087,3023 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR11,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11-089,3024 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR13,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11-115,3025 Tumor,,,,,NaN,13,NimV2,L2DR02,,,"Iwei, Translocation CGH, PDGFRB",Tumor,2010-2017,Nimblegen25_BB30
CGH11-147,3026 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR12,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11-158,3027 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR14,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11-166,3028 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR15,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11-172,3029 Tumor,,Captured,BB21_CL,,NaN,,NimV2,L2DR16,,,"Iwei, 7QGain",Tumor,2010-2017,Nimblegen18_BB21
CGH11-184,3030 Tumor,,,,,NaN,13,NimV2,L2DR03,,,"Iwei, Translocation CGH, PDGFRB",Tumor,2010-2017,Nimblegen25_BB30
CGH11-194,3031 Tumor,,Captured,BB22_CL,,NaN,,WGS,L2DR15,,,,Tumor,2010-2017,WGS1_BB22
CGH11-224,3032 Tumor,,Captured,,,NaN,13,NimV2,L2DR11,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen35_BB41
CGH11-229,3033 Tumor,,Captured,BB36_CL,46.0,Infinity,13,NimV2,L2DR07,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH11-231,3034 Tumor,,Captured,BB36_CL,90.9,Infinity,13,NimV2,L2DR08,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH11-232,3035 Tumor,,Captured,BB36_CL,90.9,Infinity,13,NimV2,L2DR09,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH11-237,3036 Tumor,,Captured,BB36_CL,90.9,Infinity,13,NimV2,L2DR10,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH11-252,3037 Tumor,,Captured,BB22_CL,,NaN,,WGS,L2DR01,,,,Tumor,2010-2017,WGS1_BB22
CGH11-259,3038 Tumor,,Captured,BB22_CL,90.9,Infinity,13,NimV2,L2DR11,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH11-275,2936 Normal,,Captured,,,NaN,,NimV2,L2DR12,,7/9/2013,"Iwei 7Q gain
, Swapna CGH screened, FFPE derived; Not sequenced, <2 ul volume remaining",,Kinome CGH Project,Nimblegen31_BB36
CGH11-315,3039 Tumor,,Captured,BB22_CL,90.9,Infinity,13,NimV2,L2DR12,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH11-339,3040 Tumor,,Captured,BB22_CL,90.9,Infinity,13,NimV2,L2DR13,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH11-399,1342 Tumor,,Captured,,,NaN,,NimV2,L2DR15,,7/9/2013,"Iwei 7Q gain
, Swapna CGH screened, FFPE derived; Not sequenced, <2 ul volume remaining",,Kinome CGH Project,Nimblegen31_BB36
CGH11-402,1343 Tumor,,Captured,,,NaN,,NimV2,L2DR14,,7/9/2013,"Iwei 7Q gain, Swapna CGH screened, FFPE derived",,Kinome CGH Project,Nimblegen31_BB36
CGH11-404,3041 Tumor,,Captured,BB22_CL,90.9,Infinity,13,NimV2,L2DR15,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH11-409,3042 Tumor,,Captured,BB22_CL,90.9,Infinity,13,NimV2,L2DR16,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CGH12_026,3043 Tumor,,Captured,,,NaN,13,NimV2,L2DR02,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen33_BB39
CGH12_039,2322 Tumor,,Captured,,,NaN,13,NimV2,L2DR03,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen33_BB39
CGH12_040,3045 Tumor,,Captured,,,NaN,13,NimV2,L2DR04,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen33_BB39
CGH12_053,3046 Tumor,,Captured,,,NaN,13,NimV2,L2DR05,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen33_BB39
CGH12_056,2321 Tumor,,Captured,,,NaN,13,NimV2,L2DR06,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen33_BB39
CGH12_058,2328 Tumor,,Captured,,,NaN,13,NimV2,L2DR14,,,"Iwei CGH, Translocation FLT4",Tumor,2010-2017,Nimblegen33_BB39
CGH12_135,3049 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR15,,,NTRK1,Tumor,2010-2017,Nimblegen8_BB11
CGH12_161,3050 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR16,,,NTRK1,Tumor,2010-2017,Nimblegen8_BB11
CGH12_224,3051 Tumor,,Captured,,,NaN,13,NimV2,L2DR15,,,"Iwei CGH, Translocation ",Tumor,2010-2017,Nimblegen33_BB39
CGH12_317,3052 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR13,,,NTRK3 | Barcode mismatch comment in note,Tumor,2010-2017,Nimblegen8_BB11
CGH12_343,3053 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR14,,,NTRK3,Tumor,2010-2017,Nimblegen8_BB11
CGH12-043,3054 Tumor,,Captured,,,NaN,13,NimV2,L2DR04,,,"Iwei, Translocation CGH, MET",Tumor,2010-2017,Nimblegen25_BB30
CGH12-104,3055 Tumor,,Captured,,,NaN,13,NimV2,L2DR12,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen35_BB41
CGH12-124,3056 Tumor,,Captured,,,NaN,13,NimV2,L2DR13,,,"Iwei CGH, 7Q Gain",Tumor,2010-2017,Nimblegen35_BB41
CGH12-345,3057 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR13,,,"Iwei, Translocation CGH NTRK1",Tumor,2010-2017,Nimblegen20_BB24
CGH12-347,3058 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR14,,,"Iwei, Translocation CGH NTRK2",Tumor,2010-2017,Nimblegen20_BB24
CGH13-003,3059 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR15,,,"Iwei, Translocation CGH BRAF",Tumor,2010-2017,Nimblegen20_BB24
CGH13-009,3060 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR16,,,"Iwei, Translocation CGH NTRK1",Tumor,2010-2017,Nimblegen20_BB24
CGH13-011,3061 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR07,,,"Iwei, Translocation CGH BRAF",Tumor,2010-2017,Nimblegen20_BB24
CGH13-033,3062 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR01,,,"Iwei, Translocation CGH NTRK1",Tumor,2010-2017,Nimblegen20_BB24
CGH13-034,3063 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR02,,,"Iwei, Translocation CGH NTRK1?",Tumor,2010-2017,Nimblegen20_BB24
CGH13-041,3064 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR03,,,"Iwei, Translocation CGH NTRK3",Tumor,2010-2017,Nimblegen20_BB24
CGH13-044,3065 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR04,,,"Iwei, Translocation CGH NTRK3",Tumor,2010-2017,Nimblegen20_BB24
CGH13-046,3066 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR05,,,"Iwei, Translocation CGH BRAF",Tumor,2010-2017,Nimblegen20_BB24
CGH13-058,3067 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR06,,,"Iwei, Translocation CGH NTRK3",Tumor,2010-2017,Nimblegen20_BB24
CGH14-059,3068 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 9,,,Iwei Translocation,Tumor,2010-2017,BioSci15_BB67
CGP-583,2091 Nevus,JJS1,Captured,CL_59,,NaN,,UCSF500,,,,JJS1_Nev_R1.fastq; JJS1_Nev_R2.fastq,Nevus,Melanoma Evolution,CL_59
CGP-584,2092 Mel,JJS1,Captured,CL_59,,NaN,,UCSF500,,,,1_MEL_R1.fastq; 1_MEL_R2.fastq,Mel,Melanoma Evolution,CL_59
CGP-585,2093 Normal,JJS10,Captured,CL_66,,NaN,,UCSF500,,,,,Normal,Melanoma Evolution,CL_66
CGP-586,2094 Nevus,JJS10,Captured,CL_66,,NaN,,UCSF500,,,,,Nevus,Melanoma Evolution,CL_66
CGP-587,2095 Mel,JJS10,Captured,CL_66,,NaN,,UCSF500,,,,,Mel,Melanoma Evolution,CL_66
CGP-600,2265 Normal,JJS7,Captured,CL_36,,NaN,,UCSF500,,,,,Normal,Melanoma Evolution,CL_36
CGP-601,2266 Nevus,JJS7,Captured,CL_36,,NaN,,UCSF500,,,,,Nevus,Melanoma Evolution,CL_36
CGP-602,2267 Mel,JJS7,Captured,CL_36,,NaN,,UCSF500,,,,,Mel,Melanoma Evolution,CL_36
CGP-603,2099 Normal,JJS8,Captured,CL_36,,NaN,,UCSF500,,,,,Normal,Melanoma Evolution,CL_36
CGP-604,2100 Nevus,JJS8,Captured,CL_36,,NaN,,UCSF500,,,,,Nevus,Melanoma Evolution,CL_36
CGP-605,2101 Mel,JJS8,Captured,CL_36,,NaN,,UCSF500,,,,,Mel,Melanoma Evolution,CL_36
CGP-606,2072 Normal,JJS14,Captured,CL_37,34.1,Infinity,,UCSF500,,,,Mean Target Coverage: 143,Normal,Melanoma Evolution,CL_37
CGP-607,2073 Nevus,JJS14,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 390,Nevus,Melanoma Evolution,CL_37
CGP-608,2074 Mel,JJS14,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 393,Mel,Melanoma Evolution,CL_37
CGP-609,2075 Normal,JJS16,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 412,Normal,Melanoma Evolution,CL_37
CGP-610,2076 Nevus,JJS16,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 385,Nevus,Melanoma Evolution,CL_37
CGP-611,2077 Mel,JJS16,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 450,Mel,Melanoma Evolution,CL_37
CGP-612,2078 Normal,JJS17,Captured,CL_37,11.6,Infinity,,UCSF500,,,,Mean Target Coverage: 28,Normal,Melanoma Evolution,CL_37
CGP-613,2079 Nevus,JJS17,Captured,CL_37,57.2,Infinity,,UCSF500,,,,Mean Target Coverage: 227,Nevus,Melanoma Evolution,CL_37
CGP-614,2080 Mel,JJS17,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 346,Mel,Melanoma Evolution,CL_37
CGP-615,2084 Normal,JJS19,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 519,Normal,Melanoma Evolution,CL_37
CGP-616,2085 Nevus,JJS19,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 396,Nevus,Melanoma Evolution,CL_37
CGP-617,2086 Mel,JJS19,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 473,Mel,Melanoma Evolution,CL_37
CGP-618,2087 Normal,JJS20,Captured,CL_37,60.3,Infinity,,UCSF500,,,,Mean Target Coverage: 272,Normal,Melanoma Evolution,CL_37
CGP-619,2088 Nevus,JJS20,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 370,Nevus,Melanoma Evolution,CL_37
CGP-620,2089 Mel,JJS20,Captured,CL_37,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 401,Mel,Melanoma Evolution,CL_37
CGP-664,2062 Normal,JJS5,Captured,CL_41,33.0,Infinity,,UCSF500,,,,Mean Target Coverage: 99,Normal,Melanoma Evolution,CL_41
CGP-665,2063 Nevus,JJS5,Captured,CL_41,33.0,Infinity,,UCSF500,,,,Mean Target Coverage: 126,Nevus,Melanoma Evolution,CL_41
CGP-666,2064 Mel,JJS5,Captured,CL_41,44.6,Infinity,,UCSF500,,,,Mean Target Coverage: 274,Mel,Melanoma Evolution,CL_41
CGP-667,2065 Normal,JJS12,Captured,CL_41,35.0,Infinity,,UCSF500,,,,Mean Target Coverage: 151,Normal,Melanoma Evolution,CL_41
CGP-668,2066 Nevus,JJS12,Captured,CL_41,15.3,Infinity,,UCSF500,,,,Mean Target Coverage: 47,Nevus,Melanoma Evolution,CL_41
CGP-669,2067 Mel,JJS12,Captured,CL_41,24.4,Infinity,,UCSF500,,,,Mean Target Coverage: 67,Mel,Melanoma Evolution,CL_41
CGP-672,2081 Normal,JJS18,Captured,CL_41,10.4,Infinity,,UCSF500,,,,Mean Target Coverage: 18,Normal,Melanoma Evolution,CL_41
CGP-673,2082 Nevus,JJS18,Captured,CL_41,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 320,Nevus,Melanoma Evolution,CL_41
CGP-674,2083 Mel,JJS18,Captured,CL_41,38.5,Infinity,,UCSF500,,,,Mean Target Coverage: 164,Mel,Melanoma Evolution,CL_41
CGP-675,2058 Normal,JJS3,Captured,CL_41,58.9,Infinity,,UCSF500,,,,Mean Target Coverage: 228,Normal,Melanoma Evolution,CL_41
CGP-676,2059 Nevus,JJS3,Captured,CL_41,42.8,Infinity,,UCSF500,,,,Mean Target Coverage: 161,Nevus,Melanoma Evolution,CL_41
CGP-677,2060 Mel1,JJS3,Captured,CL_41,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 279,Mel,Melanoma Evolution,CL_41
CGP-678,2061 Mel2,JJS3,Captured,CL_41,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 337,Mel,Melanoma Evolution,CL_41
CGP-679,2105 Normal,JJS11,Captured,CL_51,,NaN,,UCSF500,,,,,Normal,Melanoma Evolution,CL_51
CGP-680,2106 Nevus,JJS11,Captured,CL_51,,NaN,,UCSF500,,,,,Nevus,Melanoma Evolution,CL_51
CGP-681,2107 Mel1,JJS11,Captured,CL_51,,NaN,,UCSF500,,,,,Mel,Melanoma Evolution,CL_51
CGP-682,2108 Mel2,JJS11,Captured,CL_51,,NaN,,UCSF500,,,,,Mel,Melanoma Evolution,CL_51
CGP-683,2068 Normal,JJS13,Captured,CL_41,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 311,Normal,Melanoma Evolution,CL_41
CGP-684,2069 Nevus,JJS13,Captured,CL_41,46.5,Infinity,,UCSF500,,,,Mean Target Coverage: 169,Nevus,Melanoma Evolution,CL_41
CGP-685,2070 AMB,JJS13,Captured,CL_41,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 358,,Melanoma Evolution,CL_41
CGP-686,2071 Mel,JJS13,Captured,CL_41,68.8,Infinity,,UCSF500,,,,Mean Target Coverage: 351,Mel,Melanoma Evolution,CL_41
CGP-998,2091 Nevus,JJS1,Captured,CL_59,,NaN,,UCSF500,,,,,Nevus,Melanoma Evolution,CL-59
CGP-999,2092 Mel,JJS1,Captured,CL_59,,NaN,,UCSF500,,,,,Mel,Melanoma Evolution,CL-59
CGP-1481,2153 Normal,JJS21,Captured,CL_87,,NaN,,UCSF500,,,,,Normal,2010-2017,CL-87
CGP-1482,2286 Nevus,JJS21,Captured,CL_87,,NaN,,UCSF500,,,,,Nevus,2010-2017,CL-87
CGP-1483,2285 Mel,JJS21,Captured,CL_87,,NaN,,UCSF500,,,,,Mel,2010-2017,CL-87
CGP-1544,2158 Normal,VS-04_JJS22,Captured,CL_92,,NaN,,UCSF500,,,,,Normal,2010-2017,CL_92
CGP-1545,2274 Nevus,VS-04_JJS22,Captured,CL_92,,NaN,,UCSF500,,,,,Nevus,2010-2017,CL_92
CGP-1546,2273 Mel,VS-04_JJS22,Captured,CL_92,,NaN,,UCSF500,,,,,Mel,2010-2017,CL_92
CGP-1547,2159 Normal,JJS23,Captured,CL_92,,NaN,,UCSF500,,,,,Normal,2010-2017,CL_92
CGP-1548,2276 Nevus,JJS23,Captured,CL_92,,NaN,,UCSF500,,,,,Nevus,2010-2017,CL_92
CGP-1549,2275 Mel,JJS23,Captured,CL_92,,NaN,,UCSF500,,,,,Mel,2010-2017,CL_92
CGP-1550,2170 Normal,JJS24,Captured,CL_91,,NaN,,UCSF500,,,,,Normal,2010-2017,CL_91
CGP-1551,2272 Nevus,JJS24,Captured,CL_91,,NaN,,UCSF500,,,,,Nevus,2010-2017,CL_91
CGP-1552,2271 Mel,JJS24,Captured,CL_91,,NaN,,UCSF500,,,,,Mel,2010-2017,CL_91
CGP-1553,2160 Normal,JJS25,Captured,CL_92,,NaN,,UCSF500,,,,,Normal,2010-2017,CL_92
CGP-1554,2278 Nevus,JJS25,Captured,CL_92,,NaN,,UCSF500,,,,,Nevus,2010-2017,CL_92
CGP-1555,2277 Mel,JJS25,Captured,CL_92,,NaN,,UCSF500,,,,,Mel,2010-2017,CL_92
CGP-1556,2166 Normal,JJS26,Captured,CL_92,,NaN,,UCSF500,,,,,Normal,2010-2017,CL_92
CGP-1557,2280 Nevus,JJS26,Captured,CL_92,,NaN,,UCSF500,,,,,Nevus,2010-2017,CL_92
CGP-1558,2279 Mel,JJS26,Captured,CL_92,,NaN,,UCSF500,,,,,Mel,2010-2017,CL_92
CGP-1559,2161 Normal,JJS27,Captured,CL_92,,NaN,,UCSF500,,,,,Normal,2010-2017,CL_92
CGP-1560,2282 Nevus,JJS27,Captured,CL_92,,NaN,,UCSF500,,,,,Nevus,2010-2017,CL_92
CGP-1561,2281 Mel,JJS27,Captured,CL_92,,NaN,,UCSF500,,,,,Mel,2010-2017,CL_92
CGP-1575,2162 Normal,JJS28,Captured,CL_95,,NaN,,UCSF500,,,,,Normal,2010-2017,CL_95
CGP-1576,2284 Nevus,JJS28,Captured,CL_95,,NaN,,UCSF500,,,,,Nevus,2010-2017,CL_95
CGP-1577,2283 Mel,JJS28,Captured,CL_95,,NaN,,UCSF500,,,,,Mel,2010-2017,CL_95
CGP-9008,730 Tumor,CCGL-2973,Captured,KAPAEX-03,,0.00,, SeqCap EZ MedExome,,87,,,Tumor,Clinical Cases-BCC,BCB005
CGP-9023,729 Normal,CCGL-2973,Captured,KAPAEX-03,,0.00,, SeqCap EZ MedExome,,6,,,Normal,Clinical Cases-BCC,BCB005
CHG11-402,3069 Tumor,,,,,NaN,13,NimV2,L2DR14,,,Iwei 7Q Gain,Tumor,2010-2017,Nimblegen31_BB36
CHG11-409,3442 Tumor,,Captured,BB36_CL,,NaN,,NimV2,L2DR16,,7/9/2013,"Iwei 7Q gain, Swapna CGH screened, FFPE derived",,Kinome CGH Project,Nimblegen31_BB36
CHG12-335,3070 Tumor,,Captured,BB24_CL,,NaN,,NimV2,L2DR12,,,"Iwei, Translocation CGH BRAF",Tumor,2010-2017,Nimblegen20_BB24
ChIP1_1,2887 Cell Line - Control,,Captured,BB37_CL,,NaN,,,L2DR01,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_2,2888 Cell Line - Control,,Captured,BB37_CL,,NaN,,,L2DR02,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_3,2889 Cell Line - Control,,Captured,BB37_CL,,NaN,,,L2DR03,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_4,2890 Cell Line - Knockdown,,Captured,BB37_CL,,NaN,,,L2DR04,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_5,2891 Cell Line - Knockdown,,Captured,BB37_CL,,NaN,,,L2DR05,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_6,2892 Cell Line - Knockdown,,Captured,BB37_CL,,NaN,,,L2DR06,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_7,2893 Cell Line - Control,,Captured,BB37_CL,,NaN,,,L2DR07,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_8,2894 Cell Line - Control,,Captured,BB37_CL,,NaN,,,L2DR08,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_9,2895 Cell Line - Control,,Captured,BB37_CL,,NaN,,,L2DR09,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_10,2896 Cell Line - Knockdown,,Captured,BB37_CL,,NaN,,,L2DR10,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_11,2897 Cell Line - Knockdown,,Captured,BB37_CL,,NaN,,,L2DR11,,,,Others,2010-2017,ChipSeq1_BB37
ChIP1_12,2898 Cell Line - Knockdown,,Captured,BB37_CL,,NaN,,,L2DR12,,,,Others,2010-2017,ChipSeq1_BB37
CNS_29_Normal,3071 Normal,,Captured,BB17_CL,,NaN,,NimV2,L2DR02,,,N14_2,Tumor,2010-2017,Nimblegen14_BB17
CNS_29_Tumor,3072 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR01,,,N14_1,Tumor,2010-2017,Nimblegen14_BB17
CNS_30_Tumor,3073 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR03,,,N14_3,Tumor,2010-2017,Nimblegen14_BB17
CNS_31_Tumor,3074 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR04,,,N14_4,Tumor,2010-2017,Nimblegen14_BB17
CNS_33_Tumor,3075 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR05,,,N14_5,Tumor,2010-2017,Nimblegen14_BB17
CNS_34_Normal,3076 Normal,,Captured,BB17_CL,,NaN,,NimV2,L2DR07,,,N14_7,Tumor,2010-2017,Nimblegen14_BB17
CNS_34_Tumor,3077 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR06,,,N14_6,Tumor,2010-2017,Nimblegen14_BB17
CNS_35_Tumor,3078 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR08,,,N14_8,Tumor,2010-2017,Nimblegen14_BB17
CNS_36_Tumor,3079 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR09,,,N14_9,Tumor,2010-2017,Nimblegen14_BB17
CNS_37_Tumor,3080 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR10,,,N14_10,Tumor,2010-2017,Nimblegen14_BB17
CNS_38_Tumor,3081 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR11,,,N14_11,Tumor,2010-2017,Nimblegen14_BB17
CNS_39_Tumor,3082 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR12,,,N14_12,Tumor,2010-2017,Nimblegen14_BB17
CNS_40_Tumor,3083 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR13,,,N14_13,Tumor,2010-2017,Nimblegen14_BB17
CNS_41_Tumor,3084 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR14,,,N14_14,Tumor,2010-2017,Nimblegen14_BB17
CNS_42_Tumor,3085 Tumor,,Captured,BB27_CL,,NaN,,NimV2,L2DR08,,,,Tumor,2010-2017,Nimblegen22_BB27
CNS_43_Tumor,3085 Tumor,,Captured,BB27_CL,,NaN,,NimV2,L2DR09,,,,Tumor,2010-2017,Nimblegen22_BB27
CNS_44_Tumor,3087 Tumor,,Captured,BB27_CL,,NaN,,NimV2,L2DR10,,,,Tumor,2010-2017,Nimblegen22_BB27
CNS_48_Tumor,3088 Tumor,,Captured,BB27_CL,,NaN,,NimV2,L2DR11,,,,Tumor,2010-2017,Nimblegen22_BB27
CNS_49_Tumor,3089 Tumor,,Captured,BB27_CL,,NaN,,NimV2,L2DR12,,,,Tumor,2010-2017,Nimblegen22_BB27
CNS_50_Tumor,3090 Tumor,,Captured,BB27_CL,,NaN,,NimV2,L2DR13,,,,Tumor,2010-2017,Nimblegen22_BB27
CP1-5,3847 Tumor,,,BB74_CL,,NaN,,,NextFlex 5,,,,,2010-2017,Kapa3_BB74
CP1-10,3848 Tumor,,,BB74_CL,,NaN,,,NextFlex 4,,,,,2010-2017,Kapa3_BB74
CP1-20,3849 Tumor,,,BB74_CL,,NaN,,,NextFlex 3,,,,,2010-2017,Kapa3_BB74
CP1-40,3850 Tumor,,,BB74_CL,,NaN,,,NextFlex 2,,,,,2010-2017,Kapa3_BB74
CP1-80,3851 Tumor,,,BB74_CL,,NaN,,,NextFlex 1,,,,,2010-2017,Kapa3_BB74
CP1-Norm,3852 Normal,,,BB74_CL,,NaN,,,NextFlex 6,,,,,2010-2017,Kapa3_BB74
D12_54296_Norm,3091 Normal,,Captured,BB14_CL,,NaN,,NimV2,L2DR09,,,"Swapna DNA, screened",Tumor,2010-2017,Nimblegen11_BB14
D12_54296_Tumor,3092 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR10,,,"Swapna DNA, screened",Tumor,2010-2017,Nimblegen11_BB14
D12_54992_Norm,3093 Normal,,Captured,BB14_CL,,NaN,,NimV2,L2DR11,,,"Swapna DNA, screened",Tumor,2010-2017,Nimblegen11_BB14
D12_54992_Tumor,3094 Tumor,,Captured,BB14_CL,,NaN,,NimV2,L2DR13,,,"Swapna DNA, screened",Tumor,2010-2017,Nimblegen11_BB14
D12_67298_Norm,3095 Normal,,Captured,BB11_CL,,NaN,,NimV1,L2DR02,,,"lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation",Tumor,2010-2017,Nimblegen8_BB11
D12_67298_Tumor,3096 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR01,,,"lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation",Tumor,2010-2017,Nimblegen8_BB11
DLP-001,280 Normal,ME-01,Captured,KAPAEX-04,0.0,0.00,12, SeqCap EZ MedExome,,7,4/8/2019,,Normal,Melanoma Epigenetics,BCB005
DLP-01_RE,280 Normal,ME-01,Pending,,,0.00,,,,1,5/23/2019,,Normal,Melanoma Epigenetics,
DLP-02,281 Nevus,ME-01,Captured,KAPAEX-05,50.0,42.74,13, SeqCap EZ MedExome,,1,5/23/2019,,Nevus,Melanoma Epigenetics,BCB010
DLP-03,282 Mel,ME-01,Captured,KAPAEX-05,50.0,44.64,13, SeqCap EZ MedExome,,3,5/23/2019,,Mel,Melanoma Epigenetics,BCB010
DLP-04,283 Normal,ME-02,Captured,KAPAEX-08,15.7,50.65,13, SeqCap EZ MedExome,,3,8/23/2019,,Normal,Melanoma Epigenetics,BCB014
DLP-05,284 Nevus,ME-02,Captured,KAPAEX-08,26.7,92.07,13, SeqCap EZ MedExome,,4,5/23/2019,,Nevus,Melanoma Epigenetics,BCB014
DLP-06,285 Mel,ME-02,Captured,KAPAEX-05,50.0,42.02,13, SeqCap EZ MedExome,,5,5/23/2019,,Mel,Melanoma Epigenetics,BCB010
DLP-07,286 Normal,ME-03,Captured,KAPAEX-08,34.1,81.19,13, SeqCap EZ MedExome,,6,5/23/2019,,Normal,Melanoma Epigenetics,BCB014
DLP-08,287 Nevus,ME-03,Captured,KAPAEX-05,71.0,47.02,13, SeqCap EZ MedExome,,59,5/23/2019,,Nevus,Melanoma Epigenetics,BCB010
DLP-09,288 Mel,ME-03,Captured,KAPAEX-05,80.8,46.98,13, SeqCap EZ MedExome,,60,5/23/2019,,Mel,Melanoma Epigenetics,BCB010
DLP-10,289 Normal,ME-04,Captured,KAPAEX-08,37.1,63.97,13, SeqCap EZ MedExome,,8,4/8/2019,,Normal,Melanoma Epigenetics,BCB014
DLP-011,290 Nevus,ME-04,Captured,KAPAEX-01,75.9,49.93,13, SeqCap EZ MedExome,,7,1/2/2019,,Nevus,Melanoma Epigenetics,BCB001
DLP-012,291 Mel,ME-04,Captured,KAPAEX-01,75.9,23.64,13, SeqCap EZ MedExome,,8,1/2/2019,,Mel,Melanoma Epigenetics,BCB001
DLP-15,294 Nevus,ME-06,Captured,KAPAEX-08,34.8,80.93,13, SeqCap EZ MedExome,,61,5/23/2019,,Nevus,Melanoma Epigenetics,BCB014
DLP-16,295 Mel,ME-06,Captured,KAPAEX-08,62.5,85.62,13, SeqCap EZ MedExome,,62,5/23/2019,,Mel,Melanoma Epigenetics,BCB014
DLP-017,296 Nevus,ME-07,Captured,KAPAEX-02,139.5,50.00,13, SeqCap EZ MedExome,,9,1/2/2019,,Nevus,Melanoma Epigenetics,BCB001
DLP-018,297 Mel,ME-07,Captured,KAPAEX-02,150.7,50.07,13, SeqCap EZ MedExome,,10,1/2/2019,,Mel,Melanoma Epigenetics,BCB001
DLP-19,298 Nevus,ME-08,Captured,KAPAEX-05,50.0,70.42,13, SeqCap EZ MedExome,,11,5/23/2019,Sample removed from study,Nevus,Melanoma Epigenetics,BCB010
DLP-20,299 Mel,ME-08,Captured,KAPAEX-08,50.0,92.59,13, SeqCap EZ MedExome,,12,8/23/2019,Sample removed from study,Mel,Melanoma Epigenetics,BCB014
DLP-021,300 Nevus,ME-09,Captured,KAPAEX-01,91.3,49.89,13, SeqCap EZ MedExome,,13,1/2/2019,Sample removed from study,Nevus,Melanoma Epigenetics,BCB001
DLP-022,301 Mel,ME-09,Captured,KAPAEX-01,142.3,49.93,13, SeqCap EZ MedExome,,14,1/2/2019,Sample removed from study,Mel,Melanoma Epigenetics,BCB001
DLP-23,302 Normal,ME-10,Captured,KAPAEX-08,56.0,50.00,13, SeqCap EZ MedExome,,13,8/23/2019,,Normal,Melanoma Epigenetics,BCB014
DLP-24,303 Mel,ME-10,Captured,KAPAEX-08,15.5,64.58,13, SeqCap EZ MedExome,,69,5/23/2019,,Mel,Melanoma Epigenetics,BCB014
DLP-025,304 Normal,ME-07,Captured,KAPAEX-04,42.7,50.24,12, SeqCap EZ MedExome,,13,4/8/2019,,Normal,Melanoma Epigenetics,BCB005
DLP-026,305 Normal,ME-12,Captured,KAPAEX-03,100.0,36.36,12, SeqCap EZ MedExome,,14,4/8/2019,,Normal,Melanoma Epigenetics,BCB005
DLP-027,343 MIS,ME-12,Captured,KAPAEX-03,177.3,49.94,12, SeqCap EZ MedExome,,15,4/8/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-028,344 Mel,ME-12,Captured,KAPAEX-04,110.0,48.67,12, SeqCap EZ MedExome,,16,4/8/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-029,345 Normal,ME-13,Captured,KAPAEX-03,100.0,24.94,12, SeqCap EZ MedExome,,63,4/8/2019,,Normal,Melanoma Epigenetics,BCB005
DLP-030,346 Nevus,ME-13,Captured,KAPAEX-04,110.0,44.00,12, SeqCap EZ MedExome,,9,1/2/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-031,347 Mel,ME-13,Captured,KAPAEX-03,200.0,40.82,12, SeqCap EZ MedExome,,10,1/2/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-041,787 MIS,ME-24,Captured,KAPAEX-04,110.0,44.18,12, SeqCap EZ MedExome,,64,4/8/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-043,772 Mel,ME-18,Captured,KAPAEX-01,78.2,50.13,13, SeqCap EZ MedExome,,65,1/2/2019,,Mel,Melanoma Epigenetics,BCB001
DLP-044,773 Nevus,ME-18,Captured,KAPAEX-01,81.7,50.12,13, SeqCap EZ MedExome,,66,1/2/2019,,Nevus,Melanoma Epigenetics,BCB001
DLP-045,774 Mel,ME-19,Captured,KAPAEX-01,119.1,50.04,13, SeqCap EZ MedExome,,67,1/2/2019,,Mel,Melanoma Epigenetics,BCB001
DLP-046,775 Nevus,ME-19,Captured,KAPAEX-01,67.0,50.00,13, SeqCap EZ MedExome,,68,1/2/2019,,Nevus,Melanoma Epigenetics,BCB001
DLP-047,795 Mel,ME-27,Captured,KAPAEX-04,92.5,48.68,12, SeqCap EZ MedExome,,69,1/2/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-48,796 Nevus,ME-27,Captured,KAPAEX-08,28.0,60.87,13, SeqCap EZ MedExome,,70,1/2/2019,,Nevus,Melanoma Epigenetics,BCB014
DLP-049,776 Mel,ME-20,Captured,KAPAEX-01,130.8,49.92,13, SeqCap EZ MedExome,,71,1/2/2019,,Mel,Melanoma Epigenetics,BCB001
DLP-050,777 Nevus,ME-20,Captured,KAPAEX-01,110.6,50.05,13, SeqCap EZ MedExome,,72,1/2/2019,,Nevus,Melanoma Epigenetics,BCB001
DLP-052,789 Nevus,ME-25,Captured,KAPAEX-04,99.8,49.90,12, SeqCap EZ MedExome,,65,4/8/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-053,794 Mel,ME-26,Captured,KAPAEX-04,110.0,47.83,12, SeqCap EZ MedExome,,75,1/2/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-053_RE,794 Mel,ME-26,Pending,,,0.00,,,,75,5/23/2019,,Mel,Melanoma Epigenetics,
DLP-054,793 Nevus,ME-26,Captured,KAPAEX-04,58.4,48.67,12, SeqCap EZ MedExome,,76,4/8/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-054_RE,793 Nevus,ME-26,Pending,,,0.00,,,,76,5/23/2019,,Nevus,Melanoma Epigenetics,
DLP-055,779 Mel,ME-21,Captured,KAPAEX-02,136.7,50.07,13, SeqCap EZ MedExome,,73,1/2/2019,Sample removed from study,Mel,Melanoma Epigenetics,BCB001
DLP-056,780 Nevus,ME-21,Captured,KAPAEX-02,146.2,50.07,13, SeqCap EZ MedExome,,74,1/2/2019,Sample removed from study,Nevus,Melanoma Epigenetics,BCB001
DLP-59,805 Mel,ME-11,Captured,KAPAEX-04,59.1,50.08,12, SeqCap EZ MedExome,,66,5/23/2019,,Tumor,Melanoma Epigenetics,BCB005
DLP-059_RE2,805 Mel,ME-11,Captured,KAPAEX-08,30.0,50.00,12, SeqCap EZ MedExome,,83,5/24/2019,,Mel,Melanoma Epigenetics,BCB014
DLP-059_RE3,805 Mel,ME-11,Captured,KAPAEX-08,9.5,50.00,12, SeqCap EZ MedExome,,83,8/23/2019,,Mel,Melanoma Epigenetics,BCB014
DLP-061,781 Mel,ME-22,Captured,KAPAEX-01,159.5,50.00,13, SeqCap EZ MedExome,,79,1/2/2019,,Mel,Melanoma Epigenetics,BCB001
DLP-062,782 Nevus,ME-22,Captured,KAPAEX-01,71.4,49.93,13, SeqCap EZ MedExome,,80,1/2/2019,,Nevus,Melanoma Epigenetics,BCB001
DLP-065,784 Mel,ME-23,Captured,KAPAEX-03,173.8,49.94,12, SeqCap EZ MedExome,,67,4/8/2019,Sample removed from study,Tumor,Melanoma Epigenetics,BCB005
DLP-68,797 Normal,ME-27,Captured,KAPAEX-08,46.8,78.00,13, SeqCap EZ MedExome,,68,4/8/2019,,Normal,Melanoma Epigenetics,BCB014
DLP-069,778 Normal,ME-20,Captured,KAPAEX-03,100.0,44.84,12, SeqCap EZ MedExome,,71,4/8/2019,,Normal,Melanoma Epigenetics,BCB005
DLP-070,790 Normal,ME-25,Captured,KAPAEX-04,55.5,50.00,12, SeqCap EZ MedExome,,72,4/8/2019,,Normal,Melanoma Epigenetics,BCB005
DLP-071,792 Normal,ME-26,Captured,KAPAEX-04,61.7,50.16,12, SeqCap EZ MedExome,,73,4/8/2019,,Normal,Melanoma Epigenetics,BCB005
DLP-72,786 Normal,ME-23,Captured,KAPAEX-05,25.0,37.31,13, SeqCap EZ MedExome,,74,5/23/2019,Sample removed from study,Normal,Melanoma Epigenetics,BCB010
DLP-073,783 Normal,ME-22,Captured,KAPAEX-04,39.9,49.87,12, SeqCap EZ MedExome,,77,4/8/2019,,Normal,Melanoma Epigenetics,BCB005
DLP-75,788 Nevus,ME-24,Captured,KAPAEX-05,44.1,50.11,13, SeqCap EZ MedExome,,84,5/23/2019,,Nevus,Melanoma Epigenetics,BCB010
DLP-76,791 Mel,ME-25,Captured,KAPAEX-08,51.3,76.57,13, SeqCap EZ MedExome,,85,5/23/2019,,Mel,Melanoma Epigenetics,BCB014
DLP-79,801 Nevus,ME-28,Captured,KAPAEX-05,41.7,50.24,13, SeqCap EZ MedExome,,86,5/23/2019,,Nevus,Melanoma Epigenetics,BCB010
DLP-80,802 Mel,ME-28,Captured,KAPAEX-08,36.6,61.00,13, SeqCap EZ MedExome,,87,5/23/2019,,Mel,Melanoma Epigenetics,BCB014
DLP-81,785 Nevus,ME-23,Captured,KAPAEX-08,41.4,75.27,13, SeqCap EZ MedExome,,92,5/23/2019,Sample removed from study,Nevus,Melanoma Epigenetics,BCB014
DLP-83,804 Normal,ME-08,Captured,KAPAEX-08,53.5,178.33,13, SeqCap EZ MedExome,,93,5/23/2019,Sample removed from study,Normal,Melanoma Epigenetics,BCB014
DLP-85,884 MIS,ME-08,Captured,KAPAEX-05,41.0,49.40,13, SeqCap EZ MedExome,,94,5/23/2019,Sample removed from study,MIS,Melanoma Epigenetics,BCB010
DLP-86,885 MIS1,ME-23,Captured,KAPAEX-05,50.0,18.38,13, SeqCap EZ MedExome,,96,5/23/2019,,MIS,Melanoma Epigenetics,BCB010
DLP-87,895 Normal,ME-06,Captured,KAPAEX-08,51.0,50.00,13, SeqCap EZ MedExome,,95,8/23/2019,,Normal,Melanoma Epigenetics,BCB014
DLP-88,886 Blue Nevus,ME-35,Captured,KAPAEX-08,50.0,9.47,13, SeqCap EZ MedExome,,32,6/20/2019,,,Melanoma Epigenetics,BCB014
DLP-89,887 Blue Nevus,ME-30,Captured,KAPAEX-05,50.0,12.82,13, SeqCap EZ MedExome,,33,6/20/2019,,,Melanoma Epigenetics,BCB010
DLP-90,888 Blue Nevus,ME-31,Captured,KAPAEX-05,50.0,10.80,13, SeqCap EZ MedExome,,34,6/20/2019,,,Melanoma Epigenetics,BCB010
DLP-91,889 Blue Nevus,ME-32,Captured,KAPAEX-05,50.0,23.70,13, SeqCap EZ MedExome,,35,6/20/2019,,,Melanoma Epigenetics,BCB010
DLP-92,890 Blue Nevus,ME-33,Captured,KAPAEX-05,50.0,43.10,13, SeqCap EZ MedExome,,36,6/20/2019,,,Melanoma Epigenetics,BCB010
DLP-93,891 Blue Nevus,ME-34,Captured,KAPAEX-05,50.0,44.64,13, SeqCap EZ MedExome,,37,6/20/2019,,,Melanoma Epigenetics,BCB010
DLP-94,892 Mel,ME-29,Captured,KAPAEX-05,50.0,25.13,13, SeqCap EZ MedExome,,38,6/20/2019,,Mel,Melanoma Epigenetics,BCB010
DLP-95,893 Nevus,ME-29,Captured,KAPAEX-05,50.0,15.15,13, SeqCap EZ MedExome,,39,6/20/2019,,Nevus,Melanoma Epigenetics,BCB010
DLP-96,894 Normal,ME-29,Captured,KAPAEX-05,25.0,8.36,13, SeqCap EZ MedExome,,40,6/20/2019,,Normal,Melanoma Epigenetics,BCB010
DLP-98,1430 Normal,ME-18,Captured,KAPAEX-14,100.0,17.83,, SeqCap EZ MedExome,,131,8/2/2020,,,Melanoma Epigenetics,BCB023
DLP-99,1431 Normal,ME-19,Captured,KAPAEX-14,100.0,39.53,, SeqCap EZ MedExome,,132,8/2/2020,,,Melanoma Epigenetics,BCB023
DLP-100,1432 Normal,ME-24,Library failed/low yield,,,0.00,,,,133,8/2/2020,,,Melanoma Epigenetics,
DLP-101,293 Mel,ME-05,Captured,KAPAEX-15,89.0,50.00,, SeqCap EZ MedExome,,179,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-102,292 Nevus,ME-05,Captured,KAPAEX-15,62.5,50.00,, SeqCap EZ MedExome,,180,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-103,1442 MIS1,ME-06,Captured,KAPAEX-15,17.5,50.00,, SeqCap EZ MedExome,,181,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-104,1443 MIS2,ME-06,Captured,KAPAEX-15,15.0,50.00,, SeqCap EZ MedExome,,182,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-105,349 Mel,ME-14,Captured,KAPAEX-14,78.5,50.00,, SeqCap EZ MedExome,,183,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-106,351 Mel,ME-15,Captured,KAPAEX-15,128.0,50.00,, SeqCap EZ MedExome,,184,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-107,350 Nevus,ME-15,Captured,KAPAEX-15,74.0,50.00,, SeqCap EZ MedExome,,185,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-108,353 Mel,ME-16,Captured,KAPAEX-14,91.0,50.00,, SeqCap EZ MedExome,,186,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-109,352 Nevus,ME-16,Captured,KAPAEX-15,20.5,50.00,, SeqCap EZ MedExome,,187,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-110,1441 MIS1,ME-16,Captured,KAPAEX-15,23.5,50.00,, SeqCap EZ MedExome,,188,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-111,1444 MIS2,ME-16,Captured,KAPAEX-15,42.5,50.00,, SeqCap EZ MedExome,,189,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-112,354 Normal,ME-17,Library failed/low yield,,,0.00,,,,190,9/3/2020,Sample removed from study,,Melanoma Epigenetics,
DLP-113,355 MIS,ME-17,Pending,,,0.00,,,,191,9/3/2020,Sample removed from study,,Melanoma Epigenetics,
DLP-114,1433 Normal,ME-28,Captured,KAPAEX-15,161.0,50.00,, SeqCap EZ MedExome,,192,9/3/2020,,,Melanoma Epigenetics,BCB023
DLP-115,1434 Normal,ME-11,Captured,KAPAEX-14,36.0,50.00,, SeqCap EZ MedExome,,2,9/28/2020,,,Melanoma Epigenetics,BCB023
DLP-116,348 Nevus,ME-14,Captured,KAPAEX-14,35.0,50.00,, SeqCap EZ MedExome,,31,9/28/2020,,,Melanoma Epigenetics,BCB023
DLP-117,352 Nevus,ME-16,Captured,KAPAEX-14,121.0,50.00,, SeqCap EZ MedExome,,55,9/28/2020,,,Melanoma Epigenetics,BCB023
DLP-118,1441 MIS1,ME-16,Captured,KAPAEX-14,149.5,50.00,, SeqCap EZ MedExome,,56,9/28/2020,,,Melanoma Epigenetics,BCB023
DLP-119,1432 Normal,ME-24,Captured,KAPAEX-14,31.0,50.00,, SeqCap EZ MedExome,,73,9/28/2020,,,Melanoma Epigenetics,BCB023
DLP-120,1444 MIS2,ME-16,Captured,KAPAEX-14,98.5,50.00,, SeqCap EZ MedExome,,75,9/28/2020,,,Melanoma Epigenetics,BCB023
DLP-121,1447 Normal,ME-05,Captured,KAPAEX-15,141.0,50.00,, SeqCap EZ MedExome,,109,10/10/2020,,,Melanoma Epigenetics,BCB023
DLP-122,1451 Normal,ME-06,Captured,KAPAEX-15,76.0,50.00,, SeqCap EZ MedExome,,82,10/10/2020,,,Melanoma Epigenetics,BCB023
DLP-123,1446 Normal,ME-10,Captured,KAPAEX-14,76.0,50.00,, SeqCap EZ MedExome,,85,10/10/2020,,,Melanoma Epigenetics,BCB023
DLP-124,1448 Normal,ME-14,Captured,KAPAEX-14,35.0,50.00,, SeqCap EZ MedExome,,86,10/10/2020,,,Melanoma Epigenetics,BCB023
DLP-125,1449 Normal,ME-15,Captured,KAPAEX-15,150.0,29.01,, SeqCap EZ MedExome,,100,10/10/2020,,,Melanoma Epigenetics,BCB023
DLP-126,1450 Normal,ME-16,Captured,KAPAEX-14,100.0,33.33,, SeqCap EZ MedExome,,101,10/10/2020,,,Melanoma Epigenetics,BCB023
DLP-127,2111 Mel,JJS19,Captured,KAPAEX-37,88.0,50.29,13,KAPA HyperExome V1 Probes,,153,10/4/2022,,Mel,Melanoma Epigenetics,BCB067
DLP-128,2113 Normal,JJS19,Captured,KAPAEX-37,49.0,50.52,13,KAPA HyperExome V1 Probes,,154,10/4/2022,,Normal,Melanoma Epigenetics,BCB067
DLP-129,"2112 Nevus, 2130 Nevus",JJS19,Captured,KAPAEX-37,80.0,50.31,13,KAPA HyperExome V1 Probes,,155,10/4/2022,,Nevus,Melanoma Epigenetics,BCB067
DLP-130,2114 Mel,ME-43,Captured,KAPAEX-37,71.0,50.00,13,KAPA HyperExome V1 Probes,,156,10/4/2022,,Mel,Melanoma Epigenetics,BCB067
DLP-131,2115 Nevus,ME-43,Captured,KAPAEX-38,124.0,50.00,13,KAPA HyperExome V1 Probes,,157,10/4/2022,,Nevus,Melanoma Epigenetics,BCB067
DLP-132,2116 Normal,ME-43,Captured,KAPAEX-37,32.0,50.79,13,KAPA HyperExome V1 Probes,,158,10/4/2022,,Normal,Melanoma Epigenetics,BCB067
DLP-133,2131 Mel,ME-40,Captured,KAPAEX-37,63.0,50.00,13,KAPA HyperExome V1 Probes,,159,10/4/2022,,Mel,Melanoma Epigenetics,BCB067
DLP-134,2132 Nevus,ME-40,Captured,KAPAEX-37,61.0,50.00,13,KAPA HyperExome V1 Probes,,160,10/4/2022,,Nevus,Melanoma Epigenetics,BCB067
DLP-135,2133 Normal,ME-40,Captured,KAPAEX-37,27.0,50.94,13,KAPA HyperExome V1 Probes,,161,10/4/2022,,Normal,Melanoma Epigenetics,BCB067
DLP-136,281 Nevus,ME-01,Captured,KAPAEX-37,99.0,50.25,13,KAPA HyperExome V1 Probes,,162,10/4/2022,,Nevus,Melanoma Epigenetics,BCB067
DLP-137,772 Mel,ME-18,Captured,KAPAEX-38,135.0,50.00,13,KAPA HyperExome V1 Probes,,163,10/4/2022,,Mel,Melanoma Epigenetics,BCB067
DLP-138,773 Nevus,ME-18,Captured,KAPAEX-37,53.0,50.48,13,KAPA HyperExome V1 Probes,,164,10/4/2022,,Nevus,Melanoma Epigenetics,BCB067
DLP-139,776 Mel,ME-20,Captured,KAPAEX-38,138.0,40.12,13,KAPA HyperExome V1 Probes,,165,10/4/2022,,Mel,Melanoma Epigenetics,BCB067
DLP-140,781 Mel,ME-22,Captured,KAPAEX-38,138.0,50.00,13,KAPA HyperExome V1 Probes,,166,10/4/2022,,Mel,Melanoma Epigenetics,BCB067
DM_2,3099 Tumor,,,,,NaN,13,Ampliconseq,L2DR14,,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",Tumor,Desmoplastic Melanoma,Nimblegen29_BB34
DM_4_Normal,3101 Normal,,Captured,BB16_CL,,NaN,,NimV2,L2DR08,,,,Tumor,Desmoplastic Melanoma,Nimblegen13_BB16
DM_4_Tumor,3102 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR07,,,,Tumor,Desmoplastic Melanoma,Nimblegen13_BB16
DM_6_Normal,3103 Normal,,,,,NaN,13,NimV2,L2DR03,,,,Tumor,Desmoplastic Melanoma,Nimblegen35_BB41
DM_6_Tumor,3104 Tumor,,Captured,BB19_CL,,NaN,,NimV2,L2DR12,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_10_Normal,3106 Normal,,Captured,BB19_CL,,NaN,,NimV2,L2DR02,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_10_Tumor,3107 Tumor,,Captured,BB19_CL,,NaN,13,NimV2,L2DR01,,,,Tumor,Desmoplastic Melanoma,"Nimblegen16_BB19,Nimblegen27_BB32"
DM_13_2_Tumor,3110 Tumor,,,,,NaN,13,NimV2,L2DR09,,,,Tumor,Desmoplastic Melanoma,Nimblegen26_BB31
DM_17_Normal,3112 Normal,,Captured,BB19_CL,,NaN,,NimV2,L2DR04,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_17_Tumor,3113 Tumor,,Captured,BB19_CL,,NaN,,NimV2,L2DR03,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_18_Normal,3114 Normal,,Captured,BB19_CL,,NaN,,NimV2,L2DR06,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_18_Tumor,3116 Tumor,,Captured,BB19_CL,,NaN,13,NimV2,L2DR05,,,,Tumor,Desmoplastic Melanoma,"Nimblegen16_BB19,Nimblegen27_BB32"
DM_22_Normal,3117 Normal,,Captured,BB19_CL,,NaN,,NimV2,L2DR08,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_22_Tumor,3118 Tumor,,Captured,BB19_CL,,NaN,,NimV2,L2DR07,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_23_Normal,3119 Normal,,Captured,BB19_CL,,NaN,,NimV2,L2DR10,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_23_Tumor,3120 Tumor,,Captured,BB19_CL,,NaN,,NimV2,L2DR09,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_25_Normal,3121 Normal,,Captured,BB19_CL,,NaN,,NimV2,L2DR13,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_25_Tumor,3122 Tumor,,Captured,BB19_CL,,NaN,,NimV2,L2DR11,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_31_2_Tumor,3123 Tumor,,Captured,,,NaN,13,NimV2,L2DR08,,,,Tumor,Desmoplastic Melanoma,Nimblegen27_BB32
DM_31_Normal,3124 Normal,,Captured,,,NaN,13,NimV2,L2DR04,,,,Tumor,Desmoplastic Melanoma,Nimblegen35_BB41
DM_36_2_Tumor,3125 Tumor,,Captured,,,NaN,13,NimV2,L2DR09,,,,Tumor,Desmoplastic Melanoma,Nimblegen27_BB32
DM_36_Normal,3126 Normal,,Captured,,,NaN,13,NimV2,L2DR05,,,,Tumor,Desmoplastic Melanoma,Nimblegen35_BB41
DM_37_Tumor,3127 Tumor,,Captured,BB19_CL,,NaN,,NimV2,L2DR14,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_42_Normal,3128 Normal,,Captured,,,NaN,13,NimV2,L2DR06,,,,Tumor,Desmoplastic Melanoma,Nimblegen35_BB41
DM_42_Tumor,3129 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR14,,,,Tumor,Desmoplastic Melanoma,Nimblegen17_BB20
DM_43_Normal,3130 Normal,,Captured,,,NaN,13,NimV2,L2DR14,,,,Tumor,Desmoplastic Melanoma,Nimblegen38_BB45
DM_43_Tumor,3131 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR15,,,,Tumor,Desmoplastic Melanoma,Nimblegen17_BB20
DM_48_Tumor,3132 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR16,,,,Tumor,Desmoplastic Melanoma,Nimblegen17_BB20
DM_49_2_Tumor,3133 Tumor,,Captured,,,NaN,13,NimV2,L2DR02,,,,Tumor,Desmoplastic Melanoma,Nimblegen30_BB35
DM_49_Normal,3134 Normal,,Captured,,,NaN,13,NimV2,L2DR15,,,,Tumor,Desmoplastic Melanoma,Nimblegen38_BB45
DM_51_Tumor,3135 Tumor,,Captured,,,NaN,13,NimV2,L2DR04,,,,Tumor,Desmoplastic Melanoma,Nimblegen27_BB32
DM_58_Normal,3136 Normal,,Captured,,,NaN,13,NimV2,L2DR16,,,,Tumor,Desmoplastic Melanoma,Nimblegen38_BB45
DM_58_Tumor,3137 Tumor,,Captured,,,NaN,13,NimV2,L2DR06,,,,Tumor,Desmoplastic Melanoma,Nimblegen27_BB32
DM_59_Tumor,3138 Tumor,,Captured,,,NaN,13,NimV2,L2DR07,,,,Tumor,Desmoplastic Melanoma,Nimblegen27_BB32
DM_64_1_Normal,3139 Normal,,Captured,,,NaN,13,NimV2,L2DR03,,,,Tumor,Desmoplastic Melanoma,Nimblegen27_BB32
DM_64_Tumor,3140 Tumor,,Captured,,,NaN,13,NimV2,L2DR02,,,,Tumor,Desmoplastic Melanoma,Nimblegen27_BB32
DM_65_2_Tumor,3141 Tumor,,Captured,,,NaN,13,NimV2,L2DR01,,,,Tumor,Desmoplastic Melanoma,Nimblegen38_BB45
DM_68_Tumor,3142 Tumor,,Captured,,,NaN,13,NimV2,L2DR07,,,,Tumor,Desmoplastic Melanoma,Nimblegen35_BB41
DM_74_1_Tumor,3143 Tumor,,Captured,,,NaN,13,NimV2,L2DR01,,,,Tumor,Desmoplastic Melanoma,Nimblegen36_BB43
DM_74_2_Tumor,3145 Tumor,,Captured,,,NaN,13,NimV2,L2DR10,,,,Tumor,Desmoplastic Melanoma,"Nimblegen27_BB32,Nimblegen34_BB40"
DM_93_3_Tumor,3146 Tumor,,Captured,,,NaN,13,NimV2,L2DR02,,,,Tumor,Desmoplastic Melanoma,Nimblegen38_BB45
DM_93_cgn,3147 Tumor,,Captured,BB19_CL,,NaN,,NimV2,L2DR16,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_93_Normal,3148 Normal,,Captured,BB19_CL,,NaN,,NimV2,L2DR15,,,,Tumor,Desmoplastic Melanoma,Nimblegen16_BB19
DM_94_Normal,3149 Normal,,Captured,,,NaN,13,NimV2,L2DR11,,,,Tumor,Desmoplastic Melanoma,Nimblegen26_BB31
DM_94_Tumor,3150 Tumor,,Captured,,,NaN,13,NimV2,L2DR10,,,,Tumor,Desmoplastic Melanoma,Nimblegen26_BB31
DM_95_2_Tumor,3151 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR09,,,,Tumor,Desmoplastic Melanoma,Nimblegen13_BB16
DM_95_Normal,3152 Normal,,Captured,BB16_CL,,NaN,,NimV2,L2DR10,,,,Tumor,Desmoplastic Melanoma,Nimblegen13_BB16
DM_96_2_Tumor,3153 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR11,,,,Tumor,Desmoplastic Melanoma,Nimblegen13_BB16
DM_96_Normal,3154 Normal,,Captured,BB16_CL,,NaN,,NimV2,L2DR13,,,,Tumor,Desmoplastic Melanoma,Nimblegen13_BB16
DM_98_2_Normal,3155 Normal,,Captured,,,NaN,13,NimV2,L2DR13,,,,Tumor,Desmoplastic Melanoma,Nimblegen26_BB31
DM_98_Tumor,3156 Tumor,,Captured,,,NaN,13,NimV2,L2DR12,,,,Tumor,Desmoplastic Melanoma,Nimblegen26_BB31
DM_99_Normal,3159 Tumor,,Captured,,,NaN,13,NimV2,L2DR15,,,,Tumor,Desmoplastic Melanoma,Nimblegen26_BB31
DM_99_Tumor,3159 Tumor,,Captured,,,NaN,13,NimV2,L2DR14,,,,Tumor,Desmoplastic Melanoma,"Nimblegen34_BB40,Nimblegen26_BB31"
DM_100_Tumor_Pool,3160 Tumor,,Captured,,,NaN,13,NimV2,L2DR03,,,,Tumor,Desmoplastic Melanoma,Nimblegen38_BB45
DM_101_IS,3161 Unknown,,Captured,,,NaN,13,NimV2,L2DR10,,,,Tumor,Desmoplastic Melanoma,Nimblegen35_BB41
DM_101_Normal,3162 Normal,,Captured,,,NaN,13,NimV2,L2DR09,,,,Tumor,Desmoplastic Melanoma,Nimblegen35_BB41
DM_101_Tumor,3163 Tumor,,Captured,,,NaN,13,NimV2,L2DR08,,,,Tumor,Desmoplastic Melanoma,Nimblegen35_BB41
DM_102_Tumor,3164 Tumor,,Captured,,,NaN,13,NimV2,L2DR02,,,,Tumor,Desmoplastic Melanoma,Nimblegen36_BB43
DM-60-Tumor,3165 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 18,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM-61-Tumor,3166 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 19,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM-62-Tumor,3167 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 20,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM-63-Tumor,3168 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 21,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM-66-Tumor,3169 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 22,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM-67-Tumor,3170 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 23,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM-69-Tumor,3171 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 24,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM-70-Tumor,3172 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 1,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM-81-Tumor,3173 Tumor,,Captured,,,NaN,13,NimV2mix3,NextFlex 2,,,,Tumor,Desmoplastic Melanoma,BioSci15_BB67
DM1_Normal,3174 Normal,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR01,,,,Normal,Desmoplastic Melanoma,Nimblegen10_BB13
DM1_Tumor,3175 Tumor,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR02,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM1-Tert-Amplicon,3940 Tumor,,Captured,,,NaN,,NimV2,,,,"Hunter Amplicon Sequencing
; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul",Tumor,Desmoplastic Melanoma,Nimblegen44_BB54
DM2_Normal,3176 Normal,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR03,,,,Normal,Desmoplastic Melanoma,Nimblegen10_BB13
DM2_Tumor,3177 Tumor,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR04,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM2-Tert-Amplicon,3100 Tumor,,Captured,,,NaN,,NimV2,,,,"Hunter Amplicon Sequencing
; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul",Tumor,Desmoplastic Melanoma,Nimblegen44_BB54
DM5 _Tumor,3178 Tumor,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR06,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM5_Normal,3179 Normal,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR05,,,,Normal,Desmoplastic Melanoma,Nimblegen10_BB13
DM7_Normal,3180 Normal,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR07,,,,Normal,Desmoplastic Melanoma,Nimblegen10_BB13
DM7_Tumor,3181 Tumor,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR08,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM8Tumor,3105 Tumor,,Captured,,,NaN,,NimV2mix1,,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM8TumorCrest,3901 Tumor,,Captured,BB13_CL,,NaN,,NimV2mix1,,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM11_Normal,3182 Normal,,Captured,BB15_CL,,NaN,,NimV2,L2DR02,,,Less than the optimal 100 ng input conc. For End Repair,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM11_Tumor,3183 Tumor,,Captured,BB15_CL,,NaN,,NimV2,L2DR01,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM11-Tert-Amplicon,3939 Tumor,,Captured,,,NaN,,NimV2,,,,"Hunter DM Amplicon Sequencing; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul
; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul",Tumor,Desmoplastic Melanoma,Nimblegen40_BB47
DM12_Normal,3184 Normal,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR09,,,,Normal,Desmoplastic Melanoma,Nimblegen10_BB13
DM12_Tumor,3185 Tumor,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR10,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM13_Normal,3186 Normal,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR11,,,,Normal,Desmoplastic Melanoma,Nimblegen10_BB13
DM13_Tumor,3187 Tumor,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR12,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM14_Normal,3188 Normal,,Captured,BB15_CL,,NaN,,NimV2,L2DR04,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM14_Tumor,3189 Tumor,,Captured,BB15_CL,,NaN,,NimV2,L2DR03,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM14-Tert-Amplicon,3111 Tumor,,Captured,,,NaN,,NimV2,,,,"Hunter DM Amplicon Sequencing; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul
; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul

""",Tumor,Desmoplastic Melanoma,Nimblegen40_BB47
DM16_Normal,3190 Normal,,,,,NaN,13,NimV2,L2DR10,,,,Tumor,Desmoplastic Melanoma,Nimblegen25_BB30
DM16_Tumor,3191 Tumor,,,,,NaN,13,NimV2,L2DR09,,,,Tumor,Desmoplastic Melanoma,Nimblegen25_BB30
DM21_Normal,3192 Normal,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR13,,,,Normal,Desmoplastic Melanoma,Nimblegen10_BB13
DM21_Tumor,3193 Tumor,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR14,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM26_Normal,3194 Normal,,Captured,BB15_CL,,NaN,,NimV2,L2DR06,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM26_Tumor,3195 Tumor,,Captured,BB15_CL,,NaN,,NimV2,L2DR05,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM28_Normal,3196 Normal,,Captured,BB15_CL,,NaN,,NimV2,L2DR08,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM28_Tumor,3197 Tumor,,Captured,BB15_CL,,NaN,,NimV2,L2DR07,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM29_2_Tumor,3198 Tumor,,Captured,BB15_CL,,NaN,,NimV2,L2DR09,,,Less than the optimal 100 ng input conc. For End Repair,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM29_Normal,3199 Normal,,Captured,BB15_CL,,NaN,,NimV2,L2DR10,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM34_Normal,3200 Normal,,Captured,BB15_CL,,NaN,,NimV2,L2DR12,,,Less than the optimal 100 ng input conc. For End Repair,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM34_Tumor,3201 Tumor,,Captured,BB15_CL,,NaN,,NimV2,L2DR11,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM37_1_Normal,3202 Normal,,,,,NaN,13,NimV2,L2DR06,,,,Tumor,Desmoplastic Melanoma,Nimblegen25_BB30
DM45_2_Tumor,3203 Tumor,,,,,NaN,13,NimV2,L2DR07,,,,Tumor,Desmoplastic Melanoma,Nimblegen25_BB30
DM45_NFKBIE_Amplicon,3853 Tumor,,Captured,,,NaN,,NimV2,,,,"Hunter Amplicon Sequencing
; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul",Tumor,Desmoplastic Melanoma,Nimblegen44_BB54
DM45_Normal,3204 Normal,,,,,NaN,13,NimV2,L2DR08,,,,Tumor,Desmoplastic Melanoma,Nimblegen25_BB30
DM55 Normal,3205 Normal,,Captured,BB15_CL,,NaN,,NimV2,L2DR14,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM55_Tumor,3206 Tumor,,Captured,BB15_CL,,NaN,,NimV2,L2DR13,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM77_2_Tumor,3207 Tumor,,,,,NaN,13,NimV2,L2DR11,,,,Tumor,Desmoplastic Melanoma,Nimblegen25_BB30
DM77_Normal,3208 Normal,,,,,NaN,13,NimV2,L2DR12,,,,Tumor,Desmoplastic Melanoma,Nimblegen25_BB30
DM79_2_Tumor,3209 Tumor,,Captured,BB15_CL,,NaN,,NimV2,L2DR15,,,Less than the optimal 100 ng input conc. For End Repair,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM79_NFKBIE_Amplicon,3854 Tumor,,Captured,,,NaN,,NimV2,,,,"Hunter Amplicon Sequencing
; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul",Tumor,Desmoplastic Melanoma,Nimblegen44_BB54
DM79_Normal,3210 Normal,,Captured,BB15_CL,,NaN,,NimV2,L2DR16,,,,Tumor,Desmoplastic Melanoma,Nimblegen12_BB15
DM93_2_Tumor,3211 Tumor,,,,,NaN,13,NimV2,L2DR05,,,,Tumor,Desmoplastic Melanoma,Nimblegen25_BB30
DM93_CGN,3212 Tumor,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR16,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DM93_NFKBIE_Amplicon,3855 Tumor,,Captured,,,NaN,,NimV2,,,,"Hunter Amplicon Sequencing
; Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul",,Desmoplastic Melanoma,Nimblegen44_BB54
DM93_Normal,3213 Normal,,Captured,BB13_CL,,NaN,13,NimV2mix1,L2DR15,,,,Normal,Desmoplastic Melanoma,Nimblegen10_BB13
DM93_Tumor,3856 Tumor,,Captured,,,NaN,,NimV2mix1,,,,,Tumor,Desmoplastic Melanoma,Nimblegen10_BB13
DP12_200,3214 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR11,,,Dr. Lutzky's Case,Tumor,Desmoplastic Melanoma,Nimblegen7_BB10
DPN_1_Tumor,2859 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR08,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_3_Tumor,3216 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR09,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_4_Tumor,3217 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR10,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_5_Normal,2777 Normal,,,,,NaN,13,NimV2,L2DR08,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen37_BB44
DPN_5_Tumor,2863 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR11,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_6_Tumor,2864 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR12,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_7_Tumor,2778 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR13,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_8_Normal,2769 Normal,,,,,NaN,13,NimV2,L2DR08,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen34_BB40
DPN_8_Tumor,2770 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR14,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_9_Normal,3220 Normal,,,,,NaN,13,NimV2,L2DR09,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen34_BB40
DPN_9_Tumor,2867 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR15,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_10_Tumor,3222 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR16,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_11_Tumor,3223 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR01,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_12_Tumor,3224 Tumor,,Captured,BB25_CL,,NaN,,NimV2,L2DR02,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen21_BB25
DPN_14_Tumor,3225 Tumor,,Captured,BB27_CL,,NaN,,NimV2mix3,L2DR03,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen22_BB27
DPN_16_Tumor,2872 Tumor,,Captured,BB27_CL,,NaN,,NimV2mix3,L2DR04,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen22_BB27
DPN_17_Tumor,2873 Tumor,,Captured,BB27_CL,,NaN,,NimV2mix3,L2DR05,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen22_BB27
DPN_18_Normal,2771 Normal,,,,,NaN,13,NimV2,L2DR11,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen34_BB40
DPN_18_Tumor,2874 Tumor,,Captured,BB27_CL,,NaN,,NimV2mix3,L2DR06,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen22_BB27
DPN_19_Tumor,2875 Tumor,,Captured,BB27_CL,,NaN,,NimV2mix3,L2DR07,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen22_BB27
DPN_35,3230 Tumor,,Captured,,,NaN,13,NimV2,L2DR04,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen38_BB45
DPN_CNN 30,3231 Tumor,,Captured,,,NaN,13,NimV2,L2DR12,,,Iwei DPN (Control Normal Nevus),Normal,Deep Penetrating Nevus,Nimblegen37_BB44
DPN_CNN 32,3232 Normal,,Captured,,,NaN,13,NimV2,L2DR13,,,Iwei DPN (Control Normal Nevus),Normal,Deep Penetrating Nevus,Nimblegen37_BB44
DPN_Conv_35,3233 Tumor,,Captured,,,NaN,13,NimV2,L2DR05,,,Iwei DPN,Tumor,Deep Penetrating Nevus,Nimblegen38_BB45
DPN_MM 20,3234 Tumor,,Captured,,,NaN,13,NimV2,L2DR09,,,Iwei DPN (DPN like Melanoma),Tumor,Deep Penetrating Nevus,Nimblegen37_BB44
DPN_MM 21,3235 Tumor,,Captured,,,NaN,13,NimV2,L2DR10,,,Iwei DPN (DPN like Melanoma),Tumor,Deep Penetrating Nevus,Nimblegen37_BB44
DPN_MM 22,3236 Tumor,,Captured,,,NaN,13,NimV2,L2DR11,,,Iwei DPN (DPN like Melanoma),Tumor,Deep Penetrating Nevus,Nimblegen37_BB44
DPN-49-Graz,2696 Tumor,,Captured,BB90_CL,55.6,19.42,,NimV3,C1,,,,,Deep Penetrating Nevus,Kapa17_BB90
DPN49-Tumor,2696 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN50-Tumor,3860 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN51-Tumor,3861 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN52-Tumor,3862 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN53-Tumor,3863 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN54-Tumor,3864 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN55-Tumor,3865 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN56-Tumor,3866 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN57-Tumor,3867 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN58-Tumor,3868 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN59-Tumor,3869 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN60-Tumor,3870 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN61-Tumor,3871 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DPN62-Tumor,3872 Tumor,,Captured,BB87_CL,,NaN,,NimV3,,,,,Tumor,Deep Penetrating Nevus,Kapa14_BB87
DT10_63051C,3237 Normal,,,,,NaN,13,NimV2,L2DR07,,,Ivanka Normal (for #9),Normal,2010-2017,Nimblegen33_BB39
EXLP-01,1311 Normal,WS-02,Captured,"WGS-01,WGS-03,WGS-01_rerun,WGS-03_rerun",21.5,6.99,,Whole Genome Sequencing,,121,8/5/2020,Whole Genome Sequencing (WGS),Normal,Werner Syndrome,"BCB022,BCB024,BCB034,BCB035"
EXLP-02,1312 Met1,WS-02,Pending,,,0.00,,,,122,8/5/2020,,Met,Werner Syndrome,
EXLP-03,1313 Met2,WS-02,Pending,,,0.00,,,,123,8/5/2020,,Met,Werner Syndrome,
EXLP-04,1314 Met3,WS-02,Captured,"WGS-01,WGS-03,WGS-01_rerun,WGS-03_rerun",21.5,3.04,,Whole Genome Sequencing,,124,8/5/2020,Whole Genome Sequencing (WGS),Met,Werner Syndrome,"BCB022,BCB024,BCB034,BCB035"
EXLP-05,1426 Met4,WS-02,Captured,"WGS-01,WGS-03,WGS-01_rerun,WGS-03_rerun",21.5,5.00,,Whole Genome Sequencing,,125,8/5/2020,Whole Genome Sequencing (WGS),Met,Werner Syndrome,"BCB022,BCB024,BCB034,BCB035"
EXLP-06,1428 MIS1,WS-01,Library failed/low yield,,,0.00,,,,126,8/5/2020,,MIS,Werner Syndrome,
EXLP-07,1435 Invasive 2,WS-01,Library failed/low yield,,,0.00,,,,127,8/5/2020,,Others,Werner Syndrome,
EXLP-08,1438 Normal,WS-01,Pending,,,0.00,,,,128,8/5/2020,,Normal,Werner Syndrome,
EXLP-09,1439 Invasive 5,WS-01,Captured,"WGS-01,WGS-03,WGS-01_rerun,WGS-03_rerun",21.5,2.84,,Whole Genome Sequencing,,129,8/5/2020,Whole Genome Sequencing (WGS),Others,Werner Syndrome,"BCB022,BCB024,BCB034,BCB035"
EXLP-10,1440 Invasive 6,WS-01,Captured,"WGS-01,WGS-03,WGS-01_rerun,WGS-03_rerun",21.5,7.35,,Whole Genome Sequencing,,130,8/5/2020,Whole Genome Sequencing (WGS),Others,Werner Syndrome,"BCB022,BCB024,BCB034,BCB035"
EXLP-11,1438 Normal,WS-01,Captured,"WGS-01,WGS-03,WGS-01_rerun,WGS-03_rerun",21.4,14.00,,Whole Genome Sequencing,,128,9/3/2020,Whole Genome Sequencing (WGS),Normal,Werner Syndrome,"BCB022,BCB024,BCB034,BCB035"
EXLP-12,1314 Met3,WS-02,Pending,,,0.00,,,,90,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Werner Syndrome,
EXLP-13,1426 Met4,WS-02,Pending,,,0.00,,,,91,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Met,Werner Syndrome,
EXLP-14,1428 MIS1,WS-01,Library failed/low yield,,,0.00,,,,92,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Werner Syndrome,
EXLP-15,1435 Invasive 2,WS-01,Library failed/low yield,,,0.00,,,,95,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Werner Syndrome,
EXLP-16,1436 Invasive 3,WS-01,Library failed/low yield,,,0.00,,,,96,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Werner Syndrome,
EXLP-17,1437 Invasive 4,WS-01,Pending,,,0.00,,,,97,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Werner Syndrome,
EXLP-18,1439 Invasive 5,WS-01,Pending,,,0.00,,,,98,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Werner Syndrome,
EXLP-19,1440 Invasive 6,WS-01,Pending,,,0.00,,,,99,1/26/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Werner Syndrome,
EXLP-20,1311 Normal,WS-02,Captured,WGS-06,35.0,17.50,,Whole Genome Sequencing,,151,5/25/2023,1 hr adapter ligation at 20oC,Normal,Werner Syndrome,BCB046
EXLP-21,1312 Met1; 1313 Met2,WS-02,Captured,"WGS-07,WGS-13",35.0,23.03,,Whole Genome Sequencing,,152,5/25/2023,1 hr adapter ligation at 20oC,Met,Werner Syndrome,"BCB047,BCB053"
EXLP-22,1314 Met3,WS-02,Captured,WGS-08,17.5,7.58,,Whole Genome Sequencing,,153,5/25/2023,1 hr adapter ligation at 20oC. Merged with EXLP-40 for sequencing (17.5 ng each),Met,Werner Syndrome,BCB048
EXLP-23,1439 Invasive 5,WS-01,Captured,WGS-04,35.0,7.45,,Whole Genome Sequencing,,154,5/25/2023,1 hr adapter ligation at 20oC,Others,Werner Syndrome,BCB044
EXLP-24,1438 Normal; 2458 Normal 2,WS-01,Captured,WGS-09,35.0,12.68,,Whole Genome Sequencing,,155,5/25/2023,1 hr adapter ligation at 20oC,Normal,Werner Syndrome,BCB049
EXLP-25,2302 Invasive 1,WS-01,Captured,WGS-05,35.0,9.23,,Whole Genome Sequencing,,156,5/25/2023,1 hr adapter ligation at 20oC,Others,Werner Syndrome,BCB045
EXLP-26,2306 Met6,WS-02,Captured,"WGS-10,WGS-13",35.0,22.01,,Whole Genome Sequencing,,157,5/25/2023,1 hr adapter ligation at 20oC,Met,Werner Syndrome,"BCB050,BCB053"
EXLP-27,2307 Met7,WS-02,Captured,WGS-11,35.0,5.11,,Whole Genome Sequencing,,158,5/25/2023,1 hr adapter ligation at 20oC,Met,Werner Syndrome,BCB051
EXLP-28,2308 Met8,WS-02,Pending,,,0.00,,,,159,5/25/2023,1 hr adapter ligation at 20oC,Met,Werner Syndrome,
EXLP-29,2309 Met9,WS-02,Pending,,,0.00,,,,160,5/25/2023,1 hr adapter ligation at 20oC,Met,Werner Syndrome,
EXLP-30,2310 Met10,WS-02,Captured,"WGS-12,WGS-13",17.5,14.96,,Whole Genome Sequencing,,161,5/25/2023,1 hr adapter ligation at 20oC,Met,Werner Syndrome,"BCB052,BCB053"
EXLP-31,1312 Met1; 1313 Met2,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,162,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Met,Werner Syndrome,BCB058
EXLP-32,1314 Met3,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,163,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Met,Werner Syndrome,BCB058
EXLP-33,1439 Invasive 5,WS-01,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,164,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Others,Werner Syndrome,BCB058
EXLP-34,2302 Invasive 1,WS-01,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,165,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Others,Werner Syndrome,BCB058
EXLP-35,2306 Met6,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,166,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Met,Werner Syndrome,BCB058
EXLP-36,2307 Met7,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,167,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Met,Werner Syndrome,BCB058
EXLP-37,2308 Met8,WS-02,Pending,,,0.00,,,,168,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Met,Werner Syndrome,
EXLP-38,2309 Met9,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,169,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Met,Werner Syndrome,BCB058
EXLP-39,2310 Met10,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,170,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Met,Werner Syndrome,BCB058
EXLP-40,1314 Met3,WS-02,Captured,WGS-08,17.5,12.07,,Whole Genome Sequencing,,153,6/13/2023,1 hr adapter ligation at 20oC. Merged with EXLP-22 for sequencing (17.5 ng each),Met,Werner Syndrome,BCB048
EXLP-41,2306 Met6,WS-02,Pending,,,0.00,,,,157,6/13/2023,1 hr adapter ligation at 20oC,Met,Werner Syndrome,
EXLP-42,2309 Met9,WS-02,Pending,,,0.00,,,,160,6/13/2023,1 hr adapter ligation at 20oC,Met,Werner Syndrome,
EXLP-43,2310 Met10,WS-02,Captured,"WGS-12,WGS-13",17.5,16.99,,Whole Genome Sequencing,,161,6/13/2023,1 hr adapter ligation at 20oC. Sequenced as EXLP-30,Met,Werner Syndrome,"BCB052,BCB053"
EXLP-44,1312 Met1; 1313 Met2,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,162,6/19/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-44 in BCB058",Met,Werner Syndrome,
EXLP-45,1314 Met3,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,163,6/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-32 in BCB058",Met,Werner Syndrome,
EXLP-46,1439 Invasive 5,WS-01,Pending,,,0.00,,,,164,6/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Others,Werner Syndrome,
EXLP-47,2302 Invasive 1,WS-01,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,165,6/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-34 in BCB058",Others,Werner Syndrome,
EXLP-48,2306 Met6,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,166,6/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-35 in BCB058",Met,Werner Syndrome,
EXLP-49,2307 Met7,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,167,6/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-36 in BCB058",Met,Werner Syndrome,
EXLP-50,2308 Met8,WS-02,Pending,,,0.00,,,,168,6/20/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Met,Werner Syndrome,
EXLP-51,2309 Met9,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,169,6/19/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-38 in BCB058",Met,Werner Syndrome,
EXLP-52,2310 Met10,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,170,6/19/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-39 in BCB058",Met,Werner Syndrome,
EXLP-53,2306 Met6,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,166,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-35 in BCB058",Met,Werner Syndrome,
EXLP-54,2310 Met10,WS-02,Captured,KAPAEX-27,,0.00,,KAPA HyperExome V1 Probes,,170,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC; Sequenced as EXLP-39 in BCB058",Met,Werner Syndrome,
-FKP1.00,1315 Tumor,KF-01,Captured,SGPC-04,8.5,0.08,13,Whole Genome Sequencing,B5,,3/5/2018,"KAPA RNA LP Kit, Capture hyb at 65c for 4 hours.",,Fusion RNA,SGPC-04
-FKP2.00,1320 Tumor,KF-02,Captured,SGPC-04,8.5,0.30,13,Whole Genome Sequencing,B6,,3/5/2018,"KAPA RNA LP Kit, Capture hyb at 65c for 4 hours.",,Fusion RNA,SGPC-04
-FKP5.00,1321 Tumor,KF-05,Captured,SGPC-04,8.5,0.02,13,Whole Genome Sequencing,B7,,3/5/2018,"KAPA RNA LP Kit, Capture hyb at 65c for 4 hours.",,Fusion RNA,SGPC-04
-FKP6.00,1322 Tumor,DP-09,Captured,SGPC-04,8.5,0.01,13,Whole Genome Sequencing,B8,,3/5/2018,"KAPA RNA LP Kit, Capture hyb at 65c for 4 hours.",,Fusion RNA,SGPC-04
-FKP8.00,1323 Tumor,KF-08,Captured,SGPC-04,8.5,0.02,13,Whole Genome Sequencing,B9,,3/5/2018,"KAPA RNA LP Kit, Capture hyb at 65c for 4 hours.",,Fusion RNA,SGPC-04
-FKP9.00,1324 Tumor,DP-17,Captured,SGPC-04,8.5,0.01,13,Whole Genome Sequencing,B10,,3/5/2018,"KAPA RNA LP Kit, Capture hyb at 65c for 4 hours.",,Fusion RNA,SGPC-04
-FKP10.00,1325 Tumor,KF-10,Captured,SGPC-04,8.5,0.00,13,Whole Genome Sequencing,B11,,3/5/2018,"KAPA RNA LP Kit, Capture hyb at 65c for 4 hours.",,Fusion RNA,SGPC-04
-FKP11.00,2250 Tumor,KF-11,Captured,SGPC-04,8.5,0.01,13,Whole Genome Sequencing,B12,,3/5/2018,"KAPA RNA LP Kit, Capture hyb at 65c for 4 hours.",,Fusion RNA,SGPC-04
G3 DP08-21965C Normal,3804 Normal,,,,,NaN,13,NimV2,L2DR04,,,Normal,Normal,2010-2017,Nimblegen30_BB35
G3 DP08-21965C Tumor,3805 Tumor,,,,,NaN,13,NimV2,L2DR03,,,Tumor,Tumor,2010-2017,Nimblegen30_BB35
G5 DP08-4205A Normal,3244 Normal,,,,,NaN,13,NimV2,L2DR06,,,Normal,Normal,2010-2017,Nimblegen30_BB35
G5 DP08-4205A Tumor,3245 Tumor,,,,,NaN,13,NimV2,L2DR05,,,Tumor,Tumor,2010-2017,Nimblegen30_BB35
H12_22775,2424 SCC,,Captured,BB3_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-32,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
H12_22776_B5_Norm,2419 Normal,,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-27,,5/14/2012,"Melanoma, Acral; Biopsy site w/residual Acral,Toe web",Normal,2010-2017,HiSeq1_BB2
H12_22794A,2425 Mel,,Captured,BB3_CL,,0.00,16,SureSelect Human All Exon V4,NF-96-33,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
HW_2_Tumor Dissect,3246 Tumor,,,,,NaN,13,NimV2,L2DR06,,,"Hong Wu, Melanoma, Mucosal Melanoma, vulva",Tumor,2010-2017,Nimblegen26_BB31
HW_3_Tumor,3247 Tumor,,,,,NaN,13,NimV2,L2DR05,,,"Hong Wu, Melanoma, Tumor Melanoma, nasal sinus",Tumor,2010-2017,Nimblegen26_BB31
HW_8_Mucosal_Tumor,3248 Tumor,,,,,NaN,13,NimV2,L2DR11,,,Hong Wu,Tumor,2010-2017,Nimblegen27_BB32
HW_A1_Cntl,3249 Normal,,Captured,BB10_CL,,NaN,,NimV1,L2DR02,,,Hong Wu,Tumor,2010-2017,Nimblegen7_BB10
HW_A1_Tumor,3250 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR01,,,Hong Wu,Tumor,2010-2017,Nimblegen7_BB10
HW_A2_Cntl,3251 Normal,,Captured,BB10_CL,,NaN,,NimV1,L2DR04,,,Hong Wu,Tumor,2010-2017,Nimblegen7_BB10
HW_A2_Tumor,3252 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR03,,,Hong Wu,Tumor,2010-2017,Nimblegen7_BB10
HW_A3_Cntl,3253 Normal,,Captured,BB10_CL,,NaN,,NimV1,L2DR06,,,Hong Wu,Tumor,2010-2017,Nimblegen7_BB10
HW_A3_Tumor,3254 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR05,,,Hong Wu,Tumor,2010-2017,Nimblegen7_BB10
HW_A4_Cntl,3255 Normal,,Captured,BB10_CL,,NaN,,NimV1,L2DR08,,,Hong Wu,Tumor,2010-2017,Nimblegen7_BB10
HW_A4_Tumor,3256 Tumor,,Captured,BB10_CL,,NaN,,NimV1,L2DR07,,,Hong Wu,Tumor,2010-2017,Nimblegen7_BB10
HW_A5_Cntl,3257 Normal,,Captured,BB12_CL,,NaN,,NimV1,L2DR02,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A5_Tumor,3258 Tumor,,Captured,BB12_CL,,NaN,,NimV1,L2DR01,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A6_Cntl,3259 Normal,,Captured,BB12_CL,,NaN,,NimV1,L2DR04,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A6_Tumor,3260 Tumor,,Captured,BB12_CL,,NaN,,NimV1,L2DR03,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A7 Cntl,3261 Normal,,Captured,BB12_CL,,NaN,,NimV1,L2DR06,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A7_Tumor,3262 Tumor,,Captured,BB12_CL,,NaN,,NimV1,L2DR05,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A8_Cntl,3263 Normal,,Captured,BB12_CL,,NaN,,NimV1,L2DR08,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A8_Tumor,3264 Tumor,,Captured,BB12_CL,,NaN,,NimV1,L2DR07,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A9_Cntl,3265 Normal,,Captured,BB12_CL,,NaN,,NimV1,L2DR10,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A9_Tumor,3266 Tumor,,Captured,BB12_CL,,NaN,,NimV1,L2DR09,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A10_Cntl,3267 Normal,,Captured,BB12_CL,,NaN,,NimV1,L2DR12,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_A10_Tumor,3268 Tumor,,Captured,BB12_CL,,NaN,,NimV1,L2DR11,,,,Tumor,2010-2017,Nimblegen9_BB12
HW_Acral_#8_Tumor,3269 Tumor,,,,,NaN,13,NimV2,L2DR07,,,"Hong Wu, FCCC, Dissect, Acral Melanoma, Dissect",Tumor,2010-2017,Nimblegen26_BB31
IRLP-001,452 Spitz mel,SMP2,Captured,KAPAEXR-17,250.0,15.78,13, SeqCap EZ MedExome,,32,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-002,454 Spitz mel,SMP4,Captured,KAPAEXR-17,250.0,15.53,13, SeqCap EZ MedExome,,33,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-003,455 Spitz mel,SMP11,Captured,KAPAEXR-18,118.0,50.00,13, SeqCap EZ MedExome,,34,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-004,456 Spitz mel,SMP12,Captured,KAPAEXR-18,125.0,49.80,13, SeqCap EZ MedExome,,35,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-005,457 Spitz mel,SMP20,Captured,KAPAEXR-18,125.0,43.86,13, SeqCap EZ MedExome,,36,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-006,458 Spitz mel,SMP48,Captured,KAPAEXR-17,250.0,28.00,13, SeqCap EZ MedExome,,37,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-007,459 Spitz mel,SMP55,Captured,KAPAEXR-17,250.0,18.20,13, SeqCap EZ MedExome,,39,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-008,460 Spitz mel,SMP56,Captured,KAPAEXR-18,125.0,25.61,13, SeqCap EZ MedExome,,40,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-009,461 Spitz mel,SMP58,Captured,KAPAEXR-18,125.0,36.55,13, SeqCap EZ MedExome,,41,1/8/2019,,Tumor,Spitz Melanoma,BCB003
IRLP-010,462 Spitz mel,SMP58,Captured,KAPAEXR-18,125.0,23.76,13, SeqCap EZ MedExome,,42,1/8/2019,,Tumor,Spitz Melanoma,BCB003
Ivanka_5_1,3270 MELANOMA,,,,63.0,Infinity,13,NimV2,L2DR12,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_5_2,3271 MELANOMA,,,,90.9,Infinity,13,NimV2,L2DR13,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_5_3,3272 MELANOMA,,,,90.9,Infinity,13,NimV2,L2DR14,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_5_4,3273 MELANOMA,,,,90.9,Infinity,13,NimV2,L2DR15,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_5_5,3274 MELANOMA,,,,90.9,Infinity,13,NimV2,L2DR16,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_9_1,3275 Mel,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR14,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_9_2,3276 Mel,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR15,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_9_3,3277 Nevus,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR16,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_9_4,3277 Nevus,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR01,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_9_5,3279 Normal,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR02,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_10_1,3280 MELANOMA,,,,90.9,Infinity,13,NimV2,L2DR01,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_10_2,3281 MELANOMA,,,,90.9,Infinity,13,NimV2,L2DR02,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_10_3,3282 MELANOMA,,,,90.9,Infinity,13,NimV2,L2DR03,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_10_4,3283 MELANOMA,,,,73.0,Infinity,13,NimV2,L2DR04,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_10_5,3284 MELANOMA,,,,80.0,Infinity,13,NimV2,L2DR05,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen28_BB33
Ivanka_12_1,3285 MELANOMA,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR03,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_12_2,3286 MELANOMA,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR04,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_12_3,3287 MELANOMA,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR05,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_12_4,3288 MELANOMA,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR06,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_12_5,3289 MELANOMA,,Captured,BB28_CL,,NaN,,NimV2mix3,L2DR07,,,,Tumor,2010-2017,Nimblegen23_BB28
Ivanka_16_1,3290 Mel,,Captured,BB29_CL,,NaN,13,NimV2,L2DR08,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_16_2,3291 Mel,,Captured,BB29_CL,,NaN,13,NimV2,L2DR09,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_16_3,3292 Nevus,,Captured,BB29_CL,,NaN,13,NimV2,L2DR10,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_16_4,3293 Nevus,,Captured,BB29_CL,,NaN,13,NimV2,L2DR11,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_16_5,3294 Normal,,Captured,BB29_CL,,NaN,13,NimV2,L2DR12,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_20_1,3806 Mel,,Captured,BB34_CL,,NaN,13,NimV2,L2DR01,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_20_2,3807 Mel,,Captured,BB34_CL,,NaN,13,NimV2,L2DR02,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_20_3,3808 Nevus,,Captured,BB34_CL,,NaN,13,NimV2,L2DR03,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_20_4,3809 Nevus,,Captured,BB34_CL,,NaN,13,NimV2,L2DR04,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_20_5,3810 Normal,,Captured,BB34_CL,,NaN,13,NimV2,L2DR05,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_21_5_Norm,2762 Normal,,Captured,BB18_CL,,NaN,,NimV1,L2DR15,,,Ivanka Normal Resequencing,Normal,2010-2017,Nimblegen15_BB18
Ivanka_22_1,3295 Mel,,Captured,BB29_CL,,NaN,13,NimV2,L2DR13,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_22_2,3296 Mel,,Captured,BB29_CL,,NaN,13,NimV2,L2DR14,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_22_3,3297 Nevus,,Captured,BB29_CL,,NaN,13,NimV2,L2DR15,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_22_4,3298 Nevus,,Captured,BB29_CL,,NaN,13,NimV2,L2DR16,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_22_5,3299 Normal,,Captured,BB29_CL,,NaN,13,NimV2,L2DR01,,,,Tumor,2010-2017,Nimblegen24_BB29
Ivanka_23_1,2766 Tumor,,Captured,BB34_CL,,NaN,13,NimV2,L2DR06,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_23_2,2766 Tumor,,Captured,BB34_CL,,NaN,13,NimV2,L2DR07,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_23_3,2766 Tumor,,Captured,BB34_CL,,NaN,13,NimV2,L2DR08,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_23_4,2766 Tumor,,Captured,BB34_CL,,NaN,13,NimV2,L2DR09,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_23_5,2766 Tumor,,Captured,BB34_CL,,NaN,13,NimV2,L2DR10,,,Ivanka Patient Melanoma,Tumor,2010-2017,Nimblegen29_BB34
Ivanka_24_5_Norm,2150 Normal,,Captured,BB18_CL,,NaN,,NimV1,L2DR16,,,Ivanka Normal Resequencing,Normal,2010-2017,Nimblegen15_BB18
Ivanka_24-1_Tert,2919 Mel,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR06,,,RIGHT GLUTEUS,Mel,2010-2017,Nimblegen2_BB5
Ivanka_24-2_Tert,2920 Mel,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR07,,,RIGHT GLUTEUS,Mel,2010-2017,Nimblegen2_BB5
IYEH-01,2456 Tumor,CS-01,Pending,,,0.00,,,,171,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Tumor,Clinical Cases,
IYEH-02,2457 Tumor,CS-01,Pending,,,0.00,,,,172,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Tumor,Clinical Cases,
IYEH-03,2247,CS-01,Pending,,,0.00,,,,173,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",,Clinical Cases,
IYEH-07,2456 Tumor,CS-01,Pending,,,0.00,,,,171,6/19/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Tumor,Clinical Cases,
IYEH-08,2457 Tumor,CS-01,Pending,,,0.00,,,,172,6/19/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Tumor,Clinical Cases,
IYEH-09,2476 Mel,CS-01,Captured,KAPAEX-28,150.0,96.15,13,KAPA HyperExome V1 Probes,,185,7/25/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Tumor,Clinical Cases,BCB059
JBP-3-Met1,3306 Tumor,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 19,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-3-Met2,12-15765B3,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 20,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-3-MM,3305 Tumor,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 18,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-3-Norm,3304 Normal,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 17,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-4-Met1,2817 Met1,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 23,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-4-Met2,2818 Met2,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 24,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-4-MM,2819 Met2,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 22,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-4-Norm,2835 Normal,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 21,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-5-Met,2834 Met,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 3,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-5-MM,"2832 MM, 2833 MM",,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 2,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-5-Norm,2831 Normal,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 1,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-6-Met,2830 Met,,,BB74_CL,,NaN,,,NextFlex 15,,,,,2010-2017,Kapa3_BB74
JBP-6-MM,2829 MM,,,BB74_CL,,NaN,,,NextFlex 14,,,,,2010-2017,Kapa3_BB74
JBP-6-Norm,2828 Normal,,,BB74_CL,,NaN,,,NextFlex 13,,,,,2010-2017,Kapa3_BB74
JBP-7-Met,3300 Tumor,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 6,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,2010-2017,Kapa2_BB73
JBP-7-MM,2821 MM,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 5,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,Long-Triple Negative Metastatic Melanoma,Kapa2_BB73
JBP-7-Norm,2820 Normal,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 4,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,Long-Triple Negative Metastatic Melanoma,Kapa2_BB73
JBP-9-Met,2826 Met,,,BB74_CL,,NaN,,,NextFlex 12,,,,,2010-2017,Kapa3_BB74
JBP-9-MM,2827 MM,,,BB74_CL,,NaN,,,NextFlex 11,,,,Tumor,2010-2017,Kapa3_BB74
JBP-9-Norm,2822 Normal,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 7,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",,Long-Triple Negative Metastatic Melanoma,Kapa2_BB73
JBP-11-Met,2899 Met,,,BB74_CL,,NaN,,,NextFlex 18,,,,,2010-2017,Kapa3_BB74
JBP-11-MM,2824 MM,,,BB74_CL,,NaN,,,NextFlex 17,,,,,2010-2017,Kapa3_BB74
JBP-11-Norm,2901 Normal,,,BB74_CL,,NaN,,,NextFlex 16,,,,,2010-2017,Kapa3_BB74
JBU7-MVP,MVP2756.00,,Captured,BB86_CL,,NaN,,,,,,,,2010-2017,Kapa13_BB86
JBU7-Norm,2755 Normal,,Captured,BB86_CL,,NaN,,,,,,,Normal,2010-2017,Kapa13_BB86
JBU8-MVP,MVP2758.00,,Captured,BB86_CL,,NaN,,,,,,,,2010-2017,Kapa13_BB86
JBU8-Norm,2757 Normal,,Captured,BB86_CL,,NaN,,,,,,,Normal,2010-2017,Kapa13_BB86
JBU10-MVP,MVP2752.00,,Captured,BB86_CL,,NaN,,,,,,,,2010-2017,Kapa13_BB86
JBU10-Norm,2751 Normal,,Captured,BB86_CL,,NaN,,,,,,,Normal,2010-2017,Kapa13_BB86
JBU11-MVP,MVP2754.00,,Captured,BB86_CL,,NaN,,,,,,,,2010-2017,Kapa13_BB86
JBU11-Norm,2753 Normal,,Captured,BB86_CL,,NaN,,,,,,,Normal,2010-2017,Kapa13_BB86
JJS1_Nev,2091 Nevus,JJS1,Captured,XL-10,,0.00,,UCSF500,H1,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS3_Mel1,2060 Mel1,JJS3,Captured,XL-10,,0.00,,UCSF500,H3,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS3_Nev,,JJS3,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS5_Mel,,JJS5,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS5_Nev,,JJS5,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS10_Mel,,JJS10,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS10_Nev,,JJS10,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS12_Mel,,JJS12,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS12_Nev,,JJS12,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS13_Mel,2071 Mel,JJS13,Captured,XL-10,,0.00,,UCSF500,H6,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS13_Nev,2069 Nevus,JJS13,Captured,XL-10,,0.00,,UCSF500,H4,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS14_Mel,2074 Mel,JJS14,Captured,XL-11,,0.00,,UCSF500,H8,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS14_Nev,2073 Nevus,JJS14,Captured,XL-11,,0.00,,UCSF500,H7,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS16_Mel,2077 Mel,JJS16,Captured,XL-11,,0.00,,UCSF500,H10,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS16_Nev,2076 Nevus,JJS16,Captured,XL-11,,0.00,,UCSF500,H9,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS17_Mel,2080 Mel,JJS17,Captured,XL-11,,0.00,,UCSF500,H12,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS17_Nev,2079 Nevus,JJS17,Captured,XL-11,,0.00,,UCSF500,H11,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS18_Mel,,JJS18,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS18_Nev,,JJS18,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS19_Mel,,JJS19,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS19_Nev,,JJS19,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS20_Mel,,JJS20,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS20_Nev,,JJS20,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS21_Mel,,JJS21,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS21_Nev,,JJS21,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS22_Mel,,VS-04_JJS22,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS22_Nev,,VS-04_JJS22,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS23_Mel,,JJS23,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS23_Nev,,JJS23,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS25_Mel,,JJS25,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS25_Nev,,JJS25,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS26_Mel,,JJS26,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS26_Nev,,JJS26,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS27_Mel,,JJS27,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS27_Nev,,JJS27,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS28_Mel,,JJS28,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
JJS28_Nev,,JJS28,,,,NaN,,UCSF500,,,,,,Hunter_RNASeq,Hunter_RNAseq
KALP-001,2527 Normal,KA-01,Captured,KAPAEX-35,89.0,50.28,13,KAPA HyperExome V2 Probes,,126,9/6/2023,,Normal,Keratoacanthoma Study,BCB065
KALP-002,2528 Keratoacanthoma,KA-01,Captured,KAPAEX-35,170.0,47.62,13,KAPA HyperExome V2 Probes,,128,9/6/2023,,Tumor,Keratoacanthoma Study,BCB065
KALP-003,2531 Normal,KA-02,Captured,KAPAEX-36,67.0,31.60,13,KAPA HyperExome V2 Probes,,131,9/6/2023,,Normal,Keratoacanthoma Study,BCB066
KALP-004,2532 Keratoacanthoma,KA-02,Captured,KAPAEX-36,134.0,49.81,13,KAPA HyperExome V2 Probes,,132,9/6/2023,,Tumor,Keratoacanthoma Study,BCB066
KALP-005,2535 Normal,KA-03,Captured,KAPAEX-36,124.0,49.80,13,KAPA HyperExome V2 Probes,,136,9/6/2023,,Normal,Keratoacanthoma Study,BCB066
KALP-006,2536 Keratoacanthoma,KA-03,Captured,KAPAEX-36,150.0,40.32,13,KAPA HyperExome V2 Probes,,137,9/6/2023,,Tumor,Keratoacanthoma Study,BCB066
KALP-007,2539 Normal,KA-04,Captured,KAPAEX-35,160.0,49.23,13,KAPA HyperExome V2 Probes,,138,9/6/2023,,Normal,Keratoacanthoma Study,BCB065
KALP-008,2540 Keratoacanthoma,KA-04,Captured,KAPAEX-35,160.0,32.19,13,KAPA HyperExome V2 Probes,,139,9/6/2023,,Tumor,Keratoacanthoma Study,BCB065
KALP-009,2543 Normal,KA-05,Captured,KAPAEX-35,75.0,41.21,13,KAPA HyperExome V2 Probes,,140,9/6/2023,,Normal,Keratoacanthoma Study,BCB065
KALP-010,2544 Keratoacanthoma,KA-05,Captured,KAPAEX-35,150.0,42.61,13,KAPA HyperExome V2 Probes,,141,9/6/2023,,Tumor,Keratoacanthoma Study,BCB065
KALP-011,2550 Normal,KA-06,Captured,KAPAEX-35,150.0,47.77,13,KAPA HyperExome V2 Probes,,142,9/6/2023,,Normal,Keratoacanthoma Study,BCB065
KALP-012,2552 Keratoacanthoma,KA-06,Captured,KAPAEX-35,75.0,41.44,13,KAPA HyperExome V2 Probes,,186,9/6/2023,,Tumor,Keratoacanthoma Study,BCB065
KALP-013,2555 Normal,KA-07,Pending,,,0.00,,,,187,9/6/2023,,Normal,Keratoacanthoma Study,
KALP-014,2557 Normal,KA-08,Captured,KAPAEX-36,17.0,51.52,13,KAPA HyperExome V2 Probes,,188,9/6/2023,,Tumor,Keratoacanthoma Study,BCB066
KALP-015,2558 Keratoacanthoma,KA-08,Captured,KAPAEX-36,150.0,28.96,13,KAPA HyperExome V2 Probes,,189,9/6/2023,,Normal,Keratoacanthoma Study,BCB066
KALP-016,2558 Keratoacanthoma,KA-08,Pending,,,0.00,,,,190,9/6/2023,,Tumor,Keratoacanthoma Study,
KALP-017,2561 Keratoacanthoma,KA-09,Pending,,,0.00,,,,191,9/6/2023,,Tumor,Keratoacanthoma Study,
KALP-018,2562 Normal,KA-09,Pending,,,0.00,,,,192,9/6/2023,,Normal,Keratoacanthoma Study,
KALP-019,2527 Normal,KA-01,Captured,KAPAEX-35,81.0,34.32,13,KAPA HyperExome V2 Probes,,126,9/15/2023,Captured as KALP-001 in KAPAEX-35 and sequenced in BCB065.,Normal,Keratoacanthoma Study,
KALP-020,2531 Normal,KA-02,Captured,KAPAEX-36,67.0,18.66,13,KAPA HyperExome V2 Probes,,131,9/15/2023,Captured as KALP-003 in KAPAEX-36 and sequenced in BCB066.,Normal,Keratoacanthoma Study,
KALP-021,2543 Normal,KA-05,Captured,KAPAEX-35,75.0,18.75,13,KAPA HyperExome V2 Probes,,140,9/15/2023,Captured as KALP-009 in KAPAEX-35 and sequenced in BCB065.,Normal,Keratoacanthoma Study,
KALP-022,2552 Keratoacanthoma,KA-06,Captured,KAPAEX-35,75.0,12.14,13,KAPA HyperExome V2 Probes,,186,9/15/2023,Captured as KALP-012 in KAPAEX-35 and sequenced in BCB065.,Tumor,Keratoacanthoma Study,
KALP-023,2557 Normal,KA-08,Captured,KAPAEX-36,13.5,50.00,13,KAPA HyperExome V2 Probes,,188,9/15/2023,Captured as KALP-014 in KAPAEX-36 and sequenced in BCB066.,Normal,Keratoacanthoma Study,
KALP-024,2557 Normal,KA-08,Captured,KAPAEX-36,13.5,50.00,13,KAPA HyperExome V2 Probes,,188,9/15/2023,Captured as KALP-014 in KAPAEX-36 and sequenced in BCB066.,Normal,Keratoacanthoma Study,
KALP-025,2557 Normal,KA-08,Captured,KAPAEX-36,13.5,50.00,13,KAPA HyperExome V2 Probes,,188,9/15/2023,Captured as KALP-014 in KAPAEX-36 and sequenced in BCB066.,Normal,Keratoacanthoma Study,
KALP-026,2558 Keratoacanthoma,KA-08,Pending,,,0.00,,,,190,9/15/2023,,Tumor,Keratoacanthoma Study,
KALP-027,2561 Keratoacanthoma,KA-09,Captured,KAPAEX-36,75.0,21.13,13,KAPA HyperExome V2 Probes,,191,9/15/2023,,Tumor,Keratoacanthoma Study,BCB066
KALP-028,2561 Keratoacanthoma,KA-09,Captured,KAPAEX-36,75.0,21.13,13,KAPA HyperExome V2 Probes,,191,9/15/2023,Captured as KALP-027 in KAPAEX-36 and sequenced in BCB066.,Tumor,Keratoacanthoma Study,
KALP-029,2562 Normal,KA-09,Captured,KAPAEX-36,150.0,25.64,13,KAPA HyperExome V2 Probes,,192,9/15/2023,,Normal,Keratoacanthoma Study,BCB066
KAM3-T-A,2732 Tumor,,Captured,BB79_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa15_BB88
KAM10-normal,2750 Normal,,Captured,,,NaN,,NimV3,E1,,11/19/2015,,Normal,Acral Melanoma,Exome_IY1
KAM10-normal_kapa-NGv3-PE100-NGv3-ready,2750 Normal,,Captured,,,NaN,,NimV3,,,,,Normal,Acral Melanoma,Exome_IY1
KAM10-Tumor,2715 Tumor,,Captured,BB80_CL,68.8,Infinity,,NimV3,D4,,11/19/2015,,Tumor,Acral Melanoma,Kapa7_BB80
KAM10-Tumor_kapa-NGv3-PE100-NGv3-ready,2715 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Exome_IY1
KAM12-T,2721 Tumor,,Captured,,,NaN,,,,,,,Tumor,Acral Melanoma,Kapa15_BB88
KAM14-T,2730 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM26-T,2731 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM34-T,2733 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM37-T,2734 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM43-T,2735 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM48-T,2736 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM62-T,2737 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM65-T,2738 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM71-T,2739 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM75-T,2740 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa9_BB82
KAM79-T,2741 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM93-normal,2742 Normal,,Captured,,,NaN,,,D5,,11/19/2015,,Normal,Acral Melanoma,Exome_IY1
KAM93-normal_kapa-NGv3-PE100-NGv3-ready,2742 Normal,,Captured,,,NaN,,,,,,,Normal,Acral Melanoma,Exome_IY1
KAM93-tumor,2743 Tumor,,Captured,BB79_CL,45.7,Infinity,,NimV3,D6,,11/19/2015,,Tumor,Acral Melanoma,Kapa6_BB79
KAM93-tumor_kapa-NGv3-PE100-NGv3-ready,2743 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Exome_IY1
KAM95-T-B1,2744 Tumor,,Captured,BB85_CL,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM99-normal,2746 Normal,,Captured,,,NaN,,,D7,,11/19/2015,,Normal,Acral Melanoma,Exome_IY1
KAM99-normal_kapa-NGv3-PE100-NGv3-ready,2746 Normal,,Captured,,,NaN,,,,,,,Normal,Acral Melanoma,Exome_IY1
KAM99-tumor,2745 Tumor,,Captured,BB79_CL,58.1,Infinity,,NimV3,D8,,11/19/2015,,Tumor,Acral Melanoma,Kapa6_BB79
KAM99-tumor_kapa-NGv3-PE100-NGv3-ready,2745 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Exome_IY1
KAM100-normal,2716 Normal,,Captured,,,NaN,,NimV3,D9,,11/19/2015,,Normal,Acral Melanoma,Exome_IY1
KAM100-normal_kapa-NGv3-PE100-NGv3-ready,2716 Normal,,Captured,,,NaN,,NimV3,,,,,Normal,Acral Melanoma,Exome_IY1
KAM100-tumor,2717 Tumor,,Captured,BB82_CL,68.8,Infinity,,NimV3,D3,,11/19/2015,,Tumor,Acral Melanoma,Kapa9_BB82
KAM100-tumor_kapa-NGv3-PE100-NGv3-ready,2717 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Exome_IY1
KAM102-T-B,2718 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM111-normal,2747 Normal,,Captured,,,NaN,,,E6,,11/19/2015,,Normal,Acral Melanoma,Exome_IY1
KAM111-normal_kapa-NGv3-PE100-NGv3-ready,2747 Normal,,Captured,,,NaN,,,,,,,Normal,Acral Melanoma,Exome_IY1
KAM111-tumor,2748 Tumor; 2749 Tumor,,Captured,BB80_CL,68.8,Infinity,,NimV3,E7,,11/19/2015,,Tumor,Acral Melanoma,Kapa7_BB80
KAM111-tumor_kapa-NGv3-PE100-NGv3-ready,2748 Tumor; 2749 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Exome_IY1
KAM113-T-H,2719 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM116-T,2720 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM122-T-A,2722 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM123-T,2723 Tumor,,Captured,,,NaN,,NimV3,,,,,Tumor,Acral Melanoma,Kapa12_BB85
KAM127-N,2724 Normal,,Captured,BB89_CL,55.6,2.13,,NimV3,A2,,,,Normal,Acral Melanoma,Kapa16_BB89
KAM127-T,2725 Tumor,,Captured,BB89_CL,55.6,2.56,,NimV3,A1,,,,Tumor,Acral Melanoma,Kapa16_BB89
KAM128-T,2726 Tumor,,Captured,BB89_CL,55.6,37.03,,NimV3,A3,,,,Tumor,Acral Melanoma,Kapa16_BB89
KAM130-T,2727 Tumor,,Captured,BB89_CL,55.6,53.41,,NimV3,A4,,,,Tumor,Acral Melanoma,Kapa16_BB89
KAM131-N,2728 Normal,,Captured,BB89_CL,55.6,12.24,,NimV3,A6,,,,Normal,Acral Melanoma,Kapa16_BB89
KAM131-T,2729 Tumor,,Captured,BB89_CL,55.6,2.82,,NimV3,A5,,,,Tumor,Acral Melanoma,Kapa16_BB89
Kit 262,3308 Tumor,,Captured,BB5_CL,62.5,Infinity,,NimV1,L2DR16,,,Rectal,Tumor,Mucosal Melanoma,Nimblegen2_BB5
Kit_8,3309 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR12,,,Alyssa Kit Mutations,Tumor,Mucosal Melanoma,Nimblegen13_BB16
Kit_21,3310 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR14,,,Alyssa Kit Mutations,Tumor,Mucosal Melanoma,Nimblegen13_BB16
Kit_37_Acral_NRAS,3311 Tumor,,Captured,BB4_CL,,NaN,,NimV1,L2DR05,,,,Tumor,Acral Melanoma,Nimblegen1_BB004
Kit_53_Acral_NRAS,2804 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR15,,,,Tumor,Acral Melanoma,Nimblegen4 (BB007)
Kit_55,3312 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR15,,,Alyssa Kit Mutations,Tumor,Mucosal Melanoma,Nimblegen13_BB16
Kit_62__Acral_NRAS,3313 Tumor,,Captured,BB4_CL,,NaN,,NimV1,L2DR06,,,,Tumor,Acral Melanoma,Nimblegen1_BB004
Kit_76,3314 Tumor,,Captured,BB16_CL,,NaN,,NimV2,L2DR16,,,Alyssa Kit Mutations,Tumor,Mucosal Melanoma,Nimblegen13_BB16
Kit_118_Muc_NRAS,3315 Tumor,,Captured,BB4_CL,,NaN,,NimV1,L2DR07,,,,Tumor,Mucosal Melanoma,Nimblegen1_BB004
KIT_134,KIT_134,,,,,NaN,13,NimV2,L2DR02,,,"Mucosal melanoma, rectal, WT",Tumor,Mucosal Melanoma,Nimblegen32_BB38
Kit_181_Muc BRAF,3318 Tumor,,,,,NaN,13,NimV2,L2DR08,,,"Alyssa Acral Mucosal, Mucosal, BRAF, glans penis",Tumor,Mucosal Melanoma,Nimblegen26_BB31
Kit_181_Muc_BRAF,3318 Tumor,,Captured,BB4_CL,,NaN,,NimV1,L2DR08,,,,Tumor,Mucosal Melanoma,Nimblegen1_BB004
KIT_191,3319 Tumor,,,,,NaN,13,NimV2,L2DR03,,,"Acral melanoma, heel, WT",Tumor,Mucosal Melanoma,Nimblegen32_BB38
Kit_192,3320 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR15,,,N14_15,Tumor,Mucosal Melanoma,Nimblegen14_BB17
Kit_203,3321 Tumor,,Captured,BB17_CL,,NaN,,NimV2,L2DR16,,,N14_16,Tumor,Mucosal Melanoma,Nimblegen14_BB17
KIT_205,3322 Tumor,,,,,NaN,13,NimV2,L2DR04,,,"Acral melanoma, toe, WT",Tumor,Mucosal Melanoma,Nimblegen32_BB38
KIT_206,3323 Tumor,,,,,NaN,13,NimV2,L2DR05,,,"Mucosal melanoma, ?, WT",Tumor,Mucosal Melanoma,Nimblegen32_BB38
KIT_210,3324 Tumor,,,,,NaN,13,NimV2,L2DR06,,,"Mucosal melanoma, rectal, WT",Tumor,Mucosal Melanoma,Nimblegen32_BB38
KIT_217,3325 Tumor,,,,,NaN,13,NimV2,L2DR07,,,"Mucosal melanoma, vaginal, WT",Tumor,Mucosal Melanoma,Nimblegen32_BB38
KIT_225,3326 Tumor,,,,,NaN,13,NimV2,L2DR08,,,"Mucosal melanoma, anal, ",Tumor,Mucosal Melanoma,Nimblegen32_BB38
Kit_227_Acral_WT_ACACGA,2803 Mel,,Captured,BB4_CL,,NaN,,NimV1,L2DR09,,,,Mel,Acral Melanoma,Nimblegen1_BB004
Kit_227_Acral_WT_CACCTC,2803 Mel,,Captured,BB7_CL,,NaN,13,NimV1,L2DR14,,,,Mel,Acral Melanoma,Nimblegen4 (BB007)
KIT_230,3327 Tumor,,,,,NaN,13,NimV2,L2DR15,,,Alyssa Acral Mucosal DNA,Tumor,Mucosal Melanoma,Nimblegen34_BB40
KIT_244,3328 Tumor,,,,,NaN,13,NimV2,L2DR09,,,"Mucosal melanoma, urethra, WT",Tumor,Mucosal Melanoma,Nimblegen32_BB38
KIT_260,3329 Tumor,,,,,NaN,13,NimV2,L2DR10,,,"Mucosal melanoma, perirectal, ",Tumor,Mucosal Melanoma,Nimblegen32_BB38
KIT_273,3330 Tumor,,,,,NaN,13,NimV2,L2DR11,,,"Mucosal melanoma, duodenal, NRAS",Tumor,Mucosal Melanoma,Nimblegen32_BB38
Kit_275_Muc_BRAF,3331 Tumor,,Captured,BB4_CL,,NaN,,NimV1,L2DR10,,,,Tumor,Mucosal Melanoma,Nimblegen1_BB004
KIT_295,3332 Tumor,,,,,NaN,13,NimV2,L2DR12,,,"Mucosal melanoma, oral, WT",Tumor,Mucosal Melanoma,Nimblegen32_BB38
KIT_297,3333 Tumor,,,,,NaN,13,NimV2,L2DR16,,,Alyssa Acral Mucosal DNA,Tumor,Mucosal Melanoma,Nimblegen34_BB40
KIT_302,3334 Tumor,,,,,NaN,13,NimV2,L2DR01,,,Alyssa Acral Mucosal DNA,Tumor,Mucosal Melanoma,Nimblegen34_BB40
Kit_313_Mucosal,3335 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR16,,,,Tumor,Mucosal Melanoma,Nimblegen4 (BB007)
KIT_316,3336 Tumor,,,,,NaN,13,NimV2,L2DR02,,,Alyssa Acral Mucosal DNA,Tumor,Mucosal Melanoma,Nimblegen34_BB40
KR_8,3337 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR08,,,blood derived,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_150,3338 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR05,,,blood derived,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_166,3339 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR01,,,blood derived.,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_177,3340 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR04,,,blood derived,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_203,3341 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR07,,,blood derived,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_229,3342 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR06,,,blood derived,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_2030,3343 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR03,,,blood derived,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_2064,3344 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR02,,,blood derived,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_5233,3345 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR09,,,blood,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_RMK0091B,3346 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR10,,,skin,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_RMK0137C,3347 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR13,,,saliva | Barcode mismatch comment in note,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_RMK0162C,3348 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR12,,,saliva | Barcode mismatch comment in note,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_RMK0168C,3349 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR14,,,saliva,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
KR_RMK0194C,3350 Tumor,,Captured,BB18_CL,,NaN,,NimV1,L2DR11,,,Saliva-tube,Tumor,Rasopathy Syndrome,Nimblegen15_BB18
L2-HGD,3351 Intermediate,,,,,NaN,13,NimV2mix3,NextFlex 4,,,Hunter Dysplastic Nevus,Tumor,2010-2017,BioSci15_BB67
L2-Normal,3352 Normal,,,,,NaN,13,NimV2mix3,NextFlex 3,,,Hunter Dysplastic Nevus,Tumor,2010-2017,BioSci15_BB67
L3-HGD,3353 Intermediate,,,,,NaN,13,NimV2mix3,NextFlex 6,,,Hunter Dysplastic Nevus,Tumor,2010-2017,BioSci15_BB67
L3-Normal,3354 Normal,,,,,NaN,13,NimV2mix3,NextFlex 5,,,Hunter Dysplastic Nevus,Tumor,2010-2017,BioSci15_BB67
L11_96096_A2_Norm,3355 Normal,,Captured,BB11_CL,,NaN,,NimV1,L2DR04,,,"Metastatic Melanoma, Lymph Node, sentinel. Capsular nevus is present",Tumor,2010-2017,Nimblegen8_BB11
LMM-04,2494 Invasive,LMM-02,Pending,,,0.00,,,,174,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Others,Lentigo Maligna Melanoma,
LMM-05,2495 MIS,LMM-02,Pending,,,0.00,,,,175,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",MIS,Lentigo Maligna Melanoma,
LMM-07,2497 Invasive,LMM-03,Pending,,,0.00,,,,176,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Others,Lentigo Maligna Melanoma,
LMM-08,2498 MIS,LMM-03,Pending,,,0.00,,,,177,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",MIS,Lentigo Maligna Melanoma,
LMM-10,2500 Invasive,LMM-04,Pending,,,0.00,,,,178,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Others,Lentigo Maligna Melanoma,
LMM-11,2501 MIS,LMM-04,Pending,,,0.00,,,,179,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",MIS,Lentigo Maligna Melanoma,
LMM-13,2503 Invasive,LMM-05,Pending,,,0.00,,,,180,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Others,Lentigo Maligna Melanoma,
LMM-14,2504 MIS,LMM-05,Pending,,,0.00,,,,181,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",MIS,Lentigo Maligna Melanoma,
LMM-17,2451 MIS,LMM-06,Pending,,,0.00,,,,183,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",MIS,Lentigo Maligna Melanoma,
LMM-18,2452 Invasive,LMM-06,Pending,,,0.00,,,,182,5/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Others,Lentigo Maligna Melanoma,
Long-TN10-Normal,2813 Normal,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 13,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",Normal,Long-Triple Negative Metastatic Melanoma,Kapa2_BB73
Long-TN10-Tumor,2814 Tumor,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 14,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",Tumor,Long-Triple Negative Metastatic Melanoma,Kapa2_BB73
Long-TN11-Normal,2815 Normal,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 15,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",Normal,Long-Triple Negative Metastatic Melanoma,Kapa2_BB73
Long-TN11-Tumor,2816 Tumor,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 16,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",Tumor,Long-Triple Negative Metastatic Melanoma,Kapa2_BB73
Luping_ROS 1,3447 Tumor,,Captured,,,NaN,13,NimV2,L2DR07,,,"Bivona Lab, ROS 1",Tumor,2010-2017,Nimblegen38_BB45
MB_161_Normal,3356 Normal,,Captured,BB7_CL,,NaN,13,NimV1,L2DR02,,,,Normal,2010-2017,Nimblegen4 (BB007)
MB_161_Tumor,3357 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR01,,,,Tumor,2010-2017,Nimblegen4 (BB007)
MB_327_Tumor,3358 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR03,,,,Tumor,2010-2017,Nimblegen4 (BB007)
MB_760_Tumor,3359 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR05,,,,Tumor,2010-2017,Nimblegen4 (BB007)
MB_1028_Normal,3360 Normal,,Captured,BB7_CL,,NaN,13,NimV1,L2DR08,,,,Normal,2010-2017,Nimblegen4 (BB007)
MB_1029_Tumor,3361 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR07,,,,Tumor,2010-2017,Nimblegen4 (BB007)
MB_1036_Normal,3362 Normal,,Captured,BB7_CL,,NaN,13,NimV1,L2DR10,,,,Normal,2010-2017,Nimblegen4 (BB007)
MB_1046_Tumor,3363 Tumor,,Captured,BB7_CL,,NaN,13,NimV1,L2DR09,,,,Tumor,2010-2017,Nimblegen4 (BB007)
MB_1418_Normal,3364 Normal,,Captured,BB7_CL,,NaN,13,NimV1,L2DR06,,,,Normal,2010-2017,Nimblegen4 (BB007)
MB_1454_Normal,3365 Normal,,Captured,BB7_CL,,NaN,13,NimV1,L2DR04,,,,Normal,2010-2017,Nimblegen4 (BB007)
MB_1609_Normal,3366 Normal,,Captured,BB12_CL,,NaN,,NimV1,L2DR14,,,,Normal,2010-2017,Nimblegen9_BB12
MB1241_Norm,3367 Normal,,Captured,BB11_CL,,NaN,,NimV1,L2DR06,,,"Acral Normal, Frozen Tissue DNA  Extracted by Denver",Normal,2010-2017,Nimblegen8_BB11
MB1242_Tumor,3368 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR05,,,"Acral Tumor, Frozen Tissue DNA Extracted by Denver",Tumor,2010-2017,Nimblegen8_BB11
MB1421_Norm,3369 Normal,,Captured,BB11_CL,,NaN,,NimV1,L2DR10,,,"Acral Normal, Thumb, Frozen Tissue DNA extracted by Denver",Normal,2010-2017,Nimblegen8_BB11
MB1423_Norm,3370 Normal,,Captured,BB11_CL,,NaN,,NimV1,L2DR08,,,"Acral Normal Heel, FFPE Extracted DNA by Denver",Normal,2010-2017,Nimblegen8_BB11
MB1423_Tumor,3371 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR07,,,"Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver",Tumor,2010-2017,Nimblegen8_BB11
MB1424 _Tumor,3372 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR09,,,"Acral Tumor, Thumb, Frozen Tissue DNA extracted by Denver",Tumor,2010-2017,Nimblegen8_BB11
MB1428_Norm,3373 Normal,,Captured,BB11_CL,,NaN,,NimV1,L2DR13,,,"Acral Normal, Heel Frozen Tissue DNA Extracted by Denver | Barcode mismatch comment in note",Normal,2010-2017,Nimblegen8_BB11
MB1429_Tumor,3374 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR11,,,"Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver",Tumor,2010-2017,Nimblegen8_BB11
MB1617_Tumor,3375 Tumor,,Captured,BB12_CL,,NaN,,NimV1,L2DR13,,,,Tumor,2010-2017,Nimblegen9_BB12
MIN_1,3376 Mel,,Captured,,,NaN,13,NimV2,L2DR12,,,,Tumor,2010-2017,Nimblegen30_BB35
MIN_2,3377 Nevus,,Captured,,,NaN,13,NimV2,L2DR13,,,,Tumor,2010-2017,Nimblegen30_BB35
MIN_3,3378 Normal,,Captured,,,NaN,13,NimV2,L2DR14,,,,Tumor,2010-2017,Nimblegen30_BB35
MIN_4,3379 Mel,,Captured,,,NaN,13,NimV2,L2DR15,,,,Tumor,2010-2017,Nimblegen30_BB35
MIN_5,3380 Nevus,,Captured,,,NaN,13,NimV2,L2DR16,,,,Tumor,2010-2017,Nimblegen30_BB35
MIN_6,3381 Normal,,Captured,,,NaN,13,NimV2,L2DR01,,,,Tumor,2010-2017,Nimblegen30_BB35
MP41,673 Uveal Mel,UV-01,Captured,"KAPAEX-02,SGPC-12",200.0,18.37,, SeqCap EZ MedExome,,73,1/3/2019,4/25/23: deleted -LP from the LP_ID,,Uveal Melanoma,"BCB001,BCB012"
MP41-YMR1,674 Uveal Mel,UV-02,Captured,"KAPAEX-02,SGPC-12",200.0,33.17,, SeqCap EZ MedExome,,74,1/3/2019,4/25/23: deleted -LP from the LP_ID,,Uveal Melanoma,"BCB001,BCB012"
MRLP-001,3484 DN,DN-089,Captured,"SGPC-09,SGPC-11",7.8,2.02,12,Small Gene Panel,,25,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-002,3485 DN,DN-090,Captured,"SGPC-09,SGPC-11",7.8,3.74,12,Small Gene Panel,,26,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-003,3486 DN,DN-090,Captured,"SGPC-09,SGPC-11",7.8,14.74,12,Small Gene Panel,,27,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-004,3487 DN,DN-090,Captured,"SGPC-09,SGPC-11",7.8,11.49,12,Small Gene Panel,,28,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-005,3488 DN,DN-091,Captured,"SGPC-09,SGPC-11",7.8,8.14,12,Small Gene Panel,,29,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-006,3489 DN,DN-092,Captured,"SGPC-09,SGPC-11",7.8,6.73,12,Small Gene Panel,,30,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-008,3490 DN,DN-093,Captured,"SGPC-09,SGPC-11",7.8,14.20,12,Small Gene Panel,,31,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-009,3491 DN,DN-094,Captured,"SGPC-09,SGPC-11",7.8,1.74,12,Small Gene Panel,,32,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-010,3492 DN,DN-095,Captured,"SGPC-09,SGPC-11",7.8,12.60,12,Small Gene Panel,,33,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-011,3493 DN,DN-096,Captured,"SGPC-09,SGPC-11",7.8,4.44,12,Small Gene Panel,,34,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-012,3494 DN,DN-097,Captured,"SGPC-09,SGPC-11",7.8,28.93,12,Small Gene Panel,,35,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-015,3495 DN,DN-098,Captured,"SGPC-09,SGPC-11",7.8,5.83,12,Small Gene Panel,,36,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-017,3496 DN,DN-099,Captured,"SGPC-09,SGPC-11",7.8,7.51,12,Small Gene Panel,,37,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-020,3497 DN,DN-100,Captured,"SGPC-09,SGPC-11",7.8,5.62,12,Small Gene Panel,,38,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-021,3498 DN,DN-101,Captured,"SGPC-09,SGPC-11",7.8,3.60,12,Small Gene Panel,,39,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-024,3499 DN,DN-102,Captured,"SGPC-09,SGPC-11",7.8,6.20,12,Small Gene Panel,,40,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-025,3500 DN,DN-103,Captured,"SGPC-09,SGPC-11",7.8,21.69,12,Small Gene Panel,,41,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-026,3501 DN,DN-104,Captured,"SGPC-09,SGPC-11,SGPC-12",7.8,1.80,12,Small Gene Panel,,52,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011,BCB012"
MRLP-027,3502 DN,DN-105,Captured,"SGPC-09,SGPC-11,SGPC-12",7.8,2.37,12,Small Gene Panel,,43,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011,BCB012"
MRLP-029,3503 DN,DN-106,Captured,"SGPC-09,SGPC-11",7.8,6.62,12,Small Gene Panel,,44,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-030,3504 DN,DN-106,Captured,"SGPC-09,SGPC-11,SGPC-12",7.8,1.59,12,Small Gene Panel,,45,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011,BCB012"
MRLP-031,3505 DN,DN-107,Captured,"SGPC-09,SGPC-11,SGPC-12",7.8,1.90,12,Small Gene Panel,,46,2/8/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011,BCB012"
MRLP-032,3506 DN,DN-108,Captured,"SGPC-09,SGPC-11",7.8,3.09,12,Small Gene Panel,,49,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-033,3507 DN,DN-109,Captured,"SGPC-09,SGPC-11",7.8,5.31,12,Small Gene Panel,,50,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-034,3508 DN,DN-110,Captured,"SGPC-09,SGPC-11",7.8,2.71,12,Small Gene Panel,,51,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-035,3509 DN,DN-111,Captured,"SGPC-09,SGPC-11",7.8,1.87,12,Small Gene Panel,,52,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-036,3510 DN,DN-112,Captured,"SGPC-09,SGPC-11",7.8,10.28,12,Small Gene Panel,,53,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-037,3511 DN,DN-113,Captured,"SGPC-09,SGPC-11,SGPC-12",7.8,2.19,12,Small Gene Panel,,54,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011,BCB012"
MRLP-038,3512 DN,DN-114,Captured,"SGPC-09,SGPC-11",7.8,9.52,12,Small Gene Panel,,55,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-039,3513 DN,DN-115,Captured,"SGPC-09,SGPC-11",7.8,12.02,12,Small Gene Panel,,56,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MRLP-040,3514 DN,DN-116,Captured,"SGPC-09,SGPC-11,SGPC-12",7.8,2.50,12,Small Gene Panel,,57,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011,BCB012"
MRLP-041,3515 DN,DN-117,Captured,SGPC-09,7.8,2.37,12,Small Gene Panel,,58,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-042,3516 DN,DN-118,Captured,SGPC-09,7.8,9.41,12,Small Gene Panel,,59,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-043,3517 DN,DN-119,Captured,SGPC-09,7.8,2.91,12,Small Gene Panel,,60,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-044,3518 DN,DN-119,Captured,SGPC-09,7.8,3.63,12,Small Gene Panel,,61,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-045,3519 DN,DN-120,Captured,SGPC-09,7.8,27.89,12,Small Gene Panel,,62,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-046,3520 DN,DN-121,Captured,SGPC-09,7.8,8.58,12,Small Gene Panel,,63,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-047,3521 DN,DN-122,Captured,SGPC-09,7.8,11.66,12,Small Gene Panel,,64,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-048,3522 DN,DN-123,Captured,SGPC-09,7.8,3.91,12,Small Gene Panel,,65,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-049,3523 DN,DN-124,Captured,SGPC-09,7.8,5.04,12,Small Gene Panel,,66,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-050,3524 DN,DN-125,Captured,SGPC-09,7.8,2.51,12,Small Gene Panel,,67,2/13/2019,,Tumor,Dysplastic Nevi,BCB004
MRLP-051,3525 DN,DN-126,Captured,"SGPC-09,SGPC-11",7.8,19.52,12,Small Gene Panel,,68,2/13/2019,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
MS_1_Tumor,3382 Tumor,,Captured,,,NaN,13,NimV2,L2DR08,,,"Dr. Perry, Melanocytic Shwannoma",Tumor,2010-2017,Nimblegen36_BB43
N3_1,3383 Tumor,,Captured,BB6_CL,45.0,Infinity,,NimV1,L2DR01,,,sp-12-3436|mucosal melanoma +EIN,Tumor,"2010-2017,Dog Melanoma",Nimblegen3_BB6
N3_2,3384 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR02,,,sp-07-8373|mucosal melanomas-non-pigmented,Tumor,2010-2017,Nimblegen3_BB6
N3_3,3385 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR03,,,2990543-1|melanocytoma,Tumor,2010-2017,Nimblegen3_BB6
N3_4,3386 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR04,,,3146318-1|acral melanoma,Tumor,2010-2017,Nimblegen3_BB6
N3_5,3387 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR05,,,"73001, 73002|TUMOR Mucosal Melanoma, nasal sinus",Tumor,2010-2017,Nimblegen3_BB6
N3_6,3388 Normal,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR06,,,"73003|Normal Melanoma, Mucosal nasal sinus",Normal,2010-2017,Nimblegen3_BB6
N3_7,3389 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR07,,,"73004|TUMOR Melanoma, Mucosal nasal sinus",Tumor,2010-2017,Nimblegen3_BB6
N3_8,3390 Normal,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR08,,,"73005|Normal Melanoma, Mucosal nasal sinus",Normal,2010-2017,Nimblegen3_BB6
N3_9,3391 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR09,,,"73010|Tumor Melanoma, Mucosal vulva",Tumor,2010-2017,Nimblegen3_BB6
N3_10,3392 Normal,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR10,,,"73010|Normal Melanoma, Mucosal vulva",Normal,2010-2017,Nimblegen3_BB6
N3_11,3393 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR11,,,Need to Get diagnosis from Iwei|NTRK3 Translocation case,Tumor,2010-2017,Nimblegen3_BB6
N3_12,3394 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR12,,,Need to Get diagnosis from Iwei|ROS1 Translocation case,Tumor,2010-2017,Nimblegen3_BB6
N3_13,3395 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR13,,,Need to Get diagnosis from Iwei|ROS1 Translocation case,Tumor,2010-2017,Nimblegen3_BB6
N3_14,3396 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR14,,,Need to Get diagnosis from Iwei|NTRK3 Translocation case,Tumor,2010-2017,Nimblegen3_BB6
N3_15,3397 Tumor,,Captured,BB6_CL,62.5,Infinity,,NimV1,L2DR15,,,Need to Get diagnosis from Iwei|BRAF Translocation case,Tumor,2010-2017,Nimblegen3_BB6
N3_16,3398 Tumor,,Captured,BB6_CL,,NaN,,NimV1,L2DR16,,,Need to Get diagnosis from Iwei|BRAF Translocation case,Tumor,2010-2017,Nimblegen3_BB6
NGS 1-1,2848 Tumor,,Captured,BB26_CL,,NaN,,,L2DR01,,,,Tumor,2010-2017,Clinical1_BB26
NGS 1-3,2849 Normal,,Captured,BB26_CL,,NaN,,,L2DR02,,,,Normal,2010-2017,Clinical1_BB26
NGS 1-4,2850 Tumor,,Captured,BB26_CL,,NaN,,,L2DR03,,,,Tumor,2010-2017,Clinical1_BB26
NGS 1-5,2851 Tumor,,Captured,BB26_CL,,NaN,,,L2DR04,,,,Tumor,2010-2017,Clinical1_BB26
NGS 1-6,2852 Tumor,,Captured,BB26_CL,,NaN,,,L2DR05,,,,Tumor,2010-2017,Clinical1_BB26
NGS 1-7,2853 Tumor,,Captured,BB26_CL,,NaN,,,L2DR06,,,,Tumor,2010-2017,Clinical1_BB26
NGS 1-8,2854 Normal,,Captured,BB26_CL,,NaN,,,L2DR07,,,,Normal,2010-2017,Clinical1_BB26
NGS 1-9,2855 Unknown,,Captured,BB26_CL,,NaN,,,L2DR08,,,,Tumor,2010-2017,Clinical1_BB26
NGS 1-10,2856 Unknown,,Captured,BB26_CL,,NaN,,,L2DR09,,,,Tumor,2010-2017,Clinical1_BB26
NGS 1-13,2857 Unknown,,Captured,BB26_CL,,NaN,,,L2DR10,,,,Tumor,2010-2017,Clinical1_BB26
NGS 1-14,2858 Unknown,,Captured,BB26_CL,,NaN,,,L2DR11,,,,Tumor,2010-2017,Clinical1_BB26
NMLP-001,551 Nodular Mel,NM-001,Captured,"SGPC-06,SGPC-10,SGPC-13",10.9,5.07,12,Small Gene Panel,,1,12/7/2018,NM from Greece,Tumor,Nodular Melanoma,"BCB002,BCB006,BCB008,BCB013"
NMLP-003,553 Nodular Mel,NM-003,Captured,SGPC-06,10.9,5.62,12,Small Gene Panel,,2,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-004,554 Nodular Mel,NM-004,Captured,"SGPC-06,SGPC-10,SGPC-13",10.9,8.01,12,Small Gene Panel,,3,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB006,BCB008,BCB013"
NMLP-005,555 Nodular Mel,NM-005,Library failed/low yield,,,0.00,,Small Gene Panel,,4,12/7/2018,,Tumor,Nodular Melanoma,
NMLP-006,556 Nodular Mel,NM-006,Library failed/low yield,,,0.00,,Small Gene Panel,,5,12/7/2018,,Tumor,Nodular Melanoma,
NMLP-007,557 Nodular Mel,NM-007,Captured,SGPC-06,10.9,25.95,12,Small Gene Panel,,6,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-008,558 Nodular Mel,NM-008,Captured,SGPC-06,10.9,14.53,12,Small Gene Panel,,7,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-009,559 Nodular Mel,NM-009,Captured,"SGPC-06,SGPC-10,SGPC-14",10.9,28.68,12,Small Gene Panel,,8,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB006,BCB008,BCB015"
NMLP-010,560 Nodular Mel,NM-010,Captured,"SGPC-06,SGPC-10,SGPC-13",10.9,9.01,12,Small Gene Panel,,9,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB006,BCB008,BCB013"
NMLP-011,561 Nodular Mel,NM-011,Captured,"SGPC-06,SGPC-10,SGPC-13",10.9,6.06,12,Small Gene Panel,,10,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB006,BCB008,BCB013"
NMLP-012,562 Nodular Mel,NM-012,Captured,SGPC-06,10.9,28.68,12,Small Gene Panel,,11,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-013,563 Nodular Mel,NM-013,Captured,SGPC-06,10.9,7.52,12,Small Gene Panel,,12,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-014,564 Nodular Mel,NM-014,Captured,SGPC-07,10.9,90.83,12,Small Gene Panel,,13,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-015,565 Nodular Mel,NM-015,Captured,SGPC-06,10.9,31.14,12,Small Gene Panel,,14,12/7/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-016,566 Nodular Mel,NM-016,Captured,"SGPC-06,SGPC-14",10.9,5.96,12,Small Gene Panel,,15,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-017,567 Nodular Mel,NM-017,Captured,"SGPC-06,SGPC-14",10.9,5.65,12,Small Gene Panel,,16,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-018,568 Nodular Mel,NM-018,Captured,"SGPC-09,SGPC-14",7.8,3.05,12,Small Gene Panel,,17,12/11/2018,,Tumor,Nodular Melanoma,"BCB004,BCB015"
NMLP-019,569 Nodular Mel,NM-019,Captured,SGPC-06,10.9,18.79,12,Small Gene Panel,,39,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-020,570 Nodular Mel,NM-027,Captured,"SGPC-06,SGPC-14",10.9,2.18,12,Small Gene Panel,,40,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-021,571 Nodular Mel,NM-029,Captured,"SGPC-06,SGPC-14",10.9,8.86,12,Small Gene Panel,,41,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-022,572 Nodular Mel,NM-031,Captured,SGPC-06,10.9,3.27,12,Small Gene Panel,,52,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-023,573 Nodular Mel,NM-032,Captured,"SGPC-06,SGPC-14",10.9,2.66,12,Small Gene Panel,,43,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-024,574 Nodular Mel,NM-33,Captured,"SGPC-06,SGPC-14",10.9,2.51,12,Small Gene Panel,,44,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-025,575 Nodular Mel,NM-34,Captured,SGPC-06,10.9,2.06,12,Small Gene Panel,,45,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-026,576 Nodular Mel,NM-35,Captured,SGPC-06,10.9,3.77,12,Small Gene Panel,,46,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-027,577 Nodular Mel,NM-36,Captured,"SGPC-06,SGPC-14",10.9,32.06,12,Small Gene Panel,,47,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-028,578 Nodular Mel,NM-37,Captured,SGPC-06,10.9,2.19,12,Small Gene Panel,,48,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-029,579 Nodular Mel,NM-38,Captured,SGPC-06,10.9,17.03,12,Small Gene Panel,,49,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-030,580 Nodular Mel,NM-39,Captured,SGPC-06,10.9,38.93,12,Small Gene Panel,,50,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-031,581 Nodular Mel,NM-40,Captured,SGPC-06,10.9,3.00,12,Small Gene Panel,,51,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-032,582 Nodular Mel,NM-41,Captured,SGPC-06,10.9,11.60,12,Small Gene Panel,,52,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-033,583 Nodular Mel,NM-43,Captured,SGPC-07,10.9,57.37,12,Small Gene Panel,,53,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-034,584 Nodular Mel,NM-44,Captured,"SGPC-06,SGPC-10,SGPC-14",10.9,43.60,12,Small Gene Panel,,54,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB006,BCB008,BCB015"
NMLP-035,585 Nodular Mel,NM-45,Captured,"SGPC-06,SGPC-14",10.9,11.60,12,Small Gene Panel,,55,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-036,586 Nodular Mel,NM-46,Captured,SGPC-07,10.9,99.09,12,Small Gene Panel,,56,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-037,587 Nodular Mel,NM-47,Captured,"SGPC-06,SGPC-14",10.9,25.95,12,Small Gene Panel,,57,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-038,588 Nodular Mel,NM-48,Captured,"SGPC-06,SGPC-14",10.9,24.77,12,Small Gene Panel,,58,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-039,589 Nodular Mel,NM-49,Captured,SGPC-06,10.9,7.36,12,Small Gene Panel,,59,12/11/2018,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-040,590 Nodular Mel,NM-50,Captured,"SGPC-06,SGPC-14",10.9,23.19,12,Small Gene Panel,,60,,NEED TO RE SEQUENCE,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-041,591 Nodular Mel,NM-51,Captured,"SGPC-06,SGPC-14",10.9,34.06,12,Small Gene Panel,,61,,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-042,592 Nodular Mel,NM-52,Captured,SGPC-07,10.9,72.67,12,Small Gene Panel,,62,,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-043,593 Nodular Mel,NM-53,Library failed/low yield,,,NaN,,Small Gene Panel,,63,,Sample had high melanin,Tumor,Nodular Melanoma,
NMLP-044,594 Nodular Mel,NM-54,Library failed/low yield,,,0.00,,Small Gene Panel,,64,,Sample had high melanin,Tumor,Nodular Melanoma,
NMLP-045,595 Nodular Mel,NM-55,Captured,"SGPC-06,SGPC-14",10.9,19.46,12,Small Gene Panel,,65,,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-046,596 Nodular Mel,NM-58,Captured,"SGPC-06,SGPC-14",10.9,33.03,12,Small Gene Panel,,66,,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-047,597 Nodular Mel,NM-59,Library failed/low yield,,,0.00,,Small Gene Panel,,67,,"not enough LP
",Tumor,Nodular Melanoma,
NMLP-048,598 Nodular Mel,NM-60,Captured,"SGPC-06,SGPC-14",10.9,12.67,12,Small Gene Panel,,68,,,Tumor,Nodular Melanoma,"BCB002,BCB008,BCB015"
NMLP-049,599 Nodular Mel,NM-61,Captured,"SGPC-06,SGPC-10,SGPC-13",10.9,12.39,12,Small Gene Panel,,69,,,Tumor,Nodular Melanoma,"BCB002,BCB006,BCB008,BCB013"
NMLP-050,600 Nodular Mel,NM-63,Captured,SGPC-06,10.9,23.70,12,Small Gene Panel,,70,,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-051,601 Nodular Mel,NM-64,Captured,SGPC-06,10.9,23.19,12,Small Gene Panel,,71,,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-052,602 Nodular Mel,NM-65,Captured,SGPC-06,10.9,3.91,12,Small Gene Panel,,72,,,Tumor,Nodular Melanoma,"BCB002,BCB008"
NMLP-053,1006 Nodular Mel,NM-68,Captured,SGPC-19,11.0,35.48,12,Small Gene Panel,,154,9/8/2021,"KAPA HyperPLUS, 10 min Frag at 37oC, 30 min ligation at 20oC",Tumor,Nodular Melanoma,BCB032
Nu-01,1315 Tumor,KF-01,Captured,SGPC-04,1.4,1.54,,Whole Genome Sequencing,A01,,,"NuGen LP Kit, Spiked after capture clean up, NuGen A01 adapter, CACGTCTA",,Fusion RNA,SGPC-04
Nu-02,1320 Tumor,KF-02,Captured,SGPC-04,1.4,0.45,,Whole Genome Sequencing,B01,,,"NuGen LP Kit, Spiked after capture clean up, NuGen B01, AGCTAGTG",,Fusion RNA,SGPC-04
Nu-05,1321 Tumor,KF-05,Captured,SGPC-04,1.4,0.87,,Whole Genome Sequencing,C01,,,"NuGen LP Kit, Spiked after capture clean up, NuGen C01, ACTATCGC",,Fusion RNA,SGPC-04
Nu-06,1322 Tumor,DP-09,Captured,SGPC-04,1.4,0.50,,Whole Genome Sequencing,D01,,,"NuGen LP Kit, Spiked after capture clean up, NuGen D01, GCGTATCA",,Fusion RNA,SGPC-04
Nu-08,1323 Tumor,KF-08,Captured,SGPC-04,1.4,0.38,,Whole Genome Sequencing,E01,,,"NuGen LP Kit, Spiked after capture clean up, NuGen E01, ACTCTCCA",,Fusion RNA,SGPC-04
Nu-09,1324 Tumor,DP-17,Captured,SGPC-04,1.4,0.37,,Whole Genome Sequencing,F01,,,"NuGen LP Kit, Spiked after capture clean up, NuGen F01, CGTCCATT",,Fusion RNA,SGPC-04
Nu-10,1325 Tumor,KF-10,Captured,SGPC-04,1.4,0.12,,Whole Genome Sequencing,G01,,,"NuGen LP Kit, Spiked after capture clean up, NuGen G01, AGCCGTAA",,Fusion RNA,SGPC-04
Nu-11,2250 Tumor,KF-11,Captured,SGPC-04,1.4,0.66,,Whole Genome Sequencing,H01,,,"NuGen LP Kit, Spiked after capture clean up, NuGen H01, GAGTAGAG. Lung cancer with ALK fusion",,Fusion RNA,SGPC-04
OMLP-001,2017 Invasive Melanoma,OM-15,,,,0.00,,Small Gene Panel,,188,8/4/2021,DO NOT USE SEQUENCED DATA! Adapter Ligation: O/N (15 hrs) at 20oC,,Oral Mucosa Lesions,
OMLP-002,2017 Invasive Melanoma,OM-15,Captured,SGPC-19,44.5,23.30,12,Small Gene Panel,,167,8/6/2021,"DO NOT USE SEQUENCED DATA! Purigen, HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. SGPC-21: xx Cycles post Hyb, XXng captured",,Oral Mucosa Lesions,BCB032
OMLP-003,2017 Invasive Melanoma,OM-15,Captured,SGPC-19,44.5,50.00,12,Small Gene Panel,,153,8/6/2021,"DO NOT USE SEQUENCED DATA! HyperPrep, NEBRepair, Ligation: 17 hrs,16oC.",,Oral Mucosa Lesions,BCB032
OMLP-004,3399 Unknown,OM-01,Captured,SGPC-19,5.0,50.00,12,Small Gene Panel,,119,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-005,3401 Unknown,OM-03,Captured,SGPC-19,6.0,50.00,12,Small Gene Panel,,120,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-006,3403 Unknown,OM-04,Captured,SGPC-19,0.5,50.00,12,Small Gene Panel,,121,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-007,3405 Unknown,OM-05,Captured,SGPC-19,0.5,50.00,12,Small Gene Panel,,122,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-008,3407 Unknown,OM-08,Captured,SGPC-19,0.0,NaN,12,Small Gene Panel,,123,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-009,2012 Intramucosal Melanocytic Nevus,OM-10,Captured,SGPC-19,2.0,50.00,12,Small Gene Panel,,124,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-010,2013 Intramucosal Melanocytic Nevus,OM-11,Captured,SGPC-19,0.0,NaN,12,Small Gene Panel,,125,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-011,2017 Invasive Melanoma,,Captured,SGPC-19,1.0,50.00,12,Small Gene Panel,,126,9/22/2021,"DO NOT USE SEQUENCED DATA! HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-012,3409 Unknown,,Captured,SGPC-19,8.5,50.00,12,Small Gene Panel,,127,9/22/2021,"DO NOT USE SEQUENCED DATA! HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-013,3412 Unknown,OM-12,Captured,SGPC-19,0.0,NaN,12,Small Gene Panel,,128,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-014,2014 Intramucosal Nevus,OM-13,Captured,SGPC-19,1.5,50.00,12,Small Gene Panel,,129,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-015,2015 Intramucosal Nevus,OM-14,Captured,SGPC-19,0.0,NaN,12,Small Gene Panel,,130,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-016,2016 Blue Nevus,OM-16,Captured,SGPC-19,1.0,50.00,12,Small Gene Panel,,131,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-017,3414 Unknown,OM-17,Captured,SGPC-19,2.0,50.00,12,Small Gene Panel,,132,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-018,3415 Unknown,OM-18,Captured,SGPC-19,0.0,NaN,12,Small Gene Panel,,133,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-019,3416 Unknown,OM-18,Captured,SGPC-19,0.5,50.00,12,Small Gene Panel,,134,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-020,3417 Unknown,OM-18,Captured,SGPC-19,0.0,NaN,12,Small Gene Panel,,135,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-021,3418 Unknown,OM-18,Captured,SGPC-19,0.0,NaN,12,Small Gene Panel,,139,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB032
OMLP-022,2029 Atypical Melanocytic Proliferation,OM-01,Captured,SGPC-22,107.0,21.57,12,Small Gene Panel,,159,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-023,2030 Atypical Melanocytic Proliferation,OM-04,Captured,SGPC-22,107.0,29.64,12,Small Gene Panel,,160,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-024,2031 Atypical Melanocytic Proliferation,OM-05,Captured,SGPC-22,107.0,30.92,12,Small Gene Panel,,161,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-025,2032 Atypical Melanocytic Proliferation,,Captured,SGPC-22,107.0,15.44,12,Small Gene Panel,,162,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-026,2012 Intramucosal Melanocytic Nevus,OM-10,Captured,SGPC-22,107.0,22.29,12,Small Gene Panel,,163,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-027,2017 Invasive Melanoma,,Captured,SGPC-22,107.0,18.74,12,Small Gene Panel,,164,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-028,2021 Lentiginous Juntional Melanocytic Nevus,OM-22,Captured,SGPC-22,107.0,30.40,12,Small Gene Panel,,165,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-029,2022 Compound Nevus,OM-23,Captured,SGPC-22,107.0,20.98,12,Small Gene Panel,,166,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-030,2023 Intramucosal Nevus,OM-24,Captured,SGPC-22,107.0,12.72,12,Small Gene Panel,,167,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-031,2024 Intramucosal Nevus,OM-25,Captured,SGPC-22,107.0,18.64,12,Small Gene Panel,,168,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-032,2025 Blue Nevus,OM-26,Captured,SGPC-22,68.5,50.00,12,Small Gene Panel,,169,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-033,2026 Intramucosal Nevus,OM-27,Captured,SGPC-22,107.0,17.34,12,Small Gene Panel,,170,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-034,2027 Intramucosal Nevus,OM-28,Captured,SGPC-22,107.0,10.70,12,Small Gene Panel,,171,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-035,2028 Intramucosal Nevus,OM-29,Captured,SGPC-22,107.0,24.26,12,Small Gene Panel,,172,1/28/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-036,1960 Typical Melanotic Macule,OM-31,Captured,SGPC-22,107.0,50.00,12,Small Gene Panel,,182,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-037,1961 Typical Melanotic Macule,OM-32,Captured,SGPC-22,107.0,49.31,12,Small Gene Panel,,183,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-038,1962 Typical Melanotic Macule,OM-33,Captured,SGPC-22,49.0,50.00,12,Small Gene Panel,,184,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-039,1964 Typical Melanotic Macule,OM-34,Captured,SGPC-22,107.0,29.32,12,Small Gene Panel,,185,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-040,1966 Typical Melanotic Macule,OM-36,Captured,SGPC-22,88.5,50.00,12,Small Gene Panel,,186,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-041,1967 Typical Melanotic Macule,OM-37,Captured,SGPC-22,72.5,50.00,12,Small Gene Panel,,187,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-042,1968 Typical Melanotic Macule,OM-38,Captured,SGPC-22,39.5,50.00,12,Small Gene Panel,,188,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-043,1969 Typical Melanotic Macule,OM-39,Captured,SGPC-22,22.0,50.00,12,Small Gene Panel,,189,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-044,1971 Typical Melanotic Macule,OM-41,Captured,SGPC-22,107.0,33.44,12,Small Gene Panel,,190,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-045,1972 Typical Melanotic Macule,OM-42,Captured,SGPC-22,58.0,50.00,12,Small Gene Panel,,191,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-046,1973 Typical Melanotic Macule,OM-43,Captured,SGPC-22,44.0,50.00,12,Small Gene Panel,,192,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-047,1977 Mel,OM-45,Captured,SGPC-22,107.0,25.12,12,Small Gene Panel,,104,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-048,1978 Mel,OM-46,Captured,SGPC-22,107.0,35.31,12,Small Gene Panel,,105,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-049,1979 Mel,OM-47,Captured,SGPC-22,107.0,35.91,12,Small Gene Panel,,111,2/21/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-050,1959 Typical Melanotic Macule,OM-30,Captured,SGPC-22,6.0,50.00,12,Small Gene Panel,,88,3/7/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-051,"1970 Intramucosal Nevus, 2003 Intramucosal Nevus",OM-40,Captured,SGPC-22,82.5,50.00,12,Small Gene Panel,,89,3/7/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-052,1974 Superficial Melanoma,OM-44,Captured,SGPC-22,70.5,50.00,12,Small Gene Panel,,90,3/7/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-053,1975 Mel,OM-44,Captured,SGPC-22,65.5,50.00,12,Small Gene Panel,,91,3/7/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-054,1976 Invasive Mel 1,OM-44,Captured,SGPC-22,43.0,50.00,12,Small Gene Panel,,93,3/7/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-055,1983 Typical Melanotic Macule,OM-51,Captured,SGPC-22,26.0,50.00,12,Small Gene Panel,,1,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-056,1985 Typical Melanotic Macule,OM-53,Captured,SGPC-22,83.0,50.00,12,Small Gene Panel,,38,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-057,1986 Typical Melanotic Macule,OM-54,Captured,SGPC-22,59.0,50.00,12,Small Gene Panel,,84,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-058,1987 Typical Melanotic Macule,OM-55,Captured,SGPC-22,50.5,50.00,12,Small Gene Panel,,87,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-059,1989 Mel,OM-57,Captured,SGPC-22,107.0,31.47,12,Small Gene Panel,,94,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-060,1990 Atypical Melanocytic Proliferation,OM-58,Captured,SGPC-22,48.5,50.00,12,Small Gene Panel,,95,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-061,1991 Atypical Melanocytic Proliferation,OM-58,Captured,SGPC-22,23.5,50.00,12,Small Gene Panel,,96,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-062,1992 Intramucosal Nevus,OM-59,Captured,SGPC-22,107.0,37.54,12,Small Gene Panel,,100,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-063,1993 Typical Melanotic Macule,OM-60,Captured,SGPC-22,107.0,36.27,12,Small Gene Panel,,101,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-064,1994 Typical Melanotic Macule,OM-61,Captured,SGPC-22,59.5,50.00,12,Small Gene Panel,,102,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-065,1995 Typical Melanotic Macule,OM-62,Captured,SGPC-22,56.0,50.00,12,Small Gene Panel,,103,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-066,1996 Typical Melanotic Macule,OM-62,Captured,SGPC-22,107.0,32.52,12,Small Gene Panel,,106,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-067,1997 Lentiginous junctional melanocytic nevus,OM-63,Captured,SGPC-22,83.5,50.00,12,Small Gene Panel,,112,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-068,1998 Intramucosal Nevus,OM-64,Captured,SGPC-22,32.5,50.00,12,Small Gene Panel,,113,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-069,2000 Typical Melanotic Macule,OM-01,Captured,SGPC-22,107.0,35.67,12,Small Gene Panel,,114,3/24/2022,"Ligation: 30min, 20oC. 3/31/22 CHANGED PAT ID TO OM-01",,Oral Mucosa Lesions,BCB037
OMLP-070,2001 Typical Melanotic Macule,OM-01,Captured,SGPC-22,89.0,50.00,12,Small Gene Panel,,115,3/24/2022,"Ligation: 30min, 20oC. 3/31/22 CHANGED PAT ID TO OM-01",,Oral Mucosa Lesions,BCB037
OMLP-071,2002 Atypical Melanocytic Proliferation,OM-01,Captured,SGPC-22,107.0,40.84,12,Small Gene Panel,,119,3/24/2022,"Ligation: 30min, 20oC. 3/31/22 CHANGED PAT ID TO OM-01",,Oral Mucosa Lesions,BCB037
OMLP-072,2006 Typical Melanotic Macule,OM-68,Captured,SGPC-22,13.5,50.00,12,Small Gene Panel,,120,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-073,2009 Typical Melanotic Macule,OM-69,Captured,SGPC-22,48.0,50.00,12,Small Gene Panel,,157,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-074,2010 Typical Melanotic Macule,OM-70,Captured,SGPC-22,50.5,50.00,12,Small Gene Panel,,158,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
OMLP-075,2011 Typical Melanotic Macule,OM-71,Captured,SGPC-22,34.5,50.00,12,Small Gene Panel,,181,3/24/2022,"Ligation: 30min, 20oC.",,Oral Mucosa Lesions,BCB037
PG_8,3425 Unknown,,Captured,BB4_CL,62.5,Infinity,,NimV1,L2DR04,,,,Tumor,2010-2017,Nimblegen1_BB004
PMM-8-Tumor,3303 Unknown,,Captured,BB73_CL,20.4,Infinity,14,NimV2,NextFlex 12,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",Tumor,2010-2017,Kapa2_BB73
RLP-17,296 Nevus,ME-07,Captured,KAPAEX-12,165.0,50.00,, SeqCap EZ MedExome,B6,,8/20/2018,RLP-17,Nevus,Melanoma Epigenetics,BCB023
RLP-24,303 Mel,ME-10,Captured,KAPAEX-11,40.0,50.00,, SeqCap EZ MedExome,E11,,8/20/2018,RLP-24,Mel,Melanoma Epigenetics,BCB023
RLP-25,304 Normal,ME-07,Captured,KAPAEX-12,100.0,12.66,, SeqCap EZ MedExome,,1,9/27/2018,RLP-25,Normal,Melanoma Epigenetics,BCB023
RLP-57,799 Mel,ME-36,Pending,,,0.00,,,,81,11/5/2018,"RLP-57, Sample removed from study",Mel,Melanoma Epigenetics,
RLP-58,800 Nevus,ME-36,Pending,,,0.00,,,,82,11/5/2018,"RLP-58, Sample removed from study",Nevus,Melanoma Epigenetics,
RLP-64,801 Nevus,ME-28,Captured,"CAPTURE 08,SGPC-18",333.0,10.78,13, SeqCap EZ MedExome,,88,11/5/2018,RLP-64,Nevus,Melanoma Epigenetics,BCB025
RLP-65,885 MIS,ME-23,Captured,CAPTURE 08,333.0,15.37,13, SeqCap EZ MedExome,,89,11/5/2018,"RLP-65, Sample removed from study",MIS,Melanoma Epigenetics,
RLP-66,785 Nevus,ME-23,Captured,CAPTURE 08,154.0,46.95,13, SeqCap EZ MedExome,,90,11/5/2018,"RLP-66, Sample removed from study",Nevus,Melanoma Epigenetics,
RLP-67,778 Normal,ME-20,Captured,KAPAEX-09,166.7,5.83,, SeqCap EZ MedExome,,17,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-68,783 Normal,ME-22,Captured,KAPAEX-09,166.7,12.80,, SeqCap EZ MedExome,,18,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-69,792 Normal,ME-26,Captured,KAPAEX-09,166.7,12.72,, SeqCap EZ MedExome,,19,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-70,790 Normal,ME-25,Captured,KAPAEX-09,166.7,11.08,, SeqCap EZ MedExome,,20,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-71,797 Normal,ME-27,Captured,KAPAEX-10,166.7,27.74,, SeqCap EZ MedExome,,24,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-72,1434 Normal,ME-11,Captured,KAPAEX-10,166.7,44.45,, SeqCap EZ MedExome,,25,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-73,1430 Normal,ME-18,Captured,KAPAEX-09,166.7,11.81,, SeqCap EZ MedExome,,26,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-74,1431 Normal,ME-19,Captured,KAPAEX-09,166.7,13.29,, SeqCap EZ MedExome,,28,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-75,1432 Normal,ME-24,Captured,KAPAEX-10,166.7,43.30,, SeqCap EZ MedExome,,29,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-76,1433 Normal,ME-28,Captured,KAPAEX-10,166.7,8.97,, SeqCap EZ MedExome,,30,8/15/2020,,,Melanoma Epigenetics,BCB023
RLP-77,289 Normal,ME-04,Captured,KAPAEX-12,166.5,8.74,, SeqCap EZ MedExome,,168,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-78,1442 MIS1,ME-06,Captured,KAPAEX-11,333.0,48.33,, SeqCap EZ MedExome,,169,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-79,1443 MIS2,ME-06,Captured,KAPAEX-11,312.0,49.92,, SeqCap EZ MedExome,,170,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-80,303 Mel,ME-10,Captured,KAPAEX-11,244.0,50.00,, SeqCap EZ MedExome,,171,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-81,1441 MIS1,ME-16,Captured,KAPAEX-12,333.0,48.83,, SeqCap EZ MedExome,,172,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-82,1444 MIS2,ME-16,Captured,KAPAEX-12,333.0,21.05,, SeqCap EZ MedExome,,173,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-83,786 Normal,ME-23,Pending,,,0.00,,,,174,9/5/2020,Sample removed from study,,Melanoma Epigenetics,
RLP-84,885 MIS,ME-23,Pending,,,0.00,,,,175,9/5/2020,Sample removed from study,,Melanoma Epigenetics,
RLP-85,894 Normal,ME-29,Captured,KAPAEX-13,166.7,8.19,, SeqCap EZ MedExome,,176,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-86,892 Mel,ME-29,Captured,KAPAEX-13,333.0,12.84,, SeqCap EZ MedExome,,177,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-87,893 Nevus,ME-29,Captured,KAPAEX-13,333.0,10.25,, SeqCap EZ MedExome,,178,9/5/2020,,,Melanoma Epigenetics,BCB023
RLP-88,1447 Normal,ME-05,Captured,KAPAEX-10,166.7,7.86,, SeqCap EZ MedExome,,110,10/13/2020,,,Melanoma Epigenetics,BCB023
RLP-89,1451 Normal,ME-06,Captured,KAPAEX-11,159.0,50.00,, SeqCap EZ MedExome,,111,10/13/2020,,,Melanoma Epigenetics,BCB023
RLP-90,1446 Normal,ME-10,Captured,KAPAEX-11,100.0,35.97,, SeqCap EZ MedExome,,112,10/13/2020,,,Melanoma Epigenetics,BCB023
RLP-91,1448 Normal,ME-14,Captured,KAPAEX-13,166.7,23.48,, SeqCap EZ MedExome,,113,10/13/2020,,,Melanoma Epigenetics,BCB023
RLP-92,1449 Normal,ME-15,Captured,KAPAEX-10,160.0,49.84,, SeqCap EZ MedExome,,114,10/13/2020,,,Melanoma Epigenetics,BCB023
RLP-93,1450 Normal,ME-16,Captured,KAPAEX-13,166.7,23.92,, SeqCap EZ MedExome,,115,10/13/2020,,,Melanoma Epigenetics,BCB023
RLP-107,1917 Mel,CCR-011,Captured,KAPAEX-30,59.0,50.00,13,KAPA HyperExome V1 Probes,,169,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB062
RLP-108,1918 MIS,CCR-011,Captured,KAPAEX-31,34.0,50.75,13,KAPA HyperExome V1 Probes,,98,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-171, BCB063",MIS,Melanoma Epigenetics,
RLP-109,1919 Nevus,CCR-011,Captured,KAPAEX-32,45.0,50.00,13,KAPA HyperExome V1 Probes,,170,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-110,1921 Mel,CCR-021,Captured,KAPAEX-30,63.0,50.40,13,KAPA HyperExome V1 Probes,,100,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-30; Sequenced with RLP-173, BCB062",Mel,Melanoma Epigenetics,
RLP-111,1922 Nevus,CCR-021,Captured,KAPAEX-31,27.0,50.00,13,KAPA HyperExome V1 Probes,,101,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-174, BCB063",Nevus,Melanoma Epigenetics,
RLP-112,1931 Mel,CCR-142,Captured,KAPAEX-31,22.0,51.16,13,KAPA HyperExome V1 Probes,,102,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-175, BCB063",Mel,Melanoma Epigenetics,
RLP-113,1932 MIS,CCR-142,Captured,KAPAEX-31,23.0,50.00,13,KAPA HyperExome V1 Probes,,103,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-176, BCB063",MIS,Melanoma Epigenetics,
RLP-114,1933 Nevus,CCR-142,Captured,KAPAEX-31,30.0,50.85,13,KAPA HyperExome V1 Probes,,104,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-31; Sequenced with RLP-177, BCB063",Nevus,Melanoma Epigenetics,
RLP-115,1931 Mel,CCR-141,Captured,KAPAEX-30,90.0,50.00,13,KAPA HyperExome V1 Probes,,167,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB062
RLP-116,1932 MIS,CCR-141,Captured,KAPAEX-32,47.0,50.54,13,KAPA HyperExome V1 Probes,,109,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-179, BCB059",MIS,Melanoma Epigenetics,
RLP-117,1933 Nevus,CCR-141,Captured,KAPAEX-34,69.0,50.00,13,KAPA HyperExome V1 Probes,,110,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-180, BCB064",Nevus,Melanoma Epigenetics,
RLP-118,1944 Mel,CCR-302,Captured,KAPAEX-28,145.0,50.00,13,KAPA HyperExome V1 Probes,,111,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB059
RLP-119,1945 Nevus,CCR-302,Captured,KAPAEX-30,94.0,50.27,13,KAPA HyperExome V1 Probes,,112,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB062
RLP-120,1954 MIS,CCR-302,Captured,KAPAEX-34,113.0,50.00,13,KAPA HyperExome V1 Probes,,113,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB064
RLP-121,1947 Melanocytoma,CCR-008,Captured,KAPAEX-31,14.0,50.00,13,KAPA HyperExome V1 Probes,,114,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-184, BCB063",Mel,Melanoma Epigenetics,
RLP-122,1948 Nevus,CCR-008,Captured,KAPAEX-31,16.0,51.61,13,KAPA HyperExome V1 Probes,,115,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-185, BCB063",Nevus,Melanoma Epigenetics,
RLP-123,1641 Mel,CCR-008,Captured,KAPAEX-32,45.0,50.56,13,KAPA HyperExome V1 Probes,,119,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-186, BCB059",Mel,Melanoma Epigenetics,
RLP-124,1951 Mel,ME-37,Captured,KAPAEX-28,150.0,23.89,13,KAPA HyperExome V1 Probes,,168,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB059
RLP-125,1952 Nevus,ME-37,Captured,KAPAEX-28,150.0,9.90,13,KAPA HyperExome V1 Probes,,121,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-126,892 Mel,ME-29,Captured,KAPAEX-28,150.0,27.27,13,KAPA HyperExome V1 Probes,,122,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB059
RLP-127,893 Nevus,ME-29,Pending,,,0.00,,,,123,3/3/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,
RLP-128,2243 MIS,ME-15,Captured,KAPAEX-34,76.0,50.00,13,KAPA HyperExome V1 Probes,,124,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-190, BCB064",MIS,Melanoma Epigenetics,
RLP-129,2244 Nevus,ME-15,Captured,KAPAEX-30,88.0,50.00,13,KAPA HyperExome V1 Probes,,125,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB062
RLP-130,2180 Mel1,ME-47,Captured,KAPAEX-33,137.0,22.87,13,KAPA HyperExome V1 Probes,,126,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB061
RLP-131,2181 Mel2,ME-47,Captured,KAPAEX-33,137.0,21.41,13,KAPA HyperExome V1 Probes,,127,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB061
RLP-132,2182 Nevus,ME-47,Captured,KAPAEX-33,137.0,30.51,13,KAPA HyperExome V1 Probes,,128,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB061
RLP-133,2184 Mel,ME-48,Captured,KAPAEX-31,21.0,50.00,13,KAPA HyperExome V1 Probes,,129,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-195, BCB063",Mel,Melanoma Epigenetics,
RLP-134,2185 Nevus,ME-48,Captured,KAPAEX-32,36.0,50.00,13,KAPA HyperExome V1 Probes,,130,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-196, BCB059",Nevus,Melanoma Epigenetics,
RLP-135,2187 Mel,ME-49,Captured,KAPAEX-33,137.0,38.70,13,KAPA HyperExome V1 Probes,,131,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB061
RLP-136,2188 Nevus,ME-49,Captured,KAPAEX-34,120.0,43.80,13,KAPA HyperExome V1 Probes,,132,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB064
RLP-137,2190 Mel,ME-50,Captured,KAPAEX-29,89.0,50.28,13,KAPA HyperExome V1 Probes,,133,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles. KAPAEX-29; Sequenced with RLP-199, BCB059",Mel,Melanoma Epigenetics,
RLP-138,2191 Nevus,ME-50,Captured,KAPAEX-34,53.0,46.09,13,KAPA HyperExome V1 Probes,,134,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-200, BCB064",Nevus,Melanoma Epigenetics,
RLP-139,2196 Mel,ME-52,Captured,KAPAEX-34,120.0,43.48,13,KAPA HyperExome V1 Probes,,135,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB064
RLP-140,2197 MIS,ME-52,Captured,KAPAEX-34,110.0,50.23,13,KAPA HyperExome V1 Probes,,136,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB064
RLP-141,2198 Nevus,ME-52,Captured,KAPAEX-33,137.0,41.77,13,KAPA HyperExome V1 Probes,,137,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB061
RLP-142,2200 Mel,ME-53,Captured,KAPAEX-34,101.0,49.75,13,KAPA HyperExome V1 Probes,,139,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB064
RLP-143,2201 MIS,ME-53,Captured,KAPAEX-33,137.0,44.05,13,KAPA HyperExome V1 Probes,,140,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB061
RLP-144,2202 Nevus,ME-53,Captured,KAPAEX-34,119.0,50.00,13,KAPA HyperExome V1 Probes,,141,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB064
RLP-145,2204 Mel,ME-54,Captured,KAPAEX-30,47.0,50.54,13,KAPA HyperExome V1 Probes,,142,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles, KAPAEX-30; Sequenced with RLP-207, BCB062",Mel,Melanoma Epigenetics,
RLP-146,2205 Nevus,ME-54,Captured,KAPAEX-32,38.0,50.00,13,KAPA HyperExome V1 Probes,,143,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-208, BCB059",Nevus,Melanoma Epigenetics,
RLP-147,2207 MIS,ME-55,Captured,KAPAEX-33,137.0,27.45,13,KAPA HyperExome V1 Probes,,144,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB061
RLP-148,2208 Nevus,ME-55,Captured,KAPAEX-33,137.0,42.68,13,KAPA HyperExome V1 Probes,,145,3/8/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB061
RLP-149,2209 PRAME (+) Nevus,ME-55,Pending,,,0.00,,,,146,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,
RLP-150,2211  Mel,ME-56,Pending,,,0.00,,,,147,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,
RLP-151,2212 MIS,ME-56,Captured,KAPAEX-29,37.0,50.68,13,KAPA HyperExome V1 Probes,,148,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles;  KAPAEX-29; Sequenced with RLP-213, BCB059",MIS,Melanoma Epigenetics,
RLP-152,2213 Nevus,ME-56,Captured,KAPAEX-29,19.0,51.35,13,KAPA HyperExome V1 Probes,,149,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-29; Sequenced with RLP-214, BCB059",Nevus,Melanoma Epigenetics,
RLP-153,2215 Mel,ME-57,Captured,KAPAEX-31,24.0,50.00,13,KAPA HyperExome V1 Probes,,150,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-215, BCB063",Mel,Melanoma Epigenetics,
RLP-154,2237 MIS,ME-57,Captured,KAPAEX-31,29.0,50.00,13,KAPA HyperExome V1 Probes,,151,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-216, BCB063",MIS,Melanoma Epigenetics,
RLP-155,2216 Nevus,ME-57,Captured,KAPAEX-30,48.0,50.00,13,KAPA HyperExome V1 Probes,,152,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-217, BCB062",Nevus,Melanoma Epigenetics,
RLP-156,2217 Regressed Area,ME-57,Captured,KAPAEX-32,34.0,50.00,13,KAPA HyperExome V1 Probes,,153,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-218, BCB059",,Melanoma Epigenetics,
RLP-157,2219 Mel,ME-58,Captured,KAPAEX-30,28.0,50.00,13,KAPA HyperExome V1 Probes,,154,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-219, BCB062",Mel,Melanoma Epigenetics,
RLP-158,2220 MIS,ME-58,Captured,KAPAEX-32,25.0,50.00,13,KAPA HyperExome V1 Probes,,155,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-220, BCB059",MIS,Melanoma Epigenetics,
RLP-159,2221 Nevus,ME-58,Captured,KAPAEX-30,36.0,50.70,13,KAPA HyperExome V1 Probes,,156,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-221, BCB062",Nevus,Melanoma Epigenetics,
RLP-160,2223 Mel1,ME-59,Captured,KAPAEX-30,20.0,51.28,13,KAPA HyperExome V1 Probes,,157,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-222, BCB062",Mel,Melanoma Epigenetics,
RLP-161,2224 Mel2,ME-59,Captured,KAPAEX-31,22.0,51.16,13,KAPA HyperExome V1 Probes,,158,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-223, BCB063",Mel,Melanoma Epigenetics,
RLP-162,2225 Nevus,ME-59,Captured,KAPAEX-32,29.0,50.00,13,KAPA HyperExome V1 Probes,,159,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-224, BCB059",Nevus,Melanoma Epigenetics,
RLP-163,2227 Mel,ME-60,Captured,KAPAEX-34,47.0,50.54,13,KAPA HyperExome V1 Probes,,160,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-225, BCB064",Mel,Melanoma Epigenetics,
RLP-164,2228 Nevus,ME-60,Captured,KAPAEX-32,26.0,50.98,13,KAPA HyperExome V1 Probes,,161,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-226, BCB059",Nevus,Melanoma Epigenetics,
RLP-165,2230 Mel,ME-61,Captured,KAPAEX-34,120.0,50.00,13,KAPA HyperExome V1 Probes,,162,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB064
RLP-166,2231 MIS,ME-61,Captured,KAPAEX-29,24.0,16.00,13,KAPA HyperExome V1 Probes,,163,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-29; Sequenced with RLP-228, BCB059",MIS,Melanoma Epigenetics,
RLP-167,2232 Nevus,ME-61,Pending,,48.0,50.53,13,KAPA HyperExome V1 Probes,,164,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-29; Sequenced with RLP-229, BCB059",Nevus,Melanoma Epigenetics,
RLP-168,2234 Mel,ME-62,Captured,KAPAEX-31,18.0,50.00,13,KAPA HyperExome V1 Probes,,165,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; ; KAPAEX-31; Sequenced with RLP-230, BCB063",Mel,Melanoma Epigenetics,
RLP-169,2235 Nevus,ME-62,Captured,KAPAEX-31,31.0,50.82,13,KAPA HyperExome V1 Probes,,166,3/10/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-231, BCB063",Nevus,Melanoma Epigenetics,
RLP-170,1917 Mel,CCR-011,Captured,KAPAEX-30,31.0,50.00,13,KAPA HyperExome V1 Probes,,97,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB062
RLP-171,1918 MIS,CCR-011,Captured,KAPAEX-31,19.0,51.35,13,KAPA HyperExome V1 Probes,,98,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB063
RLP-172,1919 Nevus,CCR-011,Captured,KAPAEX-32,32.0,50.00,13,KAPA HyperExome V1 Probes,,99,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-173,1921 Mel,CCR-021,Captured,KAPAEX-30,19.0,51.35,13,KAPA HyperExome V1 Probes,,100,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB062
RLP-174,1922 Nevus,CCR-021,Captured,KAPAEX-31,20.0,51.28,13,KAPA HyperExome V1 Probes,,101,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB063
RLP-175,1931 Mel,CCR-142,Captured,KAPAEX-31,1.0,50.00,13,KAPA HyperExome V1 Probes,,102,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB063
RLP-176,1932 MIS,CCR-142,Captured,KAPAEX-31,15.0,50.00,13,KAPA HyperExome V1 Probes,,103,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB063
RLP-177,1933 Nevus,CCR-142,Captured,KAPAEX-31,25.0,51.02,13,KAPA HyperExome V1 Probes,,104,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB063
RLP-179,1932 MIS,CCR-141,Captured,KAPAEX-32,47.0,111.90,13,KAPA HyperExome V1 Probes,,109,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB059
RLP-180,1933 Nevus,CCR-141,Captured,KAPAEX-34,36.0,50.00,13,KAPA HyperExome V1 Probes,,110,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB064
RLP-184,1947 Melanocytoma,CCR-008,Captured,KAPAEX-31,5.0,55.56,13,KAPA HyperExome V1 Probes,,114,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Melanoma Epigenetics,BCB063
RLP-185,1948 Nevus,CCR-008,Captured,KAPAEX-31,8.0,53.33,13,KAPA HyperExome V1 Probes,,115,6/30/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB063
RLP-186,1641 Mel,CCR-008,Captured,KAPAEX-32,30.0,50.85,13,KAPA HyperExome V1 Probes,,119,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB059
RLP-190,2243 MIS,ME-15,Captured,KAPAEX-34,44.0,44.90,13,KAPA HyperExome V1 Probes,,124,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB064
RLP-195,2184 Mel,ME-48,Captured,KAPAEX-31,20.0,51.28,13,KAPA HyperExome V1 Probes,,129,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB063
RLP-196,2185 Nevus,ME-48,Captured,KAPAEX-32,28.0,50.00,13,KAPA HyperExome V1 Probes,,130,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-199,2190 Mel,ME-50,Captured,KAPAEX-29,63.0,50.00,13,KAPA HyperExome V1 Probes,,133,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB061
RLP-200,2191 Nevus,ME-50,Captured,KAPAEX-34,53.0,50.00,13,KAPA HyperExome V1 Probes,,134,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB064
RLP-207,2204 Mel,ME-54,Captured,KAPAEX-30,42.0,50.60,13,KAPA HyperExome V1 Probes,,142,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB062
RLP-208,2205 Nevus,ME-54,Captured,KAPAEX-32,40.0,50.63,13,KAPA HyperExome V1 Probes,,143,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-211,2209 PRAME (+) Nevus,ME-55,Captured,KAPAEX-34,109.0,50.23,13,KAPA HyperExome V1 Probes,,146,7/5/2023,,Nevus,Melanoma Epigenetics,BCB064
RLP-212,2211 Mel,ME-56,Captured,KAPAEX-29,150.0,47.47,13,KAPA HyperExome V1 Probes,,147,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB061
RLP-213,2212 MIS,ME-56,Captured,KAPAEX-29,108.0,50.00,13,KAPA HyperExome V1 Probes,,148,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB061
RLP-214,2213 Nevus,ME-56,Captured,KAPAEX-29,130.0,50.00,13,KAPA HyperExome V1 Probes,,149,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB061
RLP-215,2215 Mel,ME-57,Captured,KAPAEX-31,23.0,51.11,13,KAPA HyperExome V1 Probes,,150,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB063
RLP-216,2237 MIS,ME-57,Captured,KAPAEX-31,30.0,50.85,13,KAPA HyperExome V1 Probes,,151,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB063
RLP-217,2216 Nevus,ME-57,Captured,KAPAEX-30,35.0,50.00,13,KAPA HyperExome V1 Probes,,152,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB062
RLP-218,2217 Regressed Area,ME-57,Captured,KAPAEX-32,30.0,50.85,13,KAPA HyperExome V1 Probes,,153,7/5/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Melanoma Epigenetics,BCB059
RLP-219,2219 Mel,ME-58,Captured,KAPAEX-30,58.0,50.43,13,KAPA HyperExome V1 Probes,,154,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB062
RLP-220,2220 MIS,ME-58,Captured,KAPAEX-32,44.0,50.57,13,KAPA HyperExome V1 Probes,,155,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB059
RLP-221,2221 Nevus,ME-58,Captured,KAPAEX-30,58.0,50.00,13,KAPA HyperExome V1 Probes,,156,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB062
RLP-222,2223 Mel1,ME-59,Captured,KAPAEX-30,65.0,50.39,13,KAPA HyperExome V1 Probes,,157,7/11/2023,"65oC X 1 min, 15 uM adapter; 10 cycles",Mel,Melanoma Epigenetics,BCB062
RLP-223,2224 Mel2,ME-59,Captured,KAPAEX-31,28.0,50.91,13,KAPA HyperExome V1 Probes,,158,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB063
RLP-224,2225 Nevus,ME-59,Captured,KAPAEX-32,34.0,50.75,13,KAPA HyperExome V1 Probes,,159,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-225,2227 Mel,ME-60,Captured,KAPAEX-34,53.0,42.40,13,KAPA HyperExome V1 Probes,,160,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB064
RLP-226,2228 Nevus,ME-60,Captured,KAPAEX-32,42.0,50.00,13,KAPA HyperExome V1 Probes,,161,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-228,2231 MIS,ME-61,Captured,KAPAEX-29,126.0,50.00,13,KAPA HyperExome V1 Probes,,163,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",MIS,Melanoma Epigenetics,BCB061
RLP-229,2232 Nevus,ME-61,Captured,KAPAEX-29,102.0,44.54,13,KAPA HyperExome V1 Probes,,164,7/11/2023,"65oC X 1 min, 15 uM adapter; 10 cycles",Nevus,Melanoma Epigenetics,BCB061
RLP-230,2234 Mel,ME-62,Captured,KAPAEX-31,25.0,50.00,13,KAPA HyperExome V1 Probes,,165,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB063
RLP-231,2235 Nevus,ME-62,Captured,KAPAEX-31,25.0,50.00,13,KAPA HyperExome V1 Probes,,166,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB063
RLP-232,2287 Mel,ME-63,Captured,KAPAEX-29,150.0,27.52,13,KAPA HyperExome V1 Probes,,167,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB061
RLP-233,2288 Melanocytoma,ME-63,Captured,KAPAEX-29,150.0,24.15,13,KAPA HyperExome V1 Probes,,168,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Others,Melanoma Epigenetics,BCB061
RLP-234,2290 Mel,ME-64,Captured,KAPAEX-29,150.0,26.04,13,KAPA HyperExome V1 Probes,,169,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB061
RLP-235,2291 Nevus,ME-64,Captured,KAPAEX-29,150.0,50.17,13,KAPA HyperExome V1 Probes,,170,7/11/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB061
RLP-236,2292 Mel,ME-64,Captured,KAPAEX-33,137.0,14.62,13,KAPA HyperExome V1 Probes,,171,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB061
RLP-237,2294 Mel,ME-65,Captured,KAPAEX-31,31.0,50.00,13,KAPA HyperExome V1 Probes,,172,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-256, BCB063",Mel,Melanoma Epigenetics,
RLP-238,2295 MIS,ME-65,Captured,KAPAEX-31,38.0,50.00,13,KAPA HyperExome V1 Probes,,173,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-31; Sequenced with RLP-250, BCB063",MIS,Melanoma Epigenetics,
RLP-239,2296 Nevus,ME-65,Captured,KAPAEX-28,145.0,50.17,13,KAPA HyperExome V1 Probes,,174,7/18/2023,"65oC X 1 min, 15 uM adapter; 12 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-240,2297 Mel,ME-65,Captured,KAPAEX-32,30.0,50.00,13,KAPA HyperExome V1 Probes,,175,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-32; Sequenced with RLP-257, BCB059",Mel,Melanoma Epigenetics,
RLP-241,2299 Mel,ME-66,Captured,KAPAEX-28,150.0,20.41,13,KAPA HyperExome V1 Probes,,176,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Mel,Melanoma Epigenetics,BCB059
RLP-242,2300 Nevus,ME-66,Captured,KAPAEX-28,150.0,17.56,13,KAPA HyperExome V1 Probes,,177,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles",Nevus,Melanoma Epigenetics,BCB059
RLP-243,2443 Mel,ME-67,Captured,KAPAEX-33,69.0,35.57,13,KAPA HyperExome V1 Probes,,178,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-33; Sequenced with RLP-251, BCB061",Mel,Melanoma Epigenetics,
RLP-244,2444 MIS,ME-67,Captured,KAPAEX-33,78.0,50.32,13,KAPA HyperExome V1 Probes,,179,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-33; Sequenced with RLP-252, BCB061",MIS,Melanoma Epigenetics,
RLP-245,2445 Nevus,ME-67,Captured,KAPAEX-30,89.0,50.00,13,KAPA HyperExome V1 Probes,,180,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-30; Sequenced with RLP-253, BCB062",Nevus,Melanoma Epigenetics,
RLP-246,2447 Mel,ME-68,Captured,KAPAEX-34,87.0,50.29,13,KAPA HyperExome V1 Probes,,181,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; KAPAEX-34; Sequenced with RLP-254, BCB064",Mel,Melanoma Epigenetics,
RLP-247,2448 Nevus,ME-68,Captured,KAPAEX-30,57.0,50.00,13,KAPA HyperExome V1 Probes,,182,7/18/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; ; KAPAEX-30; Sequenced with RLP-255, BCB062",Nevus,Melanoma Epigenetics,
RLP-248,2459 MIS,ME-69,Captured,KAPAEX-28,150.0,26.46,13,KAPA HyperExome V1 Probes,,183,7/25/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",MIS,Melanoma Epigenetics,BCB059
RLP-249,2460 Nevus,ME-69,Captured,KAPAEX-28,150.0,31.38,13,KAPA HyperExome V1 Probes,,184,7/25/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Nevus,Melanoma Epigenetics,BCB059
RLP-250,2295 MIS,ME-65,Captured,KAPAEX-31,19.0,50.00,13,KAPA HyperExome V1 Probes,,173,8/4/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",MIS,Melanoma Epigenetics,BCB063
RLP-251,2443 Mel,ME-67,Captured,KAPAEX-33,69.0,58.97,13,KAPA HyperExome V1 Probes,,178,8/4/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Mel,Melanoma Epigenetics,BCB061
RLP-252,2444 MIS,ME-67,Captured,KAPAEX-33,49.0,50.00,13,KAPA HyperExome V1 Probes,,179,8/4/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",MIS,Melanoma Epigenetics,BCB061
RLP-253,2445 Nevus,ME-67,Captured,KAPAEX-30,34.0,50.00,13,KAPA HyperExome V1 Probes,,180,8/4/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Nevus,Melanoma Epigenetics,BCB062
RLP-254,2447 Mel,ME-68,Captured,KAPAEX-34,35.0,50.72,13,KAPA HyperExome V1 Probes,,181,8/4/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Mel,Melanoma Epigenetics,BCB064
RLP-255,2448 Nevus,ME-68,Captured,KAPAEX-30,36.0,50.00,13,KAPA HyperExome V1 Probes,,182,8/4/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Nevus,Melanoma Epigenetics,BCB062
RLP-256,2294 Mel,ME-65,Captured,KAPAEX-31,9.0,50.00,13,KAPA HyperExome V1 Probes,,172,8/4/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Mel,Melanoma Epigenetics,BCB063
RLP-257,2297 Mel,ME-65,Captured,KAPAEX-32,41.0,50.62,13,KAPA HyperExome V1 Probes,,175,8/4/2023,"65oC X 1 min, 15 uM adapter; 10 cycles; 1 hr adapter ligation at 20oC",Mel,Melanoma Epigenetics,BCB059
RLP-258,2111 Mel,JJS19,Captured,KAPAEX-39,80.0,100.00,13,KAPA HyperExome V1 Probes,,173,8/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Mel,Melanoma Epigenetics,BCB068
RLP-259,2114 Mel,ME-43,Captured,KAPAEX-39,140.0,100.00,13,KAPA HyperExome V1 Probes,,174,8/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Mel,Melanoma Epigenetics,BCB068
RLP-260,2115 Nevus,ME-43,Captured,KAPAEX-39,140.0,68.29,13,KAPA HyperExome V1 Probes,,175,8/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Nevus,Melanoma Epigenetics,BCB068
RLP-261,2130 Nevus,JJS19,Captured,KAPAEX-39,98.0,100.00,13,KAPA HyperExome V1 Probes,,176,8/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Nevus,Melanoma Epigenetics,BCB068
RLP-262,2131 Mel,ME-40,Captured,KAPAEX-39,76.0,100.00,13,KAPA HyperExome V1 Probes,,177,8/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Mel,Melanoma Epigenetics,BCB068
RLP-263,2132 Nevus,ME-40,Captured,KAPAEX-39,18.0,50.00,13,KAPA HyperExome V1 Probes,,178,8/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Nevus,Melanoma Epigenetics,BCB068
RLP-264,2193 Mel,ME-51,Captured,KAPAEX-39,140.0,51.47,13,KAPA HyperExome V1 Probes,,179,8/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Mel,Melanoma Epigenetics,BCB068
RLP-265,2194 Nevus,ME-51,Captured,KAPAEX-39,131.0,50.00,13,KAPA HyperExome V1 Probes,,180,8/29/2023,"65oC X 1 min, 15 uM adapter; 8 cycles; 1 hr adapter ligation at 20oC",Nevus,Melanoma Epigenetics,BCB068
RNA-01,280 Normal,ME-01,Captured,VM_BB_02,333.0,37.42,12, SeqCap EZ MedExome,B7,,8/20/2018,RLP-01,Normal,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-02,281 Nevus,ME-01,Captured,VM_BB_02,333.0,42.69,12, SeqCap EZ MedExome,D8,,8/20/2018,RLP-02,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-03,282 Mel,ME-01,Captured,VM_BB_01,333.0,20.30,12, SeqCap EZ MedExome,D9,,8/20/2018,RLP-03,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-04,283 Normal,ME-02,Captured,VM_BB_01,100.0,38.46,12, SeqCap EZ MedExome,D10,,8/20/2018,RLP-04,Normal,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-05,284 Nevus,ME-02,Captured,VM_BB_01,100.0,45.45,12, SeqCap EZ MedExome,D11,,8/20/2018,RLP-05,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-06,285 Mel,ME-02,Captured,VM_BB_02,210.0,47.73,12, SeqCap EZ MedExome,D12,,8/20/2018,RLP-06,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-07,286 Normal,ME-03,Captured,VM_BB_01,100.0,47.62,12, SeqCap EZ MedExome,UN,,8/20/2018,RLP-07,Normal,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-08,287 Nevus,ME-03,Captured,VM_BB_02,210.0,50.00,12, SeqCap EZ MedExome,E9,,8/20/2018,RLP-08,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-09,288 Mel,ME-03,Captured,VM_BB_02,333.0,45.00,12, SeqCap EZ MedExome,E10,,8/20/2018,RLP-09,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-10,289 Normal,ME-04,Pending,,,0.00,,,E11,,8/20/2018,RLP-10,Normal,Melanoma Epigenetics,
RNA-11,290 Nevus,ME-04,Captured,VM_BB_01,333.0,28.96,12, SeqCap EZ MedExome,H8,,8/20/2018,RLP-11,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-12,291 Mel,ME-04,Captured,VM_BB_01,333.0,28.46,12, SeqCap EZ MedExome,H9,,8/20/2018,RLP-12,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-13,292 Nevus,ME-05,Captured,VM_BB_01,333.0,18.60,12, SeqCap EZ MedExome,A3,,8/20/2018,RLP-13,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-14,293 Mel,ME-05,Captured,VM_BB_01,333.0,14.23,12, SeqCap EZ MedExome,A5,,8/20/2018,RLP-14,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-15,294 Nevus,ME-06,Captured,VM_BB_02,333.0,45.62,12, SeqCap EZ MedExome,B4,,8/20/2018,RLP-15,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-16,295 Mel,ME-06,Captured,VM_BB_02,333.0,45.62,12, SeqCap EZ MedExome,B5,,8/20/2018,RLP-16,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-18,297 Mel,ME-07,Captured,VM_BB_02,333.0,25.62,12, SeqCap EZ MedExome,D9,,8/20/2018,RLP-18,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-19,298 Nevus,ME-08,Pending,,,0.00,,,D10,,8/20/2018,"RLP-19, Sample removed from study",Nevus,Melanoma Epigenetics,
RNA-20,299 Mel,ME-08,Pending,,,0.00,,,D12,,8/20/2018,"RLP-20, Sample removed from study",Mel,Melanoma Epigenetics,
RNA-21,300 Nevus,ME-09,Captured,VM_BB_02,210.0,39.62,12, SeqCap EZ MedExome,UN,,8/20/2018,"RLP-21, Sample removed from study",Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch2
RNA-22,301 Mel,ME-09,Captured,VM_BB_01,333.0,13.76,12, SeqCap EZ MedExome,E9,,8/20/2018,"RLP-22, Sample removed from study",Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch1
RNA-23,302 Normal,ME-10,Pending,,,0.00,, SeqCap EZ MedExome,E10,,8/20/2018,RLP-23,Normal,Melanoma Epigenetics,
RNA-26,305 Normal,ME-12,Captured,VM_BB_03,333.0,30.27,13, SeqCap EZ MedExome,,2,9/27/2018,RLP-26,Normal,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-27,343 MIS,ME-12,Captured,VM_BB_03,333.0,17.43,13, SeqCap EZ MedExome,,3,9/27/2018,RLP-27,MIS,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-28,344 Mel,ME-12,Captured,VM_BB_03,333.0,9.85,13, SeqCap EZ MedExome,,4,9/27/2018,RLP-28,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-29,345 Normal,ME-13,Captured,VM_BB_03,333.0,8.81,13, SeqCap EZ MedExome,,5,9/27/2018,RLP-29,Normal,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-30,346 Nevus,ME-13,Captured,VM_BB_03,333.0,31.71,13, SeqCap EZ MedExome,,6,9/27/2018,RLP-30,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-31,347 Mel,ME-13,Captured,VM_BB_03,333.0,10.64,13, SeqCap EZ MedExome,,7,9/27/2018,RLP-31,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-32,348 Nevus,ME-14,Captured,VM_BB_03,333.0,31.12,13, SeqCap EZ MedExome,,8,9/27/2018,RLP-32,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-33,349 Mel,ME-14,Captured,VM_BB_03,333.0,34.33,13, SeqCap EZ MedExome,,9,9/27/2018,RLP-33,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-34,350 Nevus,ME-15,Captured,VM_BB_03,333.0,28.22,13, SeqCap EZ MedExome,,10,9/27/2018,RLP-34,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-35,351 Mel,ME-15,Captured,VM_BB_03,333.0,37.84,13, SeqCap EZ MedExome,,11,9/27/2018,RLP-35,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-36,352 Nevus,ME-16,Captured,VM_BB_03,333.0,18.00,13, SeqCap EZ MedExome,,12,9/27/2018,RLP-36,Nevus,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-37,353 Mel,ME-16,Captured,VM_BB_03,333.0,17.53,13, SeqCap EZ MedExome,,13,9/27/2018,RLP-37,Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-38,354 Normal,ME-17,Captured,VM_BB_03,333.0,18.20,13, SeqCap EZ MedExome,,14,9/27/2018,"RLP-38, Sample removed from study",Normal,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-39,355 MIS,ME-17,Captured,VM_BB_03,333.0,18.92,13, SeqCap EZ MedExome,,15,9/27/2018,"RLP-39, Sample removed from study",MIS,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
RNA-40,356 Mel,ME-17,Captured,VM_BB_03,333.0,19.70,13, SeqCap EZ MedExome,,16,9/27/2018,"RLP-40, Sample removed from study",Mel,Melanoma Epigenetics,Matched_sample_RNAseq_Batch3
Rob-T001-Mel,3858 Mel,,Captured,BB90_CL,,NaN,,,C3,,,,Mel,2010-2017,Kapa17_BB90
Rob-T001-Normal,3859 Normal,,Captured,BB90_CL,,NaN,,,C2,,,,Normal,2010-2017,Kapa17_BB90
Rob-T003-Mel,2860 Mel,,Captured,BB90_CL,,NaN,,,C5,,,,Mel,2010-2017,Kapa17_BB90
Rob-T003-Normal,2825 Normal,,Captured,BB90_CL,,NaN,,,C4,,,,Normal,2010-2017,Kapa17_BB90
Rob-T005-Nev,2861 Nevus,,Captured,BB90_CL,,NaN,,,C7,,,,Nevus,2010-2017,Kapa17_BB90
Rob-T005-Normal,2862 Normal,,Captured,BB90_CL,,NaN,,,C6,,,,Normal,2010-2017,Kapa17_BB90
Rob-T008-Nev,2865 Nevus,,Captured,BB90_CL,,NaN,,,C9,,,,Nevus,2010-2017,Kapa17_BB90
Rob-T008-Normal,2866 Normal,,Captured,BB90_CL,,NaN,,,C8,,,,Normal,2010-2017,Kapa17_BB90
Rob-T009-Nev,2867 Nevus,,Captured,BB90_CL,,NaN,,,C11,,,,Nevus,2010-2017,Kapa17_BB90
Rob-T009-Normal,2868 Normal,,Captured,BB90_CL,,NaN,,,C10,,,,Normal,2010-2017,Kapa17_BB90
Rob-T010-Nev,2869 Nevus,,Captured,BB90_CL,,NaN,,,D1,,,,Nevus,2010-2017,Kapa17_BB90
Rob-T010-Normal,2870 Normal,,Captured,BB90_CL,,NaN,,,C12,,,,Normal,2010-2017,Kapa17_BB90
RPA_09_0209,3426 Tumor,,,,,NaN,13,Ampliconseq,L2DR16,,,"Hunter, Desmoplastic Melanoma Amplicon Sequence",Tumor,2010-2017,Nimblegen29_BB34
S12_20321_A2_Tumor,3427 Tumor,,Captured,BB11_CL,,NaN,,NimV1,L2DR03,,,"Brain, right frontal, biopsy: Glioblastoma, WHO Grade IV ",Tumor,2010-2017,Nimblegen8_BB11
Seider_Roe,3428 Tumor,,Captured,,,NaN,13,NimV2,L2DR08,,,Seider Uveal Melanoma,Tumor,2010-2017,Nimblegen38_BB45
Seider_Uveal Melanoma,3429 Tumor,,,,,NaN,13,NimV2,L2DR06,,,Seider Uveal Melanoma,Tumor,2010-2017,Nimblegen38_BB45
SGLP-0001,1336 Tumor,DP-16,Captured,SGPC-02,10.4,1.51,,Small Gene Panel,A1,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0002,1337 Tumor,DP-17,Captured,SGPC-02,10.4,1.25,,Small Gene Panel,A2,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0003,1338 Tumor,DP-18,Captured,SGPC-02,10.4,1.43,,Small Gene Panel,A3,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0004,1339 Tumor,DP-19,Captured,SGPC-02,10.4,0.96,,Small Gene Panel,A4,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0005,1340 Tumor,DP-20,Captured,SGPC-02,10.4,1.08,,Small Gene Panel,A5,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0006,1341 Tumor,DP-21,Captured,SGPC-02,10.4,1.45,,Small Gene Panel,A6,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0007,1342 Tumor,DP-22,Captured,SGPC-02,10.4,2.65,,Small Gene Panel,A7,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0008,1343 Tumor,DP-23,Captured,SGPC-02,10.4,1.35,,Small Gene Panel,A8,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0009,1344 Tumor,DP-24,Captured,SGPC-02,10.4,3.65,,Small Gene Panel,A9,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0010,1345 Tumor,DP-25,Captured,SGPC-02,10.4,1.65,,Small Gene Panel,A10,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0011,1346 Tumor,DP-26,Captured,SGPC-02,10.4,0.98,,Small Gene Panel,A11,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0012,998 Tumor,DP-10,Captured,SGPC-02,10.4,1.32,,Small Gene Panel,A12,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0013,1347 Tumor,DP-27,Captured,SGPC-02,10.4,1.70,,Small Gene Panel,B1,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0014,1348 Tumor,DP-28,Captured,SGPC-02,10.4,1.88,,Small Gene Panel,B2,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0015,1349 Tumor,DP-29,Captured,SGPC-02,10.4,4.23,,Small Gene Panel,B3,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0016,1350 Tumor,DP-30,Captured,SGPC-02,10.4,2.51,,Small Gene Panel,B4,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0017,1351 Tumor,DP-31,Captured,SGPC-02,10.4,1.08,,Small Gene Panel,B5,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0018,1352 Tumor,DP-32,Captured,SGPC-02,10.4,1.43,,Small Gene Panel,B6,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0019,1353 Tumor,DP-33,Captured,SGPC-02,10.4,1.13,,Small Gene Panel,B7,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0020,1354 Tumor,DP-34,Captured,SGPC-02,10.4,1.74,,Small Gene Panel,B8,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0021,1355 Tumor,DP-35,Captured,SGPC-02,10.4,2.09,,Small Gene Panel,B9,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0022,1356 Tumor,DP-36,Captured,SGPC-02,10.4,1.32,,Small Gene Panel,B10,,7/6/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0023,165 DN,DN-088,Captured,"SGPC-02,SGPC-01",10.4,5.78,,Small Gene Panel,B11,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0024,166 DN,DN-001,Captured,"SGPC-02,SGPC-01",10.4,5.78,,Small Gene Panel,B12,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0025,167 DN,DN-004,Captured,"SGPC-02,SGPC-01",10.4,4.95,,Small Gene Panel,C1,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0026,168 DN,DN-008,Captured,"SGPC-02,SGPC-01",10.4,11.56,,Small Gene Panel,C2,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0027,169 DN,DN-019,Captured,"SGPC-02,SGPC-01",10.4,8.00,,Small Gene Panel,C3,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0028,170 DN,DN-026,Captured,SGPC-01,10.4,34.67,,Small Gene Panel,C4,,7/11/2017,,Tumor,Dysplastic Nevi,SGPC-01
SGLP-0029,171 DN,DN-024,Captured,"SGPC-08,SGPC-10,SGPC-14,SGPC-01,SGPC-02",60.0,12.00,12,Small Gene Panel,C5,,7/11/2017,,Tumor,Dysplastic Nevi,"BCB006,BCB015,SGPC-01,SGPC-02"
SGLP-0030,172 DN,DN-029,Captured,"SGPC-02,SGPC-01",10.8,6.10,,Small Gene Panel,C6,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0031,173 DN,DN-027,Captured,"SGPC-02,SGPC-01",10.8,6.84,,Small Gene Panel,C7,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0032,174 DN,DN-023,Captured,"SGPC-08,SGPC-10,SGPC-01,SGPC-02",7.8,5.83,12,Small Gene Panel,C8,,7/11/2017,,Tumor,Dysplastic Nevi,"BCB006,SGPC-01,SGPC-02"
SGLP-0033,175 DN,DN-034,Captured,"SGPC-02,SGPC-01",10.8,10.91,,Small Gene Panel,C9,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0034,176 DN,DN-021,Captured,"SGPC-02,SGPC-01",10.8,3.51,,Small Gene Panel,C10,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0035,177 DN,DN-038,Captured,"SGPC-02,SGPC-01",10.8,3.51,,Small Gene Panel,C11,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0036,178 DN,DN-039,Captured,"SGPC-02,SGPC-01",10.8,2.12,,Small Gene Panel,C12,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0037,179 DN,DN-042,Captured,"SGPC-02,SGPC-01",10.8,30.86,,Small Gene Panel,D1,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0038,180 DN,DN-008,Captured,"SGPC-02,SGPC-01",10.8,2.36,,Small Gene Panel,D2,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0039,181 DN,DN-019,Captured,"SGPC-02,SGPC-01",10.8,3.75,,Small Gene Panel,D3,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0040,182 DN,DN-026,Captured,"SGPC-08,SGPC-10,SGPC-01,SGPC-02",7.8,7.23,12,Small Gene Panel,D4,,7/11/2017,,Tumor,Dysplastic Nevi,"BCB006,SGPC-01,SGPC-02"
SGLP-0041,183 DN,DN-024,Captured,"SGPC-02,SGPC-01",10.8,1.53,,Small Gene Panel,D5,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0042,184 DN,DN-029,Captured,"SGPC-02,SGPC-01",10.8,1.33,,Small Gene Panel,D6,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0043,185 DN,DN-027,Captured,"SGPC-02,SGPC-01",10.8,2.65,,Small Gene Panel,D7,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0044,186 DN,DN-023,Captured,"SGPC-02,SGPC-01",10.8,1.42,,Small Gene Panel,D8,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0045,187 DN,DN-034,Captured,"SGPC-02,SGPC-01",10.8,1.41,,Small Gene Panel,D9,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0046,188 DN,DN-021,Captured,"SGPC-02,SGPC-01",10.8,1.42,,Small Gene Panel,D10,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0047,189 DN,DN-038,Captured,"SGPC-02,SGPC-01",10.8,1.77,,Small Gene Panel,D11,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0048,190 DN,DN-039,Captured,"SGPC-02,SGPC-01",10.8,1.38,,Small Gene Panel,D12,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0049,191 DN,DN-042,Captured,"SGPC-02,SGPC-01",10.8,1.09,,Small Gene Panel,E1,,7/11/2017,,Tumor,Dysplastic Nevi,"SGPC-01,SGPC-02"
SGLP-0050,1357 Tumor,DP-37,Captured,SGPC-02,10.4,2.30,,Small Gene Panel,E5,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0051,1358 Tumor,DP-38,Captured,SGPC-02,10.4,1.45,,Small Gene Panel,E6,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0052,1359 Tumor,DP-39,Captured,SGPC-02,10.4,2.27,,Small Gene Panel,E7,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0053,1360 Tumor,DP-40,Captured,SGPC-02,10.4,9.90,,Small Gene Panel,E8,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0054,1361 Tumor,DP-41,Captured,SGPC-02,10.4,1.81,,Small Gene Panel,E9,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0055,1362 Tumor,DP-42,Captured,SGPC-02,10.4,1.08,,Small Gene Panel,E10,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0056,1363 Tumor,DP-43,Captured,SGPC-02,10.4,3.50,,Small Gene Panel,E11,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0057,1364 Tumor,DP-44,Captured,SGPC-02,10.4,1.45,,Small Gene Panel,E12,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0058,1365 Tumor,DP-45,Captured,SGPC-02,10.4,1.59,,Small Gene Panel,F1,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0059,1366 Tumor,DP-46,Captured,SGPC-02,10.4,1.98,,Small Gene Panel,F2,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0060,1367 Tumor,DP-47,Captured,SGPC-02,10.4,3.46,,Small Gene Panel,F3,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0061,1368 Tumor,DP-48,Captured,SGPC-02,10.4,2.13,,Small Gene Panel,F4,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0062,1369 Tumor,DP-49,Captured,SGPC-02,10.4,2.25,,Small Gene Panel,F5,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0063,1370 Tumor,DP-50,Captured,SGPC-02,10.4,2.00,,Small Gene Panel,F6,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0064,1371 Tumor,DP-51,Captured,SGPC-02,10.4,1.46,,Small Gene Panel,F7,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0065,1372 Tumor,DP-52,Captured,SGPC-02,10.4,1.43,,Small Gene Panel,F8,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0066,1373 Tumor,DP-53,Captured,SGPC-02,10.4,1.67,,Small Gene Panel,F9,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0067,1374 Tumor,DP-54,Captured,SGPC-02,10.4,1.28,,Small Gene Panel,F10,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0068,1375 Tumor,DP-55,Captured,SGPC-02,10.4,1.74,,Small Gene Panel,F11,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0069,1376 Tumor,DP-56,Captured,SGPC-02,10.4,1.21,,Small Gene Panel,F12,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0070,1377 Tumor,DP-57,Captured,SGPC-02,10.4,3.62,,Small Gene Panel,G1,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0071,1378 Tumor,DP-58,Captured,SGPC-02,10.4,0.76,,Small Gene Panel,G2,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0072,1379 Tumor,DP-59,Captured,SGPC-02,10.4,1.12,,Small Gene Panel,G3,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0073,1380 Tumor,DP-60,Captured,SGPC-02,10.4,1.02,,Small Gene Panel,G4,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0074,1381 Tumor,DP-61,Captured,SGPC-02,10.4,2.30,,Small Gene Panel,G5,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0075,1382 Tumor,DP-62,Captured,SGPC-02,10.4,1.99,,Small Gene Panel,G6,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0076,1383 Tumor,DP-63,Captured,SGPC-02,10.4,2.03,,Small Gene Panel,G7,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0077,1384 Tumor,DP-64,Captured,SGPC-02,10.4,2.30,,Small Gene Panel,G8,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0078,1385 Tumor,DP-65,Captured,SGPC-02,10.4,2.74,,Small Gene Panel,G9,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0079,1386 Tumor,DP-66,Captured,SGPC-02,10.4,4.48,,Small Gene Panel,G10,,7/17/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0080,1387 Tumor,DP-67,Captured,SGPC-02,10.4,2.00,,Small Gene Panel,G11,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0081,1388 Tumor,DP-68,Captured,SGPC-02,10.4,1.04,,Small Gene Panel,G12,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0082,1389 Tumor,DP-69,Captured,SGPC-02,10.4,1.71,,Small Gene Panel,H1,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0083,1390 Tumor,DP-70,Captured,SGPC-02,10.4,2.80,,Small Gene Panel,H2,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0084,1391 Tumor,DP-71,Captured,SGPC-02,10.4,1.80,,Small Gene Panel,H3,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0085,1392 Tumor,DP-72,Captured,SGPC-02,10.4,2.03,,Small Gene Panel,H4,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0086,1393 Tumor,DP-73,Captured,SGPC-02,10.4,1.90,,Small Gene Panel,H5,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0087,1394 Tumor,DP-74,Captured,SGPC-02,10.4,1.50,,Small Gene Panel,H6,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0088,1395 Tumor,DP-75,Captured,SGPC-02,10.4,2.56,,Small Gene Panel,H7,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0089,1396 Tumor,DP-76,Captured,SGPC-02,10.4,1.20,,Small Gene Panel,H8,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0090,1397 Tumor,DP-77,Captured,SGPC-02,10.4,1.61,,Small Gene Panel,H9,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0091,1398 Tumor,DP-78,Captured,SGPC-02,10.4,1.55,,Small Gene Panel,H10,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0092,1399 Tumor,DP-79,Captured,SGPC-02,10.4,2.42,,Small Gene Panel,H11,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0093,1400 Tumor,DP-80,Captured,SGPC-02,10.4,2.11,,Small Gene Panel,H12,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0094,1401 Tumor,DP-81,Captured,SGPC-02,10.4,2.65,,Small Gene Panel,E4,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0095,1402 Tumor,DP-82,Captured,SGPC-02,10.4,1.00,,Small Gene Panel,E2,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0096,1403 Tumor,DP-83,Captured,SGPC-02,10.4,5.36,,Small Gene Panel,E3,,7/24/2017,,Tumor,CGH Validation,SGPC-02
SGLP-0097,192 DN,DN-001,Captured,SGPC-03,5.9,7.31,,Small Gene Panel,A1,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0098,193 DN,DN-002,Captured,SGPC-03,5.9,2.25,,Small Gene Panel,A2,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0099,194 DN,DN-004,Captured,SGPC-03,5.9,3.44,,Small Gene Panel,A3,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0100,195 DN,DN-006,Captured,"SGPC-08,SGPC-10,SGPC-14,SGPC-03",7.8,3.72,12,Small Gene Panel,A4,,8/15/2017,,Tumor,Dysplastic Nevi,"BCB006,BCB015,SGPC-03"
SGLP-0101,196 DN,DN-011,Captured,SGPC-03,5.9,1.33,,Small Gene Panel,A5,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0102,197 DN,DN-014,Captured,SGPC-03,5.9,1.10,,Small Gene Panel,A6,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0103,198 DN,DN-007,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,3.60,12,Small Gene Panel,A7,,8/15/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0104,199 DN,DN-012,Captured,SGPC-03,5.9,1.95,,Small Gene Panel,A8,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0105,200 DN,DN-005,Captured,"SGPC-08,SGPC-10,SGPC-14,SGPC-03",7.8,4.24,12,Small Gene Panel,A9,,8/15/2017,,Tumor,Dysplastic Nevi,"BCB006,BCB015,SGPC-03"
SGLP-0106,201 DN,DN-032,Captured,SGPC-03,5.9,1.58,,Small Gene Panel,A10,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0107,202 DN,DN-033,Captured,SGPC-03,5.9,1.95,,Small Gene Panel,A11,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0108,203 DN,DN-025,Captured,SGPC-03,5.9,2.34,,Small Gene Panel,A12,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0109,204 DN,DN-030,Captured,SGPC-03,5.9,2.34,,Small Gene Panel,B1,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0110,205 DN,DN-030,Captured,SGPC-03,5.9,3.08,,Small Gene Panel,B2,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0111,206 DN,DN-047,Captured,SGPC-03,5.9,29.25,,Small Gene Panel,B3,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0112,207 DN,DN-048,Captured,SGPC-03,5.9,3.66,,Small Gene Panel,B4,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0113,208 DN,DN-048,Captured,SGPC-03,5.9,2.02,,Small Gene Panel,B5,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0114,209 DN,DN-048,Captured,SGPC-03,5.9,2.79,,Small Gene Panel,B6,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0115,210 DN,DN-046,Captured,SGPC-03,5.9,3.90,,Small Gene Panel,B7,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0117,212 DN,DN-050,Captured,SGPC-03,5.8,2.25,,Small Gene Panel,B9,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0119,214 DN,DN-049,Captured,SGPC-03,5.8,2.09,,Small Gene Panel,B11,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0120,215 DN,DN-055,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,2.55,12,Small Gene Panel,B12,,8/15/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0121,216 DN,DN-055,Captured,SGPC-03,5.8,1.81,,Small Gene Panel,C1,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0122,217 DN,DN-063,Captured,SGPC-03,5.8,1.81,,Small Gene Panel,C2,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0123,218 DN,DN-051,Captured,SGPC-03,5.8,29.00,,Small Gene Panel,C3,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0124,219 DN,DN-056,Captured,SGPC-03,5.8,2.07,,Small Gene Panel,C4,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0125,220 DN,DN-065,Captured,"SGPC-08,SGPC-15,SGPC-03",7.8,2.01,12,Small Gene Panel,C5,,8/15/2017,Barcode overlap,Tumor,Dysplastic Nevi,"BCB016,SGPC-03"
SGLP-0126,221 DN,DN-060,Captured,SGPC-03,5.8,19.33,,Small Gene Panel,C6,,8/15/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0127,222 DN,DN-057,Captured,SGPC-03,5.8,1.45,,Small Gene Panel,C9,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0128,223 DN,DN-067,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,2.44,12,Small Gene Panel,C10,,8/22/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0129,224 DN,DN-064,Captured,SGPC-03,5.8,2.23,,Small Gene Panel,C11,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0130,225 DN,DN-069,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,2.79,12,Small Gene Panel,C12,,8/22/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0131,226 DN,DN-080,Captured,SGPC-03,5.8,0.73,,Small Gene Panel,D1,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0132,227 DN,DN-075,Captured,SGPC-03,5.8,1.26,,Small Gene Panel,D2,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0133,228 DN,DN-068,Captured,SGPC-03,5.8,1.21,,Small Gene Panel,D3,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0134,229 DN,DN-078,Captured,"SGPC-08,SGPC-15,SGPC-03",7.8,3.40,12,Small Gene Panel,D4,,8/22/2017,Barcode overlap,Tumor,Dysplastic Nevi,"BCB016,SGPC-03"
SGLP-0135,230 DN,DN-070,Captured,SGPC-03,5.8,3.41,,Small Gene Panel,D5,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0136,231 DN,DN-071,Captured,SGPC-03,5.8,1.18,,Small Gene Panel,D6,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0137,232 DN,DN-082,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,6.01,12,Small Gene Panel,D7,,8/22/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0138,233 DN,DN-073,Captured,SGPC-03,5.8,1.16,,Small Gene Panel,D8,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0139,234 DN,DN-085,Captured,SGPC-03,5.8,1.35,,Small Gene Panel,D9,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0140,235 DN,DN-086,Captured,SGPC-03,5.8,1.05,,Small Gene Panel,D10,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0141,236 DN,DN-081,Captured,SGPC-03,5.8,1.57,,Small Gene Panel,D11,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0142,237 DN,DN-087,Captured,SGPC-03,5.8,0.89,,Small Gene Panel,D12,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0143,238 DN,DN-003,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,6.01,12,Small Gene Panel,E1,,8/22/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0144,239 DN,DN-009,Captured,SGPC-03,5.8,2.00,,Small Gene Panel,E2,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0145,240 DN,DN-015,Captured,SGPC-03,5.8,19.33,,Small Gene Panel,E3,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0146,241 DN,DN-015,Captured,SGPC-03,5.8,14.50,,Small Gene Panel,E4,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0147,242 DN,DN-015,Captured,SGPC-03,5.8,19.33,,Small Gene Panel,E5,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0148,243 DN,DN-016,Captured,SGPC-03,5.8,1.12,,Small Gene Panel,E6,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0149,244 DN,DN-016,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,2.89,12,Small Gene Panel,E7,,8/22/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0150,245 DN,DN-018,Captured,SGPC-03,5.8,1.18,,Small Gene Panel,E8,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0151,246 DN,DN-018,Captured,SGPC-03,5.8,1.00,,Small Gene Panel,E9,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0152,247 DN,DN-022,Captured,SGPC-03,5.8,1.12,,Small Gene Panel,E10,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0153,248 DN,DN-022,Captured,SGPC-03,5.8,1.32,,Small Gene Panel,E11,,8/22/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0154,249 DN,DN-022,Captured,SGPC-03,5.8,4.46,,Small Gene Panel,F5,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0155,250 DN,DN-035,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,5.21,12,Small Gene Panel,F6,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0156,251 DN,DN-035,Captured,SGPC-03,5.8,1.61,,Small Gene Panel,F7,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0157,252 DN,DN-052,Captured,SGPC-03,5.8,58.00,,Small Gene Panel,F8,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0158,253 DN,DN-053,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,3.55,12,Small Gene Panel,F9,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0159,254 DN,DN-061,Captured,SGPC-03,5.8,8.29,,Small Gene Panel,F10,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0160,255 DN,DN-061,Captured,SGPC-03,5.8,11.60,,Small Gene Panel,F11,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0161,256 DN,DN-066,Captured,SGPC-03,5.8,4.46,,Small Gene Panel,F12,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0162,257 DN,DN-083,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,13.02,12,Small Gene Panel,G1,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0163,258 DN,DN-084,Captured,SGPC-03,5.8,1.41,,Small Gene Panel,G2,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0164,259 DN,DN-010,Captured,SGPC-03,5.8,1.41,,Small Gene Panel,G3,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0165,260 DN,DN-010,Captured,SGPC-03,5.8,2.42,,Small Gene Panel,G4,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0166,261 DN,DN-013,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,8.68,12,Small Gene Panel,G5,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0167,262 DN,DN-013,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,26.03,12,Small Gene Panel,G6,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0168,263 DN,DN-017,Captured,SGPC-03,5.8,1.71,,Small Gene Panel,G7,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0169,264 DN,DN-020,Captured,SGPC-03,5.8,2.15,,Small Gene Panel,G8,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0170,265 DN,DN-028,Captured,SGPC-03,5.8,2.07,,Small Gene Panel,G9,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0171,266 DN,DN-031,Captured,SGPC-03,5.8,1.16,,Small Gene Panel,G10,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0172,267 DN,DN-037,Captured,SGPC-03,5.8,2.23,,Small Gene Panel,G11,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0173,268 DN,DN-040,Captured,SGPC-03,5.8,1.76,,Small Gene Panel,G12,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0174,269 DN,DN-041,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,3.40,12,Small Gene Panel,H1,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0175,270 DN,DN-044,Captured,SGPC-03,5.8,1.93,,Small Gene Panel,H2,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0176,271 DN,DN-044,Captured,SGPC-03,5.8,2.15,,Small Gene Panel,H3,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0177,272 DN,DN-054,Captured,SGPC-03,5.8,1.35,,Small Gene Panel,H4,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0178,273 DN,DN-059,Captured,SGPC-03,5.8,4.14,,Small Gene Panel,H5,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0179,274 DN,DN-062,Captured,SGPC-03,5.8,1.18,,Small Gene Panel,H6,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0180,275 DN,DN-072,Captured,SGPC-03,5.8,29.00,,Small Gene Panel,H7,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0181,276 DN,DN-074,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,3.40,12,Small Gene Panel,H8,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0182,277 DN,DN-076,Captured,SGPC-03,5.8,1.05,,Small Gene Panel,H9,,8/28/2017,,Tumor,Dysplastic Nevi,SGPC-03
SGLP-0183,278 DN,DN-079,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,4.59,12,Small Gene Panel,H10,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0184,279 DN,DN-077,Captured,"SGPC-08,SGPC-11,SGPC-03",7.8,2.17,12,Small Gene Panel,H11,,8/28/2017,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-03"
SGLP-0185,1404 Tumor,DP-84,Captured,SGPC-04,6.5,5.00,,Small Gene Panel,F5,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0186,1405 Tumor,DP-85,Captured,SGPC-04,6.5,6.50,,Small Gene Panel,F6,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0187,1406 Tumor,DP-86,Captured,SGPC-04,6.5,5.91,,Small Gene Panel,F7,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0188,1407 Tumor,DP-87,Captured,SGPC-04,6.5,7.22,,Small Gene Panel,F8,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0189,1408 Tumor,DP-88,Captured,SGPC-04,6.5,2.83,,Small Gene Panel,F9,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0190,1409 Tumor,DP-89,Captured,SGPC-04,6.5,10.83,,Small Gene Panel,F10,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0191,1410 Tumor,DP-90,Captured,SGPC-04,6.5,8.13,,Small Gene Panel,F11,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0192,1411 Tumor,DP-91,Captured,SGPC-04,6.5,2.71,,Small Gene Panel,F12,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0193,1412 Tumor,DP-92,Captured,SGPC-04,6.5,5.91,,Small Gene Panel,G1,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0194,1413 Tumor,DP-93,Captured,SGPC-04,6.5,13.00,,Small Gene Panel,G2,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0195,1414 Tumor,DP-94,Captured,SGPC-04,6.5,5.00,,Small Gene Panel,G3,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0196,1415 Tumor,DP-95,Captured,SGPC-04,6.5,16.25,,Small Gene Panel,G4,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0197,1416 Tumor,DP-96,Captured,SGPC-04,6.5,5.42,,Small Gene Panel,G5,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0198,1417 Tumor,DP-97,Captured,SGPC-04,6.5,4.64,,Small Gene Panel,G6,,3/20/2018,Capture hyb at 65c for 4 hours.,Tumor,CGH Validation,SGPC-04
SGLP-0199,1328 Tumor,KIT-01,Captured,SGPC-04,6.5,21.67,13,Small Gene Panel,G7,,3/20/2018,"KIT mutant DNA samples, Capture hyb at 65c for 4 hours.",,Kit mutants,SGPC-04
SGLP-0200,1135 Tumor,KIT-02,Captured,"SGPC-04,SGPC-16",46.0,41.82,13,Small Gene Panel,G8,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0201,1136 Tumor,KIT-03,Captured,"SGPC-04,SGPC-16",60.0,46.15,13,Small Gene Panel,G9,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0202,1137 Tumor,KIT-04,Captured,"SGPC-04,SGPC-16",60.0,30.00,13,Small Gene Panel,G10,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0203,1138 Tumor,KIT-05,Captured,"SGPC-04,SGPC-16",32.0,40.00,13,Small Gene Panel,G11,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0204,1139 Tumor,KIT-06,Captured,"SGPC-04,SGPC-16",14.0,35.00,13,Small Gene Panel,G12,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0205,1140 Tumor,KIT-07,Captured,"SGPC-04,SGPC-16",50.0,45.45,13,Small Gene Panel,H1,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0206,1141 Tumor,KIT-08,Captured,"SGPC-04,SGPC-16",11.0,27.50,13,Small Gene Panel,H2,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0207,1142 Tumor,KIT-09,Captured,"SGPC-04,SGPC-16",33.0,41.25,13,Small Gene Panel,H3,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0208,1143 Tumor,KIT-10,Captured,"SGPC-04,SGPC-16",43.0,43.00,13,Small Gene Panel,H4,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0209,1144 Tumor,KIT-11,Captured,"SGPC-04,SGPC-16",6.7,22.33,13,Small Gene Panel,H5,,3/20/2018,KIT mutant DNA samples,,Kit mutants,"SGPC-04,BCB017"
SGLP-0210,1329 Tumor,KIT-12,Captured,SGPC-04,6.5,65.00,13,Small Gene Panel,H6,,3/20/2018,"KIT mutant DNA samples, Capture hyb at 65c for 4 hours.",,Kit mutants,SGPC-04
SGLP-0211,1330 Tumor,KIT-13,Captured,SGPC-04,6.5,6.50,13,Small Gene Panel,H7,,3/20/2018,"KIT mutant DNA samples, Capture hyb at 65c for 4 hours.",,Kit mutants,SGPC-04
SGLP-0212,1331 Tumor,KIT-14,Captured,SGPC-04,6.5,2.71,13,Small Gene Panel,H8,,3/20/2018,"KIT mutant DNA samples, Capture hyb at 65c for 4 hours.",,Kit mutants,SGPC-04
SGLP-0213,1332 Tumor,KIT-15,Captured,SGPC-04,6.5,9.29,13,Small Gene Panel,H9,,3/20/2018,"KIT mutant DNA samples, Capture hyb at 65c for 4 hours.",,Kit mutants,SGPC-04
SGLP-0214,1333 Tumor,KIT-16,Captured,SGPC-04,6.5,4.64,13,Small Gene Panel,H10,,3/20/2018,"KIT mutant DNA samples, Capture hyb at 65c for 4 hours.",,Kit mutants,SGPC-04
SGLP-0215,1334 Tumor,KIT-17,Captured,SGPC-04,6.5,2.95,13,Small Gene Panel,H11,,3/20/2018,"KIT mutant DNA samples, Capture hyb at 65c for 4 hours.",,Kit mutants,SGPC-04
SGLP-0216,1335 Tumor,KIT-18,Captured,SGPC-04,6.5,4.06,13,Small Gene Panel,H12,,3/20/2018,"KIT mutant DNA samples, Capture hyb at 65c for 4 hours.",,Kit mutants,SGPC-04
SGLP-0217,632 Mel,MD-01,Captured,SGPC-04,6.5,7.22,13,Small Gene Panel,A1,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0218,633 Mel,MD-02,Captured,SGPC-04,6.5,13.00,13,Small Gene Panel,A2,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0219,634 Mel,MD-03,Captured,SGPC-04,6.5,8.13,13,Small Gene Panel,A3,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0220,635 Mel,MD-04,Captured,"SGPC-04,SGPC-16",6.5,7.22,13,Small Gene Panel,A4,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0221,636 Mel,MD-05,Captured,"SGPC-04,SGPC-16",6.5,16.25,13,Small Gene Panel,A5,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0222,637 Mel,MD-06,Captured,SGPC-04,6.5,7.22,13,Small Gene Panel,A6,,,"Madrid Melanoma, Capture hyb at 65c for 4 hours.",Tumor,Melanoma Prognosis,SGPC-04
SGLP-0223,638 Mel,MD-07,Captured,"SGPC-04,SGPC-16",6.5,16.25,13,Small Gene Panel,A7,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0224,639 Mel,MD-08,Captured,"SGPC-04,SGPC-16",6.5,5.00,13,Small Gene Panel,A8,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0225,640 Mel,MD-09,Captured,SGPC-04,6.5,16.25,13,Small Gene Panel,A9,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0226,641 Mel,MD-10,Captured,SGPC-04,6.5,10.83,13,Small Gene Panel,A10,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0227,642 Mel,MD-11,Captured,SGPC-04,6.5,10.83,13,Small Gene Panel,A11,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0228,643 Mel,MD-12,Captured,SGPC-04,6.5,7.22,13,Small Gene Panel,A12,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0229,644 Mel,MD-13,Captured,SGPC-04,6.5,5.42,13,Small Gene Panel,B1,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0230,645 Mel,MD-14,Captured,"SGPC-04,SGPC-16",6.5,4.64,13,Small Gene Panel,B2,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0231,646 Mel,MD-15,Captured,SGPC-04,6.5,9.29,13,Small Gene Panel,B3,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0232,647 Mel,MD-16,Captured,"SGPC-04,SGPC-16",6.5,5.42,13,Small Gene Panel,B4,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0233,648 Mel,MD-17,Captured,SGPC-04,6.5,10.83,13,Small Gene Panel,C1,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0234,649 Mel,MD-18,Captured,SGPC-04,6.5,4.64,13,Small Gene Panel,C2,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0235,650 Mel,MD-19,Captured,"SGPC-04,SGPC-16",6.5,9.29,13,Small Gene Panel,C3,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0236,651 Mel,MD-20,Captured,SGPC-04,6.5,4.64,13,Small Gene Panel,C4,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0237,652 Mel,MD-21,Captured,SGPC-04,6.5,3.61,13,Small Gene Panel,C5,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0238,653 Mel,MD-22,Captured,SGPC-04,6.5,10.83,13,Small Gene Panel,C6,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0239,654 Mel,MD-23,Captured,SGPC-04,6.5,4.33,13,Small Gene Panel,C7,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0240,655 Mel,MD-24,Captured,"SGPC-04,SGPC-16",6.5,5.00,13,Small Gene Panel,C8,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0241,656 Mel,MD-25,Captured,"SGPC-04,SGPC-16",6.5,3.82,13,Small Gene Panel,C9,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0242,657 Mel,MD-26,Captured,"SGPC-04,SGPC-16",6.5,4.06,13,Small Gene Panel,C10,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0243,658 Mel,MD-27,Captured,"SGPC-04,SGPC-16",6.5,2.17,13,Small Gene Panel,C11,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0244,659 Mel,MD-28,Captured,"SGPC-04,SGPC-16",6.5,3.82,13,Small Gene Panel,C12,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0245,660 Mel,MD-29,Captured,"SGPC-04,SGPC-16",6.5,1.97,13,Small Gene Panel,D1,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0246,661 Mel,MD-30,Captured,"SGPC-04,SGPC-16",6.5,2.60,13,Small Gene Panel,D2,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0247,662 Mel,MD-31,Captured,SGPC-04,6.5,3.10,13,Small Gene Panel,D3,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0248,663 Mel,MD-32,Captured,"SGPC-04,SGPC-16",6.5,2.50,13,Small Gene Panel,D4,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0249,664 Mel,MD-33,Captured,"SGPC-04,SGPC-16",6.5,5.42,13,Small Gene Panel,D5,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,"SGPC-04,BCB017"
SGLP-0250,665 Mel,MD-34,Captured,SGPC-04,6.5,5.00,13,Small Gene Panel,D6,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0251,666 Mel,MD-35,Captured,SGPC-04,6.5,3.82,13,Small Gene Panel,D7,,,Capture hyb at 65c for 4 hours.,Tumor,Melanoma Prognosis,SGPC-04
SGLP-0252,618 Mel,MD-36,Captured,"SGPC-07,SGPC-10,SGPC-14",10.9,6.41,12,Small Gene Panel,D8,,,Madrid Melanoma,Tumor,Melanoma Prognosis,"BCB002,BCB008,BCB015"
SGLP-0253,627 Mel,MD-37,Captured,"SGPC-07,SGPC-10,SGPC-14",10.9,4.95,12,Small Gene Panel,D9,,,Madrid Melanoma,Tumor,Melanoma Prognosis,"BCB002,BCB008,BCB015"
SGLP-0254,628 Mel,MD-38,Captured,"SGPC-07,SGPC-14",10.0,50.00,12,Small Gene Panel,D10,,,Madrid Melanoma,Tumor,Melanoma Prognosis,"BCB002,BCB008,BCB015"
SGLP-0255,629 Mel,MD-39,Captured,"SGPC-07,SGPC-10,SGPC-14",10.9,7.79,12,Small Gene Panel,D11,,,Madrid Melanoma,Tumor,Melanoma Prognosis,"BCB002,BCB008,BCB015"
SGLP-0256,630 Mel,MD-16,Captured,"SGPC-07,SGPC-10,SGPC-14",10.9,5.74,12,Small Gene Panel,D12,,,Madrid Melanoma,Tumor,Melanoma Prognosis,"BCB002,BCB008,BCB015"
SGLP-0257,631 Mel,MD-31,Captured,"SGPC-07,SGPC-10,SGPC-14",10.9,3.76,12,Small Gene Panel,E1,,,Madrid Melanoma,Tumor,Melanoma Prognosis,"BCB002,BCB008,BCB015"
SGLP-0258,110 DN,DN-048,Captured,SGPC-05,7.0,4.67,,Small Gene Panel,A1,,,,,Dysplastic Nevi,SGPC-05
SGLP-0259,111 DN,DN-064,Captured,SGPC-05,7.0,3.18,,Small Gene Panel,A2,,,,,Dysplastic Nevi,SGPC-05
SGLP-0260,112 DN,DN-063,Captured,SGPC-05,7.0,2.50,,Small Gene Panel,A3,,,,,Dysplastic Nevi,SGPC-05
SGLP-0261,113 DN,DN-020,Captured,"SGPC-08,SGPC-05,SGPC-15",7.8,2.99,12,Small Gene Panel,A4,,,Barcode overlap,Tumor,Dysplastic Nevi,"BCB016,SGPC-05"
SGLP-0262,114 DN,DN-008,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,5.04,12,Small Gene Panel,A5,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0263,115 DN,DN-076,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,5.79,12,Small Gene Panel,A6,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0264,116 DN,DN-026,Captured,SGPC-05,7.0,11.67,,Small Gene Panel,A7,,,,,Dysplastic Nevi,SGPC-05
SGLP-0265,117 DN,DN-014,Captured,SGPC-05,7.0,2.50,,Small Gene Panel,A8,,,,,Dysplastic Nevi,SGPC-05
SGLP-0266,118 DN,DN-084,Captured,"SGPC-08,SGPC-05,SGPC-15",7.8,5.31,12,Small Gene Panel,A9,,,Barcode overlap,Tumor,Dysplastic Nevi,"BCB016,SGPC-05"
SGLP-0267,119 DN,DN-029,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,6.20,12,Small Gene Panel,A10,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0268,120 DN,DN-039,Captured,SGPC-05,7.0,2.12,,Small Gene Panel,A11,,,,,Dysplastic Nevi,SGPC-05
SGLP-0269,121 DN,DN-042,Captured,SGPC-05,7.0,2.92,,Small Gene Panel,A12,,,,,Dysplastic Nevi,SGPC-05
SGLP-0270,122 DN,DN-027,Captured,SGPC-05,7.0,2.41,,Small Gene Panel,B1,,,,,Dysplastic Nevi,SGPC-05
SGLP-0271,123 DN,DN-006,Captured,SGPC-05,7.0,2.59,,Small Gene Panel,B2,,,,,Dysplastic Nevi,SGPC-05
SGLP-0272,124 DN,DN-011,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,3.74,12,Small Gene Panel,B3,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
SGLP-0273,125 DN,DN-007,Captured,SGPC-05,7.0,2.92,,Small Gene Panel,B4,,,,,Dysplastic Nevi,SGPC-05
SGLP-0274,126 DN,DN-005,Captured,SGPC-05,7.0,3.50,,Small Gene Panel,B5,,,,,Dysplastic Nevi,SGPC-05
SGLP-0275,127 DN,DN-032,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,2.74,12,Small Gene Panel,B6,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0276,128 DN,DN-030,Captured,SGPC-05,7.0,3.04,,Small Gene Panel,B7,,,,,Dysplastic Nevi,SGPC-05
SGLP-0277,129 DN,DN-047,Captured,SGPC-05,7.0,2.80,,Small Gene Panel,B8,,,,,Dysplastic Nevi,SGPC-05
SGLP-0278,130 DN,DN-048,Captured,SGPC-05,7.0,2.19,,Small Gene Panel,B9,,,,,Dysplastic Nevi,SGPC-05
SGLP-0279,131 DN,DN-046,Captured,SGPC-05,7.0,2.00,,Small Gene Panel,B10,,,,,Dysplastic Nevi,SGPC-05
SGLP-0280,132 DN,DN-050,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,4.44,12,Small Gene Panel,B11,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0281,133 DN,DN-049,Captured,SGPC-05,7.0,3.50,,Small Gene Panel,B12,,,,,Dysplastic Nevi,SGPC-05
SGLP-0282,134 DN,DN-055,Captured,SGPC-05,7.0,2.12,,Small Gene Panel,C1,,,,,Dysplastic Nevi,SGPC-05
SGLP-0283,135 DN,DN-056,Captured,SGPC-05,7.0,1.56,,Small Gene Panel,C2,,,,,Dysplastic Nevi,SGPC-05
SGLP-0284,136 DN,DN-060,Captured,SGPC-05,7.0,2.92,,Small Gene Panel,C3,,,,,Dysplastic Nevi,SGPC-05
SGLP-0285,137 DN,DN-057,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,3.15,12,Small Gene Panel,C4,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0286,138 DN,DN-068,Captured,SGPC-05,7.0,3.33,,Small Gene Panel,C5,,,,,Dysplastic Nevi,SGPC-05
SGLP-0287,139 DN,DN-070,Captured,SGPC-05,7.0,3.33,,Small Gene Panel,C6,,,,,Dysplastic Nevi,SGPC-05
SGLP-0288,140 DN,DN-071,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,5.28,12,Small Gene Panel,C7,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0289,141 DN,DN-073,Captured,"SGPC-08,SGPC-05,SGPC-15",7.8,5.39,12,Small Gene Panel,C8,,,Barcode overlap,Tumor,Dysplastic Nevi,"BCB016,SGPC-05"
SGLP-0290,142 DN,DN-085,Captured,SGPC-05,7.0,4.38,,Small Gene Panel,C9,,,,,Dysplastic Nevi,SGPC-05
SGLP-0291,143 DN,DN-086,Captured,SGPC-05,7.0,3.50,,Small Gene Panel,C10,,,,,Dysplastic Nevi,SGPC-05
SGLP-0292,144 DN,DN-081,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,5.04,12,Small Gene Panel,C11,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0293,145 DN,DN-087,Captured,SGPC-05,7.0,4.12,,Small Gene Panel,C12,,,,,Dysplastic Nevi,SGPC-05
SGLP-0294,146 DN,DN-015,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,12.80,12,Small Gene Panel,D1,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0295,147 DN,DN-015,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,13.02,12,Small Gene Panel,D2,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0296,148 DN,DN-015,Captured,SGPC-05,7.0,23.33,,Small Gene Panel,D3,,,,,Dysplastic Nevi,SGPC-05
SGLP-0297,149 DN,DN-016,Captured,SGPC-05,7.0,7.00,,Small Gene Panel,D4,,,,,Dysplastic Nevi,SGPC-05
SGLP-0298,150 DN,DN-018,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,3.87,12,Small Gene Panel,D5,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0299,151 DN,DN-022,Captured,SGPC-05,7.0,7.00,,Small Gene Panel,D6,,,,,Dysplastic Nevi,SGPC-05
SGLP-0300,152 DN,DN-022,Captured,SGPC-05,7.0,6.36,,Small Gene Panel,D7,,,,,Dysplastic Nevi,SGPC-05
SGLP-0301,153 DN,DN-061,Captured,SGPC-05,7.0,8.75,,Small Gene Panel,D8,,,,,Dysplastic Nevi,SGPC-05
SGLP-0302,154 DN,DN-061,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,12.02,12,Small Gene Panel,D9,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0303,155 DN,DN-028,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,7.44,12,Small Gene Panel,D10,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0304,156 DN,DN-031,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,6.97,12,Small Gene Panel,D11,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0305,157 DN,DN-040,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,5.46,12,Small Gene Panel,D12,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0306,158 DN,DN-044,Captured,SGPC-05,7.0,4.67,,Small Gene Panel,E1,,,,,Dysplastic Nevi,SGPC-05
SGLP-0307,159 DN,DN-044,Captured,SGPC-05,7.0,5.00,,Small Gene Panel,E2,,,,,Dysplastic Nevi,SGPC-05
SGLP-0308,160 DN,DN-054,Captured,SGPC-05,7.0,5.38,,Small Gene Panel,E3,,,,,Dysplastic Nevi,SGPC-05
SGLP-0309,161 DN,DN-059,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,19.52,12,Small Gene Panel,E4,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011"
SGLP-0310,162 DN,DN-062,Captured,SGPC-05,7.0,35.00,,Small Gene Panel,E5,,,,,Dysplastic Nevi,SGPC-05
SGLP-0311,163 DN,DN-043,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,6.62,12,Small Gene Panel,E6,,,,Tumor,Dysplastic Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0312,164 DN,DN-058,Captured,SGPC-05,7.0,5.83,,Small Gene Panel,E7,,,,,Dysplastic Nevi,SGPC-05
SGLP-0313,1865 Junctional,LN-01,Captured,SGPC-05,7.0,2.00,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0314,675 Junctional,LN-02,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,3.38,12,Small Gene Panel,E10,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0315,676 Junctional,LN-03,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,2.21,12,Small Gene Panel,E11,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0316,677 Junctional,LN-04,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,3.74,12,Small Gene Panel,E12,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0317,678 Junctional,LN-05,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,3.43,12,Small Gene Panel,F1,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0318,679 Junctional,LN-06,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,2.60,12,Small Gene Panel,F2,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0319,680 Junctional,LN-07,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,3.41,12,Small Gene Panel,F3,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0320,681 Junctional,LN-08,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,2.91,12,Small Gene Panel,F4,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0321,682 Junctional,LN-09,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,2.99,12,Small Gene Panel,F5,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0322,1866 Junctional,LN-10,Captured,SGPC-05,7.0,3.50,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0323,1867 Compound,LN-11,Captured,SGPC-05,7.0,3.18,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0324,1868 Compound,LN-12,Captured,SGPC-05,7.0,3.04,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0325,1869 Compound,LN-13,Captured,SGPC-05,7.0,2.92,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0326,683 Compound,LN-14,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,3.53,12,Small Gene Panel,F10,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0327,1870 Compound,LN-15,Captured,SGPC-05,7.0,2.59,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0328,1871 Compound,LN-16,Captured,SGPC-05,7.0,2.59,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0329,1872 Compound,LN-17,Captured,SGPC-05,7.0,2.59,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0330,684 Compound,LN-18,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,1.72,12,Small Gene Panel,G2,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0331,1873 Compound,LN-19,Captured,SGPC-05,7.0,1.49,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0332,685 Compound,LN-20,Captured,"SGPC-08,SGPC-11,SGPC-05",7.8,1.50,12,Small Gene Panel,G4,,,Reseqencing of Previous LN,Tumor,Lentiginous Nevi,"BCB004,BCB011,SGPC-05"
SGLP-0333,1874 Compound,LN-21,Captured,SGPC-05,7.0,0.96,,Small Gene Panel,,,,,Tumor,Lentiginous Nevi,SGPC-05
SGLP-0334,604 Acral Melanoma Cells,AMC-01,Captured,"SGPC-07,SGPC-12",10.9,1.77,12,Small Gene Panel,,17,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0335,605 Acral Melanoma Cells,AMC-02,Captured,"SGPC-07,SGPC-12",10.9,2.75,12,Small Gene Panel,,18,10/13/2018,Acral Melanoma Cell Line; NEED TO RE SEQUENCE,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0336,606 Acral Melanoma Cells,AMC-03,Captured,"SGPC-07,SGPC-12",10.9,2.49,12,Small Gene Panel,,19,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0337,607 Acral Melanoma Cells,AMC-03,Captured,"SGPC-07,SGPC-12",10.9,1.51,12,Small Gene Panel,,20,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0338,608 Acral Melanoma Cells,AMC-03,Captured,"SGPC-07,SGPC-12",10.9,1.45,12,Small Gene Panel,,21,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0339,609 Acral Melanoma Cells,AMC-03,Captured,"SGPC-07,SGPC-12",10.9,1.32,12,Small Gene Panel,,22,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0340,610 Acral Melanoma Cells,AMC-07,Captured,"SGPC-07,SGPC-12",10.9,29.46,12,Small Gene Panel,,23,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0341,611 Acral Melanoma Cells,AMC-08,Captured,"SGPC-07,SGPC-12",10.9,6.81,12,Small Gene Panel,,24,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0342,612 Acral Melanoma Cells,AMC-08,Captured,"SGPC-07,SGPC-12",10.9,1.12,12,Small Gene Panel,,25,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0343,613 Acral Melanoma Cells,AMC-08,Captured,"SGPC-07,SGPC-12",10.9,1.13,12,Small Gene Panel,,26,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0344,614 Acral Melanoma Cells,AMC-08,Captured,"SGPC-07,SGPC-12",10.9,1.27,12,Small Gene Panel,,27,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0345,615 Acral Melanoma Cells,AM2-012,Captured,"SGPC-07,SGPC-12",10.9,2.53,12,Small Gene Panel,,28,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0346,616 Acral Melanoma Cells,AMC-13,Captured,"SGPC-07,SGPC-12",10.9,2.30,12,Small Gene Panel,,29,10/13/2018,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB002,BCB008,BCB012"
SGLP-0347,617 Tumor,DP-01,Captured,SGPC-07,10.9,2.61,12,Small Gene Panel,,30,10/13/2018,DNA from Dermpath/Swapna,Tumor,Possible TERT Fusion,"BCB002,BCB008"
SGLP-0348,619 Nevus?,DP-02,Captured,SGPC-07,10.9,5.27,12,Small Gene Panel,,31,10/13/2018,DNA from Dermpath/Swapna,Tumor,Possible TERT Fusion,"BCB002,BCB008"
SGLP-0349,620 Nevus?,DP-03,Captured,SGPC-07,10.9,6.73,12,Small Gene Panel,,32,10/13/2018,DNA from Dermpath/Swapna,Tumor,Possible TERT Fusion,"BCB002,BCB008"
SGLP-0350,621 Nevus?,DP-04,Captured,SGPC-07,10.9,2.56,12,Small Gene Panel,,33,10/13/2018,DNA from Dermpath/Swapna,Tumor,Possible TERT Fusion,"BCB002,BCB008"
SGLP-0351,622 Nevus?,DP-05,Captured,SGPC-07,10.9,3.77,12,Small Gene Panel,,34,10/13/2018,DNA from Dermpath/Swapna,Tumor,Possible TERT Fusion,"BCB002,BCB008"
SGLP-0352,623 Nevus?,DP-06,Captured,SGPC-07,10.9,11.60,12,Small Gene Panel,,35,10/13/2018,DNA from Dermpath/Swapna,Tumor,Possible TERT Fusion,"BCB002,BCB008"
SGLP-0353,624 Nevus?,DP-07,Captured,SGPC-07,10.9,4.22,12,Small Gene Panel,,36,10/13/2018,DNA from Dermpath/Swapna,Tumor,Possible TERT Fusion,"BCB002,BCB008"
SGLP-0354,625 Nevus?,DP-08,Captured,SGPC-07,10.9,3.18,12,Small Gene Panel,,37,10/13/2018,DNA from Dermpath/Swapna,Tumor,Possible TERT Fusion,"BCB002,BCB008"
SGLP-0356,424 Blue + spitz,SM-001,Captured,SGPC-06,10.9,14.16,12,Small Gene Panel,,73,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0357,425 Blue + spitz,SM-002,Captured,SGPC-06,10.9,17.30,12,Small Gene Panel,,74,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0358,"426 blue nevus, cellular,  DF like",SM-003,Captured,SGPC-06,10.9,5.56,12,Small Gene Panel,,75,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0359,"427 blue nevus, cellular,  DF like",SM-004,Captured,SGPC-06,10.9,7.08,12,Small Gene Panel,,76,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0360,"428 blue nevus, cellular,  DF like",SM-005,Captured,SGPC-06,10.9,14.93,12,Small Gene Panel,,77,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0361,429 common + blue,,Library failed/low yield,,,NaN,,,,78,12/20/2018,,,Nevus Library,
SGLP-0362,430 common + blue,SM-007,Captured,SGPC-07,10.9,11.01,12,Small Gene Panel,,79,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0363,431 common + blue,SM-008,Captured,SGPC-07,10.9,2.55,12,Small Gene Panel,,80,12/20/2018,Nevus from Iwei; NEED TO RE-SEQUENCE,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0364,432 common + blue,SM-009,Captured,SGPC-07,10.9,12.82,12,Small Gene Panel,,81,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0365,433 common + blue,SM-010,Captured,SGPC-07,10.9,3.77,12,Small Gene Panel,,82,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0366,434 common + blue,SM-010,Captured,SGPC-07,10.9,8.38,12,Small Gene Panel,,83,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0367,435 common + blue,SM-012,Captured,SGPC-07,10.9,3.06,12,Small Gene Panel,,84,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0368,"436 common, sclerotic dermal component",SM-013,Captured,SGPC-07,10.9,3.31,12,Small Gene Panel,,85,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0369,"437 common, sclerotic dermal component",SM-014,Captured,SGPC-07,10.9,4.05,12,Small Gene Panel,,86,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0370,"438 common, sclerotic dermal component",SM-015,Captured,SGPC-07,10.9,2.58,12,Small Gene Panel,,87,12/20/2018,Nevus from Iwei; NEED TO RE-SEQUENCE,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0371,"439 common, sclerotic dermal component",SM-016,Captured,SGPC-07,10.9,23.70,12,Small Gene Panel,,88,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0372,"440 common, sclerotic dermal component",SM-017,Captured,SGPC-07,10.9,5.74,12,Small Gene Panel,,89,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0373,"441 common, sclerotic dermal component",SM-018,Captured,SGPC-07,10.9,6.69,12,Small Gene Panel,,90,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0374,442 compound meloncytic nevus,SM-019,Captured,SGPC-07,10.9,11.98,12,Small Gene Panel,,91,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0375,"443 common, sclerotic dermal component",SM-020,Captured,SGPC-07,10.9,2.76,12,Small Gene Panel,,92,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0376,"444 blue nevus, cellular",SM-021,Captured,SGPC-07,10.9,38.93,12,Small Gene Panel,,93,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0377,"445 common, sclerotic dermal component",SM-022,Captured,SGPC-07,10.9,5.40,12,Small Gene Panel,,94,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0378,"446 DPN, pure",SM-023,Captured,SGPC-07,10.9,37.59,12,Small Gene Panel,,95,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0379,447 balloon cell nevus,SM-024,Captured,SGPC-07,10.9,15.57,12,Small Gene Panel,,96,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0380,448 common & balloon,SM-025,Captured,"SGPC-07,SGPC-16",10.9,2.27,12,Small Gene Panel,,38,12/20/2018,Nevus from Iwei,Tumor,Nevus Library,"BCB002,BCB008"
SGLP-0381,463 cellular blue nevus,BN-001,Captured,SGPC-09,7.8,7.44,12,Small Gene Panel,,69,2/21/2019,,Tumor,Nevus Library,"BCB004,BCB017"
SGLP-0382,464 cellular blue nevus,BN-002,Captured,SGPC-09,7.8,5.01,12,Small Gene Panel,,70,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0383,465 cellular blue nevus,BN-003,Captured,"SGPC-09,SGPC-11",7.8,18.16,12,Small Gene Panel,,71,2/21/2019,,Tumor,Nevus Library,"BCB004,BCB011"
SGLP-0384,466 cellular blue nevus,BN-004,Captured,SGPC-09,7.8,9.64,12,Small Gene Panel,,72,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0385,467 cellular blue nevus,BN-005,Captured,SGPC-16,8.3,48.82,12,Small Gene Panel,,73,2/21/2019,Blue Nevus,Tumor,Nevus Library,BCB017
SGLP-0386,468 cellular blue nevus,BN-006,Captured,SGPC-09,7.8,20.55,12,Small Gene Panel,,74,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0387,469 cellular blue nevus,BN-007,Captured,SGPC-16,7.3,48.67,12,Small Gene Panel,,75,2/21/2019,Blue Nevus,Tumor,Nevus Library,BCB017
SGLP-0388,470 cellular blue nevus,BN-008,Captured,SGPC-09,7.8,20.55,12,Small Gene Panel,,76,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0389,471 cellular blue nevus,BN-009,Captured,SGPC-09,7.8,16.62,12,Small Gene Panel,,73,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0390,473 cellular blue nevus,BN-011,Captured,SGPC-09,7.8,5.50,12,Small Gene Panel,,74,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0391,474 cellular blue nevus,BN-012,Captured,SGPC-09,7.8,14.20,12,Small Gene Panel,,79,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0392,478 nevus or nevus like,NL-014,Captured,SGPC-09,7.8,2.54,12,Small Gene Panel,,80,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0393,479 nevus or nevus like,NL-015,Captured,SGPC-09,7.8,1.36,12,Small Gene Panel,,81,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0394,480 nevus or nevus like,NL-016,Captured,SGPC-09,7.8,1.00,12,Small Gene Panel,,82,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0395,481 nevus or nevus like,NL-017,Captured,SGPC-09,7.8,18.60,12,Small Gene Panel,,83,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0396,482 nevus or nevus like,NL-018,Captured,SGPC-09,7.8,43.39,12,Small Gene Panel,,84,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0397,483 nevus or nevus like,NL-019,Captured,SGPC-09,7.8,20.03,12,Small Gene Panel,,85,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0398,484 nevus or nevus like,NL-020,Captured,SGPC-09,7.8,22.97,12,Small Gene Panel,,86,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0399,485 nevus or nevus like,NL-021,Captured,SGPC-09,7.8,8.22,12,Small Gene Panel,,87,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0400,486 nevus or nevus like,NL-022,Captured,SGPC-09,7.8,5.96,12,Small Gene Panel,,88,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0401,487 nevus or nevus like,NL-023,Captured,SGPC-09,7.8,4.49,12,Small Gene Panel,,89,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0402,488 nevus or nevus like,NL-024,Captured,SGPC-09,7.8,2.68,12,Small Gene Panel,,90,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0403,489 nevus or nevus like,NL-025,Captured,SGPC-09,7.8,3.72,12,Small Gene Panel,,91,2/21/2019,,Tumor,Nevus Library,BCB004
SGLP-0404,490 nevus or nevus like,CGH12-109,Captured,SGPC-08,7.8,0.80,12,Small Gene Panel,,15,2/27/2019,cases with MAP3K8 fusions,Tumor,Nevus Library,BCB004
SGLP-0405,491 nevus or nevus like,CGH12-280,Captured,SGPC-08,7.8,1.45,12,Small Gene Panel,,16,2/27/2019,cases with MAP3K8 fusions,Tumor,Nevus Library,BCB004
SGLP-0406,492 nevus or nevus like,CGH14-145,Captured,SGPC-08,7.8,1.72,12,Small Gene Panel,,18,2/27/2019,cases with MAP3K8 fusions,Tumor,Nevus Library,BCB004
SGLP-0407,493 nevus or nevus like,CGH14-348,Captured,SGPC-08,7.8,3.02,12,Small Gene Panel,,19,2/27/2019,cases with MAP3K8 fusions,Tumor,Nevus Library,BCB004
SGLP-0408,494 nevus or nevus like,CGH16-200,Captured,SGPC-08,7.8,1.70,12,Small Gene Panel,,20,2/27/2019,cases with MAP3K8 fusions,Tumor,Nevus Library,BCB004
SGLP-0409,495 nevus or nevus like,CGH17-135,Captured,SGPC-08,7.8,1.04,12,Small Gene Panel,,21,2/27/2019,cases with MAP3K8 fusions,Tumor,Nevus Library,BCB004
SGLP-0410,496 nevus or nevus like,CGH18-139,Captured,SGPC-08,7.8,0.65,12,Small Gene Panel,,22,2/27/2019,,Tumor,Nevus Library,BCB004
SGLP-0411,497 nevus or nevus like,CGH17-240,Captured,SGPC-08,7.8,1.30,12,Small Gene Panel,,23,2/27/2019,,Tumor,Nevus Library,BCB004
SGLP-0412,498 DPN-mm,CGH18-137,Captured,SGPC-08,7.8,2.12,12,Small Gene Panel,,24,2/27/2019,,Tumor,Nevus Library,BCB004
SGLP-0413,502 Junctional,LN-022,Captured,"SGPC-10,SGPC-13",5.2,26.00,12,Small Gene Panel,,17,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0414,503 Junctional,LN-023,Captured,"SGPC-10,SGPC-13",5.2,30.59,12,Small Gene Panel,,18,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0415,504 Junctional,LN-024,Captured,"SGPC-10,SGPC-13",5.2,16.25,12,Small Gene Panel,,19,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0416,505 Junctional,LN-025,Captured,"SGPC-10,SGPC-13",5.2,5.71,12,Small Gene Panel,,20,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0417,506 Junctional,LN-026,Captured,"SGPC-10,SGPC-13",5.2,6.50,12,Small Gene Panel,,21,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0418,507 Junctional,LN-027,Captured,"SGPC-10,SGPC-13",5.2,19.26,12,Small Gene Panel,,22,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0419,508 Junctional,LN-028,Pending,,,0.00,,,,24,5/7/2019,Not enough LP,Tumor,Lentiginous Nevi,
SGLP-0420,509 Junctional,LN-028,Captured,"SGPC-10,SGPC-13",5.2,21.67,12,Small Gene Panel,,25,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0421,510 Junctional,LN-030,Captured,"SGPC-10,SGPC-13",5.2,17.93,12,Small Gene Panel,,26,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0422,511 Junctional,LN-031,Captured,"SGPC-10,SGPC-13",5.2,34.67,12,Small Gene Panel,,27,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0423,512 Junctional,LN-032,Captured,"SGPC-10,SGPC-13",5.2,8.67,12,Small Gene Panel,,28,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0424,513 Junctional,LN-033,Captured,"SGPC-10,SGPC-13",5.2,8.52,12,Small Gene Panel,,29,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0425,514 Junctional,LN-034,Captured,"SGPC-10,SGPC-13",5.2,7.22,12,Small Gene Panel,,30,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0426,515 Junctional,LN-035,Captured,"SGPC-10,SGPC-13",5.2,14.86,12,Small Gene Panel,,31,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0427,516 Junctional,LN-036,Captured,"SGPC-10,SGPC-13",5.2,13.33,12,Small Gene Panel,,32,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0429,518 Junctional,LN-038,Captured,"SGPC-10,SGPC-13",5.2,15.29,12,Small Gene Panel,,33,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0430,519 Junctional,LN-038,Captured,"SGPC-10,SGPC-13",5.2,9.45,12,Small Gene Panel,,34,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0431,520 Junctional,LN-040,Captured,"SGPC-10,SGPC-13",5.2,13.68,12,Small Gene Panel,,35,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0432,521 Junctional,LN-041,Captured,"SGPC-10,SGPC-13",5.2,2.46,12,Small Gene Panel,,36,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0433,522 Congenital superficial,LN-042,Captured,"SGPC-10,SGPC-13",5.2,9.12,12,Small Gene Panel,,37,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0434,523 Congenital superficial,LN-043,Captured,"SGPC-10,SGPC-13",5.2,2.60,12,Small Gene Panel,,38,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0435,524 Congenital superficial,LN-044,Pending,,,0.00,,,,39,5/7/2019,Not enough LP,Tumor,Lentiginous Nevi,
SGLP-0436,525 Congenital superficial,LN-045,Captured,"SGPC-10,SGPC-13",5.2,4.03,12,Small Gene Panel,,40,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0437,526 Congenital superficial,LN-045,Captured,"SGPC-10,SGPC-13",5.2,8.81,12,Small Gene Panel,,41,5/7/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0438,527 Congenital superficial,LN-047,Captured,"SGPC-10,SGPC-13",5.2,5.78,12,Small Gene Panel,,2,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0439,530 Compound,LN-050,Captured,"SGPC-10,SGPC-13",5.2,2.60,12,Small Gene Panel,,4,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0440,537 Compound,,Captured,"SGPC-10,SGPC-13",5.2,2.89,12,Small Gene Panel,,5,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0441,538 Compound,LN-058,Captured,"SGPC-10,SGPC-13",5.2,5.59,12,Small Gene Panel,,6,5/14/2019,repeat qPCR,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0442,539 Compound,LN-059,Captured,"SGPC-10,SGPC-13",5.2,13.00,12,Small Gene Panel,,11,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0443,540 Compound,LN-060,Captured,"SGPC-10,SGPC-13",5.2,5.20,12,Small Gene Panel,,12,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0444,542 Compound,LN-062,Captured,"SGPC-10,SGPC-13",5.2,4.33,12,Small Gene Panel,,52,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0445,543 Compound,LN-062,Captured,"SGPC-10,SGPC-13",5.2,4.73,12,Small Gene Panel,,44,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0446,544 Compound,LN-064,Captured,"SGPC-10,SGPC-13",5.2,4.33,12,Small Gene Panel,,45,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0447,545 Compound,LN-065,Captured,"SGPC-10,SGPC-13",5.2,5.20,12,Small Gene Panel,,46,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0448,546 Compound,LN-065,Captured,"SGPC-10,SGPC-13",5.2,7.43,12,Small Gene Panel,,49,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0449,547 Compound,LN-067,Captured,"SGPC-10,SGPC-13",5.2,3.47,12,Small Gene Panel,,50,5/14/2019,,Tumor,Lentiginous Nevi,"BCB006,BCB013"
SGLP-0450,1316 Acral Mel Cells,MC-01,Captured,"SGPC-10,SGPC-12",5.2,0.58,12,Small Gene Panel,,52,5/14/2019,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB006,BCB012"
SGLP-0451,1317 Acral Mel Cells,MC-02,Captured,"SGPC-10,SGPC-12",5.2,0.38,12,Small Gene Panel,,53,5/14/2019,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB006,BCB012"
SGLP-0453,1318 Acral Mel Cells,MC-03,Captured,"SGPC-10,SGPC-12",5.2,0.29,12,Small Gene Panel,,55,5/14/2019,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB006,BCB012"
SGLP-0454,1319 Acral Mel Cells,MC-04,Captured,"SGPC-10,SGPC-12",5.2,0.66,12,Small Gene Panel,,56,5/14/2019,Acral Melanoma Cell Line,Tumor,Acral Melanoma Cell Lines,"BCB006,BCB012"
SGLP-0455,806 MELANOMA,CM-01,Captured,"SGPC-10,SGPC-13",5.2,7.54,12,Small Gene Panel,,7,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0456,807 PAM,CM-01,Captured,"SGPC-10,SGPC-13",5.2,34.67,12,Small Gene Panel,,13,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0457,808 MELANOMA,CM-04,Captured,"SGPC-10,SGPC-13",5.2,3.44,12,Small Gene Panel,,14,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0458,809 MELANOMA,CM-05,Captured,SGPC-10,5.2,2.26,12,Small Gene Panel,,15,6/4/2019,,,Conjunctival Melanoma,BCB006
SGLP-0459,810 NORMAL,CM-05,Captured,SGPC-10,5.2,1.46,12,Small Gene Panel,,16,6/4/2019,,,Conjunctival Melanoma,BCB006
SGLP-0460,811 MELANOMA,CM-07,Captured,"SGPC-10,SGPC-13",5.2,13.68,12,Small Gene Panel,,43,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0461,812 MELANOMA,CM-08,Captured,"SGPC-10,SGPC-13",5.2,8.97,12,Small Gene Panel,,47,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0462,813 MELANOMA,CM-10,Captured,"SGPC-10,SGPC-13",5.2,2.33,12,Small Gene Panel,,48,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0463,814 MELANOMA,CM-11,Captured,"SGPC-10,SGPC-13",5.2,7.88,12,Small Gene Panel,,51,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0464,815 MELANOMA,CM-12,Captured,"SGPC-10,SGPC-13",5.2,3.08,12,Small Gene Panel,,57,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0465,816 MELANOMA,CM-13,Captured,"SGPC-10,SGPC-13",5.2,3.82,12,Small Gene Panel,,58,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0466,817 PAM,CM-13,Captured,"SGPC-10,SGPC-13",5.2,10.40,12,Small Gene Panel,,59,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0467,818 MELANOMA,CM-15,Captured,"SGPC-10,SGPC-13",5.2,1.72,12,Small Gene Panel,,60,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0468,819 MELANOMA,CM-16,Captured,"SGPC-10,SGPC-13",5.2,4.44,12,Small Gene Panel,,61,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0469,820 NORMAL,CM-16,Captured,"SGPC-10,SGPC-13",5.2,8.25,12,Small Gene Panel,,62,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0470,821 MELANOMA,CM-17,Captured,"SGPC-10,SGPC-13",5.2,3.15,12,Small Gene Panel,,63,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0471,822 MELANOMA,CM-18,Captured,SGPC-10,5.2,1.72,12,Small Gene Panel,,64,6/4/2019,,,Conjunctival Melanoma,BCB006
SGLP-0472,823 NORMAL,CM-18,Library failed/low yield,,,0.00,,Small Gene Panel,,65,6/4/2019,Not enough LP,,Conjunctival Melanoma,
SGLP-0473,825 MELANOMA,CM-21,Captured,"SGPC-10,SGPC-13",5.2,4.23,12,Small Gene Panel,,66,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0474,827 MELANOMA,CM-22,Captured,SGPC-10,5.2,40.00,12,Small Gene Panel,,67,6/4/2019,,,Conjunctival Melanoma,BCB006
SGLP-0475,828 MELANOMA,CM-23,Captured,"SGPC-10,SGPC-13",5.2,2.81,12,Small Gene Panel,,68,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0476,829 MELANOMA,CM-24,Library failed/low yield,,,NaN,,Small Gene Panel,,69,6/4/2019,Not enough LP; High Melanin,,Conjunctival Melanoma,
SGLP-0477,830 MELANOMA,CM-27,Captured,"SGPC-10,SGPC-13",5.2,3.35,12,Small Gene Panel,,70,6/4/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0478,831 MELANOMA,CM-28,Captured,SGPC-10,5.2,1.18,12,Small Gene Panel,,71,6/6/2019,,,Conjunctival Melanoma,BCB006
SGLP-0479,832 NORMAL,CM-28,Captured,"SGPC-10,SGPC-11,SGPC-13",5.2,1.02,12,Small Gene Panel,,72,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB011,BCB013"
SGLP-0480,833 MELANOMA,CM-29,Captured,"SGPC-10,SGPC-11",5.2,0.80,12,Small Gene Panel,,73,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB011"
SGLP-0481,835 MELANOMA,CM-76,Captured,"SGPC-10,SGPC-11,SGPC-13",5.2,1.15,12,Small Gene Panel,,74,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB011,BCB013"
SGLP-0482,837 MELANOMA,CM-30,Captured,"SGPC-10,SGPC-11,SGPC-13",5.2,2.18,12,Small Gene Panel,,75,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB011,BCB013"
SGLP-0483,838 MELANOMA,CM-31,Library failed/low yield,,,0.00,,Small Gene Panel,,76,6/6/2019,Not enough LP; High Melanin,,Conjunctival Melanoma,
SGLP-0484,839 MELANOMA,CM-32,Captured,"SGPC-10,SGPC-11,SGPC-13",5.2,1.61,12,Small Gene Panel,,77,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB011,BCB013"
SGLP-0485,840 PAM,CM-32,Captured,"SGPC-10,SGPC-11,SGPC-13",5.2,0.92,12,Small Gene Panel,,78,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB011,BCB013"
SGLP-0486,841 NORMAL,CM-32,Captured,"SGPC-10,SGPC-13",5.2,1.55,12,Small Gene Panel,,79,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0487,842 MELANOMA,CM-33,Captured,"SGPC-10,SGPC-13",5.2,3.44,12,Small Gene Panel,,80,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0488,843 MELANOMA,CM-34,Captured,"SGPC-10,SGPC-13",5.2,10.61,12,Small Gene Panel,,81,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0489,844 MELANOMA,CM-36,Captured,"SGPC-10,SGPC-14",5.2,37.14,12,Small Gene Panel,,82,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB015"
SGLP-0490,845 MELANOMA,CM-37,Captured,"SGPC-10,SGPC-13,SGPC-14",5.2,13.00,12,Small Gene Panel,,83,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013,BCB015"
SGLP-0491,846 MELANOMA,CM-40,Captured,"SGPC-10,SGPC-13",5.2,7.32,12,Small Gene Panel,,84,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0492,847 MELANOMA,CM-41,Captured,SGPC-10,5.2,3.54,12,Small Gene Panel,,85,6/6/2019,,,Conjunctival Melanoma,BCB006
SGLP-0493,848 NORMAL,CM-41,Captured,SGPC-10,5.2,2.50,12,Small Gene Panel,,86,6/6/2019,,,Conjunctival Melanoma,BCB006
SGLP-0494,850 NEVUS,CM-42,Library failed/low yield,,,NaN,,Small Gene Panel,,87,6/6/2019,Not enough LP,,Conjunctival Melanoma,
SGLP-0495,851 NEVUS,CM-43,Captured,SGPC-10,5.2,1.83,12,Small Gene Panel,,88,6/6/2019,,,Conjunctival Melanoma,BCB006
SGLP-0496,852 NEVUS,CM-44,Captured,"SGPC-10,SGPC-13",5.2,15.29,12,Small Gene Panel,,89,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0497,853 NEVUS,CM-45,Captured,"SGPC-10,SGPC-13",5.2,6.84,12,Small Gene Panel,,90,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0498,854 NEVUS,CM-46,Captured,"SGPC-10,SGPC-13",5.2,3.29,12,Small Gene Panel,,91,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0499,855 NEVUS,CM-47,Captured,"SGPC-10,SGPC-13",5.2,2.48,12,Small Gene Panel,,92,6/6/2019,,,Conjunctival Melanoma,"BCB006,BCB013"
SGLP-0500,856 NEVUS,CM-48,Captured,SGPC-15,60.0,10.47,12,Small Gene Panel,,93,6/6/2019,,,Conjunctival Melanoma,BCB016
SGLP-0501,857 NEVUS,CM-50,Captured,SGPC-15,60.0,36.59,12,Small Gene Panel,,17,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0502,858 NEVUS,CM-51,Captured,SGPC-15,51.5,50.00,12,Small Gene Panel,,18,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0503,859 NEVUS,CM-53,Captured,SGPC-15,60.0,40.27,12,Small Gene Panel,,19,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0504,860 NEVUS,CM-54,Captured,SGPC-15,60.0,16.76,12,Small Gene Panel,,20,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0505,861 NEVUS,CM-56,Captured,SGPC-15,60.0,38.46,12,Small Gene Panel,,21,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0506,863 PAM,CM-57,Captured,SGPC-15,53.0,50.00,12,Small Gene Panel,,22,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0507,864 NORMAL,CM-57,Captured,SGPC-15,33.0,50.00,12,Small Gene Panel,,23,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0508,865 PAM,CM-58,Captured,SGPC-15,60.0,10.47,12,Small Gene Panel,,24,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0509,866 NORMAL,CM-58,Captured,SGPC-15,60.0,5.83,12,Small Gene Panel,,25,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0510,869 PAM,CM-62,Captured,SGPC-15,68.0,50.00,12,Small Gene Panel,,26,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0511,872 PAM,CM-69,Captured,SGPC-15,60.0,14.46,12,Small Gene Panel,,27,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0512,873 PAM,CM-70,Captured,SGPC-15,60.0,27.52,12,Small Gene Panel,,28,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0513,874 PAM,CM-71,Captured,SGPC-15,48.5,50.00,12,Small Gene Panel,,29,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0514,875 PAM,CM-72,Captured,SGPC-15,61.0,50.00,12,Small Gene Panel,,31,6/20/2019,,,Conjunctival Melanoma,BCB016
SGLP-0515,912 Mel,MD-40,Captured,SGPC-15,12.0,50.00,12,Small Gene Panel,,32,7/15/2019,Madrid Melanoma; 05-12693-C M1,Tumor,Melanoma Prognosis,BCB016
SGLP-0516,913 Mel,MD-41,Captured,SGPC-15,44.0,50.00,12,Small Gene Panel,,33,7/15/2019,Madrid Melanoma; 05-27343-A M1,Tumor,Melanoma Prognosis,BCB016
SGLP-0517,914 Mel,MD-42,Captured,SGPC-15,33.0,50.00,12,Small Gene Panel,,34,7/15/2019,Madrid Melanoma; 06-03046-F N1,Tumor,Melanoma Prognosis,BCB016
SGLP-0518,915 Mel,MD-43,Captured,SGPC-15,24.5,50.00,12,Small Gene Panel,,35,7/15/2019,Madrid Melanoma; 06-06325 M1,Tumor,Melanoma Prognosis,BCB016
SGLP-0519,916 Mel,MD-44,Captured,SGPC-15,64.0,50.00,12,Small Gene Panel,,36,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0520,917 Mel,MD-45,Captured,SGPC-15,0.5,50.00,12,Small Gene Panel,,37,7/15/2019,Madrid Melanoma; 10-10942-A2 M1,Tumor,Melanoma Prognosis,BCB016
SGLP-0521,918 Mel,MD-46,Captured,SGPC-15,21.5,50.00,12,Small Gene Panel,,38,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0522,919 Mel,MD-47,Captured,SGPC-15,13.5,50.00,12,Small Gene Panel,,39,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0523,920 Mel,MD-48,Captured,SGPC-15,9.0,50.00,12,Small Gene Panel,,40,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0524,921 Mel,MD-49,Captured,SGPC-15,16.0,50.00,12,Small Gene Panel,,41,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0525,922 Mel,MD-50,Captured,SGPC-15,31.0,50.00,12,Small Gene Panel,,52,7/15/2019,Madrid Melanoma; Need to resequence due to barcode error,Tumor,Melanoma Prognosis,BCB016
SGLP-0526,923 Mel,MD-51,Captured,SGPC-15,12.0,50.00,12,Small Gene Panel,,43,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0527,924 Mel,MD-52,Captured,SGPC-15,14.5,50.00,12,Small Gene Panel,,44,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0528,925 Mel,MD-53,Captured,SGPC-15,37.0,50.00,12,Small Gene Panel,,45,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0529,926 Mel,MD-54,Captured,SGPC-15,21.5,50.00,12,Small Gene Panel,,46,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0530,927 Mel,MD-55,Captured,SGPC-15,14.0,50.00,12,Small Gene Panel,,47,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0531,928 Mel,MD-56,Captured,SGPC-15,40.0,50.00,12,Small Gene Panel,,48,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0532,929 Mel,MD-57,Captured,SGPC-15,40.0,50.00,12,Small Gene Panel,,49,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0533,930 Mel,MD-58,Captured,SGPC-15,28.0,50.00,12,Small Gene Panel,,50,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0534,931 Mel,MD-59,Captured,SGPC-15,20.0,50.00,12,Small Gene Panel,,51,7/15/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0535,932 Mel,MD-60,Captured,SGPC-15,8.0,50.00,12,Small Gene Panel,,52,7/24/2019,Madrid Melanoma; Need to resequence due to barcode error,Tumor,Melanoma Prognosis,BCB016
SGLP-0536,933 Mel,MD-61,Captured,SGPC-15,28.0,50.00,12,Small Gene Panel,,53,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0537,934 Mel,MD-62,Captured,SGPC-15,21.5,50.00,12,Small Gene Panel,,54,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0538,935 Mel,MD-63,Captured,SGPC-15,15.5,50.00,12,Small Gene Panel,,55,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0539,936 Mel,MD-64,Captured,SGPC-15,33.5,50.00,12,Small Gene Panel,,56,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0540,937 Mel,MD-65,Captured,SGPC-15,38.5,50.00,12,Small Gene Panel,,57,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0541,938 Mel,MD-66,Captured,SGPC-15,41.5,50.00,12,Small Gene Panel,,58,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0542,939 Mel,MD-67,Captured,SGPC-15,41.0,50.00,12,Small Gene Panel,,59,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0543,940 Mel,MD-68,Captured,SGPC-15,10.0,50.00,12,Small Gene Panel,,60,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0544,941 Mel,MD-69,Captured,SGPC-15,45.0,50.00,12,Small Gene Panel,,61,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0545,942 Mel,MD-70,Captured,SGPC-15,41.5,50.00,12,Small Gene Panel,,62,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0546,943 Mel,MD-71,Captured,SGPC-15,36.0,50.00,12,Small Gene Panel,,63,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0547,944 Mel,MD-72,Captured,SGPC-15,33.5,50.00,12,Small Gene Panel,,64,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0548,945 Mel,MD-73,Captured,SGPC-15,25.5,50.00,12,Small Gene Panel,,65,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0549,946 Mel,MD-74,Captured,SGPC-15,36.0,50.00,12,Small Gene Panel,,66,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0550,947 Mel,MD-75,Captured,SGPC-15,14.5,50.00,12,Small Gene Panel,,67,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0551,948 Mel,MD-38,Library failed/low yield,,0.0,NaN,,,,68,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,
SGLP-0552,949 Mel,MD-77,Captured,SGPC-15,39.5,50.00,12,Small Gene Panel,,69,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0553,950 Mel,MD-24,Captured,SGPC-15,10.0,50.00,12,Small Gene Panel,,70,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0554,951 Mel,MD-79,Captured,SGPC-15,58.0,50.00,12,Small Gene Panel,,71,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0555,952 Mel,MD-80,Captured,SGPC-15,21.5,50.00,12,Small Gene Panel,,72,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0556,953 Mel,MD-80,Captured,SGPC-15,44.5,50.00,12,Small Gene Panel,,76,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0557,954 Mel,MD-25,Captured,SGPC-15,14.5,50.00,12,Small Gene Panel,,77,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0558,955 Mel,MD-26,Captured,SGPC-15,19.5,50.00,12,Small Gene Panel,,78,7/24/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB016
SGLP-0559,980 Normal,CM-08,Captured,SGPC-15,39.5,50.00,12,Small Gene Panel,,1,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0560,981 Normal,CM-13,Captured,SGPC-15,39.5,50.00,12,Small Gene Panel,,3,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0561,982 Normal,CM-15,Captured,SGPC-15,38.0,50.00,12,Small Gene Panel,,4,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0562,983 Normal,CM-22,Captured,SGPC-15,14.5,50.00,12,Small Gene Panel,,5,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0563,984 Normal,CM-31,Captured,SGPC-15,7.5,50.00,12,Small Gene Panel,,6,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0564,985 Normal,CM-33,Captured,SGPC-15,4.5,50.00,12,Small Gene Panel,,7,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0565,986 Normal,CM-36,Captured,SGPC-15,63.0,50.00,12,Small Gene Panel,,8,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0566,987 Normal,CM-37,Captured,SGPC-15,44.0,50.00,12,Small Gene Panel,,79,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0567,988 Normal,CM-40,Captured,SGPC-15,60.0,37.74,12,Small Gene Panel,,80,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0568,989 Normal,CM-41,Captured,SGPC-15,31.0,50.00,12,Small Gene Panel,,81,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0569,990 Normal,CM-48,Captured,SGPC-15,60.0,24.49,12,Small Gene Panel,,82,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0570,991 Normal,CM-53,Captured,SGPC-15,60.0,23.17,12,Small Gene Panel,,83,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0571,992 Normal,CM-54,Captured,SGPC-15,60.0,20.13,12,Small Gene Panel,,84,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0572,993 Normal,CM-61,Captured,SGPC-15,55.0,50.00,12,Small Gene Panel,,85,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0573,994 Normal,CM-62,Captured,SGPC-15,43.5,50.00,12,Small Gene Panel,,86,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0574,995 Normal,CM-69,Captured,SGPC-15,18.5,50.00,12,Small Gene Panel,,87,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0575,996 Normal,CM-07,Captured,SGPC-15,54.5,50.00,12,Small Gene Panel,,88,8/5/2019,,,Conjunctival Melanoma,BCB016
SGLP-0576,956 Mel,MD-84,Captured,SGPC-14,18.5,50.00,12,Small Gene Panel,,89,8/5/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB015
SGLP-0577,957 Mel,MD-85,Captured,SGPC-14,49.0,50.00,12,Small Gene Panel,,90,8/5/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB015
SGLP-0578,958 Mel,MD-86,Captured,SGPC-14,60.0,34.09,12,Small Gene Panel,,91,8/5/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB015
SGLP-0579,959 Mel,MD-27,Captured,SGPC-14,40.0,50.00,12,Small Gene Panel,,92,8/5/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB015
SGLP-0580,960 Mel,MD-31,Captured,SGPC-14,60.0,42.86,12,Small Gene Panel,,94,8/5/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB015
SGLP-0581,961 Mel,MD-28,Captured,SGPC-14,30.0,50.00,12,Small Gene Panel,,95,8/5/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB015
SGLP-0582,962 Mel,MD-29,Captured,SGPC-14,80.0,50.00,12,Small Gene Panel,,96,8/5/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB015
SGLP-0583,963 Mel,MD-32,Captured,SGPC-16,60.0,25.97,12,Small Gene Panel,,15,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0584,964 Mel,MD-92,Captured,SGPC-16,60.0,29.41,12,Small Gene Panel,,16,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0585,965 Mel,MD-93,Captured,SGPC-16,60.0,25.53,12,Small Gene Panel,,17,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0586,966 Mel,MD-94,Captured,SGPC-16,5.0,50.00,12,Small Gene Panel,,18,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0587,967 Mel,MD-95,Captured,SGPC-16,10.5,50.00,12,Small Gene Panel,,19,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0588,968 Mel,MD-96,Captured,SGPC-16,17.5,50.00,12,Small Gene Panel,,20,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0589,969 Mel,MD-97,Captured,SGPC-16,40.0,50.00,12,Small Gene Panel,,21,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0590,970 Mel,MD-98,Captured,SGPC-16,20.5,50.00,12,Small Gene Panel,,22,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0591,971 Mel,MD-99,Captured,SGPC-16,20.0,50.00,12,Small Gene Panel,,23,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0592,972 Mel,MD-100,Captured,SGPC-16,36.0,50.00,12,Small Gene Panel,,24,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0593,973 Mel,MD-101,Captured,SGPC-16,69.0,50.00,12,Small Gene Panel,,25,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0594,974 Mel,MD-102,Captured,SGPC-16,60.0,50.00,12,Small Gene Panel,,26,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0595,975 Mel,MD-103,Captured,SGPC-16,60.0,36.14,12,Small Gene Panel,,27,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0596,976 Mel,MD-06,Captured,SGPC-16,39.5,50.00,12,Small Gene Panel,,28,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0597,977 Mel,MD-105,Captured,SGPC-16,27.5,50.00,12,Small Gene Panel,,29,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0598,978 Mel,MD-106,Captured,SGPC-16,52.0,50.00,12,Small Gene Panel,,30,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0599,979 Mel,MD-107,Captured,SGPC-16,60.0,34.29,12,Small Gene Panel,,31,8/13/2019,Madrid Melanoma,Tumor,Melanoma Prognosis,BCB017
SGLP-0600,2328 Tumor,DP-09,Captured,SGPC-14,60.0,10.93,12,Small Gene Panel,,32,8/13/2019,PRKC fused cases,Tumor,PRKC Fused Cases,BCB015
SGLP-0601,2329 Tumor,DP-10,Captured,SGPC-14,60.0,17.09,12,Small Gene Panel,,33,8/13/2019,PRKC fused cases,Tumor,PRKC Fused Cases,BCB015
SGLP-0602,2330 Tumor,DP-11,Captured,SGPC-14,60.0,22.14,12,Small Gene Panel,,34,8/13/2019,PRKC fused cases,Tumor,PRKC Fused Cases,BCB015
SGLP-0603,2331 Tumor,DP-12,Captured,SGPC-14,60.0,12.45,12,Small Gene Panel,,35,8/13/2019,NRAS sequencing,Tumor,NRAS Amplified,BCB015
SGLP-0604,2332 Tumor,DP-13,Captured,SGPC-14,60.0,11.83,12,Small Gene Panel,,36,8/13/2019,NRAS sequencing,Tumor,NRAS Amplified,BCB015
SGLP-0605,2333 Tumor,DP-14,Captured,SGPC-14,60.0,15.63,12,Small Gene Panel,,37,8/13/2019,NRAS sequencing,Tumor,NRAS Amplified,BCB015
SGLP-0606,2334 Tumor,DP-15,Captured,SGPC-14,60.0,18.35,12,Small Gene Panel,,38,8/13/2019,Atypical Spitz tumor-nodule,Tumor,Atypical Spitz Progression,BCB015
SGLP-0607,2335 Tumor,DP-15,Captured,SGPC-14,60.0,38.96,12,Small Gene Panel,,39,8/13/2019,Atypical Spitz tumor-nevus,Tumor,Atypical Spitz Progression,BCB015
SGLP-0608,1004 Nodular Mel,NM-66,Captured,SGPC-16,60.0,15.79,12,Small Gene Panel,,32,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0609,1005 Nodular Mel,NM-67,Captured,SGPC-16,60.0,40.00,12,Small Gene Panel,,33,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0610,1006 Nodular Mel,NM-68,Captured,SGPC-16,60.0,42.86,12,Small Gene Panel,,34,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0611,1007 Nodular Mel,NM-69,Captured,SGPC-16,65.0,50.00,12,Small Gene Panel,,35,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0612,1008 Nodular Mel,NM-70,Captured,SGPC-16,25.0,50.00,12,Small Gene Panel,,36,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0613,1009 Nodular Mel,NM-71,Captured,SGPC-16,65.0,50.00,12,Small Gene Panel,,37,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0614,1010 Nodular Mel,NM-72,Captured,SGPC-16,60.0,50.00,12,Small Gene Panel,,39,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0615,1011 Nodular Mel,NM-73,Captured,SGPC-16,60.0,31.58,12,Small Gene Panel,,40,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0616,1012 Nodular Mel,NM-74,Captured,SGPC-16,30.0,50.00,12,Small Gene Panel,,41,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0617,1013 Nodular Mel,NM-75,Captured,SGPC-16,60.0,12.24,12,Small Gene Panel,,43,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0618,1014 Nodular Mel,NM-76,Captured,SGPC-16,50.0,50.00,12,Small Gene Panel,,44,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0619,1015 Nodular Mel,NM-77,Captured,SGPC-16,60.0,27.27,12,Small Gene Panel,,45,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0620,1016 Nodular Mel,NM-78,Captured,SGPC-16,60.0,50.00,12,Small Gene Panel,,46,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0621,1017 Nodular Mel,NM-79,Captured,SGPC-16,60.0,37.50,12,Small Gene Panel,,47,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0622,1018 Nodular Mel,NM-80,Captured,SGPC-16,60.0,20.69,12,Small Gene Panel,,48,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0623,1019 Nodular Mel,NM-81,Captured,SGPC-16,60.0,42.86,12,Small Gene Panel,,50,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0624,1020 Nodular Mel,NM-82,Captured,SGPC-16,25.0,50.00,12,Small Gene Panel,,51,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0625,1021 Nodular Mel,NM-83,Captured,SGPC-16,35.0,50.00,12,Small Gene Panel,,52,9/24/2019,,,Nodular Melanoma,BCB017
SGLP-0626,1025 Mel,MD-14,Captured,SGPC-16,60.0,41.10,12,Small Gene Panel,,79,10/16/2019,Madrid Melanoma; 200ng; No repair,Tumor,Melanoma Prognosis,BCB017
SGLP-0627,1025 Mel,MD-14,Captured,SGPC-16,60.0,27.40,12,Small Gene Panel,,80,10/16/2019,Madrid Melanoma; 200ng; repair,Tumor,Melanoma Prognosis,BCB017
SGLP-0628,1035 Mel,MD-121,Captured,SGPC-16,52.0,50.00,12,Small Gene Panel,,81,10/16/2019,Madrid Melanoma; 250ng; No repair,Tumor,Melanoma Prognosis,BCB017
SGLP-0629,1035 Mel,MD-121,Captured,SGPC-16,52.0,39.69,12,Small Gene Panel,,86,10/16/2019,Madrid Melanoma; 250 ng; repair,Tumor,Melanoma Prognosis,BCB017
SGLP-0630,1044 Mel,MD-130,Captured,SGPC-16,60.0,34.68,12,Small Gene Panel,,88,10/16/2019,Madrid Melanoma; 500ng; No repair,Tumor,Melanoma Prognosis,BCB017
SGLP-0631,1044 Mel,MD-130,Captured,SGPC-16,60.0,23.72,12,Small Gene Panel,,89,10/16/2019,Madrid Melanoma; 500ng; repair,Tumor,Melanoma Prognosis,BCB017
SGLP-0632,1025 Mel,MD-14,Captured,SGPC-16,60.0,21.98,12,Small Gene Panel,,90,10/16/2019,Madrid Melanoma; 500ng; No repair; 4 Cycles,Tumor,Melanoma Prognosis,BCB017
SGLP-0633,1035 Mel,MD-121,Captured,SGPC-16,60.0,35.71,12,Small Gene Panel,,93,10/16/2019,Madrid Melanoma; 500ng; No repair; 4 Cycles,Tumor,Melanoma Prognosis,BCB017
SGLP-0634,1057 Mel,MD-10,Captured,SGPC-16,25.5,32.28,12,Small Gene Panel,,95,10/16/2019,Madrid Melanoma; 500ng; No repair; 4 Cycles,Tumor,Melanoma Prognosis,BCB017
SGLP-0635,1057 Mel,MD-10,Captured,SGPC-16,25.5,50.00,12,Small Gene Panel,,96,10/16/2019,Madrid Melanoma; 1000ng; No repair; 4 Cycles,Tumor,Melanoma Prognosis,BCB017
SGLP-0636,1025 Mel,MD-14,Captured,SGPC-16,63.5,30.38,12,Small Gene Panel,,91,10/16/2019,Madrid Melanoma; 1000ng; No repair; 3 Cycles,Tumor,Melanoma Prognosis,BCB017
SGLP-0637,1035 Mel,MD-121,Captured,SGPC-16,63.5,50.00,12,Small Gene Panel,,94,10/16/2019,Madrid Melanoma; 1000ng; No repair; 3 Cycles,Tumor,Melanoma Prognosis,BCB017
SGLP-0638,1022 Mel,MD-108,Captured,SGPC-16,50.0,50.00,12,Small Gene Panel,,53,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0639,1023 Mel,MD-05,Captured,SGPC-16,16.0,50.00,12,Small Gene Panel,,54,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0640,1024 Mel,MD-18,Captured,SGPC-16,60.0,41.67,12,Small Gene Panel,,55,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0641,1026 Mel,MD-112,Captured,SGPC-16,38.0,50.00,12,Small Gene Panel,,56,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0642,1027 Mel,MD-113,Captured,SGPC-16,41.5,50.00,12,Small Gene Panel,,57,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0643,1028 Mel,MD-114,Captured,SGPC-16,49.0,50.00,12,Small Gene Panel,,11,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0644,650 Mel,MD-19,Captured,SGPC-16,9.5,50.00,12,Small Gene Panel,,59,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0645,651 Mel,MD-20,Captured,SGPC-16,44.0,50.00,12,Small Gene Panel,,60,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0646,1031 Mel,MD-21,Captured,SGPC-16,56.0,50.00,12,Small Gene Panel,,13,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0647,1032 Mel,MD-118,Captured,SGPC-16,60.5,50.00,12,Small Gene Panel,,14,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0648,1033 Mel,MD-119,Captured,SGPC-16,22.5,50.00,12,Small Gene Panel,,64,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0649,1034 Mel,MD-17,Captured,SGPC-16,28.0,50.00,12,Small Gene Panel,,65,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0650,1036 Mel,MD-122,Captured,SGPC-16,40.0,50.00,12,Small Gene Panel,,66,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0651,1037 Mel,MD-22,Captured,SGPC-16,2.0,50.00,12,Small Gene Panel,,67,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0652,647 Mel,MD-16,Captured,SGPC-16,60.0,40.00,12,Small Gene Panel,,68,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0653,1039 Mel,MD-125,Captured,SGPC-16,16.5,50.00,12,Small Gene Panel,,69,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0654,646 Mel,MD-15,Captured,SGPC-16,35.0,50.00,12,Small Gene Panel,,70,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0655,1041 Mel,MD-127,Captured,SGPC-16,60.0,41.10,12,Small Gene Panel,,72,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0656,1042 Mel,MD-128,Captured,SGPC-16,11.5,50.00,12,Small Gene Panel,,74,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0657,1043 Mel,MD-13,Captured,SGPC-16,66.0,50.00,12,Small Gene Panel,,76,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0658,1045 Mel,MD-131,Captured,SGPC-16,21.0,50.00,12,Small Gene Panel,,77,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0659,1046 Mel,MD-132,Captured,SGPC-16,52.0,50.00,12,Small Gene Panel,,78,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0660,638 Mel,MD-07,Captured,SGPC-16,32.0,50.00,12,Small Gene Panel,,5,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0661,1048 Mel,MD-12,Captured,SGPC-16,60.0,30.00,12,Small Gene Panel,,7,11/7/2019,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB017
SGLP-0662,1049 Mel,MD-135,Captured,SGPC-17,18.5,45.12,12,Small Gene Panel,,121,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0663,1050 Mel,MD-23,Captured,SGPC-17,60.0,31.41,12,Small Gene Panel,,122,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0664,1051 Mel,MD-137,Captured,SGPC-17,39.7,45.11,12,Small Gene Panel,,123,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0665,1052 Mel,MD-138,Captured,SGPC-17,57.4,44.84,12,Small Gene Panel,,124,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0666,1053 Mel,MD-139,Captured,SGPC-17,32.0,45.07,12,Small Gene Panel,,125,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0667,1054 Mel,MD-140,Captured,SGPC-17,29.1,44.77,12,Small Gene Panel,,126,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0668,1055 Mel,MD-141,Captured,SGPC-17,35.2,45.13,12,Small Gene Panel,,127,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0669,1056 Mel,MD-142,Captured,SGPC-17,22.4,44.80,12,Small Gene Panel,,128,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0670,1058 Mel,MD-144,Captured,SGPC-17,17.5,44.87,12,Small Gene Panel,,129,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0671,1059 Mel,MD-11,Captured,SGPC-17,59.4,45.00,12,Small Gene Panel,,130,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0672,1060 Mel,MD-146,Captured,SGPC-17,60.0,37.04,12,Small Gene Panel,,131,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0673,1061 Mel,MD-147,Captured,SGPC-17,18.4,44.88,12,Small Gene Panel,,132,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0674,1062 Mel,MD-148,Captured,SGPC-17,11.0,45.83,12,Small Gene Panel,,133,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0675,1063 Mel,MD-149,Captured,SGPC-17,52.0,44.83,12,Small Gene Panel,,134,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0676,1064 Mel,MD-150,Captured,SGPC-17,17.3,45.53,12,Small Gene Panel,,135,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0677,1065 Mel,MD-151,Captured,SGPC-17,37.0,45.12,12,Small Gene Panel,,136,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0678,1066 Mel,MD-152,Captured,SGPC-17,15.5,44.29,12,Small Gene Panel,,137,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0679,1067 Mel,MD-153,Captured,SGPC-17,34.8,45.19,12,Small Gene Panel,,138,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0680,1068 Mel,MD-154,Captured,SGPC-17,42.3,45.00,12,Small Gene Panel,,139,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0681,1069 Mel,MD-155,Captured,SGPC-17,35.9,44.87,12,Small Gene Panel,,140,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0682,1070 Mel,MD-156,Captured,SGPC-17,37.4,45.06,12,Small Gene Panel,,141,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0683,1071 Mel,MD-157,Captured,SGPC-17,36.7,44.76,12,Small Gene Panel,,142,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0684,1072 Mel,MD-158,Captured,SGPC-17,8.1,45.00,12,Small Gene Panel,,143,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0685,1073 Mel,MD-159,Captured,SGPC-17,18.4,44.88,12,Small Gene Panel,,144,5/30/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0686,1074 Mel,MD-09,Captured,SGPC-17,69.7,44.97,12,Small Gene Panel,,145,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0687,1075 Mel,MD-161,Captured,SGPC-17,68.0,45.03,12,Small Gene Panel,,146,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0688,1078 Mel,MD-08,Captured,SGPC-17,60.0,23.53,12,Small Gene Panel,,147,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0689,1079 Mel,MD-108,Captured,SGPC-17,60.0,31.25,12,Small Gene Panel,,148,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0690,1080 Mel,MD-165,Captured,SGPC-17,18.7,44.52,12,Small Gene Panel,,149,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0691,1081 Mel,MD-166,Captured,SGPC-17,11.2,44.80,12,Small Gene Panel,,150,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0692,1082 Mel,MD-167,Captured,SGPC-17,23.7,44.72,12,Small Gene Panel,,151,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0693,1083 Mel,MD-168,Captured,SGPC-17,50.1,45.14,12,Small Gene Panel,,152,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0694,1085 Mel,MD-170,Captured,SGPC-17,16.5,41.25,12,Small Gene Panel,,153,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0695,1086 Mel,MD-171,Captured,SGPC-17,15.9,39.75,12,Small Gene Panel,,154,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0696,1087 Mel,MD-172,Captured,SGPC-17,34.0,42.50,12,Small Gene Panel,,155,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0697,1088 Mel,MD-173,Captured,SGPC-17,5.6,56.00,12,Small Gene Panel,,156,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0698,1089 Mel,MD-174,Captured,SGPC-17,4.1,45.56,12,Small Gene Panel,,157,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0699,1090 Mel,MD-175,Captured,SGPC-17,67.1,45.03,12,Small Gene Panel,,158,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0700,1091 Mel,MD-176,Captured,SGPC-17,28.1,45.32,12,Small Gene Panel,,159,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0701,1092 Mel,MD-177,Captured,SGPC-17,60.0,24.19,12,Small Gene Panel,,160,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0702,1093 Mel,MD-178,Captured,SGPC-17,60.0,28.17,12,Small Gene Panel,,161,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0703,1094 Mel,MD-179,Captured,SGPC-17,22.2,45.31,12,Small Gene Panel,,162,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0704,1095 Mel,MD-180,Captured,SGPC-17,27.0,45.00,12,Small Gene Panel,,163,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0705,1096 Mel,MD-181,Captured,SGPC-17,60.0,36.59,12,Small Gene Panel,,164,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0706,1097 Mel,MD-182,Captured,SGPC-17,45.7,44.80,12,Small Gene Panel,,165,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0707,1098 Mel,MD-183,Captured,SGPC-17,21.2,45.11,12,Small Gene Panel,,166,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0708,1099 Mel,MD-184,Captured,SGPC-17,23.8,44.91,12,Small Gene Panel,,167,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0709,1100 Mel,MD-185,Captured,SGPC-17,28.3,44.92,12,Small Gene Panel,,168,5/31/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0710,1101 Mel,MD-186,Captured,SGPC-17,37.0,50.00,12,Small Gene Panel,,169,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0711,1102 Mel,MD-187,Captured,SGPC-17,55.8,49.82,12,Small Gene Panel,,170,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0712,1103 Mel,MD-188,Captured,SGPC-17,60.0,28.57,12,Small Gene Panel,,171,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0713,1104 Mel,MD-189,Captured,SGPC-17,1.2,60.00,12,Small Gene Panel,,172,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0714,1106 Mel,MD-191,Captured,SGPC-17,35.3,49.72,12,Small Gene Panel,,173,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0715,1107 Mel,MD-192,Captured,SGPC-17,4.8,48.00,12,Small Gene Panel,,174,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0716,1108 Mel,MD-193,Captured,SGPC-17,37.6,50.13,12,Small Gene Panel,,175,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0717,1109 Mel,MD-194,Captured,SGPC-17,7.9,49.38,12,Small Gene Panel,,176,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0718,1110 Mel,MD-195,Captured,SGPC-17,60.0,24.59,12,Small Gene Panel,,177,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0719,1111 Mel,MD-196,Captured,SGPC-17,35.3,49.72,12,Small Gene Panel,,178,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0720,1112 Mel,MD-197,Captured,SGPC-17,47.3,49.79,12,Small Gene Panel,,179,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0721,1113 Mel,MD-198,Captured,SGPC-17,34.9,49.86,12,Small Gene Panel,,180,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0722,1114 Mel,MD-199,Captured,SGPC-17,41.2,50.24,12,Small Gene Panel,,181,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0723,1115 Mel,MD-200,Captured,SGPC-17,17.8,49.44,12,Small Gene Panel,,182,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0724,1116 Mel,MD-201,Captured,SGPC-17,60.0,37.04,12,Small Gene Panel,,183,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0725,1117 Mel,MD-202,Captured,SGPC-17,25.6,50.20,12,Small Gene Panel,,184,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0726,1118 Mel,MD-203,Captured,SGPC-17,27.8,49.64,12,Small Gene Panel,,185,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0727,1119 Mel,MD-204,Captured,SGPC-17,42.2,50.24,12,Small Gene Panel,,186,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0728,1120 Mel,MD-205,Captured,SGPC-17,36.0,50.00,12,Small Gene Panel,,187,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0729,1121 Mel,MD-206,Captured,SGPC-17,33.2,50.30,12,Small Gene Panel,,188,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0730,1122 Mel,MD-207,Captured,SGPC-17,26.1,52.20,12,Small Gene Panel,,189,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0731,1123 Mel,MD-208,Captured,SGPC-17,52.7,47.91,12,Small Gene Panel,,190,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0732,1125 Mel,MD-210,Captured,SGPC-17,5.2,52.00,12,Small Gene Panel,,191,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0733,1126 Mel,MD-211,Captured,SGPC-17,52.9,48.09,12,Small Gene Panel,,192,6/6/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0734,1127 Mel,MD-212,Captured,SGPC-17,15.9,49.69,12,Small Gene Panel,,97,6/11/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0735,1128 Mel,MD-213,Captured,SGPC-17,24.2,50.42,12,Small Gene Panel,,98,6/11/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0736,1129 Mel,MD-214,Captured,SGPC-17,24.0,50.00,12,Small Gene Panel,,99,6/11/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0737,1130 Mel,MD-215,Captured,SGPC-17,1.6,53.33,12,Small Gene Panel,,100,6/11/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0738,1131 Mel,MD-216,Captured,SGPC-17,34.2,50.29,12,Small Gene Panel,,101,6/11/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0739,1132 Mel,MD-217,Captured,SGPC-17,19.1,50.26,12,Small Gene Panel,,102,6/11/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0740,1133 Mel,MD-218,Captured,SGPC-17,47.4,49.89,12,Small Gene Panel,,103,6/11/2020,Madrid Melanoma; 100s shear time,Tumor,Melanoma Prognosis,BCB020
SGLP-0741,1252 DN,DN-130,Captured,SGPC-17,60.0,27.91,12,Small Gene Panel,,104,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0742,1254 DN,DN-132,Captured,SGPC-17,60.0,38.22,12,Small Gene Panel,,105,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0743,1256 DN,DN-134,Captured,SGPC-17,36.6,50.14,12,Small Gene Panel,,106,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0744,1257 DN,DN-135,Captured,SGPC-17,60.0,15.19,12,Small Gene Panel,,107,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0745,1258 DN,DN-136,Captured,SGPC-17,10.1,50.50,12,Small Gene Panel,,108,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0746,1259 DN,DN-137,Captured,SGPC-17,60.0,13.25,12,Small Gene Panel,,109,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0747,1260 DN,DN-138,Captured,SGPC-17,60.0,20.55,12,Small Gene Panel,,110,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0748,1261 DN,DN-139,Captured,SGPC-17,60.0,24.79,12,Small Gene Panel,,111,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0749,1262 DN,DN-140,Captured,SGPC-17,60.0,33.33,12,Small Gene Panel,,112,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0750,1263 DN,DN-141,Captured,SGPC-17,60.0,21.28,12,Small Gene Panel,,113,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0751,1264 DN,DN-142,Captured,SGPC-17,60.0,24.39,12,Small Gene Panel,,114,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0752,1266 DN,DN-144,Captured,SGPC-17,60.0,28.44,12,Small Gene Panel,,115,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0753,1267 DN,DN-145,Captured,SGPC-17,60.0,20.62,12,Small Gene Panel,,116,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0754,1268 DN,DN-146,Captured,SGPC-17,60.0,13.86,12,Small Gene Panel,,117,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0755,1269 DN,DN-147,Captured,SGPC-17,60.0,26.79,12,Small Gene Panel,,118,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0756,1270 DN,DN-148,Captured,SGPC-17,60.0,12.22,12,Small Gene Panel,,119,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0757,1273 DN,DN-151,Captured,SGPC-17,6.7,51.54,12,Small Gene Panel,,120,6/11/2020,,,Dysplastic Nevi,BCB020
SGLP-0758,1275 DN,DN-153,Captured,SGPC-17,40.1,50.13,12,Small Gene Panel,,5,,,,Dysplastic Nevi,BCB020
SGLP-0759,1279 DN,DN-157,Captured,SGPC-17,17.5,50.00,12,Small Gene Panel,,6,,,,Dysplastic Nevi,BCB020
SGLP-0760,1280 DN,DN-158,Captured,SGPC-17,41.0,50.00,12,Small Gene Panel,,15,,,,Dysplastic Nevi,BCB020
SGLP-0761,1281 DN,DN-159,Captured,SGPC-17,60.0,34.48,12,Small Gene Panel,,16,,,,Dysplastic Nevi,BCB020
SGLP-0762,1282 DN,DN-160,Captured,SGPC-17,60.0,23.26,12,Small Gene Panel,,17,,,,Dysplastic Nevi,BCB020
SGLP-0763,1283 DN,DN-161,Captured,SGPC-17,44.8,49.78,12,Small Gene Panel,,18,,,,Dysplastic Nevi,BCB020
SGLP-0764,1284 DN,DN-162,Captured,SGPC-17,19.5,50.00,12,Small Gene Panel,,19,,,,Dysplastic Nevi,BCB020
SGLP-0765,1246 Acral Melanoma Cells,MC-02,Captured,SGPC-17,60.0,4.91,12,Small Gene Panel,,20,6/18/2020,MK cell culture: 12.2019 batch,,Acral Melanoma Cell Lines,BCB020
SGLP-0766,1247 Acral Melanoma Cells,MC-03,Captured,SGPC-17,60.0,7.32,12,Small Gene Panel,,21,6/18/2020,MK cell culture: 12.2019 batch,,Acral Melanoma Cell Lines,BCB020
SGLP-0767,1248 Acral Melanoma Cells,AMC-07,Captured,SGPC-17,60.0,4.84,12,Small Gene Panel,,22,6/18/2020,,,Acral Melanoma Cell Lines,BCB020
SGLP-0768,878 DPN-mm,DPN-01,Captured,SGPC-17,56.2,51.09,12,Small Gene Panel,,23,6/18/2020,,,Deep Penetrating Melanoma,BCB020
SGLP-0769,879 DPN-mm,DPN-02,Captured,SGPC-17,60.0,12.00,12,Small Gene Panel,,27,6/18/2020,,,Deep Penetrating Melanoma,BCB020
SGLP-0770,882 DPN-mm,DPN-05,Captured,SGPC-17,55.1,50.09,12,Small Gene Panel,,28,6/18/2020,,,Deep Penetrating Melanoma,BCB020
SGLP-0771,911 DPN-mm,DPN-06,Captured,SGPC-17,38.0,47.50,12,Small Gene Panel,,29,6/18/2020,,,Deep Penetrating Melanoma,BCB020
SGLP-0772,1420 NEVUS,NL-022,Captured,SGPC-17,60.0,9.84,12,Small Gene Panel,,30,6/18/2020,,,Cafe au Lait,BCB020
SGLP-0773,1421 NEVUS,NL-022,Captured,SGPC-17,60.0,27.27,12,Small Gene Panel,,31,6/18/2020,,,Cafe au Lait,BCB020
SGLP-0774,1445 Nevus,SN-01,Captured,SGPC-18,40.5,50.00,12,Small Gene Panel,,97,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0775,1452 Nevus,SN-02,Captured,SGPC-18,51.0,50.00,12,Small Gene Panel,,98,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0776,1454 Nevus,SN-04,Captured,SGPC-18,60.0,34.88,12,Small Gene Panel,,99,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0777,1455 Nevus,SN-05,Captured,SGPC-18,56.0,50.00,12,Small Gene Panel,,100,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0778,1456 Nevus,SN-06,Captured,SGPC-18,60.0,26.20,12,Small Gene Panel,,101,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0779,1457 Nevus,SN-07,Captured,SGPC-18,160.0,24.81,12,Small Gene Panel,,102,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0780,1459 Nevus,SN-09,Captured,SGPC-18,26.5,50.00,12,Small Gene Panel,,103,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0781,1460 Nevus,SN-10,Captured,SGPC-18,60.0,29.70,12,Small Gene Panel,,104,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0782,1463 Nevus,SN-13,Captured,SGPC-18,60.0,24.00,12,Small Gene Panel,,105,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0783,1464 Nevus,SN-14,Captured,SGPC-18,130.0,25.24,12,Small Gene Panel,,106,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0784,1465 Nevus,SN-15,Captured,SGPC-18,90.0,25.50,12,Small Gene Panel,,107,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0785,1467 Nevus,SN-17,Captured,SGPC-18,115.0,25.05,12,Small Gene Panel,,108,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0786,1469 Nevus,SN-19,Captured,SGPC-18,59.0,50.00,12,Small Gene Panel,,109,11/18/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0787,1480 Nevus,SN-20,Captured,SGPC-18,60.0,35.71,12,Small Gene Panel,,110,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0788,1481 Nevus,SN-21,Captured,SGPC-18,140.0,24.56,12,Small Gene Panel,,111,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0789,1482 Nevus,SN-22,Captured,SGPC-18,75.0,24.83,12,Small Gene Panel,,112,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0790,1483 Nevus,SN-23,Captured,SGPC-18,85.0,24.71,12,Small Gene Panel,,113,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0791,1484 Nevus,SN-24,Captured,SGPC-18,60.0,41.38,12,Small Gene Panel,,114,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0792,1485 Nevus,SN-25,Captured,SGPC-18,42.5,50.00,12,Small Gene Panel,,115,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0793,1487 Nevus,SN-27,Captured,SGPC-18,180.0,23.94,12,Small Gene Panel,,116,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0794,1488 Nevus,SN-28,Captured,SGPC-18,120.0,24.74,12,Small Gene Panel,,117,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0795,1461 Nevus,SN-11,Captured,SGPC-18,60.0,34.09,12,Small Gene Panel,,118,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0796,1462 Nevus,SN-12,Captured,SGPC-18,60.0,32.43,12,Small Gene Panel,,119,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0797,1466 Nevus,SN-16,Captured,SGPC-18,55.5,50.00,12,Small Gene Panel,,120,11/25/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0798,2303 Tumor,SCH-01,Captured,SGPC-18,150.0,16.32,12,Small Gene Panel,,121,11/25/2020,Seattle Children's Hospital,,Seattle Children's Hospital -GENOMICS OF CUTANEOUS NEVI AND HEMANGIOMAS IN RING CHROMOSOME 7,BCB025
SGLP-0799,2303 Tumor,SCH-01,Captured,SGPC-18,300.0,5.26,12,Small Gene Panel,,122,12/2/2020,Seattle Children's Hospital,,Seattle Children's Hospital -GENOMICS OF CUTANEOUS NEVI AND HEMANGIOMAS IN RING CHROMOSOME 7,BCB025
SGLP-0800,1458 Nevus,SN-08,Captured,SGPC-18,57.0,50.00,12,Small Gene Panel,,123,12/5/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0801,1468 Nevus,SN-18,Captured,SGPC-18,18.0,50.00,12,Small Gene Panel,,124,12/5/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0802,1486 Nevus,SN-26,Captured,SGPC-18,65.0,50.00,12,Small Gene Panel,,125,12/5/2020,,Nevus,Sclerotic Nevi,BCB025
SGLP-0803,1455 Nevus,SN-05,Captured,SGPC-19,2.0,50.00,12,Small Gene Panel,,140,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",Nevus,Sclerotic Nevi,BCB032
SGLP-0804,1456 Nevus,SN-06,Captured,SGPC-19,6.0,50.00,12,Small Gene Panel,,141,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",Nevus,Sclerotic Nevi,BCB032
SGLP-0805,1462 Nevus,SN-12,Captured,SGPC-19,11.0,50.00,12,Small Gene Panel,,142,9/22/2021,"HyperPlus; Frag: 10min,37oC; NEBRepair, Ligation: 30min, 20oC.",Nevus,Sclerotic Nevi,BCB032
SGLP-0806,1865 Junctional,LN-01,Captured,SGPC-21,102.0,17.32,12,Small Gene Panel,,105,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0807,675 Junctional,LN-02,Captured,SGPC-21,102.0,22.08,12,Small Gene Panel,,106,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0808,676 Junctional,LN-03,Captured,SGPC-21,102.0,17.26,12,Small Gene Panel,,108,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0809,677 Junctional,LN-04,Captured,SGPC-21,102.0,20.99,12,Small Gene Panel,,109,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0810,678 Junctional,LN-05,Captured,SGPC-21,102.0,27.35,12,Small Gene Panel,,110,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0811,679 Junctional,LN-06,Captured,SGPC-21,102.0,19.47,12,Small Gene Panel,,111,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0812,680 Junctional,LN-07,Captured,SGPC-21,102.0,20.48,12,Small Gene Panel,,112,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0813,681 Junctional,LN-08,Captured,SGPC-21,102.0,17.65,12,Small Gene Panel,,113,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0814,682 Junctional,LN-09,Captured,SGPC-21,102.0,11.70,12,Small Gene Panel,,114,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0815,1866 Junctional,LN-10,Captured,SGPC-21,102.0,22.42,12,Small Gene Panel,,115,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0816,1867 Compound,LN-11,Captured,SGPC-21,102.0,16.83,12,Small Gene Panel,,116,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0817,1868 Compound,LN-12,Captured,SGPC-21,102.0,22.42,12,Small Gene Panel,,117,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0818,1869 Compound,LN-13,Captured,SGPC-21,102.0,29.65,12,Small Gene Panel,,118,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0819,683 Compound,LN-14,Captured,SGPC-21,102.0,18.82,12,Small Gene Panel,,119,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0820,1870 Compound,LN-15,Captured,SGPC-21,102.0,21.61,12,Small Gene Panel,,120,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0821,1871 Compound,LN-16,Captured,SGPC-21,102.0,17.59,12,Small Gene Panel,,121,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0822,1872 Compound,LN-17,Captured,SGPC-21,102.0,9.08,12,Small Gene Panel,,122,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0823,684 Compound,LN-18,Captured,SGPC-21,102.0,15.60,12,Small Gene Panel,,123,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0824,1873 Compound,LN-19,Captured,SGPC-21,102.0,12.86,12,Small Gene Panel,,124,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0825,685 Compound,LN-20,Captured,SGPC-21,102.0,9.56,12,Small Gene Panel,,125,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0826,1874 Compound,LN-21,Captured,SGPC-21,102.0,10.19,12,Small Gene Panel,,126,11/2/2021,"HyperPREP; Ligation: 20min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0827,1875 Compound Melanocytic Nevus,LN-069,Captured,SGPC-21,19.0,50.00,12,Small Gene Panel,,173,2/8/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0828,1876 Nevus,LN-069,Captured,SGPC-21,6.0,50.00,12,Small Gene Panel,,174,2/8/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0829,1877 Lentigo Simplex,LN-070,Captured,SGPC-21,29.5,50.00,12,Small Gene Panel,,175,2/8/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0830,1878 Junctional Melanocytic Nevus,LN-070,Captured,SGPC-21,22.0,50.00,12,Small Gene Panel,,176,2/8/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0831,1879 Lentigo Simplex,LN-071,Captured,SGPC-21,27.5,50.00,12,Small Gene Panel,,177,2/8/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0832,1880 Junctional Melanocytic Nevus,LN-071,Captured,SGPC-21,43.0,50.00,12,Small Gene Panel,,178,2/8/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0833,1881 Nevus,LN-072,Captured,SGPC-21,32.5,50.00,12,Small Gene Panel,,179,2/8/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0834,1882 Lentigo Simplex,LN-073,Captured,SGPC-21,27.0,50.00,12,Small Gene Panel,,180,2/8/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0835,1883 Nevus,LN-073,Captured,SGPC-21,102.0,24.58,12,Small Gene Panel,,127,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0836,1884 Mel,LN-073,Captured,SGPC-21,102.0,34.00,12,Small Gene Panel,,128,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0837,1885 Nevus,LN-074,Captured,SGPC-21,102.0,18.78,12,Small Gene Panel,,129,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0838,1886 Nevus,LN-075,Captured,SGPC-21,102.0,10.71,12,Small Gene Panel,,130,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0839,1888 Nevus,LN-077,Captured,SGPC-21,42.5,50.00,12,Small Gene Panel,,131,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0840,1889 Mel,LN-077,Captured,SGPC-21,102.0,19.88,12,Small Gene Panel,,132,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0841,1890 Lentigo Simplex,LN-078,Captured,SGPC-21,102.0,24.82,12,Small Gene Panel,,133,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0842,1891 Seborrheic Keratosis,LN-078,Captured,SGPC-21,102.0,42.86,12,Small Gene Panel,,134,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0843,1892 Lentigo Simplex,LN-079,Captured,SGPC-21,102.0,29.91,12,Small Gene Panel,,135,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0844,1894 Nevus,LN-080,Captured,SGPC-21,102.0,38.78,12,Small Gene Panel,,136,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0845,1895 Lentigo Simplex,LN-081,Captured,SGPC-21,37.0,50.00,12,Small Gene Panel,,137,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0846,1896 Nevus,LN-081,Captured,SGPC-21,84.0,50.00,12,Small Gene Panel,,138,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0847,1897 Nevus,LN-081,Captured,SGPC-21,32.5,50.00,12,Small Gene Panel,,139,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0848,1898 Lentigo Simplex,LN-082,Captured,SGPC-21,17.5,50.00,12,Small Gene Panel,,140,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0849,1899 Nevus,LN-082,Captured,SGPC-21,37.5,50.00,12,Small Gene Panel,,141,2/24/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0850,1900 Nevus,LN-083,Captured,SGPC-21,102.0,24.82,12,Small Gene Panel,,142,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0851,1905 Lentigo Simplex,LN-084,Captured,SGPC-21,102.0,15.04,12,Small Gene Panel,,143,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0852,1906 Junctional Nevus,LN-084,Captured,SGPC-21,102.0,8.89,12,Small Gene Panel,,144,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0853,1911 Nevus,LN-085,Captured,SGPC-21,102.0,38.64,12,Small Gene Panel,,145,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0854,1912 Nevus,LN-085,Captured,SGPC-21,102.0,13.28,12,Small Gene Panel,,146,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0855,1913 Lentigo Simplex,LN-085,Captured,SGPC-21,102.0,35.54,12,Small Gene Panel,,147,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0856,1914 Lentigo Simplex,LN-085,Captured,SGPC-21,102.0,16.06,12,Small Gene Panel,,148,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0857,1901 Lentigo Simplex,LN-086,Captured,SGPC-21,102.0,13.23,12,Small Gene Panel,,149,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0858,1902 Nevus,LN-086,Captured,SGPC-21,102.0,13.58,12,Small Gene Panel,,150,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0859,1907 Lentigo Simplex,LN-087,Captured,SGPC-21,102.0,11.46,12,Small Gene Panel,,151,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0860,1908 Junctional Nevus,LN-087,Captured,SGPC-21,102.0,13.32,12,Small Gene Panel,,152,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0861,1903 Lentigo Simplex,LN-088,Captured,SGPC-21,102.0,10.94,12,Small Gene Panel,,153,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0862,1904 Nevus,LN-088,Captured,SGPC-21,102.0,12.93,12,Small Gene Panel,,154,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0863,1909 Compound Melanocytic Nevus,LN-076,Captured,SGPC-21,102.0,14.09,12,Small Gene Panel,,155,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
SGLP-0864,1910 Compound Melanocytic Nevus,LN-076,Captured,SGPC-21,102.0,12.98,12,Small Gene Panel,,156,3/7/2022,"HyperPREP; Ligation: 30min, 20oC.",Tumor,Lentiginous Nevi,BCB039
Sk-Mel-23,2759 Cell Line,,Captured,,,NaN,,NimV1,L2DR01,,,,Mel,"Melanocyte Cell Line,CGH Project",RNAaccess3_BB78
SKMEL5-1,2845 Cell Line,,Captured,SKMEL_CL,,NaN,,,,,,,Mel,"Melanocyte Cell Line,CGH Project",Acral melanoma lines_mRNA_Seq_AL1806051_R1
SKMEL5-2,2846 Cell Line,,Captured,SKMEL_CL,,NaN,,,,,,,Mel,"Melanocyte Cell Line,CGH Project",Acral melanoma lines_mRNA_Seq_AL1806051_R1
SKMEL5-3,2847 Cell Line,,Captured,SKMEL_CL,,NaN,,,,,,,Mel,"Melanocyte Cell Line,CGH Project",Acral melanoma lines_mRNA_Seq_AL1806051_R1
SKMEL28-1,2842 Cell Line,,Captured,SKMEL_CL,,NaN,,,,,,,Mel,"Melanocyte Cell Line,CGH Project",Acral melanoma lines_mRNA_Seq_AL1806051_R1
SKMEL28-2,2843 Cell Line,,Captured,SKMEL_CL,,NaN,,,,,,,Mel,"Melanocyte Cell Line,CGH Project",Acral melanoma lines_mRNA_Seq_AL1806051_R1
SKMEL28-3,2844 Cell Line,,Captured,SKMEL_CL,,NaN,,,,,,,Mel,"Melanocyte Cell Line,CGH Project",Acral melanoma lines_mRNA_Seq_AL1806051_R1
SM_1_Tumor,2779 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR01,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_2_Normal,2780 Normal,,Captured,BB23_CL,,NaN,,NimV2,L2DR02,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_2_Tumor,2781 Tumor,,Captured,BB23_CL,,NaN,,NimV2,L2DR01,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_3_Tumor,2782 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR02,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_4_Normal,2783 Normal,,Captured,BB20_CL,,NaN,,NimV2,L2DR04,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_4_Tumor,2784 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR03,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_5_Normal,2785 Normal,,Captured,BB20_CL,,NaN,,NimV2,L2DR06,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_5_Tumor,2786 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR05,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_6_Tumor,2787 Tumor,,Captured,BB23_CL,,NaN,,NimV2,L2DR03,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_7_Normal,2788 Normal,,Captured,BB23_CL,,NaN,,NimV2,L2DR05,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_7_Tumor,2789 Tumor,,Captured,BB23_CL,,NaN,,NimV2,L2DR04,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_8_Normal,2790 Normal,,Captured,BB23_CL,,NaN,,NimV2,L2DR07,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_8_Tumor,2791 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR08,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,"Nimblegen17_BB20,Nimblegen19_BB23"
SM_9_Normal,2793 Normal,,Captured,BB23_CL,,NaN,,NimV2,L2DR09,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_9_Tumor,2794 Tumor,,Captured,BB23_CL,,NaN,,NimV2,L2DR08,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_10_Tumor,2795 Tumor,,Captured,BB23_CL,,NaN,,NimV2,L2DR10,,,Spitzoid Melanoma,Tumor,Spitzoid Melanoma,Nimblegen19_BB23
SM_11_Tumor,2796 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR09,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_12_Tumor,2797 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR10,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_16_Normal,2798 Normal,,Captured,BB20_CL,,NaN,,NimV2,L2DR13,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_16_Tumor,2799 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR11,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
SM_18_Tumor,2800 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR12,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,"Nimblegen17_BB20,Nimblegen19_BB23"
SM7_Tumor,2802 Tumor,,Captured,BB20_CL,,NaN,,NimV2,L2DR07,,,Spitzoid Melanoma Maria,Tumor,Spitzoid Melanoma,Nimblegen17_BB20
T12_562,2405 Unknown,,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-10,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_6261A,2400 Melanocytic Nevus,,Captured,BB2_CL,62.5,6.10,16,SureSelect Human All Exon V4,NF-96-1,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_6261B,2401 Melanocytic Nevus,,Captured,BB2_CL,62.5,14.88,16,SureSelect Human All Exon V4,NF-96-2,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_12366,2402 SCC,,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-3,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_12467,2403 Melanocytic Nevus,,Captured,BB2_CL,50.0,2.50,16,SureSelect Human All Exon V4,NF-96-4,,5/14/2012,Hybridization Input DNA Manipulation,Tumor,2010-2017,HiSeq1_BB2
T12_12470D,2404 BCC,,Captured,BB2_CL,62.5,6.51,16,SureSelect Human All Exon V4,NF-96-8,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_12626,2407 Cellular Dermatofibroma,,Captured,BB2_CL,25.0,1.25,16,SureSelect Human All Exon V4,NF-96-13,,5/14/2012,Hybridization Input DNA Manipulation,Tumor,2010-2017,HiSeq1_BB2
T12_12647,2406 Melanocytic Nevus,,Captured,BB2_CL,62.5,9.47,16,SureSelect Human All Exon V4,NF-96-12,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_12750B,2411 SCC,,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-18,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_13152_Tumor,2410 Melanocytic Nevus,,Captured,BB2_CL,15.0,1.35,16,SureSelect Human All Exon V4,NF-96-17,,5/14/2012,Hybridization Input DNA Manipulation,Tumor,2010-2017,HiSeq1_BB2
T12_13587_B2,2408 SCC,,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-14,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_13587_B2_0_5ug,2422 SCC,,Captured,BB2_CL,62.5,6.25,16,SureSelect Human All Exon V4,NF-96-30,,5/14/2012,"Diluted Input Library DNA, Samples 44-46 were dilutions made from sample 23 to test how the same template with varying input concentrations under the required 1 ug input effects sequencing.",Tumor,2010-2017,HiSeq1_BB2
T12_13587_B2_0_25ug,2423 SCC,,Captured,BB2_CL,62.5,12.50,16,SureSelect Human All Exon V4,NF-96-31,,5/14/2012,"Diluted Input Library DNA, Samples 44-46 were dilutions made from sample 23 to test how the same template with varying input concentrations under the required 1 ug input effects sequencing.",Tumor,2010-2017,HiSeq1_BB2
T12_13587_B2_0_75ug,2421 SCC,,Captured,BB2_CL,62.5,4.17,16,SureSelect Human All Exon V4,NF-96-29,,5/14/2012,"Diluted Input Library DNA, Samples 44-46 were dilutions made from sample 23 to test how the same template with varying input concentrations under the required 1 ug input effects sequencing.",Tumor,2010-2017,HiSeq1_BB2
T12_18438A,"2409 SCC, in situ",,Captured,BB2_CL,62.5,7.81,16,SureSelect Human All Exon V4,NF-96-15,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_19596,"2412 SCC, in situ",,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-19,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
T12_21726A_Tumor,2416 Dermatofibroma,,Captured,BB2_CL,62.5,19.90,16,SureSelect Human All Exon V4,NF-96-24,,5/14/2012,None; Dermatofibroma,Tumor,2010-2017,HiSeq1_BB2
T12_22172_Norm,2414 Normal,,Captured,BB2_CL,62.5,8.42,16,SureSelect Human All Exon V4,NF-96-22,,," Normal Tumor Pair; Bowen's Disease,Left lateral back; SCC, in situ",Normal,"2010-2017,Bowen's Disease",HiSeq1_BB2
T12_22172_Tumor,"2415 SCC, in situ",,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-23,,5/14/2012,"Normal Tumor Pair; Bowen's Disease,Left lateral back; SCC, in situ",Tumor,"2010-2017,Bowen's Disease",HiSeq1_BB2
T12_22573,2426 Melanocytic Nevus,,Captured,BB3_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-34,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22582A,2427 Melanocytic Nevus,,Captured,BB3_CL,62.5,7.04,16,SureSelect Human All Exon V4,NF-96-36,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22587,2428 Melanocytic Nevus,,Captured,BB3_CL,62.5,4.04,16,SureSelect Human All Exon V4,NF-96-40,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22592,2429 Keratosis,,Captured,BB3_CL,62.5,4.66,16,SureSelect Human All Exon V4,NF-96-41,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22597_100ng,2430 BCC,,Captured,BB3_CL,62.5,31.25,16,SureSelect Human All Exon V4,NF-96-61,,6/8/2012,Samples 73-76 were dilutions made from sample 58 to test how the same template with varying input concentrations ( under the required 1 ug input) effects sequencing.,Tumor,2010-2017,HiSeq2_BB3
T12_22597_250ng,2430 BCC,,Captured,BB3_CL,62.5,12.50,16,SureSelect Human All Exon V4,NF-96-60,,6/8/2012,Samples 73-76 were dilutions made from sample 58 to test how the same template with varying input concentrations ( under the required 1 ug input) effects sequencing.,Tumor,2010-2017,HiSeq2_BB3
T12_22597_500ng,2430 BCC,,Captured,BB3_CL,62.5,6.25,16,SureSelect Human All Exon V4,NF-96-59,,6/8/2012,Samples 73-76 were dilutions made from sample 58 to test how the same template with varying input concentrations ( under the required 1 ug input) effects sequencing.,Tumor,2010-2017,HiSeq2_BB3
T12_22597_700ng,2430 BCC,,Captured,BB3_CL,62.5,4.46,16,SureSelect Human All Exon V4,NF-96-58,,6/8/2012,Samples 73-76 were dilutions made from sample 58 to test how the same template with varying input concentrations ( under the required 1 ug input) effects sequencing.,Tumor,2010-2017,HiSeq2_BB3
T12_22597_1000ng,2430 BCC,,Captured,BB3_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-43,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22602A,2431 Melanocytic Nevus,,Captured,BB3_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-44,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22602B,2432 Melanocytic Nevus,,Captured,BB3_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-45,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22603,"2433 Pilomatricoma, cystic",,Captured,BB3_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-46,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22604,2434 BCC,,Captured,BB3_CL,62.5,11.24,16,SureSelect Human All Exon V4,NF-96-47,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22720A1,2435 Leiomyoma,,Captured,BB3_CL,62.5,8.45,16,SureSelect Human All Exon V4,NF-96-49,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22868,2436 Melanocytic Nevus,,Captured,BB3_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-50,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22884C,2437 Melanocytic Nevus,,Captured,BB3_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-51,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22884D,2438 Melanocytic Nevus,,Captured,BB3_CL,62.5,15.02,16,SureSelect Human All Exon V4,NF-96-52,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22886,2439 Melanocytic Nevus,,Captured,BB3_CL,,0.00,16,SureSelect Human All Exon V4,NF-96-53,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22894B,2440 Melanocytic Nevus,,Captured,BB3_CL,62.5,10.31,16,SureSelect Human All Exon V4,NF-96-55,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22898,2441 Melanocytic Nevus,,Captured,BB3_CL,62.5,3.19,16,SureSelect Human All Exon V4,NF-96-56,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22900,2442 SCC,,Captured,BB3_CL,62.5,5.17,16,SureSelect Human All Exon V4,NF-96-57,,6/8/2012,,Tumor,2010-2017,HiSeq2_BB3
T12_22901A_Norm,2417 Normal,,Captured,BB2_CL,62.5,6.29,16,SureSelect Human All Exon V4,NF-96-25,,5/14/2012,"Normal Tumor Pair; Melanocytic Nevus; Intradermal, forehead; PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)",Normal,2010-2017,HiSeq1_BB2
T12_22901A_Tumor,2418 Tumor,,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-26,,5/14/2012,"Normal Tumor Pair; Melanocytic Nevus; Intradermal, forehead; PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)
",Tumor,2010-2017,HiSeq1_BB2
T12-19187A,2413 Dermatofibroma,,Captured,BB2_CL,62.5,3.13,16,SureSelect Human All Exon V4,NF-96-20,,5/14/2012,None,Tumor,2010-2017,HiSeq1_BB2
TCR-Beta-1,3836 Tumor,,Captured,BB74_CL,,NaN,,,NextFlex 23,,,,,2010-2017,Kapa3_BB74
TCR-Beta-2,3837 Tumor,,Captured,BB74_CL,,NaN,,,NextFlex 24,,,,,2010-2017,Kapa3_BB74
Thomas_SK_MEL_23,3434 Cell Line,,Captured,,,NaN,13,NimV2,L2DR01,,,SKMEL23(Cell Line),Tumor,2010-2017,Nimblegen31_BB36
U5LP-01,2251 Tumor,MP-01,Captured,UCSF500-01,90.0,88.24,,NimV4,,1,7/2/2019,,Tumor,Hockemeyer Melanoma Project,BCB009
U5LP-02,2252 Tumor,MP-02,Captured,UCSF500-01,90.0,33.33,,NimV4,,3,7/2/2019,,Tumor,Hockemeyer Melanoma Project,BCB009
U5LP-03,2257 Tumor,MP-03,Captured,UCSF500-01,90.0,41.47,,NimV4,,8,7/2/2019,,Tumor,Hockemeyer Melanoma Project,BCB009
U5LP-04,2254 Tumor,MP-04,Captured,UCSF500-01,90.0,74.38,,NimV4,,9,7/11/2019,,Tumor,Hockemeyer Melanoma Project,BCB009
U5LP-05,2255 Tumor,MP-01,Captured,UCSF500-01,90.0,150.00,,NimV4,,10,7/11/2019,,Tumor,Hockemeyer Melanoma Project,BCB009
U5LP-06,2256 Tumor,MP-02,Captured,UCSF500-01,90.0,85.71,,NimV4,,12,7/2/2019,,Tumor,Hockemeyer Melanoma Project,BCB009
U5LP-08,2258 Tumor,MP-04,Captured,UCSF500-01,69.0,150.00,,NimV4,,42,7/16/2019,,Tumor,Hockemeyer Melanoma Project,BCB009
U5LP-09,2259 Normal,MP-01,Captured,UCSF500-01,60.0,36.14,,NimV4,,43,7/2/2019,,Normal,Hockemeyer Melanoma Project,BCB009
U5LP-10,2260 Normal,MP-02,Captured,UCSF500-01,60.0,36.14,,NimV4,,44,7/2/2019,,Normal,Hockemeyer Melanoma Project,BCB009
U5LP-11,2261 Normal,MP-03,Captured,UCSF500-01,60.0,47.24,,NimV4,,45,7/2/2019,,Normal,Hockemeyer Melanoma Project,BCB009
U5LP-12,2262 Normal,MP-04,Captured,UCSF500-01,60.0,45.11,,NimV4,,46,7/2/2019,,Normal,Hockemeyer Melanoma Project,BCB009
U5LP-13,2253 Tumor,MP-03,Captured,UCSF500-01,4.5,90.00,,NimV4,,49,7/2/2019,,Tumor,Hockemeyer Melanoma Project,BCB009
UM_1,2760 Uveal Mel,,Captured,,,NaN,,NimV2,,,,"Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul",Tumor,Uveal Melanoma,Nimblegen38_BB45
UM_2,2761 Uveal Mel,,Captured,,,NaN,,NimV2,,,,"Tert 1, Tert 2, and Tert 3 spike-in at 10pg/ul; SF3B1 1 and SF3B1 2 spike-in at 4pg/ul; NFKBIE spike-in at 10pg/ul",Tumor,Uveal Melanoma,Nimblegen38_BB45
UM23,3838 Uveal Mel,,Captured,BB74_CL,,NaN,,,NextFlex 19,,,,Mel,Uveal Melanoma,Kapa3_BB74
UM24,3839 Uveal Mel,,Captured,BB74_CL,,NaN,,,NextFlex 20,,,,Mel,Uveal Melanoma,Kapa3_BB74
UM25,3840 Uveal Mel,,Captured,BB74_CL,,NaN,,,NextFlex 21,,,,Mel,Uveal Melanoma,Kapa3_BB74
UM26,3841 Uveal Mel,,Captured,BB74_CL,,NaN,,,NextFlex 22,,,,Mel,Uveal Melanoma,Kapa3_BB74
UM38-Normal,2694 Normal,,Captured,BB86_CL,,NaN,,,,,,,Normal,Uveal Melanoma,Kapa13_BB86
UM38-Tumor,2695 Tumor,,Captured,BB86_CL,,NaN,,,,,,,Tumor,Uveal Melanoma,Kapa13_BB86
VMRLP-41,1310 Mel,ME-24,Captured,CAPTURE 01,333.0,10.12,13, SeqCap EZ MedExome,,65,11/5/2018,RLP-41,Mel,Melanoma Epigenetics,BCB003
VMRLP-42,788 Nevus,ME-24,Captured,CAPTURE 01,333.0,18.19,13, SeqCap EZ MedExome,,66,11/5/2018,RLP-42,Nevus,Melanoma Epigenetics,BCB003
VMRLP-43,794 Mel,ME-18,Captured,CAPTURE 01,333.0,12.62,13, SeqCap EZ MedExome,,67,11/5/2018,RLP-43,Mel,Melanoma Epigenetics,BCB003
VMRLP-44,773 Nevus,ME-18,Captured,CAPTURE 02,333.0,15.43,13, SeqCap EZ MedExome,,68,11/5/2018,RLP-44,Nevus,Melanoma Epigenetics,BCB003
VMRLP-45,774 Mel,ME-19,Captured,CAPTURE 02,333.0,17.89,13, SeqCap EZ MedExome,,69,11/5/2018,RLP-45,Mel,Melanoma Epigenetics,BCB003
VMRLP-46,775 Nevus,ME-19,Captured,CAPTURE 02,333.0,20.15,13, SeqCap EZ MedExome,,70,11/5/2018,RLP-46,Nevus,Melanoma Epigenetics,BCB003
VMRLP-47,795 Mel,ME-27,Captured,CAPTURE 03,333.0,29.01,13, SeqCap EZ MedExome,,71,11/5/2018,RLP-47,Mel,Melanoma Epigenetics,BCB003
VMRLP-48,796 Nevus,ME-27,Captured,CAPTURE 03,333.0,18.49,13, SeqCap EZ MedExome,,72,11/5/2018,RLP-48,Nevus,Melanoma Epigenetics,BCB003
VMRLP-49,776 Mel,ME-20,Captured,CAPTURE 03,333.0,6.98,13, SeqCap EZ MedExome,,73,11/5/2018,RLP-49,Mel,Melanoma Epigenetics,BCB003
VMRLP-50,777 Nevus,ME-20,Captured,CAPTURE 04,333.0,36.80,13, SeqCap EZ MedExome,,74,11/5/2018,RLP-50,Nevus,Melanoma Epigenetics,BCB003
VMRLP-51,791 Mel,ME-25,Captured,CAPTURE 04,333.0,10.96,13, SeqCap EZ MedExome,,75,11/5/2018,RLP-51,Mel,Melanoma Epigenetics,BCB003
VMRLP-52,789 Nevus,ME-25,Captured,CAPTURE 04,333.0,8.34,13, SeqCap EZ MedExome,,76,11/5/2018,RLP-52,Nevus,Melanoma Epigenetics,BCB003
VMRLP-53,794 Mel,ME-26,Captured,CAPTURE 05,333.0,6.08,13, SeqCap EZ MedExome,,77,11/5/2018,RLP-53,Mel,Melanoma Epigenetics,BCB003
VMRLP-54,793 Nevus,ME-26,Captured,CAPTURE 05,333.0,9.83,13, SeqCap EZ MedExome,,78,11/5/2018,RLP-54,Nevus,Melanoma Epigenetics,BCB003
VMRLP-55,779 Mel,ME-21,Captured,CAPTURE 05,333.0,8.39,13, SeqCap EZ MedExome,,79,11/5/2018,"RLP-55, Sample removed from study",Mel,Melanoma Epigenetics,BCB003
VMRLP-56,780 Nevus,ME-21,Captured,CAPTURE 06,333.0,10.22,13, SeqCap EZ MedExome,,80,11/5/2018,"RLP-56, Sample removed from study",Nevus,Melanoma Epigenetics,BCB003
VMRLP-59,805 Mel,ME-11,Captured,CAPTURE 06,333.0,23.04,13, SeqCap EZ MedExome,,83,11/5/2018,RLP-59,Mel,Melanoma Epigenetics,BCB003
VMRLP-60,803 Nevus,ME-11,Captured,CAPTURE 06,333.0,31.30,13, SeqCap EZ MedExome,,84,11/5/2018,RLP-60,Nevus,Melanoma Epigenetics,BCB003
VMRLP-61,781 Mel,ME-22,Captured,CAPTURE 07,333.0,6.43,13, SeqCap EZ MedExome,,85,11/5/2018,RLP-61,Mel,Melanoma Epigenetics,BCB003
VMRLP-62,782 Nevus,ME-22,Captured,CAPTURE 07,333.0,11.63,13, SeqCap EZ MedExome,,86,11/5/2018,RLP-62,Nevus,Melanoma Epigenetics,BCB003
VMRLP-63,802 Mel,ME-28,Captured,CAPTURE 07,333.0,10.29,13, SeqCap EZ MedExome,,87,11/5/2018,RLP-63,Mel,Melanoma Epigenetics,BCB003
VMRLP-101,896 Mel,P_MEL202,Captured,KAPAEX-06,333.0,4.61,12,SeqCap EZ Prime Exome,,9,8/7/2019,cell culture,Mel,Melanoma Epigenetics,BCB015
VMRLP-102,897 Mel,P_MEL202,Captured,KAPAEX-06,333.0,4.47,12,SeqCap EZ Prime Exome,,10,8/7/2019,cell culture,Mel,Melanoma Epigenetics,BCB015
VMRLP-103,898 Mel,P_MEL202,Captured,KAPAEX-06,333.0,4.94,12,SeqCap EZ Prime Exome,,11,8/7/2019,cell culture,Mel,Melanoma Epigenetics,BCB015
VMRLP-104,899 Mel,P_MEL202,Captured,KAPAEX-07,333.0,5.22,12,SeqCap EZ Prime Exome,,12,8/7/2019,cell culture,Mel,Melanoma Epigenetics,BCB015
VMRLP-105,900 Mel,P_MEL202,Captured,KAPAEX-07,333.0,5.13,12,SeqCap EZ Prime Exome,,13,8/7/2019,cell culture,Mel,Melanoma Epigenetics,BCB015
VMRLP-106,901 Mel,P_MEL202,Captured,KAPAEX-07,333.0,4.98,12,SeqCap EZ Prime Exome,,14,8/7/2019,cell culture,Mel,Melanoma Epigenetics,BCB015
VS-01,2154 Capture Area A1,VS-01,Captured,10X_01,7.0,2.95,,Visium Human Transcriptome Probe Set v1.0,,SI-TS-A1,7/21/2022,SI-TS-A1,,Visium Spatial Gene Expression,IYEH001
VS-02,2155 Capture Area B1,VS-02,Captured,10X_01,6.9,3.51,,Visium Human Transcriptome Probe Set v1.0,,SI-TS-A2,7/21/2022,SI-TS-A2,,Visium Spatial Gene Expression,IYEH001
VS-03,2156 Capture Area C1,VS-03,Captured,10X_01,6.7,2.50,,Visium Human Transcriptome Probe Set v1.0,,SI-TS-A3,7/21/2022,SI-TS-A3,,Visium Spatial Gene Expression,IYEH001
VS-04,2157 Capture Area D1,VS-04_JJS22,Captured,10X_01,7.0,2.74,,Visium Human Transcriptome Probe Set v1.0,,SI-TS-A4,7/21/2022,SI-TS-A4,,Visium Spatial Gene Expression,IYEH001
VS-05,2684 Capture Area A1,VS-05,Captured,10X_02,3.5,4.81,,Visium Human Transcriptome Probe Set v1.0,,SI-TS-A5,10/6/2023,LOT #: 164486,,Visium Spatial Gene Expression,IYEH002
VS-06,2685 Capture Area B1,VS-06,Captured,10X_02,3.5,2.83,,Visium Human Transcriptome Probe Set v1.0,,SI-TS-A6,10/6/2023,LOT #: 164486,,Visium Spatial Gene Expression,IYEH002
VS-07,2686 Capture Area C1,VS-07,Captured,10X_02,3.5,6.11,,Visium Human Transcriptome Probe Set v1.0,,SI-TS-A7,10/6/2023,LOT #: 164486,,Visium Spatial Gene Expression,IYEH002
VS-08,2687 Capture Area D1,VS-08,Captured,10X_02,3.5,5.00,,Visium Human Transcriptome Probe Set v1.0,,SI-TS-A8,10/6/2023,LOT #: 164486,,Visium Spatial Gene Expression,IYEH002
WM8,2836 Acral Melanoma Cells,,Captured,BB14_CL,,NaN,,NimV2,L2DR15,,3/25/2013,"Wistar, Fusion Project, Cell Line DNA",Tumor,"Wistar Fusion Project,Acral Melanoma Cell Lines",Nimblegen11_BB14
WM51,2837 Acral Melanoma Cells,,Captured,BB12_CL,,NaN,,NimV1,L2DR15,,3/25/2013,,Tumor,"Wistar Fusion Project,Acral Melanoma Cell Lines",Nimblegen9_BB12
WM1963,2838 Acral Melanoma Cells,,Captured,BB14_CL,,NaN,,NimV2,L2DR14,,3/25/2013,"Wistar, Fusion Project, Cell Line DNA",Tumor,"Wistar Fusion Project,Acral Melanoma Cell Lines",Nimblegen11_BB14
WM3622,2839 Acral Melanoma Cells,,Captured,BB14_CL,,NaN,,NimV2,L2DR12,,3/25/2013,"Wistar, Fusion Project, Cell Line DNA",Tumor,"Wistar Fusion Project,Acral Melanoma Cell Lines",Nimblegen11_BB14
WM3912,2840 Acral Melanoma Cells,,Captured,BB14_CL,,NaN,,NimV2,L2DR16,,3/25/2013,"Wistar, Fusion Project, Cell Line DNA",Tumor,"Wistar Fusion Project,Acral Melanoma Cell Lines",Nimblegen11_BB14
WM3918,2841 Acral Melanoma Cells,,Captured,BB12_CL,,NaN,,NimV1,L2DR16,,3/25/2013,,Tumor,"Wistar Fusion Project,Acral Melanoma Cell Lines",Nimblegen9_BB12
WP_11,3435 Tumor,,Captured,BB4_CL,,NaN,,NimV1,L2DR01,,,Iwei Autopsy,Tumor,2010-2017,Nimblegen1_BB004
WP_23,3436 Tumor,,Captured,BB4_CL,,NaN,,NimV1,L2DR02,,,Iwei Autopsy,Tumor,2010-2017,Nimblegen1_BB004
WP_29,3437 Tumor,,Captured,BB4_CL,,NaN,,NimV1,L2DR03,,,Iwei Autopsy,Tumor,2010-2017,Nimblegen1_BB004
WTMM-17-Tumor,2805 Tumor,,Captured,BB67_CL,,NaN,13,NimV2mix3,NextFlex 10,,,UCSF Wild Type Melanoma,Tumor,Wild Type Melanoma,BioSci15_BB67
WTMM-18-Tumor,2806 Tumor,,Captured,BB67_CL,,NaN,13,NimV2mix3,NextFlex 11,,,UCSF Wild Type Melanoma,Tumor,Wild Type Melanoma,BioSci15_BB67
WTMM-19-Tumor,2807 Tumor,,Captured,BB67_CL,,NaN,13,NimV2mix3,NextFlex 12,,,UCSF Wild Type Melanoma,Tumor,Wild Type Melanoma,BioSci15_BB67
WTMM-20-Tumor,2808 Tumor,,Captured,BB67_CL,,NaN,13,NimV2mix3,NextFlex 13,,,UCSF Wild Type Melanoma,Tumor,Wild Type Melanoma,BioSci15_BB67
WTMM-21-Tumor,2809 Tumor,,Captured,BB67_CL,,NaN,13,NimV2mix3,NextFlex 14,,,UCSF Wild Type Melanoma,Tumor,Wild Type Melanoma,BioSci15_BB67
WTMM-22-Tumor,2810 Tumor,,Captured,BB67_CL,,NaN,13,NimV2mix3,NextFlex 15,,,UCSF Wild Type Melanoma,Tumor,Wild Type Melanoma,BioSci15_BB67
WTMM-23-Tumor,2811 Tumor,,Captured,BB67_CL,,NaN,13,NimV2mix3,NextFlex 16,,,UCSF Wild Type Melanoma,Tumor,Wild Type Melanoma,BioSci15_BB67
WTMM-24-Tumor,2812 Tumor,,Captured,BB67_CL,,NaN,13,NimV2mix3,NextFlex 17,,,UCSF Wild Type Melanoma,Tumor,Wild Type Melanoma,BioSci15_BB67
XD-1-1-Tumor,3302 Tumor,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 11,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",Tumor,2010-2017,Kapa2_BB73
XD-1-Tumor,3301 Tumor,,Captured,BB73_CL,50.0,Infinity,14,NimV2,NextFlex 10,,8/14/2014,"Spike-in Bait Mix 3: TERT1, TERT2, TERT3, SF3B1,SF3B2, NFKBIE",Tumor,2010-2017,Kapa2_BB73
XuRLP-001,2336 Cell Line,,Captured,XuCL-1,250.0,5.41,13, SeqCap EZ MedExome,,18,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-002,2337 Cell Line,,Captured,XuCL-1,250.0,5.85,13, SeqCap EZ MedExome,,19,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-003,2338 Cell Line,,Captured,XuCL-1,250.0,6.17,13, SeqCap EZ MedExome,,20,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-004,2339 Cell Line,,Captured,XuCL-1,250.0,6.25,13, SeqCap EZ MedExome,,21,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-005,2340 Cell Line,,Captured,XuCL-2,250.0,5.71,13, SeqCap EZ MedExome,,22,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-006,2341 Cell Line,,Captured,XuCL-2,250.0,5.68,13, SeqCap EZ MedExome,,23,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-007,2342 Cell Line,,Captured,XuCL-2,250.0,5.71,13, SeqCap EZ MedExome,,24,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-008,2343 Cell Line,,Captured,XuCL-2,250.0,8.01,13, SeqCap EZ MedExome,,25,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-009,2344 Cell Line,,Captured,XuCL-3,250.0,5.49,13, SeqCap EZ MedExome,,26,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-010,2345 Cell Line,,Captured,XuCL-3,250.0,5.11,13, SeqCap EZ MedExome,,27,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-011,2346 Cell Line,,Captured,XuCL-3,250.0,5.33,13, SeqCap EZ MedExome,,28,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-012,2347 Cell Line,,Captured,XuCL-3,250.0,5.69,13, SeqCap EZ MedExome,,29,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-013,2348 Cell Line,,Captured,XuCL-4,250.0,5.63,13, SeqCap EZ MedExome,,30,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-014,2349 Cell Line,,Captured,XuCL-4,250.0,7.60,13, SeqCap EZ MedExome,,31,1/7/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-015,2350 Cell Line,,Captured,XuCL-4,250.0,5.84,13, SeqCap EZ MedExome,,43,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-016,2351 Cell Line,,Captured,XuCL-4,250.0,5.91,13, SeqCap EZ MedExome,,44,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-017,2352 Cell Line,,Captured,XuCL-5,250.0,6.76,13, SeqCap EZ MedExome,,45,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-018,2353 Cell Line,,Captured,XuCL-5,250.0,6.14,13, SeqCap EZ MedExome,,46,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-019,2354 Cell Line,,Captured,XuCL-5,250.0,5.69,13, SeqCap EZ MedExome,,47,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-020,2355 Cell Line,,Captured,XuCL-5,250.0,5.79,13, SeqCap EZ MedExome,,48,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-021,2356 Cell Line,,Captured,XuCL-6,250.0,5.87,13, SeqCap EZ MedExome,,49,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-022,2357 Cell Line,,Captured,XuCL-6,250.0,5.72,13, SeqCap EZ MedExome,,50,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-023,2358 Cell Line,,Captured,XuCL-6,250.0,6.20,13, SeqCap EZ MedExome,,51,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-024,2359 Cell Line,,Captured,XuCL-6,250.0,5.76,13, SeqCap EZ MedExome,,52,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-025,2360 Cell Line,,Captured,XuCL-7,250.0,5.25,13, SeqCap EZ MedExome,,53,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-026,2361 Cell Line,,Captured,XuCL-7,250.0,5.30,13, SeqCap EZ MedExome,,54,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-027,2362 Cell Line,,Captured,XuCL-7,250.0,5.62,13, SeqCap EZ MedExome,,55,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-028,2363 Cell Line,,Captured,XuCL-7,250.0,5.73,13, SeqCap EZ MedExome,,56,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-029,2364 Cell Line,,Captured,XuCL-8,250.0,5.42,13, SeqCap EZ MedExome,,57,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-030,2365 Cell Line,,Captured,XuCL-8,250.0,5.41,13, SeqCap EZ MedExome,,58,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-031,2366 Cell Line,,Captured,XuCL-8,250.0,5.53,13, SeqCap EZ MedExome,,59,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-032,2367 Cell Line,,Captured,XuCL-8,250.0,5.73,13, SeqCap EZ MedExome,,60,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-033,2368 Cell Line,,Captured,XuCL-9,250.0,5.97,13, SeqCap EZ MedExome,,61,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-034,2369 Cell Line,,Captured,XuCL-9,250.0,5.91,13, SeqCap EZ MedExome,,62,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-035,2370 Cell Line,,Captured,XuCL-9,250.0,5.56,13, SeqCap EZ MedExome,,63,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-036,2371 Cell Line,,Captured,XuCL-9,250.0,5.73,13, SeqCap EZ MedExome,,64,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-037,2372 Cell Line,,Captured,XuCL-10,250.0,5.64,13, SeqCap EZ MedExome,,91,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-038,2373 Cell Line,,Captured,XuCL-10,250.0,5.38,13, SeqCap EZ MedExome,,92,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-039,2374 Cell Line,,Captured,XuCL-10,250.0,5.27,13, SeqCap EZ MedExome,,93,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-040,2375 Cell Line,,Captured,XuCL-10,250.0,6.19,13, SeqCap EZ MedExome,,94,1/10/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-041,2376 Cell Line,,Captured,XuCL-11,250.0,5.18,13, SeqCap EZ MedExome,,95,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-042,2377 Cell Line,,Captured,XuCL-11,250.0,5.47,13, SeqCap EZ MedExome,,96,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-043,2378 Cell Line,,Captured,XuCL-11,250.0,5.76,13, SeqCap EZ MedExome,,1,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-044,2379 Cell Line,,Captured,XuCL-11,250.0,5.40,13, SeqCap EZ MedExome,,2,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-045,2380 Cell Line,,Captured,XuCL-12,250.0,5.94,13, SeqCap EZ MedExome,,3,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-046,2381 Cell Line,,Captured,XuCL-12,250.0,5.63,13, SeqCap EZ MedExome,,4,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-047,2382 Cell Line,,Captured,XuCL-12,250.0,5.46,13, SeqCap EZ MedExome,,5,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-048,2383 Cell Line,,Captured,XuCL-12,250.0,5.75,13, SeqCap EZ MedExome,,6,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-049,2384 Cell Line,,Captured,XuCL-13,250.0,5.56,13, SeqCap EZ MedExome,,7,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-050,2385 Cell Line,,Captured,XuCL-13,250.0,7.65,13, SeqCap EZ MedExome,,8,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-051,2386 Cell Line,,Captured,XuCL-13,250.0,6.65,13, SeqCap EZ MedExome,,9,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-052,2387 Cell Line,,Captured,XuCL-13,250.0,6.13,13, SeqCap EZ MedExome,,10,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-053,2388 Cell Line,,Captured,XuCL-14,250.0,5.58,13, SeqCap EZ MedExome,,11,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-054,2389 Cell Line,,Captured,XuCL-14,250.0,5.62,13, SeqCap EZ MedExome,,12,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-055,2390 Cell Line,,Captured,XuCL-14,250.0,5.27,13, SeqCap EZ MedExome,,13,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-056,2391 Cell Line,,Captured,XuCL-14,250.0,6.72,13, SeqCap EZ MedExome,,14,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-057,2392 Cell Line,,Captured,XuCL-15,250.0,9.80,13, SeqCap EZ MedExome,,15,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-058,2393 Cell Line,,Captured,XuCL-15,250.0,10.20,13, SeqCap EZ MedExome,,16,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-059,2394 Cell Line,,Captured,XuCL-15,250.0,11.11,13, SeqCap EZ MedExome,,17,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-060,2395 Cell Line,,Captured,XuCL-15,250.0,12.95,13, SeqCap EZ MedExome,,81,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-061,2396 Cell Line,,Captured,XuCL-16,250.0,5.84,13, SeqCap EZ MedExome,,82,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-062,2397 Cell Line,,Captured,XuCL-16,250.0,6.44,13, SeqCap EZ MedExome,,88,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-063,2398 Cell Line,,Captured,XuCL-16,250.0,6.02,13, SeqCap EZ MedExome,,89,1/24/2019,,Mel,Melanoma Cell Line,BCB003
XuRLP-064,2399 Cell Line,,Captured,XuCL-16,250.0,7.46,13, SeqCap EZ MedExome,,90,1/24/2019,,Mel,Melanoma Cell Line,BCB003